Novel one-pot methods for the synthesis of heterocycles and functional aromatic compounds by Henry, Martyn Craig
 
 
 
 
 
 
 
 
Henry, Martyn Craig (2020) Novel one-pot methods for the synthesis of 
heterocycles and functional aromatic compounds. PhD thesis. 
 
http://theses.gla.ac.uk/81620/ 
 
Copyright and moral rights for this work are retained by the author  
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge  
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author  
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author  
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
Enlighten: Theses  
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
 
Novel One-Pot Methods for the 
Synthesis of Heterocycles and 
Functional Aromatic Compounds 
Martyn C. Henry, MChem 
A thesis submitted in part fulfilment of the requirements 
of the degree of Doctor of Philosophy 
 
 School of Chemistry 
College of Science & Engineering 
University of Glasgow 
July 2020  
 
2 
Abstract 
This PhD focused on the development of transition metal-catalysed one-pot 
processes for the rapid and selective formation of aryl C–N and C–O bonds from 
unactivated aryl C–H bonds. The key feature, common to all the processes, was the 
activation of aryl rings via a regioselective, iron triflimide-catalysed halogenation. 
After a brief description of a new iodination process in the first R&D section of this 
thesis, the second section details the development of a one-pot intermolecular aryl 
C–N bond forming process by copper-catalysed cross-coupling of in situ generated 
aryl iodides with unactivated N-nucleophiles. 
 
The third section describes the extension of this methodology for the synthesis of 
indolines and 2,3-dihydrobenzofurans by intramolecular cross-coupling with 
pendant N- or O-nucleophiles. In addition to the synthesis of small libraries of 
heterocycles, this one-pot process was used as the key reaction in the 8-step total 
synthesis of neolignan natural product, (+)-obtusafuran. 
 
The fourth and fifth sections detail the development of several one-pot processes 
for the synthesis of benzo[b]furans, benzoxazoles and benzothiazoles directly from 
the corresponding α-arylketones, N-arylbenzamides and N-arylthiobenzamides. 
Mechanistic insights as well as the synthesis of a range of biologically active 
heterocycles are presented. 
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1.0 Introduction 
1.1 Transition Metal-Catalysed Aromatic C–N Bond Formation 
Arene C–N bonds are prevalent in valuable natural products, pharmaceutical 
agents, biologically active compounds and organic materials, hence, a wide range 
of methods have been developed for the synthesis of this motif.1,2 In particular, 
transition metal catalysis has proved indispensable in this endeavor.3 There are 
three significant pathways through which this can occur: pre-functionalisation of aryl 
substrates then cross-coupling with N-nucleophiles; C–H activation then cross-
coupling with pre-functionalised amino sources; or direct C–H/N–H coupling of 
unactivated aromatic compounds and amines (Scheme 1). The latter approach, 
known as cross-dehydrogenative coupling, is a highly desirable and long sought 
reaction mode and is in the early stages of development with work currently ongoing 
to fully realise its potential.4–7 
 
Scheme 1: Transition metal-mediated C–N bond formation 
1.1.1 Pre-Functionalisation of the Arene Partner 
In the opening years of the 20th century, Ullmann and Goldberg discovered the 
reaction of aryl halides with amines or alcohols in the presence of copper which 
allowed regioselective C–N or C–O bond formation.8,9 Despite its potential, this 
reaction failed to gain wide applicability in the synthetic community due to the harsh 
reaction conditions, with the reaction temperature often exceeding 200 °C and 
requiring the use of stoichiometric copper reagents. This changed around the year 
2000, with reports from Ma,10,11 Goodbrand,12 Nicolaou,13 Liebkind14 and 
Buchwald15–18 demonstrating that bidentate, chelating copper ligands resulted in a 
substantial rate acceleration and allowed for this transformation to be carried out 
under comparatively mild conditions. These reports brought about a resurgence of 
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12 
interest in this copper-catalysed transformation and as a result, this reaction has 
since become the focus of intense research in a bid to widen the scope and utility.19–
21 This focus has allowed the development of a ‘copper-catalysis toolbox’ in which 
a vast array of protocols have been optimised using a range of copper sources and 
bidentate ligands, including N,N-, O,O- and N,O-chelators (Scheme 2).22 With 
careful selection of copper salt, bidentate ligand and base, this transformation can 
be used for a wide variety of aryl halide and amine coupling partners under relatively 
mild reaction conditions.23–25 
 
Scheme 2: Ullmann-Goldberg ‘copper-catalysis toolbox’ 
The Ullmann-Goldberg reaction has largely been superseded by the development 
of palladium-catalysed methods which have since become the primary method for 
the formation of aryl C–N bonds. Beginning in 1983, Migita disclosed a cross-
coupling reaction between aryl bromides and tin amides using palladium-catalysis.26 
The following year, Panek and Boger discovered a facile palladium-mediated 
intramolecular amination which allowed for the synthesis of a carboline ring system 
as a key step in their total synthesis of anti-tumour antibiotic, lavendamycin (1).27 
After attempts at the ring closure of 2 using an intramolecular SNAr reaction failed 
to give any product due to the non-coplanarity of the biaryl system, the use of 
tetrakis(triphenylphosphine)palladium(0) was investigated. Despite requiring an 
excess of the palladium complex, the C–N bond formation was efficient and allowed 
the formation of β-carboline 3 in 84% yield (Scheme 3). It was thought that the 
success of this transformation was the accessibility of a twisted 6-membered 
palladacycle from which reductive elimination could readily occur. 
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Scheme 3: Panek and Boger's palladium-mediated C–N bond formation 
The palladium-catalysed C–N bond forming reaction remained underexploited until 
the 1990s, when Buchwald and Hartwig independently offered mechanistic insights 
and improved the scope of Migita’s original work for the coupling of aryl halides and 
tin amides.28,29 Soon after this, both groups reported that this transformation could 
be undertaken using tin-free conditions, avoiding toxic reagents and non-trivial work-
up procedures, while allowing the coupling of unactivated alkyl amines, including 
secondary cyclic amines.30,31 The use of sterically hindered, large cone-angle 
phosphine ligands in combination with a suitable base and solvent was vital for this 
reaction. Since these initial studies, this methodology rapidly evolved into a general 
cross-coupling procedure with a wide scope and functional group tolerance, allowing 
the coupling of aryl halides with a wide variety of N-nucleophiles.32,33 For more 
difficult cross-coupling reactions, the reactivity can be easily improved by altering 
the phosphine ligands, affecting the σ-donation and π-back donation and hence, 
tuning the electronic and steric environment at the palladium metal centre. To date, 
there are multiple generations of phosphine ligands as well as a range of palladium 
complexes which offer this possibility.34,35 Limitations of this methodology endure 
however, with the requirement for strongly basic conditions, generally high reaction 
temperatures and the use of expensive and toxic palladium pre-catalysts.36 
Contemporaneous with the development of the Buchwald-Hartwig amination, a 
distinctive oxidative cross-coupling approach for aryl C–N formation was under 
investigation (Scheme 4). In the 1980s, the N-arylation of amine derivatives was 
studied involving the cross-coupling of nucleophilic arylbismuth or aryllead 
compounds with catalytic quantities of copper(II) acetate.37,38 These reactions used 
an inexpensive source of copper and proceeded at room temperature however, 
N
H2N
Br
N
HN MeMe
CO2MeMeO2C CO2MeMeO2C
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there was considerable toxicity associated with the metalated aryl reagents 
alongside their difficult preparation. For example, aryllead triacetate reagents are 
typically prepared by the reaction of lead tetraacetate with the desired aryl stannane 
in the presence of catalytic quantities of mercury trifluoroacetate.39 To address these 
issues, the copper-mediated Chan-Evans-Lam reaction was developed and first 
described in 1998.40–42 This method substitutes the aromatic bismuth or lead 
reagents for commercially available or readily accessible aryl boronic acids, uses 
mild reaction conditions under an atmosphere of air and allows the coupling with a 
wide range of N-nucleophiles such as anilines, amides, sulfonamides, ureas and 
alkyl amines. The Chan-Evans-Lam coupling has since become the focus of many 
mechanistic investigations and has found wide applicability in natural product 
synthesis and medicinal chemistry.43 
 
Scheme 4: Nucleophile-nucleophile cross-coupling for C–N bond formation 
1.1.2 Pre-Functionalisation of the Amino Source 
An alternative method involves the direct amination of aromatic C–H bonds with 
activated, electrophilic amino reagents. This approach allows selective activation of 
inert aromatic C–H bonds with transition-metals and then reaction of the in situ 
generated nucleophilic metalated intermediate with an electrophilic aminating 
reagent, resulting in C–N bond formation (Scheme 5). As well as insertion into C–H 
bonds, the transition-metal catalyst can oxidatively cleave the polarised N–X bonds 
of the electrophilic amines hence, no external oxidants are required in this process. 
A wide variety of novel aminating agents have been reported including 
hydroxylamines,44,45 chloroamines,46–50 substituted oximes,51 N-methoxyamides,52 
1,4,2-dioxazol-5-ones,53 anthranils54 and hypervalent amidobenziodoxolones55 
each with individually optimised catalytic conditions. In addition, the use of N-
fluorobenzenesulfonamide (NFSI) has gained attention as an efficient amidating 
agent in a wide range of palladium-catalysed cross-coupling protocols.56–58  
X
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Scheme 5: C–H amination with activated aminating agents 
In a distinct process, transition metals and electrophilic hydroxylamines have been 
used for the direct preparation of anilines, presumably via radical-mediated 
pathways.59 For example, the Morandi group developed a practical synthesis of 
anilines using iron(II)-catalysis while Sanford and co-workers reported a room 
temperature, titanium(III)-mediated aryl-C–H amination with hydroxylamine 
hydrochloride as the inexpensive amine source (Scheme 6).60,61 These protocols 
are operationally simple and use inexpensive, stable reagents under mild conditions 
however, ortho/para-selectivity was often poor with unsymmetrical aromatic 
substrates. For example, the reaction of anisole with hydroxylamine hydrochloride 
under Sanford’s conditions resulted in a 1:2.2 mixture of ortho- to para-regiosiomers 
in 76% yield as well as some di-aminated product (<20% yield). Similar iron-
promoted redox processes have been reported by Ritter62 and Jiao63 for the 
synthesis of anilines by C–H amination of unactivated aryl compounds. 
 
Scheme 6: Morandi and Sanford’s aniline synthesis by C–H amination 
1.2 Direct C–H/N–H Cross-Dehydrogenative Coupling 
Aryl C–N bond formation by direct C–H/N–H cross-dehydrogenative coupling 
(Scheme 7) represents the most step- and atom economical route as there is no 
requirement for pre-activation of either coupling partner, avoiding tedious starting 
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material synthesis and stoichiometric waste such as halide-salts. These advantages 
notwithstanding, several challenges need to be overcome before this method is 
generally applicable to the same extent as the Ullmann-Goldberg, Buchwald-
Hartwig and Chan-Evans-Lam cross-coupling reactions. Primarily, formation of a C–
N bond with formal loss of H2 is a thermodynamically unfavourable process as the 
strong C–H and N–H bonds of the reactants are converted into weaker bonds. As a 
consequence, a sacrificial oxidant is almost always required as an appropriate 
external driving force. The high activation barrier associated with this transformation 
can also be reduced by careful selection of transition metal and ligand combinations 
while ensuring the compatibility of the oxidative conditions with the chosen catalytic 
system. Furthermore, the highly nucleophilic unactivated amines and amides, 
present in excess, bind strongly to transition metal centres and often results in 
catalyst deactivation. With highly active primary amine nucleophiles, regioselectivity 
is a non-trivial issue and requires the use of auxiliary directing groups, particularly 
with intermolecular cross-couplings. 
 
Scheme 7: C–N bond formation by cross-dehydrogenative coupling 
1.2.1 Intermolecular ortho-C–N Bond Formation with Copper Catalysis 
The first known examples of transition metal-mediated intermolecular cross-
dehydrogenative amidation with unactivated N-nucleophiles were reported by Yu 
and Chatani in 2006.64,65 In both processes, a 2-pyridyl group was used as a 
directing group to facilitate the copper-mediated cleavage of the inert ortho-C–H 
bond of 4 which then permitted cross-coupling with aniline to give 5 (Scheme 8). Yu 
evoked a radical-mediated C–H activation mechanism, with single electron transfer 
from the coordinated copper(II)-metal centre to the arene ring.64 Due to the difficult 
nature of this transformation, stoichiometric quantities of the copper(II) species were 
required as well as a very high reaction temperature. 
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Scheme 8: Copper-promoted intermolecular ortho-C–H amidation of 2-phenylpyridine 
These early observations encouraged intense research in the field of cross-
dehydrogenative amination and led to the development of catalytic protocols for the 
ortho-C–H amination of 2-arylpyridines with unactivated amines and amides.66–71 
For example, Shen and co-workers reported a copper-catalysed cross-
dehydrogenative coupling of 2-arylpyridines with phthalimide as the aminating 
source and with molecular oxygen as a terminal oxidant (Scheme 9).68 This method 
used only 10 mol% of copper acetate however, the reactions required high 
temperature (150 °C) and extended reaction times of up to 72 h. The authors 
proposed that this amidation procedure represented an efficient access to 
arylamines, as phthalimide acts as an ammonia surrogate and can be converted to 
the primary aniline derivative by reaction with hydrazine using the Gabriel reaction. 
 
Scheme 9: Copper-catalysed ortho-C–H amidation with phthalimide 
Similarly, John and Nicholas found that this C–H amination/amidation process was 
efficient using copper(II) acetate (20 mol%) and oxygen for the coupling of 2-
phenylpyridine with a range of N-nucleophiles including sulfonamides, benzamides 
and electron-deficient anilines.67 The exact mechanism of copper(II)-catalysed aryl 
C–N bond formation is still not established however, a plausible catalytic cycle has 
been proposed (Scheme 10).67 The first step involves coordination of copper(II) 
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acetate to the 2-pyridine nitrogen atom of 4 followed by C–H activation, either by 
single-electron transfer or electrophilic aromatic substitution, to give organocopper 
intermediate 5. Ligand exchange of the acetate with the N-nucleophile results in the 
formation of complex 6 which is followed by protonation and one-electron oxidation 
to give a copper(III) intermediate 7. Reductive elimination of 7 then gives ortho-
amidated 2-phenylpyridine compound 8 with simultaneous release of copper(I) 
acetate, which then undergoes aerobic oxidation to regenerate the active catalyst. 
 
Scheme 10: Proposed mechanism for the intermolecular C–H amidation of 2-
phenylpyridines 
With the 2-pyridine directing group, these copper-catalysed C–H amination 
reactions required strong oxidants, high temperatures and long reaction times. 
Furthermore, the 2-pyridine functionality is intrinsic to the compound and cannot be 
removed, further limiting the synthetic utility of these protocols. To address these 
issues, new removeable auxiliary directing groups, derived from simple carboxylic 
acid and aniline compounds were developed.72 In 2013, Daugulis and co-workers 
demonstrated that 8-aminoquinoline was an effective bidentate chelator and 
permitted the selective activation and amination of inert ortho-C–H bonds.73 This 
procedure used a copper and silver catalytic system with N-methylmorpholine N-
oxide (NMO) as an oxidant and allowed the coupling of 9 with morpholine which 
gave 10 in 87% yield (Scheme 11). This procedure tolerated a wide range of cyclic 
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and acyclic secondary amines under relatively mild conditions. No explicit 
mechanistic studies were undertaken however, similar to other copper-catalysed 
cross-coupling procedures, this reaction was thought to proceed via an aryl-
copper(III) intermediate.74 The group were then able to expand the scope of this 
process to include electron-rich primary amines and electronically neutral anilines 
with a lower reaction temperature (80 °C), albeit with the requirement for one 
equivalent of copper(II) acetate. This new protocol was efficient in the absence of 
the silver co-catalyst and with tetrabutylammonium iodide as the oxidant.75 A 
modified system using copper carbonate hydroxide and tetramethylguanidine as a 
base allowed the cross-coupling of a range of N-heterocycles including pyrazole, 
carbazole and 7-azaindole. 
 
Scheme 11: 8-Aminoquinoline directed, intermolecular C–H amination of benzamides 
The 8-aminoquinoline auxiliary has since found wide utility in a variety of cross 
dehydrogenative coupling reactions.76–78 For example, Jana and co-workers were 
able to use this directing group and expand the scope of the transformation to 
include electron-rich anilines under basic conditions, although two equivalents of 
copper(II) acetate were required.77 In most cases, the presence of even a trace 
amount of molecular oxygen was found to be detrimental to the reaction therefore, 
a mixture of silver(I) acetate and tetrabutylammonium bromide were found to be the 
optimal oxidising agents. In their study, the coupling of 8-aminoquinoline protected 
benzoic acid 11 with 2,3-dimethylaniline, gave coupled product 12 in 62% yield. 
Alkaline hydrolysis of 12 gave mefenamic acid (13), a non-steroidal anti-
inflammatory drug (Scheme 12). 
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Scheme 12: Synthesis of mefenamic acid (13) by copper-mediated C–H amination 
The Bolm group has recently undertaken several studies into the cross-
dehydrogenative coupling of unreactive C–H bonds and N-sulfoximines.69,79 More 
specifically, the group developed a one-pot, two-step process for the synthesis of 
free anilines which used an 8-aminoquinoline auxiliary to direct copper(II) acetate-
catalysed cross-dehydrogenative coupling of dibenzothiophene sulfoximine as an 
ammonia surrogate (Scheme 13).78 This process was efficient for a range of 
substituted benzamides however, some limitations were noted. With a 4-bromo 
analogue, reductive dehalogenation was found to be a significant side-reaction, 
while with a 3-methyl substituted benzamide, a mixture of regioisomers was 
obtained. Without isolation of the N-arylated sulfoximines, radical mediated S=N 
bond cleavage was achieved using a mixture of tris(trimethylsilyl)silane and AIBN in 
toluene at 100 °C which gave the parent aniline and completed the one-pot process. 
This methodology does provide selective access to 2-aminobenzamides however, 
is limited due to atom inefficiency and the requirement of extended reaction times 
(up to six days in some cases). 
 
Scheme 13: ortho-C–H Amination with dibenzothiophene sulfoximine as an ammonia 
surrogate 
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Arrayas and Rodrigues reported that picolinamide protected aniline derivatives are 
good substrates for intermolecular copper-catalysed amination.80 With 
(diacetoxyiodo)benzene as an oxidant and a reaction temperature of 80 °C, this 
cross dehydrogenative coupling was efficient for a range of cyclic, secondary 
amines. A few months after this report, Chen and co-workers disclosed the same 
picolinamide directed, oxidative C–H amination process.81 With PhI(OAc)2 as an 
oxidant and in the presence of magnesium chloride, this reaction proceeded at room 
temperature, was complete in 4 h and generally gave a wide-range of ortho-
aminated aromatic compounds in excellent yields. The facile nature of this 
transformation was ascribed to the binding of the imidate O-atom to copper, 
facilitating C–H amination through the formation of a stable 6-membered O-ligated 
metallacycle (Scheme 14). Although this organometallic pathway was hypothesised, 
the authors could not rule out a single electron transfer mechanism as the addition 
of TEMPO was shown to inhibit the reactions. Due to the electron-deficient pyridine 
ring, the picolinic acid auxiliary was easily removed under basic conditions and gave 
the ortho-aminated aniline in 95% yield. 
 
Scheme 14: Copper-catalysed ortho-C–H amination of picolinamide protected anilines 
Yu and Dai exploited the well-known strong coordinating ability of oxazoline to 
copper(II) catalysts82 and developed an amide tethered oxazoline directing group 
for the direct cross-dehydrogenative coupling of aryl-C–H bonds and N-
nucleophiles.83–85 This protocol used stoichiometric or excess quantities of 
copper(II) acetate and allowed the efficient coupling of oxazoline-substituted N-
arylbenzamides and heteroaryl substrates with a wide range of sulfonamides, 
benzamides and electron-deficient anilines (Scheme 15).83 The scope of this 
process has recently been expanded to include a wide range of N-heterocycles 
including imidazole, pyrazole, pyridine, purine as well as azaindoles.84 
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Scheme 15: Oxazoline directed, copper-catalysed C–N bond formation 
The Yu group then applied this C–H amination and amidation methodology for the 
late-stage functionalisation of telmisartan (14), an angiotensin II receptor antagonist, 
used in the treatment of high-blood pressure and heart failure (Scheme 16).85 The 
oxazoline auxiliary was installed using a simple amide coupling reaction between 
the carboxylic acid functional group and 2-(4,5-dihydrooxazol-2-yl)aniline using 
HATU. This was followed by directed activation of the ortho-C–H bond with 
copper(II) acetate which permitted cross-coupling with 2-nitroaniline and gave 15 in 
89% yield. 
 
Scheme 16: Late-stage functionalisation of telmisartan (14) 
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Subsequent studies within the Yu and Dai groups investigated the use of weakly 
coordinating amide auxiliaries with the assistance of a monodentate oxazoline 
ligand for cross dehydrogenative coupling reactions (Scheme 17).86 They proposed 
that while strongly chelating auxiliaries are efficient for C–H activation, they often 
form 5- or 6-membered cyclometalated intermediates which are thermodynamically 
stable and hence, less reactive in the subsequent functionalisation step.87 This limits 
the scope and utility of such a process. A drastic reduction of the electron density of 
the benzamide auxiliary necessarily decreases the ability of the amide nitrogen to 
donate electrons to the vacant d-orbitals of the metal centre. It is then reasoned that 
this decreased electron donation will lead to a less stable metallacycle, thereby 
kinetically assisting the amination step. In this context, the very electron deficient 
2,3,5,6-tetrafluoro-4-trifluoromethyl)phenyl-substituted amide was used as a 
directing group in this copper-mediated, oxazoline accelerated C–H amination 
procedure (Scheme 17). This worked with electron-rich, unprotected cyclic 
secondary amines and gave the desired coupled products in moderate yields. 
 
Scheme 17: Intermolecular ortho-C–H amination with weakly coordinating directing group 
In 2017, Chang and co-workers developed an elegant copper-mediated, oxazoline-
directed C−H amination with aqueous ammonia as the amino source.88 The use of 
ammonia as an amino source for the direct cross-coupling amination of unreactive 
C–H bonds remains a significant challenge in synthetic chemistry.89,90 Firstly, 
transition metal-catalysed activation of N–H bonds of ammonia is a difficult, 
energetically demanding process with a bond dissociation energy of 107 kcal/mol. 
Secondly, ammonia is an excellent ligand for transition metals, binding almost 
exclusively via the σ-donation of the nitrogen lone pair, resulting in rapid formation 
of a metal-amido ‘Werner’ complex, inevitably leading to inhibition of the catalytic 
turnover in the desired amination reaction.91 
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Critical to the success of Chang’s method was the use of a soft, d10 copper(I)-
complex which avoided the strong coordination of ammonia and minimised catalyst 
deactivation. After initial coordination of copper(I) to the bidentate, oxazoline 
auxiliary of 16, oxidation is assumed to occur to give a copper(II) intermediate 
(Scheme 18). Activation of the ortho-C–H bond then occurs, presumably by acetate-
assisted deprotonative cupration to afford a cyclometalated copper(II) intermediate 
which then undergoes ligand exchange with ammonia and gives intermediate 17. 
Interestingly, DFT calculations revealed that deprotonation of ammonia from 
copper(II) intermediate 17 was thermodynamically not feasible however, it was 
found that 17 can disproportionate and produce a lower energy copper(III) 
intermediate. The hard Lewis acidic nature of copper(III) complex 18 increases the 
strength of the metal-ligand interactions and lowers the energy of 18 relative to 
copper(II) intermediate 17. As a consequence, the acidity of the amine ligand 
drastically increases, with the energy barrier for deprotonation of metal-amino 
complex 18 being reduced by 13 pKa units. After deprotonation of metal-amino 
complex 18, facile reductive elimination from 19 then gives aniline 20 in 70% yield. 
 
Scheme 18: Copper-catalysed ortho-C–H amination with aqueous ammonia 
This methodology was used for the late-stage amination of pharmaceutically 
relevant compounds, including oxazoline-substituted bexarotene (21) (Scheme 19). 
Treatment of 21 with excess aqueous ammonia, copper(I) acetate, sodium acetate 
and NMO allowed the selective installation of an amino group and gave 22 in 45% 
yield. Alkaline hydrolysis of the oxazoline auxiliary gave the amino derivative of 
bexarotene (23) in 85% yield. 
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Scheme 19: Late-stage functionalisation of bexarotene (21) 
1.2.2 Intermolecular ortho-C–N Bond Formation with Other Transition Metals 
In addition to copper-catalysis, other inexpensive and abundant first-row transition 
metals in conjunction with bidentate, chelating auxiliaries have been successfully 
used for cross-dehydrogenative coupling reactions.92–95 For example, Liu and 
Zhang reported an 8-aminoquinoline directed, nickel-catalysed ortho-C–H 
amination of benzamides with cyclic and acyclic secondary amines.92 Elevated 
reaction temperatures (140 °C) were necessary for high yields of the coupled 
products, while primary aliphatic amines and anilines were incompatible with the 
oxidising conditions of this protocol. Very recently, Tan and co-workers directly 
employed ammonia gas in a nickel-mediated cross dehydrogenative amination, also 
directed by an 8-aminoquinoline auxiliary (Scheme 20).93 This method required a 
stoichiometric quantity of nickel(II) chloride in combination with tetrabutylammonium 
acetate (TBBA) to allow conversion to the aminated benzamide products and avoid 
the poisoning of the nickel species. Despite the harsh reaction conditions (140 °C), 
the functional ortho-amino adducts were isolated in moderate to high yields. While 
silver trifluoroacetate was not required for an efficient transformation, higher yields 
were obtained when two equivalents of this additive were used. 
Me
Me
Me
Me
Me
N
H
O
N O
NH4OH (13.5 equiv.)
CuOAc (25 mol%)
NaOAc (2 equiv.)
NMO (3 equiv.), DMSO
100 °C, 12 h, 45%
Me
Me
Me
Me
Me
N
H
O
N O
KOH, EtOH
80 °C, 12 h, 85%
NH2
Me
Me
Me
Me
Me
CO2H
NH2
23
21 22
 
26 
 
Scheme 20: Nickel-promoted ortho-C–H amination with ammonia 
A plausible mechanism for this transformation was proposed in this study (Scheme 
21). The nickel(II) salt reacts with 24 to give an 8-aminoquinoline-coordinated 
intermediate, which then undergoes base-assisted cleavage of the ortho-C–H bond 
to give nickel(II) intermediate 25. Nickel(III) intermediate 26 is formed by oxidation 
of 25, presumably by a nickel-mediated disproportionation pathway and perhaps 
promoted by the presence of the silver(I) salt. After reaction of intermediate 26 with 
gaseous ammonia, deprotonation of the bound amino complex gives nickel(III) 
intermediate 27. Reductive elimination then provides 2-aminobenzamide 28. 
 
Scheme 21: Nickel(II)-mediated amination mechanism 
New methods have been developed for the selective dehdrogenative C–H/N–H 
coupling with cobalt-catalysis.94,95 Specifically, cobalt(II) catalysis has been 
exploited for the amination of 2-benzamidopyridine N-oxides with secondary alkyl 
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amines in a simple reaction protocol (Scheme 22).94 A bidentate N,O-chelating 
group in combination with silver nitrate as an oxidant were found to be the most 
efficient combination, resulting in the formation of a range of C–N coupled products 
in high yields and at a relatively low reaction temperature (85 °C). Similar to copper-
catalysed methods, catalyst deactivation of the cobalt catalyst was observed when 
acyclic secondary amines were used in this procedure. The functional group 
tolerance was demonstrated as cyclic secondary amines bearing an unprotected 
secondary alcohol and a cyclic ketal were efficient substrates in this cross-coupling. 
The use of ferrocene as an oxidant and with the 8-aminoquinoline directing group 
subsequently allowed the expansion of this methodology to include aniline N-
nucleophiles for the dual C–H/N–H cross-coupling, which allowed the synthesis of 
highly substituted triarylamines.95 
 
Scheme 22: Cobalt(II)-catalysed cross-dehydrogenative coupling 
Similar auxiliary directed, cobalt-catalysed cross-dehydrogenative coupling 
reactions have been reported in which electrochemistry is utilised in the modulation 
of the transition metal oxidation state, thus removing the requirement for external 
oxidants.96–100 These procedures tolerate a wide range of benzamides and 
secondary cyclic amines and operate under mild conditions with green solvents, 
driven by the evolution of hydrogen gas. 
Second and third row transition metals such as palladium,101–103 silver,104 
ruthenium,105,106 rhodium107–110 and iridium111,112 have also been successful in 
enabling directed ortho-C–H/N–H cross-dehydrogenative coupling reactions. More 
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specifically, d6 Ru(II), Rh(III) and Ir(III) complexes are known to facilitate a wide 
range of C–H activation reactions due to their ability to form metalacycles under mild 
conditions.113,114 First reported by Bergman in 1982,115 half-sandwich 
pentamethylcyclopentadiene (Cp*) rhodium and iridium complexes have shown 
remarkable activity towards the activation of inert C(sp3)–H and C(sp2)–H bonds.116–
119 This exceptional C–H bond activation does come with a cost however, as the 
subsequent amination step is more difficult due to the inherent stability of these 
rhoda- and iridacyclic complexes. This necessitates the careful selection of 
oxidants, additives and reaction conditions to effect this transformation. In this 
regard, Su and co-workers developed a rhodium(III)-catalysed ortho-C–H amidation 
with sulfonamides and amides which operated under relatively mild conditions 
compared with previously developed copper-promoted methods (Scheme 23).107 It 
was proposed that the mildness of this protocol was due to the facile activation of 
the inert ortho-C–H bond via the formation of half-sandwich rhodacycle 29. 
Oxidation of this rhodium(III) intermediate results in the formation of very electron-
deficient rhodium(V) nitrenoid intermediate 30 which readily undergoes rapid 
reductive elimination to form the C–N bond followed by protonolysis to release the 
desired coupled products. As well as 2-pyridine, a range of auxiliaries were 
screened and the easily installable oxazoline functionality was shown to be the most 
efficient directing group. 
 
Scheme 23: Rhodium(III)-catalysed intermolecular ortho-C–H amidation; aReaction 
performed at 100 °C 
Harrity and co-workers later expanded the scope of this oxazoline directed, 
rhodium(III)-catalysed ortho-C–H amidation of a wide range of aromatic compounds 
R
NH2R2 (1 equiv.)
[Cp*RhCl2]2 (2.5 mol%)
AgSbF6 (10 mol%)
PhI(OAc)2 (1.5 equiv.)
CH2Cl2, 60 °C, 24 h
DG
R
NHR2
DG
N
NHTsF3C NHTs
N
O
NHTs
N
O
O2N
N
NHCOCF3
90% 84% 92%81%
RhIII
NH2TsN
Me
Me Me
Me
Me
R
R RhVN
Me
Me Me
Me
Me
R
R
NTs
N
NHSO2Bn
65%a
29 30
 
29 
including π-deficient pyridines.108,109 In addition, the ortho-amidated products 
synthesised by this method were hydrolysed and cyclised with formamidine acetate, 
providing an efficient route towards functionalised 4-aminoquinazolines and 
quinazolinones. This was demonstrated with the total synthesis of erlotinib (36), a 
tyrosine kinase inhibitor used in the treatment of pancreatic and lung cancers 
(Scheme 24).108 The synthesis began by the installation of the oxazoline auxiliary 
directing group which was easily achieved in four-steps from benzoic acid 31. After 
conversion of 31 to the corresponding amide by coupling of the acyl chloride with 2-
aminoethanol, tosylation of the alcohol then effected cyclisation of the amide under 
basic conditions. The rhodium(III)-catalysed cross-dehydrogenative coupling with 
trifluoroacetamide was then performed on 32 with only 2.5 mol% catalyst loading 
under very mild conditions (40 °C for 16 h) and gave coupled product 33 in 86% 
yield. Alkaline hydrolysis of trifluoromethylamide adduct 33 gave the crude aniline, 
which then underwent reaction with formamidine acetate and gave 4-
aminoquinazoline 34 in 82% yield. Following this, 34 was converted to the 
corresponding quinazolinone 35 in 71% yield under acidic conditions. Introduction 
of a chlorine atom at the 4-position by reaction with phosphoryl chloride was 
followed by nucleophilic aromatic substitution with 3-ethynylaniline, which 
completed the total synthesis of erlotinib (36) in 25% yield over ten-steps. 
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Scheme 24: Total synthesis of erlotinib (36) 
Around the same time as these rhodium(III)-catalysed amination reports, Chang and 
co-workers developed a room temperature, iridium-catalysed oxidative C–H 
amination reaction with unactivated, electron-deficient anilines in the presence of a 
silver(I) salt (Scheme 25).111 The authors proposed that the use of a bulky N-
adamantyl group, would favour carbonyl O-coordination and facilitate the activation 
of the ortho-C–H bond via a stable, half sandwich iridacycle 37, analogous to the 
rhodium(III)-catalysed mechanism. Pentamethylcyclopentadienyl iridium(III) acetate 
(10 mol%), silver triflimide and copper acetate were found to be the optimal 
combination to allow the selective ortho-amination to proceed with a wide-range of 
electron-deficient anilines in high yields. The desired amination reaction did not 
occur in the absence of the silver(I) salt but instead resulted in the quantitative 
formation of cationic iridacycle adduct 37, an analogue of which was isolated and 
characterised by X-ray crystallography. In addition, with this catalytic system, 
electron-rich or N-substituted anilines exhibited very poor reactivity. With these 
observations, it was proposed that the reaction proceeds through a high-valent 
iridium(V) nitrenoid intermediate, accessible through several silver(I)-promoted 
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proton-coupled electron transfers. This then undergoes nitrenoid insertion followed 
by proto-demetalation to deliver the C–N coupled products. 
 
Scheme 25: Iridium(III)-catalysed intermolecular ortho-C–H amination 
With the success of the iridium-catalysed cross-coupling of benzamides and 
unactivated anilines, the procedure was then extended to include more challenging 
alkyl amine nucleophiles by careful tuning and optimisation of the catalytic 
system.112 The use of a 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) and 1,2-
dichloroethane solvent combination was critical to prevent catalyst deactivation, 
presumably my mitigation of the nucleophilicity of the alkyl amine due to hydrogen 
bonding with the solvent.120 
1.2.3 meta- and para-C–N Bond Formation 
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reaction for an overall meta-functionalised product.124 This palladium(II)-catalysed 
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amination procedure required an N-adamantyl substituted 3-amino-2-
hydroxypyridine ligand, a pendant pyridine directing group, a modified norbornene 
derivative and a silver salt for maximum efficiency. For example, treatment of 38 
with this intricate combination of reagents gave meta-coupled product 39 in 63% 
yield (Scheme 26). The Boc protecting group and pyridine auxiliary could then be 
removed by reaction of 39 with HBr which gave aniline 40, a key intermediate in the 
synthesis of a BRAF inhibitor, in 83% yield. The high yields of meta-coupled 
products and broad reaction scope notwithstanding, this method does require an 
electrophilic nitrogen source and suffers from poor atom economy due to necessity 
of an N-protecting group, a chelating auxiliary and norbornene as a transient 
mediator. 
 
Scheme 26: meta-Directed, palladium-catalysed C–H amination with activated amines 
To tackle some of these issues and improve this work, Falck and co-workers 
developed a more practical meta-selective amination procedure (Scheme 27).125 
Although still requiring an electrophilic source of nitrogen, this method used an earth 
abundant, inexpensive iron catalyst in conjunction with a simpler, weakly basic 
pyridyl directing group. The iron(III) chloride-catalysed reaction of picolinate 
protected benzyl alcohol 41 with hydroxylamine-O-sulfonic acid (HOSA) in the 
presence of triethylamine and HFIP gave meta-substituted aniline 42 in 72% yield 
at room temperature. The authors reasoned that the selectivity originates from the 
formation of 5-membered iron nitrenoid intermediate 43 which then undergoes 
intramolecular electrophilic aromatic substitution. 
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Scheme 27: Iron-catalysed meta-C–H amination 
Similarly, the use of cross-dehydrogenative coupling for selective para-amination 
remains underdeveloped. Over the past decade there have been significant efforts 
into the development of extended template directing groups which enable the 
selective transition metal-catalysed functionalisation of the para-C–H bond 
however, these have yet to be extended to more challenging amination 
reactions.126,127 Hartwig and co-workers reported a direct palladium-catalysed 
intermolecular aryl-C–H/N–H coupling reaction of phthalimides which gave para-
products.128 Arene substrates with either blocked ortho-positions or bulky iPr or tBu 
groups were required but this still resulted in equal mixtures of meta- and para-N-
aryl phthalimides. The regioselectivity of this method was partially improved by the 
DeBoef group who developed an electrophilic aromatic metalation procedure using 
gold(I)-catalysis.129 By activating N-nucleophiles in situ through treatment with 
PhI(OAc)2, the iodane derived phthalimide can then react with a gold(III) arene 
intermediate, to give the C–N coupled products by reductive elimination. A major 
limitation to both these procedures is the requirement of these reactions to be 
performed in neat arene which inevitably limits the substrate scope to relatively 
simple aromatic compounds. Very recently, a para-selective C–H amidation reaction 
by the copper-catalysed dimerisation of anilide substrates via a radical addition 
mechanism was reported.130 
A more general approach was described by Suna and co-workers who showed that 
electron-rich aromatic compounds can first be activated by reaction with hypervalent 
iodonium reagents (Scheme 28).131,132 The corresponding unsymmetrical diaryl λ3-
iodane species were then coupled with a range of unactivated amines in a copper-
catalysed one-pot process. Various aromatic compounds were coupled with primary 
amines, secondary cyclic amines, electron-deficient anilines and N-heterocycles in 
excellent yields, under very mild reaction conditions. In the first step, the use of a 
sterically encumbered 2,4,6-triisopropylphenyl (TIPP) substituted iodonium reagent 
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as well as strong, alkoxy electronic directing groups were responsible for the 
observed para-selectivity of the electron aromatic substitution. The versatility of this 
method was demonstrated with the synthesis of gram-negative antibiotic linezolid 
(44) by cross-coupling with morpholine. 
 
Scheme 28: para-C–H Amination via hypervalent iodine intermediates; a With one equivalent 
of Cu(MeCN)4BF4 
1.3 Intermolecular C–H/N–H Cross-Dehydrogenative Coupling of Acidic C–H 
Bonds 
Another significant approach to dehydrogenative aromatic C–N bond formation is 
the activation and coupling of electron-deficient (hetero)arenes with unactivated N-
nucleophiles. The first reports of this type of cross-dehydrogenative amination 
reaction came from simultaneous publications from the groups of Mori and 
Schreiber in 2009, which showed the feasibility of the coupling of the C-2 position 
of azoles with amines and amides (Scheme 29).133,134  
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Scheme 29: Intermolecular amination of acidic C–H bonds 
The exact mechanistic details of this copper-catalysed oxidative C–H 
amination/amidation process remain uncertain however, both groups have 
proposed a mechanism to account for the observed reactivity (Scheme 30). The first 
step involves the base-promoted formation of organocopper intermediate 45. Ligand 
exchange with the N-nucleophile would give intermediate 46 which is then followed 
by reductive elimination to generate the C–N coupled heterocycle. Molecular oxygen 
is then responsible for the regeneration of the active copper(II) catalyst, completing 
the catalytic cycle. 
 
Scheme 30: Proposed catalytic cycle for the copper-catalysed amination of azoles 
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Successive investigations provided significantly improved reaction conditions of this 
copper-catalysed cross-dehydrogenative coupling which allowed for a broader 
scope of heterocycle and (hetero)arene substrates as well as N-nucleophiles.135–139 
For example, Bolm and Miura reported the cross-coupling of oxadiazoles, 
benzoxazoles and benzothiazoles with N-sulfoximines, while Shi and co-workers 
used copper(II) chloride complexes for the direct amination of benzoxazoles with 
primary amines, with both methods operating under ambient temperatures.135,136 
This was further elaborated by Miura and co-workers who showed that a range of 
ortho-alkynylanilines can undergo oxidative C–H/N–H cross-coupling with 
oxadiazoles and other functional azoles, which was followed by benzannulation to 
form N-azoylindoles in a high yielding one-pot process (Scheme 31).137 The 
copper(II) catalyst serves a dual purpose, first by catalysing the cross-coupling of 
the acidic C–H bond of azoles with anilines, then acting as a π-acid for activation of 
the alkyne functional group of 47, enabling 5-endo-dig cyclisation which gave 48 in 
90% yield. 
 
Scheme 31: Miura's domino sequence for the synthesis of N-azolylindoles 
In addition to the acidic C–H bonds of azole analogues, other acidic aromatic C–H 
bonds have been employed in these cross-coupling reactions. Su and co-workers 
demonstrated that polyfluoroarenes were sufficiently electron-poor to undergo 
cross-coupling with electron-deficient aniline substrates in a copper-catalysed, 
TEMPO mediated reaction for the synthesis of biarylamines.140 Moreover, this 
copper-catalysed functionalisation of acidic C–H bonds has been applied to the 
selective C-2 amination and amidation reactions of quinoline N-oxides.79,141,142 With 
selectfluor as an oxidant, the direct C-2 amination of quinolines with N-heterocycles 
was achieved without having to first synthesise the N-oxide derivative.143 
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As well as these copper-catalysed methods, other first-row transition metals such 
as cobalt,144 manganese144,145 and nickel146 have been used for cross-
dehydrogenative coupling reactions. The Chang group has developed a 
mechanistically distinct process, assisted with a Brønsted acid, for the C-2 
amination of benzoxazoles with aliphatic amines (Scheme 32).144 This procedure 
used low catalyst loadings of cobalt(II) acetate (2 mol%) and tolerated cyclic and 
acyclic secondary amines under mild conditions however, no coupled products were 
obtained when primary amines were used. When the cobalt(II) catalyst was 
exchanged with manganese(II) acetate (10 mol%) and with an elevated reaction 
temperature (70 °C), primary amines were coupled with benzoxazoles, with even 
aqueous ammonia being tolerated as a nucleophile, albeit in 25% yield. 
 
Scheme 32: Cobalt or manganese-catalysed amination of benzoxazoles 
During the course of these studies, a significant by-product was ring-opened 
amidine species 52. In addition, with a deuterium label at the C-2 position, no kinetic 
isotope effect was detected, which implies that the cleavage of the acidic C–H bond 
is not involved in the rate-determining step. On the basis of these observations, a 
plausible mechanism of this transformation was suggested (Scheme 33). The 
Brønsted acid additive initially protonates benzoxazole 49 to produce the 
substantially more electrophilic oxazolium salt 50, which is then susceptible to 
nucleophilic attack by the unactivated amine. The resulting oxazolidine adduct 51 is 
in equilibrium with ring-opened amidine species 52, which is favoured with primary 
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amines and ammonia. The cobalt or manganese metal catalyst, in combination with 
aqueous tert-butyl hydroperoxide solution (TBHP), facilitates the rearomatisation of 
adduct 51 via two single electron transfer steps, generating 2-aminobenzoxazolidine 
species 53. 
 
Scheme 33: Proposed mechanism for the C–H amination of benzoxazoles 
1.4 Intramolecular C–H/N–H Cross-Dehydrogenative Coupling 
In 2005, Buchwald and co-workers reported the first known intramolecular oxidative 
cross-dehydrogenative coupling process for the synthesis of N-acylcarbazoles 
(Scheme 34).147 In this process, coordination of palladium acetate to the amide 
nitrogen facilitated the activation of the ortho-C–H bond and allowed the formation 
of an intermediate 6-membered palladacycle, from which reductive elimination then 
provided the carbazole products in excellent yields while releasing Pd(0).148 The 
Pd(0) species was then re-oxidised to Pd(II) by stoichiometric quantities of copper(II) 
acetate in the presence of molecular oxygen, in a similar manner to the Wacker 
process. 
 
Scheme 34: Buchwald's synthesis of N-acylcarbazoles 
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Inspired by Buchwald’s novel intramolecular cross-dehydrogenative amination 
procedure, the Shi group used sequential palladium(II)-catalysed C–H activation 
reactions to construct both the biaryl system and the N-acylcarbazole ring.149 This 
methodology was then used for the preparation of natural product 4-
deoxycarbazomycin B, without the requirement of pre-activated starting materials 
(Scheme 35). 
 
Scheme 35: The use of C–H functionalisation reactions for the synthesis of 4-
deoxycarbazomycin B 
Following Buchwald’s seminal study, the use of other oxidants such as oxone150 or 
hypervalent iodine species (PhI(OAc)2)151 have been shown to expedite the C–N 
reductive elimination step. This occurs by oxidation of the Pd(II) intermediate to a 
high-valent Pd(IV)-palladacycle, allowing this transformation to take place at room 
temperature. Oxidation of Pd(II) intermediates to high oxidation state Pd(IV)-
complexes followed by reductive elimination has emerged as a significant paradigm 
in catalysis and has been implicated in a wide range of C–H functionalisation 
reactions.152–155 In addition to palladium catalysis, the Chang group reported that 
this oxidative carbazole synthesis can be catalysed using copper while Miura and 
co-workers developed an iridium(III)/copper(I)-catalytic system for the cyclisation of 
2-aminobiphenyls.156,157  
This general approach for intramolecular C–H/N–H using palladium- or copper-
catalysis has been applied to the preparation of a wide range of benzannulated 
heterocycles, such as benzimidazoles,158 pyrido[1,2-a]benzimidazoles,159 2-
oxindoles,160 2-quinolinones161 and 3-arylindazoles.162 For instance, Yu and co-
workers used a range of N-methoxy- or N-benzyloxyamides as substrates in a 
palladium(II)-catalysed C–H lactamisation reaction for the synthesis of 2-oxindoles 
and 3,4-dihydroquinolinones in a high yielding process (Scheme 36).160 Excess 
quantities of copper(II) chloride and silver acetate were required for re-oxidation of 
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the palladium catalyst. Despite the harsh reaction conditions, cyclised product 55 
was isolated in 95% yield from N-benzyloxyamide 54. Reductive cleavage of the N–
O bond of 55 using samarium iodide provided parent ɣ-lactam 56 in 92% yield. 
 
Scheme 36: Palladium(II)-catalysed synthesis of 2-oxoindoles 
In 2008, the Yu group developed a tandem-catalytic process for the synthesis of 
indolines and tetrahydroisoquinolines from arylethylamines utilising a Pd(II)-
catalysed C–H activation reaction.163 In this distinct process, palladium(II) acetate 
and iodoacetate, formed in situ by the reaction of (diacetoxyiodo)benzene and 
iodine, are used for the activation and iodination of aromatic C–H bonds. This is 
followed by intramolecular amination with copper(I) iodide providing indolines in a 
compatible one-pot process. As well as requiring a high temperature (130 °C) and 
an extended reaction time (96 h), this reaction suffered from poor regioselectivity. 
The use of N-triflimide protected phenylethylamine 57 in this one-pot process, 
resulted in the formation of mono- and di-iodinated compounds during the first step, 
both of which underwent subsequent N-heterocyclisation and gave 58 and 59 in 
20% and 35% yield, respectively (Scheme 37). This lack of selectivity was 
circumvented either by using a stoichiometric amount of copper iodide to accelerate 
the amination reaction of the mono-iodinated precursor, or by blocking the position 
ortho- to the aminoethyl side-chain. 
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Scheme 37: Yu's synthesis of indolines via intramolecular C–H amination; aReaction 
performed using 1 equiv. CuI; bReaction performed using 0.5 equiv. CuI. 
The Yu group improved this methodology by the development of a procedure for 
direct, oxidative intramolecular C–H amination for the synthesis of indolines from 
phenylethylamines (Scheme 38).164 This new approach avoided the requirement of 
incorporation of the oxidant into the products. Similar to previous methods, the first 
step involved the coordination of the triflimide nitrogen of 60 to palladium, facilitating 
the C–H insertion reaction and delivering a 6-membered palladium(II) intermediate. 
Next, oxidation of this intermediate to yield a Pd(IV) intermediate from which facile 
C–N reductive elimination could occur, gave indoline product 61. A wide range of 
oxidants were screened however, in most cases this resulted in no formation of the 
indoline and often led to undesired reductive elimination from the palladium(IV) 
intermediate, forming acetoxylated or halogenated by-products in significant yields 
(40–50%). There was some success when using the one-electron oxidant, 
cerium(IV) sulfate, and a small library of indolines were produced in moderate to 
good yields however, it was proposed that the presence of sulfate ions was 
impeding the reaction by forming unreactive palladium sulfate as the reaction 
progressed. To avoid these unwanted reductive elimination events, an established 
F+ oxidant, 1-fluoro-2,4,6-trimethylpyridinium triflate,165,166 was used instead. It was 
proposed that the strength of the Pd–F bond prevented undesired reductive 
elimination and encouraged the Pd(IV) complex to eliminate along the desired 
pathway, forming the C–N bond. The use of DMF in stoichiometric quantities or 
excess was found to be essential, possibly due to its role as a labile ligand in this 
process. 
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Scheme 38: Role of oxidants in palladium-catalysed N-heterocyclisation 
The use of chelating groups to assist transition metal-catalysed C–H activation has 
allowed this transformation to proceed with milder conditions and lower catalyst 
loadings. For example, the groups of Chen and Daugulis independently reported the 
use of picolinamide (PA) as an auxiliary to direct palladium-catalysed activation of 
aryl-C–H bonds and intramolecular cross-coupling with tethered N-nucleophiles 
(Scheme 39).167,168 Under these conditions, picolinamide protected 
phenylethyamine 62 was converted to indoline 63 in 90% yield. 
 
Scheme 39: Picolinamide-assisted intramolecular C–H amination 
Similar to previous methods, this transformation likely proceeds through a 
Pd(II)/Pd(IV) catalytic cycle (Scheme 40). The first step involves the coordination of 
palladium to the amide and pyridine functionality of N-phenylethylpicolinamide (62), 
giving intermediate 64. The close proximity of the coordinatively unsaturated 
palladium(II) centre to the ortho-C–H bond results in an agostic interaction and 
subsequent insertion, and provides Pd(II) intermediate 65. Oxidation of Pd(II) 
intermediate 65 with an excess of (diacetoxyiodo)benzene gives palladium(IV) 
intermediate 66, which can then undergo selective reductive elimination to form the 
new C–N bond and indoline product 63. 
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Scheme 40: Proposed mechanism for the chelation-controlled N-heterocyclisation 
The mild nature of this picolinamide directed intramolecular C–H amination was 
exemplified by Chen and co-workers.169 This reaction was found to proceed at 60 
°C with catalyst loadings as low as 0.5 mol% and tolerated a wide range of sensitive 
and labile functionality, such as aryl C–I bonds. The methodology was used for the 
cyclisation of phenylethylamine 67 which gave indoline 68, a key intermediate in the 
total synthesis of natural product and glycosidic food dye, betanin (Scheme 41). 
 
Scheme 41: Key step in the formal synthesis of betanin 
This picolinamide directed, palladium-catalysed C−H functionalisation approach has 
been applied to the more demanding synthesis of benzazetidines by the Chen 
group.170 Treatment of picolinamide protected benzylamine 69 with palladium 
acetate and excess (diacetoxyiodo)benzene resulted in thermodynamically 
favoured ortho-acetoxylation and gave C–H oxygenated product 73 in 67% yield 
(Scheme 42). It is believed that the mechanism proceeds as a result of C–OAc 
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reductive elimination from putative Pd(IV) intermediate 70, which computational 
studies have shown typically occurs through a five-membered transition state with 
the new C–O bond formed from the carbonyl oxygen.171,172 Interestingly, in this 
reaction, benzazetidine 72 was formed in 19% yield, despite the significant ring 
strain. To optimise this reaction for benzazetidine formation, the group used a novel 
oxidising agent, phenyliodonium dimethyl malonate (PhI[DMM]), which was 
proposed to facilitate the thermodynamically unfavorable C–N bond formation. By 
tethering the carboxylate ligands with a rigid linker, the conformation of the high-
valent palladium intermediates were constrained, which would suppress C–O 
reductive elimination, while encouraging the kinetically controlled formation of the 
strained 4-membered ring. This theory was confirmed as using PhI(DMM), C–N 
reductive elimination from Pd(III) was found to be the major reaction pathway and 
gave benzazetidine 72 in 72% yield, while ortho-C–H acetoxylation product 73 was 
isolated in only 9% yield. In this case, DFT calculations suggested bimetallic 
Pd(III)/Pd(III) intermediate 71 with bridging dimethyl malonate as a catalytic resting 
state before reductive elimination. Palladium(III) species have been previously 
implicated in C–H activation reactions however, it is usually unclear whether 
disproportionation to Pd(II) and Pd(IV) occurs during the catalytic cycle.172–174 This 
strategy to minimise C–OAc reductive elimination from highly strained palladium 
species was highly effective for the synthesis of a range of benzazetidines. In 
addition, the group observed that with ortho-arylbenzylamine substrates, the 
formation of 4-membered cyclisation products was favoured over 
thermodynamically stable six-membered rings. 
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Scheme 42: Benzazetidine synthesis with a novel oxidant 
Since these initial reports involving the use of picolinamide auxiliaries, a variety of 
N-directing groups have been used for palladium-catalysed intramolecular C–N 
bond forming reactions.175–178 These chelating groups include 2-pyridinesulfonyl,175 
1-benzyl-1,2,3-triazole-4-carboxylate,176 oxalyl amides177 and N-
methoxyiminoacyl,178 which have all been employed in this oxidative transformation 
and gave the corresponding indolines in excellent yields (Scheme 43). 
 
Scheme 43: Auxiliaries as directing groups for the synthesis of indolines; a1-fluoro-2,4,6-
trimethylpyridinium tetrafluoroborate used as an oxidant 
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A modified directing group featuring a glycine dimethylamide (GDMA) motif allowed 
Zhao and co-workers to perform multiple C–H activation reactions in a palladium-
catalysed cascade process.179 This one-pot methodology comprises sequential 
intermolecular β-C(sp3)–H arylation and C(sp2)–H amidation reactions for the 
synthesis of a range of 2-quinolinones from various GDMA-protected 2-
phthalimidopropanoic acid derivatives and aryl iodides. Upon completion of the first 
step, the palladium catalyst was re-utilised in the intramolecular cross-
dehydrogenative coupling step, with the addition of the hypervalent iodine reagent 
which facilitated oxidation to Pd(IV) and subsequent reductive elimination. This gave 
a series of 3-phthalimido-2-quinolinones in good yields, with no oligomerisation by 
arylation of the amide observed. The chemoselectivity was demonstrated when 2-
bromoiodobenzene was applied in the one-pot process, as the reactive C–Br is 
unaffected throughout the palladium-catalysed arylation and amidation steps 
(Scheme 44). 
 
Scheme 44: Palladium-catalysed cascade process for the synthesis of 2-quinolinone 
heterocycles 
1.5 Conclusions 
Of the principle methods of C–N bond formation, C–H/N–H cross-dehydrogenative 
coupling reactions offer the most promise in terms of efficiency and atom economy 
(Scheme 45). The majority of these intermolecular transformations used copper-
catalysis in combination with an auxiliary directing group as well as an external 
oxidant for selective ortho-C–N bond formation. With careful tuning of catalytic 
conditions and using other transition metals such as nickel, cobalt, ruthenium, 
rhodium and iridium, milder conditions and a broader scope of N-nucleophile could 
be achieved. In contrast, very few methods exist for para-selective C–N bond 
formation while there are no methods for meta-directed transition metal-catalysed 
C–H/N–H cross-coupling reactions to date. In addition, acidic C–H bonds of arenes 
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and (hetero)arenes are more reactive in these transition metal-catalysed processes 
and can readily undergo intermolecular cross-coupling with unactivated amines and 
amides. Since these reports of intermolecular cross-dehydrogenative coupling 
reactions, there has been a surge in methods for related intramolecular amination 
for the synthesis of a wide variety of functional N-heterocycles such as carbazoles, 
indolines, benzazetidines and quinolinones. 
 
Scheme 45: C–H/N–H cross-dehydrogenative coupling 
The advantages of this dehydrogenative, transition metal-catalysed C–H amination 
approach are apparent, with no requirement for substrate pre-functionalisation 
which results in a high atom economy and a large reservoir of potential aromatic 
hydrocarbon staring materials. The high atom economy notwithstanding, several 
challenges remain before this method is made more practical and widely applicable. 
These include the need to further expand the scope of the N-nucleophile while 
ensuring compatibility with the transition metal catalyst, the use of environmentally 
benign oxidants in the process and the removal of the requirement for auxiliary 
directing groups in order to control the regioselectivity. Further to this, the amination 
of more distal meta- and para-positions is yet to be achieved with unactivated amine 
nucleophiles. 
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2.0 Results and Discussion 
2.1 Regioselective Iodination of Arenes via Lewis Acid-Catalysed Activation 
of N-Iodosuccinimide 
2.1.1 Introduction 
Aryl halides and (hetero)aryl halides are very important synthetic intermediates in 
organic chemistry, used in a vast range of synthetic transformations, not least the 
construction of C–C, C–N, C–O and C–S bonds via transition metal-catalysed cross-
coupling reactions.180,181 They also find great utility in the formation of 
organometallic reagents and as precursors for nucleophilic aromatic substitution 
reactions.182 In these processes, the much weaker C–X bonds of aryl iodides and 
bromides find more utility compared to aryl chlorides and fluorides. In addition to 
their synthetic importance, the use of halogenated arenes are indispensable in the 
field of medical imaging and in the understanding of diseases associated with 
neurology and oncology, through the use of aryl compounds containing radioactive 
halogen isotopes.183 
Halogenation of aryl C–H bonds is most frequently performed via electrophilic 
aromatic substitution with an electrophilic halogen source. A traditional method 
involves the use of elemental bromine or iodine however, this approach usually 
suffer from poor regiocontrol, often resulting in the formation of poly-halogenated 
aromatic compounds.184–186 Alternatively, aryl halogenation reactions are frequently 
carried out using corrosive reagents such as thionyl halides, hydrogen bromide or 
iodine monochloride under harsh conditions.187–189 Wang and co-workers reported 
an example of this process, that allowed regioselective bromination of anilides using 
hydrogen bromide, selectfluor and water as a solvent.190 Another approach for aryl 
iodination involved the combination of iodide salts such as sodium iodide or 
ammonium iodide and oxidants such as hydrogen peroxide, sodium chlorite and 
hypervalent iodine(III) or iodine(V) reagents.191–196 Despite the mild reaction 
conditions, the use of a strong oxidant may be incompatible with more complex 
aromatic substrates bearing sensitive functional groups. 
 
49 
N-Halosuccinimides (NXS, X = Cl, Br, I) have recently gained attention as very 
useful halogen sources due to their stability and ease of handling. These are 
significantly less reactive than other halogen sources and usually are only applicable 
to electron-rich arenes using forcing reaction conditions. For this reason, attention 
has turned to developing strategies to increase the reactivity of N-halosuccinimides 
by activation using Brønsted or Lewis acid catalysis (Scheme 46). For example, the 
iodination of arenes has been achieved using N-iodosuccimimide (NIS) in harsh 
acidic media such as TFA,197,198 triflic acid199 and recently using HFIP as a 
solvent.200 In addition, the use of the boron trifluoride diethyl etherate adduct allowed 
for the iodination of electron deficient arenes, albeit with a mixture of 
regioisomers.201 Transition metals have found great utility in activation of NXS, 
through co-ordination of the carbonyl functionality.202,203 Indium(III),204 
zirconium(IV)205 and gold(I)206 complexes have all been used for the development 
of efficient aromatic halogenation procdures. 
  
Scheme 46: Brønsted/Lewis acid-catalysed activation of NXS 
In a distinct process, Wang and co-workers developed a gold(III) chloride-catalysed 
bromination procedure using N-bromosuccinimide (Scheme 47).207 As well as Lewis 
acid activation of NBS, this process involved the simultaneous activation of the 
arene component, via direct metalation to form an organometallic arylgold(III) 
species, allowing for rapid bromination. It was then demonstrated that this Au(III)-
catalysed bromination could be used in combination with the Miyaura borylation 
reaction, the Suzuki-Miyaura and the Sonogashira cross-coupling reactions, in a 
one-pot process. In addition, copper(0)-catalysed C–N bond formation was possible 
using the succinimide by-product generated during the halogenation step. 
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Scheme 47: Gold(III)-catalysed halogenation 
Further to this, a number of C–H activation strategies have emerged for the 
halogenation of arenes using palladium(II),208 rhodium(III),209 ruthenium(0),210 
cobalt(III)211 and copper(II)212 catalysis. While these methods are highly efficient, 
allowing the synthesis of aryl bromides and iodides in excellent yield, they require 
the use of appropriate auxiliary directing groups and hence, are only effective for 
ortho-halogenation in most cases. In contrast, Miura and co-workers have used 
Lewis base catalysis for direct electrophilic aromatic halogenation using N-
halosuccinimides (Scheme 48).213 The nucleophilic sulfur atom of the triptycenyl 
substituted sulfide (Trip-SMe) catalyst interacts with the NXS halogenating reagent 
to generate a halonium complex as a hexafluoroantimony salt. This highly 
electrophilic halogen atom is then able to undergo electrophilic aromatic substitution 
with various aryl systems, including BINOL and strychnine. 
 
Scheme 48: Lewis base-catalysed halogenation 
Other Lewis base catalysts have been reported for the halogenation of aromatic 
rings including disulfides,214,215 thioureas216 and anilines,217 which all proceed via 
the formation of reactive halonium cation-Lewis base complexes or by formation of 
halo-amines. 
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2.1.2 Previous Work in the Sutherland Group 
Previous work in the Sutherland group focused on the development of methodology 
for the mild iodination of arenes in the context of developing of novel SPECT tracers 
for radionuclide imaging of neurological conditions and cancer. In this regard, the 
group developed a nickel-catalysed Finkelstein reaction for the synthesis of aryl 
iodides from less reactive aryl bromides and used this in the preparation of a SPECT 
tracer for the imaging of human nicotinic acetylcholine receptors.218,219 Further to 
this, procedures have been developed for the synthesis of aryl iodides by the 
substitution of (pseudo)halides such as boronates.220,221 In addition, the group 
developed methodology which allowed the synthesis of stable diazonium salts from 
readily available anilines using a polymer-supported nitrite reagent which could 
undergo Sandmeyer-type reactions using [125I]iodide for the preparation of 
radiolabelled aryl iodides.222,223  
In 2015, the group develop a new protocol for the Lewis acid activation of NIS for 
rapid and regioselective aryl iodination by electrophlic aromatic substitution.224 An 
activity screen of a range of transition metal Lewis acid catalysts for the iodination 
of anisole using NIS revealed that FeCl3 was highly effective, leading to 100% 
conversion after 1.5 h. While this was an effective catalyst for electron rich arenes, 
less activated aromatic compounds required significantly higher catalytic loadings 
of FeCl3, in some cases up to 1 equivalent. From this limited substrate scope, it 
became apparent that a more active form of Fe(III) was required. Metal triflimides 
had been shown to be powerful Lewis acids due to the highly delocalised, weakly 
coordinating nature of the triflimide counterion and on that basis, it was proposed 
that iron(III) triflimide would be a more effective Lewis acid catalyst for the activation 
of N-iodosuccinimide.225,226 It was also shown that iron(III) triflimide could be made 
by the simple dissolution of FeCl3 in the readily available and inexpensive ionic 
liquid, 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide 
([BMIM]NTf2).227 Using the combination of FeCl3 (5 mol%) and [BMIM]NTf2 as a 
reaction solvent, led to a marked increase in rate when applied to electron deficient 
arenes. This process was then used with a wide range of electron rich aromatic 
compounds, also bearing deactivating groups, resulting in the formation of a library 
of aryl iodides in high yields (Scheme 49). 
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Scheme 49: Iron(III) triflimide-catalysed iodination substrate scope 
This iron(III) triflimide-catalysed procedure was used in the synthesis of 
pharmaceutically relevant compounds such as PIMBA (74), for imaging of breast 
cancer tumours (Figure 1).228 Other targets synthesised were (–)-IBZM (75), a 
SPECT imaging agent and a dopamine D2 receptor antagonist,229 and 8-
iodoharmaline (76), a monoamine oxidase inhibitor.230 It should be noted that NIS 
is incompatible with highly nucleophilic substrates therefore, the basic nitrogen 
atoms in these compounds were first protected as tetrafluoroborate salts before 
being subjected to electrophilic aromatic substitution under these conditions. 
 
Figure 1: Utility of iron(III) triflimide-catalysed iodination 
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It was shown that the use of a highly charged, hard iron(III) Lewis acid led to the 
formation of bis-iodinated products when using particularly active aromatic 
compounds such as phenols. To overcome this limitation, a complementary 
procedure was developed using a softer silver(I) triflimide catalyst to tune the 
activation of NIS and supress over-iodination.231 This methodology was extended 
for the radioiodination of active arenes using radiolabelled NIS, generated by the 
reaction of [125I]iodide with N-chlorosuccinimide. In an extension of this method, the 
iron(III) triflimide was effective for the activation of NCS for the chlorination of 
activated arenes (Scheme 50).232 In general, higher temperatures and longer 
reaction times were required which was expected due to the stronger N–Cl bond of 
NCS. 
 
Scheme 50: Iron(III) triflimide-catalysed chlorination of arenes 
The Sutherland group is currently involved in the development of PET imaging 
agents that can act as antagonists of sphingosine-1-phosphate 5 (S1P5) in the 
human brain and could be used in understanding the demylelination process, 
associated with neurological conditions such as multiple sclerosis. A group from 
Novartis reported a series of benzamide compounds which proved to be potent and 
selective S1P5 receptor antagonists.233 Building on this work, a previous PhD 
student, Tim Morgan, identified two lead compounds 77 and 78 as potential PET 
radiotracers for the imaging of S1P5, based on their binding affinity and selectivity 
for S1P5 as determined by their physiochemical properties (Figure 2). 
 
Figure 2: Lead S1P5 receptor antagonists 
Cl
R
FeCl3 (2.5 mol%)
[BMIM]NTf2 (7.5 mol%)
60 °C, 12–48 h
53–97%
R
N OO
Cl
Me
OMe
CONH2
NH
Me Me
F
OMe
CONH2
NH
Me Me
F
77 78
 
54 
To synthesise potential precursors for the radiofluorination of benzamide 79 to give 
a potential PET radiotracer for S1P5 imaging, a reactive iodine functional group had 
to be selectively installed to allow further transformations. Previous attempts to 
synthesise iodinated benzamide 80 with NIS and FeCl3 (5 mol%) using excess 
quantities of [BMIM]NTf2 resulted in poor selectivity, with the formation of a mixture 
of mono- and di-iodinated compounds, 80 and 81 (Scheme 51).234 As a 
consequence of competing iodination at the C-5 position of the benzamide ring, 
mono-iodinated compound 80 was isolated in only 5% yield. 
 
Scheme 51: Previous attempted iodination of benzamide 79 
2.1.3 Project Aims 
The first aim of this PhD was to build upon previous work in the group and 
investigate the iron(III)-catalysed electrophilic aromatic iodination of electron-rich 
arenes with NIS as the halogenating reagent and using [BMIM]NTf2 in catalytic 
quantities instead of as a reaction solvent (Scheme 52). It was proposed that, using 
FeCl3 (2.5 mol%) and [BMIM]NTf2 (7.5 mol%), would allow for the formation of the 
highly Lewis acidic Fe(NTf2)3 catalyst which would facilitate the activation of NIS via 
coordination to the carbonyl oxygen. Another goal of this project was to use this 
regioselective iodination procedure to synthesise a potential precursor for the 
development of a PET radiotracer for the imaging of the S1P5. 
 
Scheme 52: Iron(III)-triflimide-catalysed iodination of activated arenes 
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2.1.4 Iron(III)-Catalysed Iodination of Arenes 
The project began by using a combination of FeCl3 (2.5 mol%) and [BMIM]NTf2 (7.5 
mol%) for the generation of iron(III) triflimide and subsequent activation of NIS 
(Scheme 53). The triflimide counterion is weakly coordinating as a consequence of 
the highly delocalised nature of the negative charge which results in an 
enhancement of the Lewis acidity of the iron(III) species, due to the increased 
positive charge density on the metal cation. Applying this catalytic system to anisole 
using toluene as a solvent resulted in full conversion to 4-iodoanisole (82a) in 4 h, 
with no formation of the ortho-regioisomer. This process was then applied to other 
electron-rich aromatic compounds such as phenol, acetanilide and 2,3-
dihydrobenzofuran giving the corresponding aryl iodides 82b–82d in 79–92% yield. 
ortho-Iodination of 4-nitroaniline gave aryl iodide 82e in 74% yield. 
 
Scheme 53: Aromatic iodination using catalytic quantities of [BMIM]NTf2 
2.1.5 Application to the Synthesis of an S1P5 Imaging Agent  
To synthesise a potential precursor, to generate [18F]-fluorinated benzamide 84, 
selective electrophilic aromatic iodination of 79 could afford iodinated compound 80, 
directed into the para-position of the upper 2,6-dimethyl substituted aniline ring 
(Scheme 54). It was proposed that the aryl ring bearing the amide functionality 
would be sufficiently deactivated as to minimise iodination at the C-5 position, para 
to the methoxy group. In addition to this, the benzamide ring is sterically shielded 
by the 2,6-dimethyl substituted aniline substituents, limiting access of the large 
iodine atom. Aryl iodide 80 could then be subjected to palladium-catalysed 
stannylation reaction to form aryl stannane 83. Fluoro-destannylation with 
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[18F]fluoride would then give compound 84, a potential PET radiotracer for S1P5 
imaging. 
 
Scheme 54: Proposed route towards fluorine-18 precursor 84 
As previous attempts to synthesise iodinated benzamide 80 using FeCl3 (5 mol%) 
and [BMIM]NTf2 (2 equiv.) led to a mixture of mono- and di-iodinated products, it 
was proposed that the use of the larger, less charged silver(I) Lewis acid catalyst 
would improve these selectivity issues, disfavouring iodination of the sterically 
congested benzamide ring. The initial reaction of 79 and NIS using AgNTf2 in 
dichloromethane resulted in only 40% conversion to mono- and di-iodinated 
products after 22 h under reflux (Table 1, entry 1). Only the di-iodinated compound 
could be separated by flash column chromatography leaving an inseparable mixture 
of desired product 80 and starting material 79 in a 2:1 ratio. Changing the solvent to 
toluene allowed for the reaction to be performed at higher temperature (70 °C). The 
higher reaction temperature allowed the energy barrier associated with the 
formation of the Wheland intermediate to be overcome which led to 70% conversion 
after 2 h. The conversion to 80 did not improve upon heating under reflux for a 
subsequent 20 h and a ratio of 3:1 of 80 to 79 was obtained (entry 2). To push the 
reaction to completion while minimising di-iodination, 1.2 equivalents of NIS were 
added initially, followed by 0.3 equivalents after 4 h (entry 3). This reaction was 
performed at a slightly higher temperature (80 °C) over 20 h and led to 86% 
conversion of the starting material. After separating the di-iodinated material, this 
gave a 6:1 mixture of 80 and 79. Further increasing the equivalents of NIS (2.5 
equiv. in total), added to the reaction mixture in portions over 20 h, led to no change 
in the ratio of 80:79 (entry 4). It was clear that adding more than 2.0 equivalents of 
NIS was not resulting in an improved conversion of benzamide 79, due to 
decomposition of NIS at 80 °C and an increased formation of the di-iodinated 
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compound. In addition, extended reaction times (>20 h) were unnecessary and were 
likely only leading to degradation of iodinated product 80. 
Table 1: Optimisation of the iodination reaction 
 
Entry Solvent NIS 
(equiv.) 
Temperature 
(°C) 
Time (h) Ratio of 
80:79a 
1 CH2Cl2 1.0 40 22 2:1 
2 toluene 1.0 70 22 3:1 
3 toluene 1.5 80 20 6:1 
4 toluene 2.5 80 20 6:1 
aDetermined using 1H NMR spectroscopy 
The reaction of benzamide 79 with NIS and AgNTf2 in toluene at 70 °C allowed for 
85% conversion of the starting material after 7 h (Scheme 55). After separating the 
di-iodinated compound by flash column chromatography, starting material 79 was 
separated by recrystallisation, giving aryl iodide 80 in 31% yield. Next, a palladium-
catalysed stannylation of aryl iodide 80 using hexamethylditin in the presence of 
lithium chloride was performed to give aryl stannane 83 in 65% yield. Compound 83 
was unstable when exposed to silica gel due to protodestannylation therefore flash 
column chromatography was performed with neutral alumina. 
 
Scheme 55: Synthesis of [18F]-fluorinated benzamide precursor 83 
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2.1.6 Conclusions and Outlook 
An efficient and highly regioselective procedure for the iodination of activated arenes 
was developed which avoided the use of [BMIM]NTf2 as the reaction solvent 
(Scheme 56). The combination of FeCl3 (2.5 mol%) and [BMIM]NTf2 (7.5 mol%) 
allowed the generation of the highly Lewis acidic iron(III) triflimide species in situ 
which was an effective catalyst for the activation of NIS and resulted in the selective 
iodination of aromatic compounds such as anisole, phenol and acetanilide. The use 
of [BMIM]NTf2 as a reagent in catalytic quantities, as opposed to as a reaction 
solvent, would ensure that this iodination procedure was compatible with further 
transformations during the development of one-pot processes. Despite the 
effectiveness of iron(III) triflimide as a Lewis acid catalyst for the activation of NIS, 
the use of silver(I) triflimide was required for the iodination of benzamide derivative 
79. This is due to the lower charge density of the silver(I) ion, compared to the highly 
charged iron(III) ion, which resulted in better overall selectivity by suppressing di-
iodination. Palladium-catalysed stannylation of this iodinated benzamide gave aryl 
stannane 83 which is a precursor for [18F]-fluorinated benzamide 84, a potential PET 
radiotracer for S1P5 imaging. 
 
Scheme 56: Iron(III) triflimide-catalysed iodination of arenes 
With the development of an efficient iodination procedure using NIS, it was 
envisioned that iron(III) triflimide could be utilised as a powerful Lewis acid for the 
activation of other electrophiles. For example, it is proposed that using iron(III) 
triflimide in conjunction with N-(arylthio)succinimides would lead to the formation of 
an electrophilic source of sulfur and allow for the synthesis of aryl thioethers 
(Scheme 57). Such a process could then be used for the synthesis of biologically 
active compounds. Currently, this transformation can only be achieved using harsh 
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conditions such as the reaction of electron-rich arenes and thiosuccinimides using 
TFA or TfOH as Lewis acid catalysts.235,236 
 
Scheme 57: Proposed synthesis of thioethers 
In 2020, Katayev and co-workers reported the use of bench-stable nitrosuccinimide 
and nitrosaccarin reagents for ipso-nitration of aryl boronic acids under mild 
conditions.237 These nitrating reagents could be employed in the iron(III)-catalysed 
electrophilic aromatic substitution reaction for the selective formation of aryl C–N 
bonds (Scheme 58). After preparation of the nitrosuccinimide reagent using 
literature conditions,238 activation using iron(III) triflimide could allow the 
regioselective nitration of aryl C–H bonds under mild conditions. This method would 
not require pre-functionalised starting materials and would avoid the use of 
corrosive, concentrated acids. 
 
Scheme 58: Proposed aryl C–H nitration reaction 
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2.2 One-pot Intermolecular Amination of Aryl C–H Bonds  
2.2.1 Previous Work in the Sutherland Group 
In 2017, the group published methodology that allowed the selective amination of 
para-C–H bonds of electron-rich aromatic compounds.239 This method used 
regioselective, iron(III) triflimide-catalysed bromination to activate aryl rings followed 
by ligand assisted, copper(I)-catalysed cross-coupling with N-nucleophiles in a one-
pot process. As part of the optimisation of this process using anisole, it was found 
that while the use of the ionic liquid, [BMIM]NTf2, as a solvent allowed for full 
conversion to the brominated intermediate, no amination was observed in the 
second step (Scheme 59). To overcome this incompatibility, a catalytic protocol was 
developed using iron(III) chloride (2.5 mol%) and [BMIM]NTf2 (7.5 mol%) in toluene. 
This allowed for complete conversion to the brominated intermediate under mild 
conditions (40 °C, 4 h) and 45% conversion was then observed to the C–N coupled 
product in the Cu(I)-catalysed second step. It was found that the addition of water 
during the Ullmann coupling step allowed for dissolution of the inorganic base and 
facilitated better mixing of the reagents which led to near quantitative conversion to 
coupled product 85 and an isolated yield of 78%. 
 
Scheme 59: One-pot, para-directed coupling of anisole and indole 
The process was then applied to the coupling of aromatic substrates, bearing 
activating and deactivating groups, with a range of N-nucleophiles giving a small 
library of para-aminated products (Scheme 60). This process was efficient for the 
coupling of functional anisole, aniline, acetanilide and phenol compounds with N-
heterocyclic nucleophiles such as pyrazole, imidazole and 2-pyrrolidinone as well 
as benzamides and sulfonamides. 
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Scheme 60: One-pot, two-step para-C–H amination of arenes 
During this previous study, a limitation of the one-pot process was demonstrated 
with the ortho-bromination/N-arylation of 4-nitroaniline (86), which yielded a 2:1 
mixture of the coupled product 87 and 4-nitroaniline starting material (Scheme 61). 
Analysis of the 1H NMR spectrum of the bromination reaction mixture showed full 
conversion under more forcing conditions (70 °C) after 5 h. However, it was 
proposed that the slower ortho-amination process resulted in a competing reaction 
pathway involving protodecupration which led to the regeneration of the starting 
material from the brominated intermediate. 
 
Scheme 61: Previous attempted ortho-amination of 4-nitroaniline (86) 
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2.2.2 Project Aims 
The first key objective of this project was to develop a one-pot, two-step process 
using the previously described iron(III) triflimide-catalysed iodination procedure 
(chapter 2.1) to activate aryl rings, followed by copper-catalysed cross-coupling with 
N-nucleophiles (Scheme 62). It was proposed that using aryl iodide intermediates 
in the one-pot process would allow for a more efficient cross-coupling reaction, 
owing to the lower bond dissociation energy of the carbon-iodine bond compared to 
the carbon-bromine bond. Another aim of this project was the application of this one-
pot iodination/copper-catalysed cross-coupling process for efficient ortho-C–H 
amination when the para-position is blocked. This would build on previous work in 
the group and involve optimisation of the one-pot process to minimise 
protodecupration during the C–N bond forming step. 
 
Scheme 62: Proposed one-pot para-iodination/amination process 
2.2.3 One-Pot para-Amination of Aryl C–H Bonds 
The initial aim of this project was to use NIS for arene activation, then utilise the 
reactive C–I bond in a copper(I)-catalysed amination/amidation for the selective 
functionalisation of para-C–H bonds. The model substrates chosen to investigate 
this coupling were anisole and pyrazole, which gave the best results in the previous 
bromination protocol. Lewis acid activation of NIS using iron(III) triflimide in toluene, 
followed by addition of anisole resulted in full conversion to the iodinated 
intermediate in 4 h at 40 °C, with only the para-regioisomer observed (Scheme 63). 
In the same pot, copper-catalysed cross-coupling with pyrazole in the presence of 
an ancillary ligand gave coupled product 88a in 94% yield after 20 h. 
H
DG FeCl3 (2.5 mol%) [BMIM]NTf2 (7.5 mol%)
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Scheme 63: para-Directed coupling of anisole and pyrazole 
Encouraged by this result, the scope of the intermolecular copper(I)-catalysed 
cross-coupling reaction using aryl iodide intermediates was explored (Scheme 64). 
Using pyrazole as the nucleophile, the scope of the arene coupling partner was first 
investigated. Anisole, acetanilide and phenol derivatives were found to undergo 
regioselective iodination and subsequent amination, giving coupled products 88a–
88e in 51–94% yield. In the case of 2-fluorophenol, the low yield of 88e can be 
attributed to the formation of the homo-coupled compound as a minor by-product. 
Using anisole, a series of N-nucleophiles such as imidazole, 2-pyrrolidinone, 
benzamide and 4-fluorobenzenesulfonamide gave coupled products 88f–88i in 78–
86% yield. It is worth noting that the coupling of anisole and 2-pyrrolidone was 
performed at a lower temperature (130 °C) than the previously developed 
bromination procedure (150 °C) and gave coupled product 88g in better overall yield 
(78% vs 58%). Benzyl carbamate was also used as a nucleophile in the one-pot 
process giving Cbz protected aniline 88j in 43% yield. 
FeCl3 (2.5 mol%)
[BMIM]NTf2 (7.5 mol%)
NIS, toluene, 40 °C, 4 h
then pyrazole, CuI (10 mol%)
DMEDA (20 mol%), Cs2CO3
water, 130 °C, 20 h, 94%
N
MeO
MeO
N
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Scheme 64: One-pot, two-step para-C–H amination/amidation 
Limitations of the one-pot process were observed when using nucleophiles such as 
1,2,3-triazole, acetamide and dibenzylamine with anisole, which gave no coupled 
products 88k–88m (Figure 3). Additionally, none of these coupled products were 
obtained even upon increasing the temperature (150 °C) or extending the reaction 
time (up to 72 h), with no conversion from 4-iodoanisole (82a) observed. Using tert-
butyl carbamate gave only traces of coupled product 88n (<10% conversion), while 
using phenol as a nucleophile resulted in no conversion to diaryl ether 88o. 
 
Figure 3: Limitation of the one-pot process 
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It was considered that succinimide, generated in situ during the iodination step, 
could be utilised as a nucleophile in the subsequent C–N bond forming step 
(Scheme 65). However, attempts at this resulted in no formation of coupled product 
88p, even at elevated temperature (150 °C). 
 
Scheme 65: Coupling of anisole and succinimide 
2.2.4 Mechanism of the One-Pot Two-Step Process 
A proposed mechanism for the one-pot, two-step aryl C–N bond forming process is 
shown in Scheme 66. As previously described, the combination of iron(III) chloride 
and [BMIM]NTf2 leads to the formation of iron(III) triflimide. The highly delocalised, 
weakly coordinating nature of the triflimide anion results in the effective activation of 
NIS, promoting rapid, regioselective electrophilic aromatic substitution of anisole. In 
the second step, the addition of copper(I) iodide and the bidentate ligand, N,N′-
dimethylethylenediamine (89) allows the formation of 1,2-diamine-ligated copper(I) 
intermediate 90. Subsequent reaction of copper(I) intermediate 90 with the N-
nucleophile and base generates the three-coordinate copper(I) amidated species 
91. Kinetic studies by Buchwald and Blackmond have shown that this active catalytic 
species is in equilibrium with the unreactive amine or amidate dimer, [Cu(I)-Nu2] 92, 
which is the major species at low 1,2-diamine ligand concentration.240,241 The exact 
mechanism of haloarene activation remains unclear however it is believed to 
proceed either via oxidative addition to give neutral Cu(III) species 93, single 
electron transfer (SET) to form a Cu(II) intermediate or by an iodine atom transfer 
(IAT) mechanism.242–244 DFT calculations have revealed that Cu(III) intermediates 
are kinetically accessible via either concerted oxidative addition or by inner sphere 
electron transfer from a Cu(II) intermediate.243,245 Reaction pathways involving aryl 
free radical intermediates, such as SET and IAT mechanisms, have largely been 
ruled out using experimental methods to detect radical intermediates.246 
Furthermore, direct evidence for the Cu(I)/Cu(III) redox cycle has been observed 
with isolation of stable Cu(III) complexes with macrocyclic ligands which were 
MeO [BMIM]NTf2 (7.5 mol%)
toluene, 40 °C, 4 h
MeO
CuI (10 mol%)
DMEDA (20 mol%)
Cs2CO3, water
130–150 °C, 24 h MeO
INISFeCl3 (2.5 mol%) N
O
O
88p82a
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characterised using X-ray crystallography.247,248 Finally, facile reductive elimination 
of 93 then forms the coupled products while simultaneously regenerating the 1,2-
diamine ligated copper(I) complex 90. It is evident that the iron(III)-catalysed 
iodination and copper(I)-catalysed amination are highly compatible in the one-pot 
process. 
 
Scheme 66: Proposed mechanism for one-pot, two-step process 
2.2.5 One-Pot Process Using Aliphatic Amine Nucleophiles 
Using an aliphatic amine, morpholine, in the one-pot process gave low conversion 
(<10%) to coupled product 88q (Scheme 67). It was though that the catalytic activity 
of the copper(I) species was supressed due to competitive binding of the electron-
rich alkylamine nucleophile, which is present in significantly higher concentration 
than the diamine ligand. In an attempt to overcome this limitation, the copper ligand 
was changed from DMEDA (89) to 2-isobutyrylcyclohexanone (94), a 1,3-diketone 
ligand which has been shown to be effective in the Cu(I)-catalysed amination of 
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simple aryl halides using aliphatic primary amines and secondary cyclic 
amines.249,250 Ligand 94 exists in a delocalised enolate form and has found utility in 
more difficult Goldberg-type coupling reactions.21 Mechanistic investigations into the 
role of 1,3-diketonate ligated copper species have suggested that stronger binding 
has prevented multiple ligations of the aliphatic amine nucleophile, reducing the 
energy barrier for oxidative addition of the aryl iodide.251–253 Using ligand 94 in the 
one-pot process resulted in only 20% conversion to coupled product 88q. Increasing 
the concentration of ligand 94 (40 mol%) and changing the solvent from toluene to 
DMF did not result in an improvement in conversion. 
 
Scheme 67: Coupling of anisole and morpholine 
In order to investigate the poor conversion to the coupled product, the reaction of 4-
iodoanisole (82a) and morpholine was performed as a single step. Using CuI (10 
mol%) and 2-iso-butyrylcyclohexanone (94) (20 mol%), 90% conversion to coupled 
product 88q was observed, which was then isolated in a 60% yield (Table 2, entry 
1). N-Succinimide (1 equiv.), a by-product of the iodination step, was added to 
determine whether it played a detrimental role in the C–N coupling step (entry 2) 
and a conversion to the coupled product of 80% was recorded. Another experiment 
was performed where FeCl3 and [BMIM]NTf2 were added which resulted in 80% 
conversion to 88q after 40 h (entry 3). Addition of N-succinimide, FeCl3 and 
[BMIM]NTf2 resulted in 70% conversion to 88q after 40 h (entry 4). It was evident 
that the C–N coupling with morpholine proceeded in the presence of FeCl3, the ionic 
liquid and N-succinimide, albeit at a slower rate. 
  
FeCl3 (2.5 mol%)
[BMIM]NTf2 (7.5 mol%)
NIS, toluene, 40 °C, 4 h
then morpholine, CuI (10 mol%)
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Table 2: Coupling of 4-iodoanisole and morpholine 
 
Entry Additive Time (h) Conversion 
(%)a 
1 none 20 90 
2 N-succinimide (1 equiv.) 40 80 
3 FeCl3 (2.5 mol%) and [BMIM]NTf2 (7.5 mol%) 40 80 
4 N-succinimide (1 equiv.), FeCl3 (2.5 mol%) 
and [BMIM]NTf2 (7.5 mol%) 
40 70 
aDetermined using 1H NMR spectroscopy. 
Taking this decrease of rate into account, the one-pot reaction was repeated with a 
lower catalytic loading of FeCl3 (2 mol%) and [BMIM]NTf2 (5 mol%), in order to 
reduce the interference of these reagents in the subsequent C–N coupling step 
(Scheme 68). In addition to lowering the concentration of reagents from the first 
step, the loading of the 1,3-diketone ligand was increased to 30 mol%. Also, the 
number of equivalents of morpholine were reduced from 1.5 to 1.2, to minimise 
undesired ligation to the copper(I)-catalyst. The result was 86% conversion after 48 
h at 150 °C and coupled product 88q was isolated in 50% yield. 
 
Scheme 68: One-pot, two-step synthesis of 88q 
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2.2.6 Synthesis of SC-560 
The N-aryl trifluoromethylpyrazole, SC-560 (88r) has been shown to selectively 
inhibit the cyclooxygenase enzyme, COX-1, over COX-2 and hence has potential 
therapeutic use as an anti-inflammatory agent.254 It was proposed that SC-560 could 
be synthesised by the direct functionalisation of the para-C–H bond of anisole 
followed by coupling of pyrazole 95 using the iron(III)/copper(I)-catalysed one-pot 
procedure (Scheme 69). 
 
Scheme 69: Retrosynthesis of SC-560 (88r) 
The α,β-unsaturated trifluoromethyl ketone 97 was synthesised from 4-
chlorobenzaldehyde (96) using a crossed aldol condensation with 1,1,1-
trifluoroacetone (Scheme 70).255 Mechanistically, this aldol reaction proceeds via an 
enamine intermediate. A tandem cyclisation/1,5-H shift reaction between 
trifluoromethyl enone 97 and p-toluenesulfonyl hydrazide was then used to form the 
3-trifluoromethylpyrazole derivative 95 in 66% yield, using the procedure of Wang 
and co-workers.256 It was proposed that the use of ethanol as the solvent 
suppresses the formation of the diazo by-product via the Bamford-Stevens reaction 
on the intermediate hydrazone salt. 
 
Scheme 70: Synthesis of pyrazole 95 
3-Trifluoromethylpyrazole derivative 95 was then investigated as a nucleophile 
following iron(III) triflimide-catalysed iodination of anisole (Table 3). Using DMEDA 
and a reaction temperature of 130 °C for 24 h resulted in no conversion to the 
coupled product 88r (entry 1). Increasing the temperature to 150 °C also gave no 
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conversion to 88r after 48 h (entry 2). The coupling between aryl iodide 82a and 
pyrazole 95 has previously been reported by Jamison and co-workers.257 In their 
protocol, they performed the cross-coupling reaction using trans-N,N′-
dimethylcyclohexane-1,2-diamine (98) as the copper ligand in 1,4-dioxane which 
gave SC-560 88r in 70% yield. It was therefore decided to change the ligand from 
DMEDA (89) to trans-N,N′-dimethylcyclohexane-1,2-diamine (98) and this gave 88r 
in 8% yield (entry 3). Next, after forming the aryl iodide, the N-arylation step was 
performed in a mixture of toluene and 1,4-dioxane at 150 °C for 60 h, using 3 
equivalents of pyrazole 95 (entry 4). These conditions resulted in the isolation of the 
coupled product 88r in 23% yield. It was thought that the electron-withdrawing 
nature of the 3-trifluoromethyl and 5-aryl substituents led to an overall decrease in 
the nucleophilicity of pyrazole 95, contributing to the inefficiency of this N-arylation 
reaction. In addition, the steric bulk of the 5-aryl substituent makes pyrazole 95 too 
hindered for this transformation to proceed under these conditions, either by 
increasing the energy required for oxidative addition or inhibiting ligation of 95 to the 
Cu(I)-centre. This cross-coupling reaction required harsh conditions with long 
reaction times (60 h), a high reaction temperature (150 °C) and used a large excess 
of pyrazole 88r (3 equiv.) therefore, it was decided not to pursue any further 
optimisation. 
Table 3: Coupling of anisole and pyrazole 95 
 
Entry Pyrazole 
(equiv.) 
Ligand 
(20 mol%) 
Solvent Temperature 
(°C) Time (h) Yield of 88r (%) 
1 1.1 89 toluene 130 24 n/a 
2 1.1 89 toluene 150 48 n/a 
3 1.1 98 toluene 150 48 8 
4 3 98 toluene/1,4
-dioxane 
150 60 23 
MeO MeO
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MeO
N N
CF3
Cl
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toluene, 40 °C ligand (20 mol%)
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2.2.7 One-Pot ortho-Amination of Aryl C–H Bonds 
The one-pot iron(III)-catalysed iodination and copper-catalysed C–N bond forming 
process was next investigated for the selective ortho-amination/amidation of arenes. 
The key objective was to improve upon the ortho-bromination/amination of 4-
nitroaniline previously attempted in the group and completely supress the de-
halogenation pathway in favour of C–N bond formation. It was proposed that this 
could be achieved by using NIS in the activation step. The weaker C–I bond would 
lower the energy requirement for oxidative addition and hence, lead to a more 
efficient procedure, minimising the undesired protodecupration process. This project 
began with the optimisation of the one-pot ortho-C–H amination of 4-
aminobenzonitrile (99) with pyrazole. Iron(III) chloride (5 mol%) and [BMIM]NTf2 (15 
mol%) were used in the activation step, resulting in full conversion to ortho-iodide 
intermediate 100 in 5h at 70 °C. DMEDA ligand-assisted, copper(I)-catalysed 
coupling with pyrazole then gave a 3:1 mixture of coupled product 101a and reduced 
compound 99 (Table 4, entry 1). Performing the cross-coupling step at a lower 
temperature (130 °C) improved the ratio of 101a and 99 to 6:1, implying that 
protodecupration is disfavoured at lower temperatures (entry 2). To improve this 
process and reduce the ratio of 101a and 99 further, alternative copper-chelating 
ligands were used in the second step. Diketone ligand 94, which has previously 
been shown to be effective in more challenging coupling reactions by forming more 
stable, anionic copper intermediates, was used in the one-pot process. As diketone 
ligands are weaker nucleophiles than nitrogen-containing ligands, they do not tend 
to undergo O-arylation, a reaction pathway implicated in catalyst deactivation.249,258 
The use of ligand 94 did allow for the formation of coupled product 101a but offered 
no improvement in the product ratio (entry 3). Studies by Buchwald and co-workers 
have suggested that the use of cyclic diamine ligands improves the efficiency of 
copper-catalysed N-arylation reactions by increasing the stability of the active 
copper-nucleophile intermediate.15,16 On that basis, trans-N,N′-
dimethylcyclohexane-1,2-diamine (98) was used in the one-pot process which 
resulted in higher selectivity of 12:1 for 101a versus 99 (entry 4). It was clear that, 
while the choice of copper ligand did improve the product ratio, copper-catalysed 
dehalogenation remained a competing reaction pathway. To prevent this, the 
number of equivalents of pyrazole were increased which led to complete 
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suppression of the reductive de-halogenation pathway, allowing for generation of 
only the coupled product 101a, which was isolated in 60% yield (entry 5). 
Table 4: Optimisation of the one-pot ortho-C–H amination 
 
Entry Pyrazole 
(equiv.) 
Ligand (20 
mol%) 
Temp. (°C) Ratio 
(101a:99)a 
1 1.5 89 150 3:1 
2 1.5 89 130 6:1 
3 1.5 94 130 5:1 
4 1.5 98 130 12:1 
5 3 98 130 101a only 
aDetermined using 1H NMR spectroscopy 
The optimised conditions were then used to evaluate the substrate scope of the 
one-pot ortho-amination of a range of activated aromatic compounds with pyrazole 
(Scheme 71). A variety of para-substituted aniline derivatives, bearing electron-
withdrawing groups, were submitted to the iron(III)-catalysed iodination and 
copper(I)-catalysed cross-coupling with pyrazole which gave ortho-substituted 
compounds 87, 101a–101d in 58–71% yield. It is worth noting that this method 
allows ortho-amination of anilines without the requirement of a protecting group or 
covalent chelation-controlled directing group. Despite the use of relatively 
nucleophilic arenes, no intermolecular self-arylation of the aniline functional group 
was observed. Next, the one-pot process was extended for the ortho-substitution of 
anisole derivatives bearing multiple activating groups, which gave coupled products 
101e–101k in 42–71% yield. A substrate bearing a free carboxylic acid functional 
group was also tolerated in this process and gave coupled product 101k in 53% 
yield. The use of the highly regioselective iron(III) triflimide iodination ultimately led 
to the formation of exclusively ortho-coupled products even when using electron-
NH2 NH2
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CNCN
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I
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rich arenes with multiple activating groups. The modest yields for some compounds 
(e.g. 101g and 101h) was due to co-elution with the excess pyrazole nucleophile 
during flash column chromatography, complicating the purification procedure. 
 
Scheme 71: Scope of arene in the one-pot process; aIodination step was complete after 20 h, 
bIodination step was performed at 40 °C, cPyrazole (1.5 equiv.) used. 
When anisole and phenol derivatives 102a–102d bearing electron withdrawing 
groups in the para-position where submitted to the iron(III)-catalysed iodination step, 
only trace amounts of ortho-iodinated products were observed (Figure 4). In 
addition, there was no conversion to the aryl iodide when using acetanilide as a 
directing group. This lack of conversion is attributed to the deactivated nature of 
these aryl systems towards electrophilic aromatic substitution. 
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Figure 4: Limitations of one-pot process 
Using the standard one-pot conditions for 4-methylanisole (103), a variety of N-
nucleophiles were evaluated (Scheme 72). Applying benzamides, sulfonamides and 
2-pyrrolidone as nucleophiles in the one-pot process gave the corresponding ortho-
coupled products, 104a–104g in 52–78% yield. Other N-heterocycles such as 
pyrrole, indole and imidazole required a longer reaction time (36 h) for the copper-
catalysed amination step, however, this still gave the coupled products, 104h–104j 
in 25–51% yield. Limitations were found when investigating the scope of the 
nucleophilic coupling partner in the one-pot process. As before, the electron-rich 
aliphatic amine, morpholine, was not tolerated and led to the formation of only traces 
of coupled product 104k. This is likely due to the competitive binding of morpholine 
with the active Cu(I)-catalyst. When using the hindered N-heterocyclic nucleophile 
3,5-dimethylpyrazole, no formation of 104l was observed, even at 150 °C for 96 h 
and the addition of a further portion of copper iodide (10 mol%) and ligand 98 (20 
mol%). Coupling at the ortho-position of 4-methylanisole (103) with a 5-substituted 
pyrazole is obviously too sterically demanding under these conditions. 
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Scheme 72: Scope of nucleophile in the one-pot process 
Another limitation of this method was found during the investigation of the ortho-
substitution of phenols. For example, using p-cresol (105) as a substrate in the one-
pot process yielded 25% of coupled product 106 (Scheme 73). The iodination step 
using iron(III) triflimide (5 mol%) was sluggish, with 55% conversion of starting 
material 105 after 18 h at 70 °C and a 10:1 mixture of the desired mono-iodinated 
and poly-iodinated compound was obtained. This mixture was then submitted to 
copper-catalysed cross-coupling step with pyrazole. Both the moderate conversion 
and poor selectivity encountered in the electrophilic aromatic substitution step 
account for the low yield of 106. 
 
Scheme 73: Coupling of p-cresol and pyrazole 
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It was previously shown the reaction of a hard, highly charged Fe(III) Lewis acid 
catalyst with active phenol substrates led to the formation of bis-iodinated 
compounds, reducing the yield of the desired mono-iodinated products.231 For this 
reason, a less charged, softer Ag(I) Lewis acid catalyst was used to catalyse the 
iodination of p-cresol (105). Using silver(I) triflimide (7.5 mol%) to catalyse the 
iodination step allowed for 90% conversion to the desired mono-ortho-iodinated 
regioisomer, as determined by 1H NMR spectroscopy. Subsequent copper(I)-
catalysed amination with pyrazole, however, led to a 1:1 mixture of coupled product 
106 and p-cresol (105) and 106 was isolated in 37% yield (Table 5, entry 1). To limit 
this competing reductive dehalogenation pathway, the reaction was performed 
using 5 equivalents of pyrazole however, this resulted in no improvement, with 106 
again isolated in 37% yield (entry 2). The reaction was next performed at 150 °C 
and this gave a 1.4:1 ratio of coupled product 106 to p-cresol (105), with a lower 
isolated yield of 26%, perhaps due to decomposition of 106 (entry 3). The C–N 
coupling step was next attempted without the addition of water, a possible source 
of hydrogen atoms responsible for the protodecupration side-reaction. This resulted 
in a 0.8:1 mixture of 106 to 105 with the lower overall isolated yield due to the poor 
solubility and therefore poor mixing of reagents (entry 4). Attempts to minimise the 
de-halogenation and increase the isolated yield of 106 did not improve the outcome 
therefore, the best conditions were those of entry 1. 
Table 5: One-pot ortho-amination of p-cresol 
 
Entry Temperature 
(°C) 
Pyrazole 
(equiv.) 
water Ratio of 
106:105a 
Isolated yield 
of 106 (%) 
1 130 3 yes 1:1 37 
2 130 5 yes 1:1 37 
2 150 3 yes 1.4:1 26 
3 130 3 no 0.8:1 15 
aDetermined by 1H NMR spectroscopy. 
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2.2.8 Late-stage Functionalisation of 3,4-Dihydroquinolin-2-ones 
Following the examination of the scope and limitations of the one-pot intermolecular 
ortho-amination process, it was next used for the synthesis of a pharmaceutically 
relevant target. Palmer and co-workers have shown that 3,4-dihydroquinolin-2-ones 
are potential, effective small molecule inhibitors of the bromodomain tripartite motif 
containing protein 24 (TRIM24), which has been implicated in human cancer.259,260 
Over-expression of this particular protein is often correlated with aggressive tumour 
growth and poor patient prognosis.261,262 It was proposed that the one-pot iodination 
and ortho-amidation process could be used for the rapid, selective late-stage 
functionalisation of N-methyl 3,4-dihydroquinolin-2-one 107, allowing access to 
bromodomain inhibitor 108a and a library of novel analogues (Scheme 74). 
 
Scheme 74: Proposed synthesis of TRIM24 inhibitor 108a 
Firstly, 3,4-dihydroquinolin-2-one 107 was prepared by Rochelle McGrory, an MSci 
project student, using a one-pot, four-step process previously developed in the 
group (Scheme 75).263 This involved the conversion of 4-methoxy-2-nitroaniline 
(109) into the corresponding diazonium tosylate salt, using a resin-bound nitrite 
reagent. In the same-pot, this diazonium salt was then utilised during a palladium-
catalysed Heck-Matsuda cross-coupling reaction with methyl acrylate. Subjecting 
this mixture to 2.5 bar pressure of hydrogen, while re-utilising the palladium catalyst, 
resulted in the reduction of both the alkene and the nitro group, which allowed for in 
situ cyclisation to form the 3,4-dihydroquinolin-2-one core. This gave 3,4-
dihydroquinolin-2-one 110 in 79% yield over the four steps. Subsequent methylation 
using sodium hydride and methyl iodide under standard conditions, gave N-methyl 
quinolinone 107 in 92% yield. 
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Scheme 75: Synthesis of N-methyl-3,4-dihydroquinolin-2-one 107 
The one-pot ortho-amidation process was then applied to N-methylquinolin-2-one 
107, and the late-stage functionalisation of the C-6 position (Scheme 76). Iodination 
of 107 was found to proceed using lower catalyst loadings of both FeCl3 (2.5 mol%) 
and [BMIM]NTf2 (7.5 mol%) and was complete in 4 h. Following this, copper(I)-
catalysed cross-coupling with benzenesulfonamide completed the one-pot process 
and gave TRIM24 inhibitor 108a in 56% yield. This one-pot process was then used 
for the late-stage synthesis of novel analogues of bioactive compound 108a. 
Coupling of 107 with sulfonamide and benzamide nucleophiles as well as pyrazole 
and 2-pyrrolidinone gave coupled products 108b–108f in 51–61% yield. It should be 
noted that compounds 108b and 108d–108f were synthesised by Rochelle 
McGrory. 
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Scheme 76: One-pot synthesis of TRIM24 inhibitor 108a and novel analogues; aThe second 
step required 72 h 
2.2.9 One-Pot Iron and Copper-Catalysed Iodination and Sonogashira Cross-
Coupling Reaction 
In the past decade, it has been shown that Sonogashira cross-coupling reactions 
can be performed under palladium-free conditions using iron264 or copper 
catalysis.265 Therefore, another aim of this project was to develop a one-pot method 
for the construction of C–C bonds directly from aryl C–H bonds. Initially, this was 
investigated using anisole and phenylacetylene as coupling partners (Scheme 77). 
As reported above, iron(III)-catalysed of anisole resulted in full conversion to the 
iodide intermediate after 4 h. Following this, coupling with phenylacetylene using 
CuI (10 mol%) led to 70% conversion to coupled product 111, which was then 
isolated in 39% yield. A major by-product in this process was acetophenone, 
resulting from the hydration of the alkyne under the basic aqueous conditions. In 
fact, iron(III) triflimide has been shown to effectively coordinate to the π-electron rich 
systems, facilitating the addition of water to alkynes.266 
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Scheme 77: One-pot coupling of anisole and phenylacetylene 
The reaction of 4-iodoanisole (82a) and phenylacetylene was performed as a single 
step to determine the optimal base and ligand combination. As the use of water in 
the reaction was resulting in hydration of the alkyne, a mixture of toluene and 1,4-
dioxane was instead used. Using copper(I) iodide (10 mol%) and cesium carbonate, 
multiple ligands were screened including DMEDA (89), 2-isobutyrylcyclohexanone 
(94), trans-N,N′-dimethylcyclohexane-1,2-diamine (98), and TMHD (112) (Table 6, 
entries 1,2,3 and 4). DMEDA (89) was found to be the most effective and gave 41% 
conversion to coupled product 111. A change of base to potassium carbonate led 
to a substantial decrease in conversion, whereas the use of potassium phosphate 
gave comparable conversion (entries 5 and 6). The use of a soluble organic base, 
triethylamine, resulted in the formation of only traces of 111 (entry 7). To investigate 
the effect of an iron(III) catalyst on the cross-coupling of 82a and phenylacetylene, 
FeCl3 (2.5 mol%) was added (entry 8). This resulted in only 20% conversion to 
coupled product 111. Iron(III) triflimide (2.5 mol%) was next added however this 
neither hindered nor improved the cross-coupling reaction (entry 9). 
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Table 6: Optimisation of the Sonogashira reaction 
 
Entry Ligand (20 
mol%) 
Base (2 equiv.) Additive Conversion 
(%)a 
1 89 Cs2CO3 none 41 
2 94 Cs2CO3 none 20 
3 98 Cs2CO3 none 33 
4 112 Cs2CO3 none 8 
5 89 K2CO3 none 25 
6 89 K3PO4 none 41 
7 89 Et3N none traces 
8 89 Cs2CO3 FeCl3 (2.5 mol%) 20 
9 89 Cs2CO3 Fe(NTf2)3 (2.5 mol%) 40 
aDetermined by 1H NMR spectroscopy 
2.2.10 Conclusions and Outlook 
The regioselective iodination of arenes using the Lewis acid, iron(III) triflimide, was 
combined with a copper(I)-catalysed, ligand-assisted coupling with unactivated N-
nucleophiles allowing for the para-amination of C–H bonds in a one-pot process 
(Scheme 78). Using this method, a small library of para-C–N coupled products were 
synthesised and, with some optimisation, allowed the coupling of electron rich 
morpholine with anisole. In addition, when the para-position was blocked, the one-
pot method allowed for ortho-amination and amidation of aromatic compounds. This 
methodology was applicable to a series of anisole derivatives and permitted ortho-
amination of anilines, without the necessity of a protecting or chelation-based 
directing group. The synthetic utility of this method was demonstrated by the late-
base
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I
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stage functionalisation of a quinoline-2-one scaffold, allowing for the synthesis of a 
bromodomain-containing protein inhibitor as well as a series of novel analogues.  
 
Scheme 78: Summary of the one-pot, two-step iodination/amination process 
This methodology was extended to C–C bond formation, using the Fe(III)-catalysed 
activation, followed by Cu(I)-catalysed coupling with phenyl acetylene in a 
palladium-free Sonogashira-type process. After further optimisation of the one-pot 
iron(III)/Cu(I)-catalysed Sonogashira process, an application of this methodology is 
the synthesis of benzannulated heterocycles (Scheme 79). ortho-Iodination of 
anilines and subsequent C–C bond formation would then allow for cyclisation of the 
internal nitrogen nucleophile, facilitated by coordination of the re-utilised Fe(III) ion 
to the alkyne, leading to the formation of indoles in a one-pot, three-step process.  
 
Scheme 79: Proposed one-pot, three-step synthesis of indoles 
This methodology could then be applied to the synthesis of other, larger heterocyclic 
ring systems, such as dihydroisoquinolines (Scheme 80). 
 
Scheme 80: Proposed one-pot, three-step synthesis of 1,2-dihydroisoquinolines 
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Borylation of aryl bromides has been recently demonstrated using a cooperative iron 
and copper-catalysed protocol, avoiding the use of palladium catalysis.267 In 
addition, several methods of copper(I)-catalysed borylation of aryl halides have 
previously been reported.268,269 To build on this work, it was proposed that the 
regioselective iron(III)-catalysed iodination could be used in combination with a 
Cu(I)-catalysed C–B bond formation for the one-pot borylation of C–H bonds. An 
initial result demonstrated the feasibility of copper-catalysed borylation using the 
conditions developed by Marder and co-workers with the synthesis of coupled 
product 113 in 33% yield (Scheme 81).269 
 
Scheme 81: Copper(I)-catalysed borylation of 4-iodoanisole (82a) 
It was envisioned that, after extensive optimisation, this copper-catalysed borylation 
would be incorporated into the one-pot process, combining with the iron(III) 
triflimide-catalysed iodination, for the efficient synthesis of pinacol borane-derived 
aryl compounds (Scheme 82). 
 
Scheme 82: One-pot C–H borylation 
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2.3 One-Pot, Two-Step Synthesis of Indolines and Dihydrobenzofurans 
2.3.1 Introduction 
Indoline and 2,3-dihydrobenzofuran scaffolds can be widely found in a range of 
natural products, pharmaceutical agents and biologically active compounds.270,271 
For example, physostigmine (114), a natural product from the African Calabar bean 
(Physostigma venenosum), is a potent reverse cholinesterase inhibitor which has 
shown promise in the treatment of Alzheimer’s disease (Figure 5).272 Another 
example is natural product lawsonicin (115), a major component in hazelnut 
(Corylus avellana L.) shell extracts, which has recently been investigated for its 
antioxidant effects and cytotoxic activity on human cancer cell lines.273 In addition 
to this, indoline 116 was found to be the lead compound in a study of the small 
molecule modulation of protein-protein interactions.274 More specifically, 116 was 
found to inhibit the PTK2 protein tyrosine kinase enzyme and hence, has 
applications in the prevention of cancer metathesis. Further examples that include 
these structural motifs are liliflol A (117), a potent COX-2 inhibitor275 and neolignan 
natural product (+)-obtusafuran (118). 
 
Figure 5: Indoline and 2,3-dihydrobenzofuran scaffold in biologically active compounds and 
natural products 
It is this prevalence in biologically important compounds that has led to considerable 
efforts being focused towards the discovery and development of efficient methods 
for the synthesis of these functional heterocycles.276,277 Traditionally, indolines and 
2,3-dihydrobenzofurans have been prepared by the alkylation of ortho-substituted 
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phenols and anilines. This approach is exemplified by Larock and co-workers who 
used a palladium-catalysed heteroannulation of dienes with o-iodoanilines and o-
iodophenols then subsequent heterocyclisation for the synthesis of indolines and 
2,3-dihydrobenzofurans (Scheme 83).278 This method was contingent on the use of 
1,3-dienes, which do not have β-hydrogen atoms, and hence, intramolecular 
nucleophilic attack on the π-allyl intermediate occurs instead of the formation of 
Heck-type products by β-hydride elimination. 
 
Scheme 83: Larock's synthesis of indolines and 2,3-dihydrobenzofurans 
An improvement of this method was developed by Jamieson and co-workers, with 
the extension to terminal alkenes using a dual nickel/photoredox catalytic 
protocol.279 A novel synthesis of 1-aminoindolines was reported by Glorius which 
employs diazenecarboxylates as directing groups in a rhodium(III)-catalysed C–H 
insertion followed by nucleophilic addition to alkenes (Scheme 84).280 
 
Scheme 84: Glorius' synthesis of 1-aminoindolines 
While these procedures offer convenient access to these heterocyclic scaffolds, 
they often rely on the use of highly functionalised starting materials and precious 
transition metal catalysts. A more general strategy for the synthesis of these 
heterocyclic ring systems is the Buchwald-Hartwig or Ullmann-Goldberg type 
aromatic C–N and C–O bond forming process of o-halogenated phenylethylamine 
and phenylethylalcohols (Scheme 85). These transition metal-catalysed 
approaches have found wide utility for the preparation of five- and six-membered 
benzofused heterocycles and have been applied in the synthesis of natural 
products, including Panek’s total synthesis of alkaloid (+)-isatisine A.281 Seminal 
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work by the Yu group presented the possibility of intramolecular cross coupling of 
unactivated aryl-C–H bonds with internal N–H nucleophiles.163 The method, 
described in chapter 1.4, allowed for the direct synthesis of indolines from N-
triflimide protected phenylethylamines employing a Pd(II)/Cu(I)-catalysed tandem 
C–H iodination/amination sequence. In the years since this work was first reported, 
there have been a series of improvements offered on this strategy, mainly the use 
of N-chelating groups and oxidising agents such as hypervalent iodine compounds. 
This strategy was highly effective for the synthesis of 5- and 6-membered nitrogen 
heterocycles, yet not entirely applicable to the synthesis of 2,3-dihydrobenzofurans 
due to the incompatibility of the oxidising conditions with primary and secondary 
alcohol substrates. 
 
Scheme 85: Synthetic routes towards indolines and 2,3-dihydrobenzofurans 
A notable exception to this was reported by Yu, using palladium-catalysed aryl C–
H activation and C–O cyclisation of phenylethylalcohols for dihydrobenzofuran 
synthesis.282 The success of this method was dependent on the use of tertiary 
alcohols, preventing the possibility of oxidation. Also, the correct choice of oxidant 
was critical with the most efficient being a hypervalent iodine species, 
diacetoxyiodobenzene. This oxidising agent allowed for the oxidation of the Pd(II) 
intermediate to Pd(IV) from which facile reductive elimination of the C–O bond could 
occur. This palladium-catalysed C–H activation/C–O cyclisation was later used in 
combination with a rhodium-catalysed C–H insertion for the enantioselective 
synthesis of trans-disubstituted 2,3-dihydrobenzofurans from aryldiazoacetates and 
protected benzyl alcohols.283 
Zakarian and co-workers have since reported a mechanistically distinct approach 
for the preparation of dihydrobenzofurans involving direct, oxidative aryl C–O bond 
formation (Scheme 86).284 This methodology involves the activation of 
phenylethylalcohols using non-symmetric diaryl-iodonium salts allowing for copper-
catalysed cyclisation to occur at room temperature under very mild conditions. 
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Electron rich arenes were reacted with a hypervalent iodine(III) reagent, 
[bis(trifluoroacetoxy)iodo]benzene (PIFA), which resulted in the rapid formation of a 
diaryl-l3-iodane intermediate. Subsequent exposure to a copper-catalyst results in 
oxidative addition of the C–I bond resulting in a Cu(III) species to which the internal 
oxygen nucleophile ligates. Reductive elimination then gives the 2,3-
dihydrobenzofuran products, while regenerating the active Cu(I)-catalyst. 
 
Scheme 86: Copper-catalysed synthesis of 2,3-dihydrobenzofurans reported by Zakarian 
2.3.2 Project Aims 
The main objective of this project was to develop a one-pot intramolecular C–N and 
C–O bond forming process for the synthesis of indoline and 2,3-dihydrobenzofuran 
heterocycles (Scheme 87). This would build upon the previously developed 
intermolecular C–N bond forming process (chapter 2.2) and would utilise the 
previously developed regioselective iron(III)-catalysed iodination for initial arene 
activation followed by a copper(I)-catalysed heterocyclisation with pendant nitrogen 
or oxygen nucleophiles. The first key objective of this project was the development 
of a concise, efficient synthetic route towards various N-protected 
phenylethylamines and phenylethylalcohols from readily available starting 
materials. These substrates would then be used in the optimisation and investigation 
of the scope of the one-pot process. Finally, this methodology would then be applied 
to the synthesis of bioactive and pharmaceutically relevant target molecules. 
MeO OH
PIFA
CF3CH2OH, Et3N, rt–50 °C
0.1–36 h
then Et3N
Cu(hfacac)2 (20 mol%), rt
8–16 h, 22–97%
R
MeO
R O
CuILn
ArI + CF3CO2− Et3NH+
MeO OH
R I+
Ar
MeO
CuIII
O
Ln
R
I(O2CCF3)2
reductive 
elimination
oxidative
addition
 
88 
 
Scheme 87: Proposed synthesis of indolines and dihydrobenzofurans using a one-pot 
process 
2.3.3 Synthesis of Phenylethylamines Substrates 
The first stage of this project investigated a short and efficient synthesis of N-
protected phenylethylamines from commercially available benzaldehydes (Scheme 
88). Firstly, the Henry reaction was employed using nitromethane and ammonium 
acetate to perform a one-carbon homologation.285 In this reaction, ammonium 
acetate is used for the deprotonation of nitromethane and the generation of a 
resonance stabilised nitronate species, which then undergoes an aldol reaction with 
the benzaldehyde. This results in the formation of a β-nitroalcohol which, under the 
reaction conditions, undergoes dehydration to form desired nitroalkene. This 
procedure was efficient when applied to electron rich benzaldehydes 119a–119f and 
gave the corresponding nitrostyrene compounds 120a–120f as exclusively E-
isomers in 73–97% yield. Evidence for alkene E-selectivity was observed using 1H 
NMR spectroscopy, with large trans coupling constants of 13.6 Hz for nitrostyrenes 
120a–120f. The use of these conditions with electron-deficient benzaldehydes 119g 
and 119h resulted in the formation of complex mixtures however, the isolation of 
compounds 120g and 120h was possible, albeit in 31% and 26% yield, respectively. 
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Scheme 88: Synthesis of nitrostyrenes using a nitroaldol reaction 
Nitrostyrene 120a was then submitted to hydrogenation in the presence of palladium 
on carbon, which was effective in reducing the olefin functionality, though was 
unsuccessful in reducing the resulting aliphatic nitro group to the primary amine. A 
new approach was therefore investigated, using the procedure of Varma and 
Kabalka, to reduce the vinyl nitro moiety in one-pot (Scheme 89).286 This method 
involved the treatment of nitrostyrene compound 120a with a combination of sodium 
borohydride and boron trifluoride diethyl etherate, generating borane-THF complex 
in situ. This resulted in the successful reduction of both the alkene and nitro group 
in a single step, giving 3-methoxyphenylethylamine 121a in 92% yield. 
 
Scheme 89: Vinyl nitro reduction using the procedure of Varma and Kabalka 
3-Methoxyphenylethylamine (121a) was then derivatised with a series of nitrogen 
protecting groups under standard conditions, to give a range of N-protected 
phenylethylamines 122a–122f in up to 94% yield (Scheme 90). 
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Scheme 90: N-Protection of 3-methoxyphenylethylamine (121a) 
Having developed a strategy for reduction of the vinyl nitro group, the series of 
nitrostyrene compounds 120b–120g were subjected to these conditions (Scheme 
91). The crude phenylethylamines 121b–121h were isolated by an acid-base 
extraction in 58–78% yield and used without purification in the next step. 
Interestingly, for compounds 120f and 120g, this method is selective for the 
reduction of the vinyl nitro functionality over the aromatic nitro group. Tosylation 
under standard conditions allowed access to a small library of N-tosyl protected 
phenylethylamine substrates 123a–123g for the one-pot intramolecular C–N bond 
forming process. 
 
Scheme 91: Synthesis of N-tosyl protected phenylethylamines 123a–123g 
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The aromatic nitro functionality in compounds 123f and 123g were reduced using 
tin dichloride dihydrate giving anilines 124a and 124b in good yields (Scheme 92). 
N-Protection of the anilines using acetic anhydride resulted in the formation of 
substrates 125a and 125b to be used in the one-pot process. 
 
Scheme 92: Synthetic route towards N-tosyl protected phenylethylamines with aniline and 
acetamide directing groups 
A two-carbon homologation was performed using a Wittig reaction with 
cyanomethylene triphenylphosphorane and m-anisaldehyde (119a) which gave 
vinyl nitrile compound 126 in a 79% yield as a 3:1 mixture of E and Z isomers 
(Scheme 93). Acrylonitrile 126 was hydrogenated at 2.5 bar of pressure, using a 
Parr apparatus, in the presence of palladium on charcoal and hydrochloric acid to 
give the aliphatic amine as a hydrochloride salt. Reaction of this ammonium salt with 
p-toluenesulfonyl chloride gave sulfonamide 127 in a 63% over the two-steps. 
 
Scheme 93: Synthesis of tosyl protected amine 127 
Amide 129 was prepared by reaction of 3-methoxyphenylacetic acid (128) with 
thionyl chloride forming an acyl chloride intermediate in situ (Scheme 94). 
Subsequent treatment of this acid chloride with ammonium hydroxide solution 
resulted in the formation of 3-methoxyacetamide (129) in 42% yield. 
 
Scheme 94: Synthesis of amide 129 
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2.3.4 Synthesis of Phenylethylalcohol Substrates 
A series of alcohol substrates for the one-pot procedure were either commercially 
available or synthesised in one step by reduction of the carboxylic acids 130a and 
130b using lithium aluminium hydride giving alcohols 131a and 131b (Scheme 95). 
 
Scheme 95: Synthesis of phenylethylalcohol substrates 111a and 111b  
Additional substrates were prepared using 3-methoxyphenylacetic acid (128). This 
was converted to the corresponding methyl ester 132 using sulfuric acid and 
methanol in 99% yield (Scheme 96). This methyl ester was treated with three 
equivalents of methylmagnesium bromide and gave the tertiary alcohol 133 in 77% 
yield. Dimethylation of the a-position of methyl ester 132 using sodium hydride and 
methyl iodide followed by reduction gave neopentyl alcohol 134. 
 
Scheme 96: Synthetic route towards tertiary alcohol 133 and neopentyl alcohol 134 
Reduction of the aromatic nitro group of phenylethylalcohol 135 using tin dichloride 
dihydrate gave aniline 136 in 32% yield (Scheme 97). This was then protected using 
acetic anhydride to give acetanilide 137 in 42% yield. 
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Scheme 97: Synthesis of substituted acetanilide derivative 137 
In addition to the range of phenylethylalcohols prepared, a series of longer chain 
alcohols were synthesised. To achieve this, a Horner-Wadsworth-Emmons reaction 
using Masamune-Roush conditions287 was performed on m-anisaldehyde (119a) 
and 3,4,5-trimethoxybenzaldehyde (119d) to form the corresponding (E)-α,β-
unsaturated ester 138a and 138b, respectively (Scheme 98). In this reaction, the 
mild Lewis acid, lithium chloride coordinates to the carbonyl oxygen of triethyl 
phosphonoacetate, increasing the acidity of the methylene hydrogens which allows 
the use of a relatively weak base such as DBU. This process resulted in the 
formation of exclusively E-isomers based on the large 15.9 Hz trans coupling 
constants observed in the 1H NMR spectra of both compounds. Subsequent 
reduction of both the olefin and ester functional groups using lithium aluminium 
hydride gave alcohols 139a and 139b. The electron-rich trimethoxy-substituted aryl 
ring is in conjugation with the α,β-unsaturated ester functionality and hence, the 
electron density at the β-position is increased as a consequence. This hinders the 
conjugate addition of the hydride species which is reflected by the modest yield of 
alcohol 139b. 
 
Scheme 98: Synthesis of propyl alcohol derivatives 139a and 139b via an HWE reaction 
The synthesis of a longer chain, phenylbutylalcohol 141 was synthesised in one-
step by the reduction of carboxylic acid 140 using lithium aluminium hydride in 92% 
yield (Scheme 99). 
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Scheme 99: Synthesis of (3,4-dimethoxyphenyl)butanol (141) 
2.3.5 One-Pot Intramolecular Amination of C–H Bonds 
With a library of N-protected phenylethylamines in hand, their application in a one-
pot iodination/intramolecular amination was investigated. The initial aim was to 
evaluate N-benzoyl protected 3-methoxyphenylethylamine 122a as a substrate for 
selective para-iodination and then investigate the potential of the resulting activated 
aryl intermediate to undergo an intramolecular, copper(I)-catalysed N-arylation. It 
was proposed that the para-directing nature of the 3-methoxy substituent would lead 
iodination at the C-6 position and formation of exclusively the para-regioisomer. 
However, it was also considered that iodination could occur at the C-4 position due 
to steric hindrance caused by the N-benzoyl ethylamine side chain. Therefore, it 
was necessary to isolate the iodinated compound and determine which regioisomer 
had formed. 
The iodination of benzoyl protected phenylethylamine 122a was performed using 
standard conditions for halogenation with N-iodosuccinimide, iron(III) chloride (2.5 
mol%) and [BMIM]NTf2 (7.5 mol%) (Scheme 100). After 5 hours at 40 °C, it was 
clear from analysis of the crude reaction mixture by 1H NMR spectroscopy that there 
was full conversion to exclusively one regioisomer and 142 was isolated in 89% 
yield. Analysis of the 1H NMR spectra of 142 clearly showed three resonances in 
the aromatic region with ortho- and meta-coupling constants, indicative of a 1,3,4-
trisubstituted aromatic system. Two of these resonances were below 7 ppm, typical 
of aromatic hydrogen atoms that have been significantly shielded due to their 
proximity to the electron-rich methoxy group, entirely consistent with 142. In 
addition, 2D NMR experiments were carried out, mainly heteronuclear multiple-bond 
correlation (HMBC) spectroscopy, to ascertain the position of the iodine atom. There 
was an HMBC signal between the CH2 of the alkyl chain and the characteristically 
up-field shifted aromatic carbon bonded to the iodine atom. Also, there were two 
HMBC signals correlating with the quaternary carbon bearing the methoxy group 
MeO
MeO
OHMeO
MeO
CO2H LiAlH4
THF, 0 °C to rt
4.5 h, 92%
140 141
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which would not be the case with C-4 ortho-iodination. With this evidence, it was 
clear that exclusively the para-iodinated product 142 had formed. 
 
Scheme 100: Regioselective iodination of benzoyl protected phenylethylamine 122a 
The iodinated compound 142 was subjected to the ligand assisted, copper(I)-
catalysed cyclisation using copper(I) iodide (10 mol%), DMEDA (20 mol%) and 
cesium carbonate which resulted in the formation of indoline 143a in 68% yield 
(Scheme 101). 
 
Scheme 101: Cu(I)-catalysed cyclisation of aryl iodide 142 
Having investigated the feasibility of the iron(III) triflimide-catalysed iodination and 
copper(I)-catalysed N-arylation as single steps, these were next combined in a one-
pot procedure (Scheme 102). The regioselective iodination was followed by the 
intramolecular C–N bond formation to give indoline 143a in 79% yield. It is worth 
noting that performing each step separately, resulted in the formation of indoline 
143a in a significantly lower overall yield (59%) than for the one-pot process. The 
negation of the need to purify and handle the iodinated intermediate is partly 
responsible for the greater yield for the one-pot process. 
 
Scheme 102: Synthesis of benzoyl protected indoline 143a in a one-pot procedure 
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A range of nitrogen protecting groups were examined to evaluate the most efficient 
nucleophile for the intramolecular Cu(I)-catalysed N-arylation (Scheme 103). Firstly, 
acetyl protected phenylethylamine 122b was an excellent substrate for the one-pot 
process and gave indoline 143b in 87% yield. A 5:1 mixture of rotamers were 
observed in the 1H and 13C NMR spectra of indoline 143b due to restricted rotation 
of the amide C–N bond. Next, both N-Cbz and N-Boc carbamate nucleophiles were 
utilised in the one-pot procedure giving the corresponding indolines 143c and 143d 
in 63% and 56% yield, respectively. The appearance of rotamers was also observed 
for these two compounds however, these were resolved when the 1H and 13C NMR 
spectra were recorded at 100 °C in DMSO-d6. The use of N-sulfonamide 
nucleophiles in the one-pot process resulted in very efficient formation of indolines 
143e and 143f in excellent yields. In particular, the best result was obtained for the 
iodination and cyclisation of N-tosyl phenylethylamine 122f resulting in the 
preparation of indoline 143f in 93% yield. 
 
Scheme 103: One-pot iodination/cyclisation of N-protected 3-methoxyphenylethylamines 
122a–122f 
To gain some understanding of the role of catalysts and reagents in this process, 
some control reactions were performed with 122e. Using FeCl3 (2.5 mol%) and 
[BMIM]NTf2 (7.5 mol%), generating Fe(NTf2)3 in situ, led to full conversion to a single 
regioisomer 144 in 4 h (Table 7, entry 1). It was shown that the aryl ring of N-mesyl 
protected phenylethylamine 122e could undergo electrophilic aromatic iodination 
using NIS, with only [BMIM]NTf2 as a catalyst (entry 2). This reaction was slower 
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overall (7 h) and resulted in a 10:1 mixture of para- and ortho-regiosisomers 
(144:145). Moreover, performing the aryl iodination without the use of the iron(III)-
triflimide catalyst resulted in full conversion after 22 h and again gave a 10:1 mixture 
of 144:145 (entry 3). Thus, for rapid and highly regioselective iodination, iron(III) 
triflimide is required. 
Table 7: Effect of iron and [BMIM]NTf2 in the electrophilic aromatic iodination of 122e 
 
Entry FeCl3 (mol%) [BMIM]NTf2 
(mol%) 
Time (h) Ratio (144: 
145)a 
1 2.5 7.5 4 144 only 
2 n/a 7.5 7 10:1 
3 n/a n/a 22 10:1 
aDetermined using 1H NMR spectroscopy 
Having identified tosyl protected nitrogen as the most suitable nucleophile and 
developed the optimised conditions, the scope of the one-pot iodination and 
cyclisation process was next explored (Scheme 104). Using a range of electron-rich 
N-tosyl phenylethylamines 123a–123e with strong alkoxy directing groups in the 
one-pot process, gave the corresponding indolines 146a–146e as single 
regioisomers, in 69–93% yield. Next, aniline derivatives 124a and 124b were used 
in the one-pot process and gave indolines 146f and 146h in 70% and 55% yield, 
respectively. Acetanilide derivative 125a was also a good substrate for the 
activation/cyclisation process and gave indoline 146h in 64% yield. N-Tosyl 
protected phenylethylamine 125b containing N-acetyl and chlorine substituents 
failed to undergo iodination, even at 70 °C, with only starting material being 
recovered. Using N-bromosuccinimide, full conversion to the brominated 
intermediate was observed at 40 °C. Completion of this one-pot process then gave 
indoline 146i in 43% yield. This one-pot process was also successfully used for the 
synthesis of other benzannulated heterocycles. For instance, iron(III)-catalysed 
iodination and copper(I)-catalysed cyclisation of anisole derivative with an N-
tosylpropylamine side chain 127 gave the 6-membered tetrahydroquinoline 146j in 
I
NHMsNHMsMeO MeONIS, FeCl3 [BMIM]NTf2
toluene, 40 °C
NHMsMeO
+
I
144 145122e
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85% yield while primary amide, 3-methoxyphenylacetamide (129), gave oxindole 
146k in 65% yield. 
 
Scheme 104: One-pot, two-step synthesis of N-heterocycles 
For these indolines to find use as valuable synthetic intermediates towards natural 
products or pharmaceutically relevant compounds, the tosyl protecting group 
required removal to allow further functionalisation of the nitrogen atom. This was 
achieved by treating the N-tosyl indoline 146a with magnesium turnings resulting in 
the removal of the tosyl group, giving indoline 147 in 67% yield (Scheme 105). 
 
Scheme 105: Removal of N-tosyl protecting group of indoline 146a 
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2.3.6 One-Pot Intramolecular Etherification of C–H Bonds 
Following the successful application of the one-pot iron(III)-catalysed iodination and 
copper(I)-catalysed heterocyclisation for the synthesis of N-heterocycles, it was 
proposed that this process could be applied to a series of alcohol substrates for the 
synthesis of O-heterocycles. The transformation of 3-methoxyphenylethan-2′-ol to 
2,3-dihydro-5-methoxybenzofuran (149a) was investigated using the previously 
developed conditions (Scheme 106). The standard conditions for iodination were 
used, leading to full conversion to 148 after 4 h at 40 °C. Investigation of the 1H 
NMR spectra of the crude reaction mixture confirmed that iodination had proceeded 
exclusively at the position para to the methoxy directing group. In the second step, 
a slightly higher temperature (150 °C) was necessary to allow conversion to the 
cyclised product 149a which was then isolated in 65% yield. This requirement for 
harsher conditions may be due to the fact that aliphatic alcohols are less nucleophilic 
than the analogous N-tosyl substrates. 
 
Scheme 106: One-pot iodination/cyclisation of 3-methoxyphenylethan-2′-ol 
Using these conditions, the scope of this one-pot intramolecular C–O bond forming 
process was next explored for the synthesis of a small library of O-heterocycles 
(Scheme 107). A range of substrates with activated aryl rings and primary and 
tertiary alcohol nucleophiles were successfully utilised in the process, giving 2,3-
dihydrobenzofurans 149a–149f in up to 72% yield. Interestingly, tertiary alcohol 133 
gave the corresponding dihydrobenzofuran in 69% yield while the neopentyl alcohol 
134 resulted in no cyclisation. In this case, full conversion to the iodinated 
intermediate was observed however the steric hindrance caused by disubstitution 
in the benzylic position may have prevented oxidative addition of the Cu(I)-species. 
This method did not allow the synthesis of highly strained 4-membered oxetane 
heterocycle 149h with no conversion from the iodinated intermediate observed. 
Application of (3-methoxyphenyl)-propan-3′-ol to the iron(III)/copper(I)-catalysed 
one-pot procedure gave dihydrobenzopyran 149i in 57% yield. Using similar propyl 
alcohols gave similar results and benzopyrans 149j and 149k were isolated in 56% 
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and 51% yield, respectively. The lower yields observed for the benzopyran formation 
was a result of a competing copper(I)-catalysed dehalogenation reaction pathway 
during this more difficult cyclisation. 
 
Scheme 107: One-pot, two-step synthesis of O-heterocycles 
As this methodology was successfully applied to the synthesis of 5- and 6-
membered benzofused heterocycles, it was postulated that 7-membered 
benzoxepine analogues could be prepared in a similar manner. Under standard 
conditions, (3,4-dimethoxyphenyl)butan-4′-ol (141) underwent regioselective 
iodination in 4 h at 40 °C. However, performing the second step using CuI (10 mol%) 
and DMEDA (20 mol%) resulted in the isolation of cyclised product 150 in only 11% 
yield, owing to poor conversion from the iodinated intermediate (Table 8, entry 1). A 
longer reaction time (48 h) resulted in the isolation of benzoxepine 150 in 19% yield 
(entry 2). Using trans-N,N′-dimethylcyclohexane-1,2-diamine as a ligand and a 
longer reaction time (72 h) resulted in formation of trace amounts of 150 with mostly 
copper-catalysed de-halogenation observed (entry 3). 8-Hydroxyquinoline has been 
successfully employed previously as a ligand for a copper-catalysed cyclisation for 
7-membered ring formation.288 For this reason, it was used in the attempted one-
pot synthesis of compound 150 (entry 4). Under these conditions, the result was full 
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conversion from the iodinated intermediate back to the alcohol starting material as 
a result of de-halogenation. As this is a difficult cyclisation process, the catalytic 
loadings of copper iodide and DMEDA were increased to 20 mol% and 40 mol% 
respectively (entry 5). After 72 h at 150 °C, from 1H NMR spectroscopic analysis of 
the crude reaction mixture, there was a 1:1 mixture of the de-halogenated starting 
material 141 and the cyclised product 150 ultimately leading to the isolation of 150 
in only an 8% yield. Despite the attempts, the challenging synthesis of this 7-
membered ring system could not be improved beyond 19% yield. 
Table 8: One-pot synthesis of 7-membered O-heterocycle 150 
 
Entry CuI 
(mol%) 
Ligand Time 
(h) 
Yield 
(%) 
1 10 DMEDA (20 mol%) 20 11 
2 10 DMEDA (20 mol%) 48 19 
3 10 trans-N,N′-dimethylcyclohexane-1,2-
diamine (20 mol%) 
72 n/a 
4 10 8-hydroxyquinoline (20 mol%) 72 n/a 
5 20 DMEDA (40 mol%) 72 8 
It is worth noting that the only previously reported synthesis of 150 was the oxidative 
cyclisation of (3,4-dimethoxyphenyl)butan-4′-ol (141) catalysed by thallium(III) 
trifluoroacetate, mediated by boron trifluoride.289 This resulted in the formation of 
aromatic radical cations followed by intramolecular cyclisation with the internal 
oxygen nucleophile, giving benzoxepine 150 in a low 13.5% yield. 
In an attempt to improve the efficiency of this 7-membered ring formation, the tertiary 
alcohol 152 was synthesised (Scheme 108). This was achieved in 77% yield over 
two steps from carboxylic acid 140 by first converting to methyl ester 151 then 
adding three equivalents of methylmagnesium bromide. The aim of using this 
tertiary alcohol 152 in the one-pot process was to exploit the Thorpe-Ingold effect to 
increase the rate of cyclisation, leading to an overall more efficient approach. 
 NIS, FeCl3 (2.5 mol%)
[BMIM]NTf2 (7.5 mol%)
toluene, 40 °C, 4 h
then CuI, DMEDA 
Cs2CO3, water, 150 °C
150
OH
O
MeO
MeO
MeO
MeO
141
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Instead, there was no conversion to benzoxepine heterocycle 154, with only 
iodinated intermediate 153 being returned. 
 
Scheme 108: Attempted synthesis of benzoxepine derivative 154 
2.3.7 Synthesis of Corsifuran A 
Corsifuran A (155), a metabolite from the Mediterranean liverwort Corsinia 
coriandrina, is an example of a natural product featuring a 2-aryl substituted 2,3-
dihydrobenzofuran scaffold.290 Jones and co-workers reported the first asymmetric 
synthesis of corsifuran A in 2008.291 Their method involved a oxazaborolidine-
catalysed asymmetric reduction and then subsequent Buchwald-Hartwig-type, 
palladium-catalysed intramolecular cross-coupling. Further to this, the Glorius group 
reported the synthesis of corsifuran A via the reduction of the unsaturated 
benzo[b]furan precursor using a ruthenium-catalysed, high-pressure (60 bar) 
hydrogenation mediated with N-heterocyclic carbene ligands.292 Using this 
methodology, they were able to synthesise corsifuran A in 80% yield and 99:1 
enantiomeric ratio (er). 
It was proposed that the iron(III)-catalysed activation and copper(I)-catalysed 
cyclisation would find utility in the synthesis of the dihydrobenzofuran ring system of 
corisfuran A in a one-pot procedure. The proposed retrosynthetic analysis is shown 
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in scheme 109. Synthesis of the 2-aryl 2,3-dihydrobenzofuran ring of corsifuran A 
could be achieved in one-pot using the iron(III)-catalysed iodination followed by 
copper(I)-catalysed etherification process from chiral alcohol 156a. Alcohol 156a 
could be synthesised by employing aspects of the work by Jones and co-workers to 
achieve the asymmetric reduction of ketone 157a using a Corey-Bakshi-Shibata 
(CBS) or other oxazaborolidine catalyst. 
 
Scheme 109: Proposed retrosynthesis of (+)-corsifuran A (155) 
The synthesis of racemic corsifuran A began with the preparation of Weinreb amide 
158 from 3-methoxyphenylacetic acid (128) and N,O-dimethylhydroxylamine using 
EDCI and HOBt as coupling agents (Scheme 110). A Grignard addition was 
performed using 4-methoxyphenylmagnesium bromide, generated in situ, and 
Weinreb amide 158, which gave the aryl ketone 157a in 48% yield. In addition, aryl 
ketones 157b and 157c were synthesised via Grignard addition with the Weinreb 
amide 158. Reduction of the ketone functionality with sodium borohydride gave 
racemic benzyl alcohols 156a–156c in excellent yields. 
O
OMe
MeO
MeO
OH
OMe
MeO
O
OMe
corsifuran A (155) 156a
157a
Intramolecular
C-O bond
formation
Asymmetric 
reduction
 
104 
 
Scheme 110: Synthesis of racemic benzylic alcohols 156a–156c 
Benzylic alcohol 156a was treated with N-iodosuccinimide under standard iron(III)-
catalysed conditions (Scheme 111). The presence of two activated aryl rings in 156a 
led to a complex mixture of products during the iodination step. The mixture was 
subjected to the copper(I)-catalysed C–O cross-coupling which resulted in the 
formation of racemic corsifuran A (155) in only 29% yield. It was thought that, as 
well as aryl iodination para to the methoxy group, iodination of the next most 
activated ortho-position as well as poly-iodination was resulting in a complex mixture 
of products. The regioselectivity was not improved by using N-bromosuccinimide for 
the activation step and again, a complex mixture of multiple compounds was 
obtained. Using secondary benzylic alcohols 156b and 156c, bearing less electron 
rich aromatic rings allowed for exclusive iodination para to the 3-methoxy group and 
the synthesis of 2-aryl 2,3-dihydrobenzofurans 159a and 159b in 64% and 63% 
yield, respectively. 
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Scheme 111: One-pot synthesis of 2-aryl substituted 2,3-dihydrobenzofurans 155,159 
2.3.8 Synthesis of (+)-Obtusafuran 
To demonstrate the versatility and functional group tolerance of the one-pot process 
and further explore its application in natural product synthesis, this method was 
applied to the synthesis of (+)-obtusafuran (118), a neolignan first isolated from the 
heartwood of Dalbergia retusa293 and more recently other Dalbergia species.294–296 
In a study by Frappier and co-workers, (+)-obtusafuran was able to inhibit in vitro 
growth of chloroquine-resistant strain FcB1 of P.falciparum with an IC50 value of 8.7 
µM.294 In addition to its reported antiplasmodial properties, it has been demonstrated 
that (+)-obtusafuran possesses potent anti-carcinogenic activity through its 
induction of quinone reductase, a carcinogen detoxifying enzyme.297 
Racemic obtusafuran had previously been prepared by an acid-catalysed, thermal 
rearrangement of neoflavanoid obtusaquinol as reported by Manners in 1973.298 It 
wasn’t until 2013 that Chen and Weisel at Merck reported the first asymmetric 
synthesis of (+)-obtusafuran.299 This involved the use of an enantioselective 
hydrogenation to produce a chiral alcohol in a dynamic kinetic resolution process. 
This alcohol was then subjected to a copper(I)-catalysed cross-coupling reaction to 
synthesise the trans-substituted dihydrobenzofuran core. More recently, work by 
Morken and co-workers demonstrated a total synthesis of (+)-obtusafuran in 27% 
overall yield (Scheme 112).300 Their methodology involves a enantio- and 
diastereoselective conjunctive cross-coupling of b-alkenylboranate complexes with 
phenyl lithium and aryl bromides in the presence of methylated acenaphthoquinone 
(mac) ligands. This allowed for the preparation of chiral benzylic alcohol 160 in 68% 
yield and 20:1 dr. A palladium-catalysed oxidative cyclisation of 160 followed by 
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removal of the silicon protecting group afforded (+)-obtusafuran (118) in 40% yield 
and greater than 99:1 er. 
 
Scheme 112: Morken’s synthesis of (+)-obtusafuran (118) 
Our strategy involved using the one-pot iron(III)-catalysed iodination/copper(I)-
catalysed intramolecular C–O bond formation to construct the trans-disubstituted 
furan core (Scheme 113). This required the synthesis of chiral benzylic alcohol 161 
by applying a Merck-type enantioselective hydrogenation, involving a base-
mediated dynamic kinetic resolution, to a-methyl phenyl ketone 162.301–303 
 
Scheme 113: Retrosyntheic analysis of (+)-obtusafuran (118) 
The synthesis of (+)-obtusafuran began with an amide coupling of 3-hydroxy-4-
methoxyphenylacetic acid (163) and N,O-dimethylhydroxylamine using EDCI and 
HOBt which gave Weinreb amide 164 in 68% yield (Scheme 114). This was followed 
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by protection of the phenol as a TBDMS ether under standard conditions, giving 
compound 165, in quantitative yield. Addition of phenylmagnesium bromide to 
Weinreb amide 165 at 0 °C gave phenyl ketone 166 in 74% yield. This was followed 
by a-methylation of ketone 166, using LiHMDS and methyl iodide, which gave 
prochiral ketone 167 in good overall yield. 
 
Scheme 114: Synthesis of α-methylketone 167 
This key intermediate 167 was then subjected to the enantioselective hydrogenation 
using the commercially available Noyori-type chiral catalyst, RuCl2[(S)-DM-
Segphos][(S)-DAIPEN] (Scheme 115).302–304 Potassium tert-butoxide is used for 
epimerisation of the α-position of 167, allowing for the interconversion of 
enantiomers through their common enol intermediate. Initially, the hydrogenation 
was performed at 2.5 bar of pressure using 0.15 mol% of the Ru(II)-catalyst, 
however, this resulted in no conversion to chiral benzylic alcohol 168 after 48 h. 
Increasing the pressure to 10 bar resulted in 60% conversion to alcohol product 168 
after 48 h. Finally, using 10 bar of pressure and increasing the loading of the Ru(II)-
catalyst to 2 mol% gave secondary alcohol 168 as a single diastereomer, in 95% 
enantiomeric excess and 64% yield. The enantiomeric excess was determined 
using chiral HPLC, calibrated with the corresponding racemic mixture. 
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Scheme 115: Asymmetric hydrogenation of 167 via dynamic kinetic resolution 
Chiral benzylic alcohol 168 was then applied in the one-pot process (Scheme 116). 
The iron(III)-catalysed iodination required a slightly higher temperature (50 °C) and 
a slightly longer reaction time (7 h) than less functionalised substrates. Again, only 
the para-regioisomer formed and no oxidation of the susceptible benzylic position 
was observed. Following the iodination step, standard copper(I)-catalysed 
conditions were used to form trans-disubstituted benzofuran 169 in 63% yield, in 
one-pot. TBAF was then used for the deprotection of the silyl ether which completed 
the total synthesis of (+)-obtusafuran in 16% yield over 8-steps. The spectroscopic 
data and optical rotation of (+)-obtusafuran (118) were wholly consistent with 
literature values, indicating no epimerisation of either stereocentre. 
 
Scheme 116: Final steps of the total synthesis of (+)-obtusafuran (118) 
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2.3.9 DFT Calculations 
Iron(III)-catalysed activation of the N-protected phenylethylamines and 
phenyethylalcohols gave exclusively the para-iodinated regioisomers and no 
iodination was observed at the most sterically accessible ortho-position or any other 
activated position of the aromatic ring. To rationalise this experimental observation, 
DFT calculations were performed by Hans Martin Senn at the University of Glasgow. 
This study used the Hirshfeld partitioning scheme and electrophilic Fukui functions 
to assess the reactivity of different sites of N-mesyl protected phenylethylamine 
122e towards electrophilic attack (Table 9). The Hirshfeld charges, the difference 
between charge density of a free atom and the atom in a molecule, calculated for 
the unsubstituted aromatic carbons of 122e showed that C-5 was the least 
favourable site for attack by an electrophile (entry 1). However, this method was not 
able differentiate between C-2, C-4 or C-6 as the most nucleophilic site. To 
distinguish these positions, the electrophilic Fukui functions were calculated. These 
functions describe the electron density distribution in a frontier molecular orbital and 
hence allow the prediction of the most electrophilic and nucleophilic sites of a 
molecule. If it is assumed that the reactivity of 122e towards electrophilic aromatic 
substitution is wholly controlled by frontier molecular orbitals, then the Fukui function 
can be approximated by the density of the HOMO. More specifically, the condensed 
Fukui function contracts the Fukui functions to distinct positions (atoms) offering an 
estimation of the orbital coefficients on each aromatic carbon atom, using both 
Mulliken and Hirshfield population analysis. Using this method, the largest 
contribution to the HOMO was found to reside on C-6 and hence this is the most 
nucleophilic site (entries 2 and 3). Further analysis was performed using a “dual 
descriptor” Δf, which combines the separate electrophilic and nucleophilic Fukui 
functions into one descriptor. More positive values of Δf indicate sites for 
nucleophilic attack whereas more negative values show the most likely site for 
electrophilic attack. The Δf values calculated for phenylethylamine 122e fully confirm 
the observed regioselectivity of this electrophilic aromatic iodination undertaken in 
this project (entry 4). 
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Table 9: Reactivity descriptors calculated for the aromatic carbons of 
methoxyphenylethylamine 122e 
 
 
aDFT Calculations were performed using Gaussian 09 with the M06-2X exchange-
correlation functional, def2-TZVP basis set and PCM solvent model for toluene 
Using these computational methods, it was shown that the most nucleophilic site of 
the aromatic ring of 122e is centred around C-6 as the pz atomic orbital of this atom 
makes the largest contribution to the HOMO (Figure 6). 
 
Figure 6: Fukui indices (contribution to the HOMO in %) from Mulliken population analysis 
  
3
4
5
6
1
2
MeO NHMs
122e
Entry Reactivity descriptorsa C-2 C-4 C-5 C-6 
1 qH/e −0.065 −0.071 −0.042 −0.065 
2 f−(qH) 0.082 0.078 0.065 0.140 
3 f−(HOMO) 13 11 6 27 
4 Δf−(HOMO) 7 4 12 −15 
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2.3.10 Conclusions 
By combining the regioselective iron(III)-triflimide-catalysed iodination with a 
copper(I)-catalysed intramolecular C–N and C–O bond forming process, a general 
one-pot method for the synthesis of N- and O-heterocyclic scaffolds was developed 
(Scheme 117). This method uses inexpensive, readily available transition metal-
catalysts and avoids pre-functionalised substrates, as is the requirement with 
traditional Buchwald-Hartwig and Ullmann-type intramolecular couplings. In 
general, this method has no issues with over-iodination and, when using primary 
and secondary benzylic alcohols, no oxidation was observed as may be the case 
with traditional palladium-catalysed methods. The use of this one-pot procedure as 
the key step in preparation of (+)-obtusafuran showed the general utility and 
applicability of this methodology for the total synthesis of natural products. Finally, 
DFT calculations using Fukui functions provided a molecular orbital explanation for 
the high levels of regioselectivity that were observed during the iron(III) triflimide-
catalysed electrophilic aromatic iodination step. 
 
Scheme 117: One-pot, two-step synthesis of functional N- and O-heterocycles 
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2.4 One-Pot, Two-Step Synthesis of Benzo[b]furans 
2.4.1 Introduction 
The benzo[b]furan ring system is a common motif found in many natural products 
and pharmaceutically relevant compounds. Isolated from many plant and marine 
sources, 2-substituted analogues in particular display interesting antimicrobial, 
antifungal and anti-inflammatory properties.305–307 Frondosin B (170), first isolated 
from the marine sponge Dysidea frondosa, is a member of a sesquiterpene family 
found to be an inhibitor of interleukin-8 (IL-8) receptors (Figure 7).308 IL-8 is largely 
responsible for the recruitment and accumulation of neutrophils, implicated in a wide 
range of autoimmune disorders such as rheumatoid arthritis therefore, receptor 
antagonists such as frondosin B are therapeutic lead compounds for the treatment 
of such inflammatory diseases.309,310 For this reason, a number of total syntheses 
of 170 have been reported.311–314 Another example of a benzo[b]furan with 
bioactivity is (−)-machaeriol B (171), a natural product isolated from Machaerium 
multiflorum with potent in vitro antimicrobial and antimalarial activity.315 Vibsanol A 
(172) is a benzo[b]furan-type lignan natural product isolated from the bark of 
Vibumum awabuki with moderate antioxidant properties.316,317 Another natural 
product containing the benzo[b]furan scaffold is ribisin A (173), which has been 
demonstrated to enhance nerve growth factor and hence, is potentially effective in 
the treatment of brain trauma and Alzheimer disease.318,319 In addition, moracin P 
(174), part of the moracin family of natural products, has anticarcinogenic 
properties.320 
 
Figure 7: Benzo[b]furan motif in biologically active compounds 
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As the benzo[b]furan scaffold is ubiquitous in biologically active compounds, 
substantial efforts have been directed to new synthetic methods for their 
preparation.321–323 A common approach involves the O-heterocyclisation of ortho-
alkynylphenols, mediated by transition metals such as palladium,324,325 copper,326 
zinc,327 or indium (Scheme 118).328 This involves π-Lewis acid activation of the 
alkyne functionality, allowing 5-endo-dig cyclisation of the oxygen nucleophile. 
Protodemetalation or reaction with other suitable electrophiles allow for the 
formation of the substituted benzo[b]furan heterocycles. 
 
Scheme 118: O-Heterocyclisation of ortho-alkynylphenols 
A variety of reliable one-pot methods have been developed for the heteroannulation 
of 2-halophenols and alkynes, which combine a palladium-catalysed Sonogashira 
coupling with an in-situ oxidative cyclisation.329 This is widely applicable to a range 
of 2-bromo and 2-iodophenols with various unactivated alkynes, allowing for the 
synthesis of highly functional benzo[b]furans.330–334 As well as the use of expensive 
palladium catalysts, it was shown that this domino Sonogashira/cyclisation-type 
process could also be catalysed by copper(I) iodide with parts per billion quantities 
of palladium or by sub-mol% quantities of Cu(II) pincer complexes.335,336 This 
method has recently been expanded to include the use of less reactive but more 
widely available 2-chlorophenol substrates.337–339 For example, Li and co-workers 
have developed a one-pot method for the synthesis of benzo[b]furans using a 
catalytic system composed of [Pd(η3-C3H5)Cl]2 and a pyridine-derived, 
tetraphosphine ligand (Scheme 119).340 Low catalyst loadings (<0.1 mol%) were 
used with a wide range of halophenol substrates, including chlorophenols. 
 
Scheme 119: Li's Pd-catalysed Sonogashira and cyclisation of 2-halophenols 
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A new approach to benzo[b]furan synthesis which has recently gained attention is 
the ortho-C–H activation/olefination or alkynylation of free phenols followed by 
transition metal-catalysed oxidative cyclisation.341–344 This is typified by Sahoo and 
co-workers who reported a ligand-assisted, palladium-catalysed heteroannulation 
of phenols under basic conditions (Scheme 120).345 This method tolerates a wide-
range of unactivated, internal alkynes, allowing for selective activation and 
functionalisation of the ortho-C–H bonds of phenol substrates, followed by O-
heterocyclisation in a one-pot process. 
 
Scheme 120: Benzo[b]furan synthesis using a C–H functionalisation/cyclisation approach 
While less common, synthesis of benzo[b]furans by formation of the C7a–O bond 
has been reported via transition metal-catalysed cyclisation of 2-haloarylketones. 
This approach was demonstrated by Willis and co-workers, who showed that 
enolates of 1-(2-bromoaryl)ketones could undergo a palladium-catalysed, ligand 
assisted O-arylation, for the synthesis of 2,3-disubstituted benzo[b]furans (Scheme 
121).346 
 
Scheme 121: Willis' Pd-catalysed intramolecular O-arylation of enolates 
Similar reactions of 2-haloarylketones have also been described using non-precious 
copper(I) salts, often requiring high temperature reactions under basic 
conditions.347,348 More recently, Bolm and co-workers demonstrated that iron(III) 
chloride could be used to catalyse this transformation (Scheme 122).349 In their 
study, they examined the catalytic activity of trace metal impurities present in a 
commercial sample of FeCl3. While the use of ultra-pure FeCl3 (99.995%, 10 mol%) 
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gave benzo[b]furan 175 in 79% yield, the use of trace amounts of CuCl2 (0.0088 
mol%, 344 ppm) also gave 175, in 60% yield. 
  
Scheme 122: Bolm's synthesis of benzo[b]furans using iron or copper salts 
The Bolm group had previously focused on the development of cross-coupling 
reactions using purely iron catalysis. To this end, they studied a range of arylation 
reactions using aryl halides with N-nucleophiles, amides, phenols and thiols 
catalysed by a single iron salt.350–354 The optimal results were obtained when using 
FeCl3 (10 mol%) of 98% purity in combination with a chelating, bidentate ligand such 
as DMEDA or THMD (20 mol%). Following this, the group noted a correlation 
between the catalytic activity and the particular iron catalyst they used, where both 
the commercial source and purity determined the efficiency of the cross-coupling 
between N-sulfoximines and aryl iodides.355 This phenomena was also observed by 
the Buchwald group at MIT, compelling Buchwald and Bolm to re-examine the 
coupling reactions using various sources of FeCl3, with purities ranging from 98% to 
99.99%.356 For the coupling of 4-iodoanisole (82a) and pyrazole, the use of FeCl3 
with 98% purity from Merck gave coupled product 88a in 87% yield (Scheme 123). 
Interestingly, using FeCl3 with 98% purity from a different source (Aldrich) led to a 
significant reduction in the yield of 88a (26%) while using FeCl3 (99.99% purity) gave 
88a in only 9% yield. Adding a small quantity of Cu2O (5 ppm) to the reaction mixture 
containing FeCl3 (99.99% purity) led to compete recovery of the efficiency and 88a 
was isolated in 78% yield. Provided the ligand concentration remained constant and 
in large excess, the reaction could be catalysed by trace quantities of Cu2O (5 ppm) 
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in the absence of any iron salt. This gave coupled product 88a in 77% yield, 
demonstrating the very high-catalytic activity of copper salts, even when present in 
trace quantities. This high catalytic activity was further elucidated with additional 
experiments by Norrby and Bolm, showing that catalyst loadings as low as 0.001 
mol% of copper(II) salts were sufficient to give coupled products in excellent 
yields.357 A detailed kinetic study of the N-arylation of pyrazole with phenyl iodide 
then demonstrated the critical necessity of DMEDA in this process, a unique ligand 
which allows high conversion at very low concentration of metal catalyst.358 
 
Scheme 123: Metal salts in cross-coupling reactions 
2.4.2 Project Aims 
The main aim of this project was the development of a one-pot method for the 
synthesis of highly substituted benzo[b]furans from simple 1-aryl or 1-alkylketones, 
avoiding the need to pre-halogenate the ketone starting materials. This method was 
to involve a highly regioselective iron(III)-catalysed electrophilic aromatic 
halogenation followed by transition metal-catalysed C–O cyclisation (Scheme 124). 
Building on the work by Bolm and co-workers, the potential for a single iron(III) salt 
to catalyse both the aryl C–H halogenation step and the intramolecular O-arylation 
step in a tandem process would be investigated. In addition to this, with the 
knowledge that even trace quantities of copper salts are highly catalytically active, 
homeopathic, parts per million copper loadings of copper will be examined for the 
C–O cyclisation step. 
 
Scheme 124: Proposed one-pot synthesis of benzo[b]furans 
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An important objective of this project was to establish quick and efficient synthetic 
routes towards 1-aryl and 1-alkylketone substrates. With this achieved, the scope 
of the one-pot process would examine the impact of different electronic and steric 
properties of the ketone substrates. The methodology would then be applied to the 
synthesis of natural products and biologically active compounds containing the 
benzo[b]furan unit, such as corsifuran C (176), the antimicrobial agent caleprunin B 
(177) and the antifungal compound moracin F (178) (Figure 8). 
 
Figure 8: Biologically active benzo[b]furan targets 
2.4.3 Synthesis of Ketone Substrates 
To begin this study, a series of 1-aryl or 1-alkylketones were synthesised from 
commercially available starting materials. The initial approach proposed to access 
the required α-arylketone substrates for the one-pot process was via a Weinreb 
amide intermediate (Scheme 125).359 For example, 3-methoxyphenylacetic acid 
(128) was converted to Weinreb amide 158 under standard amide coupling 
conditions, then subsequent reaction with 4-chlorophenylmagnesium bromide 
allowed the multigram-scale synthesis of ketone 157b in 93%. Using other 
commercially available Grignard reagents and Weinreb amides 158 and 179, this 
process was extended for the synthesis of a series of 1-aryl and 1-alkylketones 
157c, 180a–180c. 
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Scheme 125: Synthesis of 1-aryl and 1-alkylketones via a Weinreb amide 
While this was an efficient and mild method for the synthesis of some aryl ketones, 
it was restricted by the expense and limited commercial availability of Grignard 
reagents. Therefore, other methods for the preparation of Grignard reagents in situ 
from widely available aryl bromides were sought. The reaction of 2-bromomesitylene 
with magnesium turnings resulted in the formation of 2-mesitylmagnesium bromide 
(Scheme 126). Addition of the magnesium reagent to Weinreb amide 158 resulted 
in no conversion to the aryl ketone, despite a 70 °C reaction temperature for 24 h. 
After work-up of the reaction mixture, the 1H NMR spectra of the crude material 
showed a mixture of unreacted Weinreb amide 158 and mesitylene. This suggests 
that the steric bulk associated with ortho,ortho-methyl substituents prevented 
addition of the Grignard reagent. 
 
Scheme 126: Attempted synthesis of a hindered α-aryl ketone by in-situ formation of a 
Grignard reagent 
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with aryl halides in a magnesium-halogen exchange reaction (Scheme 127). This 
reaction was attempted with various electron-rich and electron-deficient aryl 
bromides and iodides however, in all cases only complex mixtures of unidentified 
by-products were observed. 
 
Scheme 127: Attempted synthesis of α-aryl ketones via magnesium-halogen exchange 
reactions 
Alternative methods for the synthesis of α-arylketone were then investigated. 
Consequently, it was found that α-aryl ketones could be synthesised directly from 
phenylacetic acids via a Claisen condensation with various functionalised aryl esters 
(Scheme 128). This method utilised readily available starting materials and avoided 
the use of the expensive or unstable organometallic reagents. This method was 
applicable to aromatic esters, with electron-deficient substituents in the o-, m- and 
p-positions, and allowed the synthesis of a range of α-arylketones 181a–181e in up 
to 73% yield. 
 
Scheme 128: Claisen condensation 
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The proposed mechanism for this Claisen condensation reaction is shown below 
(Scheme 129). Firstly, treatment of 3-methoxyphenylacetic acid (128) with the 
hindered base, LiHMDS, results in rapid removal of the most acidic carboxylic acid 
proton and formation of the lithium carboxylate salt. A further equivalent of LiHMDS 
then performs subsequent deprotonation at the α-position to give the lithium enolate, 
which can in turn perform nucleophilic attack of the methyl ester, resulting in the 
formation of 1,3-dicarbonyl intermediate 182. This β-ketoacid lithium carboxylate 
salt can undergo decarboxylation, producing lithium enolate 183. A mildly acidic 
work-up with ammonium chloride followed by keto-enol tautomerism affords the 
desired 1-arylketones. 
 
Scheme 129: Mechanism of the Claisen condensation 
Friedel-Crafts acylation reactions were employed to synthesise a further small 
library of α-arylketones (Scheme 130). To achieve this, 3-methoxyphenylacetic acid 
(128) was converted into the corresponding acyl chloride by reaction with thionyl 
chloride. Subsequent electrophilic aromatic substitution with anisole using 
stoichiometric quantities of aluminium trichloride gave aryl ketone 157a in 80% yield. 
Following this, a range of phenylacetic acid substrates were subjected to these 
conditions which allowed for the preparation of arylketones 184a–184d using either 
anisole or mesitylene. 
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Scheme 130: Friedel-Crafts acylation 
To synthesise a small library of arylketones with nitrogen directing groups attached 
to the α-aryl ring, the nitro group of ketone 184d was reduced using tin(II) chloride, 
which gave aniline compound 165 in 86% yield (Scheme 131). The amino 
functionality of 185 was then protected with synthetically useful protecting groups, 
such as Cbz, Boc and acetamide, which gave arylketones 186a–186c. 
 
Scheme 131: Synthesis of α-arylketones with nitrogen directing groups 
Aldehyde 188, an additional substrate for the one-pot process, was synthesised by 
oxidation of phenylethyl alcohol 187 using Dess-Martin periodinane (Scheme 132). 
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Scheme 132: Oxidation of 3,4-dimethoxyphenylethyl alcohol (187) 
A further series of ketone substrates were prepared via a palladium-catalysed α-
arylation reaction using a procedure by Buchwald and co-workers (Scheme 133).361 
Under basic conditions and in the presence of Pd2(dba)3 and an electron rich 
phosphine ligand (xantphos), cyclohexanone, α-tetralone or cycloheptanone were 
reacted with 3-iodoanisole and gave α-arylated ketones 189a–189c in moderate 
yields. The ketone starting materials were used in excess (2 equivalents) in this 
reaction and led to difficultly in purifying the products, which had similar retention on 
silica gel. This resulted in lower overall yields of the coupled products. 
 
Scheme 133: Palladium-catalysed α-arylation of cyclic ketones 
2.4.4 Optimisation of One-Pot Processes 
Initial studies of the one-pot synthesis of benzo[b]furans applied iron(III)-catalysed 
iodination then copper(I)-cyclisation to α-arylketone 157b (Scheme 134). Using 
iron(III) triflimide for the activation of NIS resulted in iodination of 157b in 4 h at 40 
°C. Despite the substantial steric effect of the meta-arylethanone substituent, 
analysis of the 1H NMR spectrum of the crude reaction mixture revealed exclusive 
iodination at the C-6 position. The second-step of the one-pot process involved the 
use of copper(I) iodide (10 mol%) and DMEDA (20 mol%), which allowed the 
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isolation of benzo[b]furan 190a in 59% yield. Using different ligands in the copper(I)-
catalysed cyclisation had no discernible effect upon the efficiency or isolated yield. 
For example, the use of diketone ligand 94 and cyclohexanediamine ligand 98 
during the second step of the one-pot process gave benzo[b]furan 190a in 53% and 
55% yield, respectively. 
 
Scheme 134: Initial synthesis of benzo[b]furan 190a from α-arylketone 157b 
Next, it was investigated whether a single iron salt could be used for both the 
electrophilic aromatic substitution and cyclisation steps in a tandem-catalytic, one-
pot process (Table 10). Use of FeCl3 (2.5 mol%) of 97% purity during the one-pot 
process, allowed for formation of benzo[b]furan 190a, without the addition of 
copper(I) iodide in the second step (entry 1). A complication arose when it was 
discovered that all grades of commercial FeCl3 contain significant amounts of metal 
contaminants, including sufficient levels of copper to catalyse the O-arylation step. 
For example, FeCl3 with 99.9% impurity has 31.1 ppm of Cu while 99.99% FeCl3 
contains 24.1 ppm of Cu impurities. The levels of copper impurities specified in the 
batch analysis of commercial samples of FeCl3 was verified using inductively 
coupled plasma-atomic emission spectroscopy (ICP-AES). However, this offered 
the prospect to develop a one-pot procedure using a single iron complex in which 
the residual ppm quantities of copper could be used to catalyse the cyclisation. The 
use of FeCl3 (2.5 mol%) of 99.9% purity gave the corresponding benzo[b]furan 190a 
in 44% yield (entry 2). Doubling the catalytic loading of FeCl3 to 5 mol% resulted in 
a more efficient cyclisation, giving 190a in 60% yield (entry 3). Further increasing 
the loading of FeCl3 to 10 mol% resulted in a marginal increase in the yield of 190a 
to 63% (entry 4). In contrast, a reduction of the catalyst loading to 1 mol%, resulted 
in a reduction in yield of 190a to 47% (entry 5). With a purer source of FeCl3 
(99.99%), containing 24.1 ppm of copper impurities, benzo[b]furan 190a was 
isolated in 65% yield (entry 6). Based on these results, the use of FeCl3 (99.9% 
purity) at 5 mol% loading was deemed optimal for the one-pot process involving 
iron(III)-catalysed iodination, followed by cyclisation, catalysed by residual copper. 
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Ultrapure iron(III) salts were next investigated to discover whether a single iron 
complex (not contaminated by copper), could be used for the entire one-pot process. 
As ultrapure iron(III) chloride is not commercially available, alternative sources of 
iron were used. When iron(III) oxide (99.995% purity) was used, the iodination step 
was very sluggish, eventually reaching 70% conversion after 72 h at 70 °C. The 
subsequent cyclisation step was efficient however, giving benzo[b]furan 190a in 
35% yield (entry 7). Ultrapure iron(III) nitrate nonahydrate, which contains no copper 
impurities, in combination with [BMIM]NTf2 was found to be an effective Lewis acid 
for regioselective iodination with full conversion to the iodide intermediate after 5 h 
at 40 °C. Using only this iron complex for the entire one-pot process gave 
benzo[b]furan 190a in 55% yield (entry 8). 
Table 10: Optimisation of the metal catalyst for the synthesis of benzo[b]furan 190a 
 
Entry Iron Catalyst Catalyst 
Loading 
(mol%) 
Catalyst 
Purity (%) 
Copper 
Impurities 
(ppm) 
Isolated 
Yield (%) 
1 FeCl3 2.5 97 n/a 48 
2 FeCl3 2.5 99.9 31.1 44 
3 FeCl3 5 99.9 31.1 60 
4 FeCl3 10 99.9 31.1 63 
5 FeCl3 1 99.9 31.1 47 
6 FeCl3 5 99.99 24.1 65 
7 Fe2O3 5 99.995 1.6 35 
8 Fe(NO3)3•9H2O 5 99.999 ND 55 
The effect of the ligand and temperature during the cyclisation step were 
investigated using the optimal procedure involving 5 mol% loading of FeCl3 (99.9% 
purity) (Table 11). Using 2-isobutyrylcyclohexanone (94) and trans-N,N′-
dimethylcyclohexane-1,2-diamine (98) resulted in less efficient cyclisation reactions, 
giving benzo[b]furan 190a in 24% and 44% yield, respectively (entries 1 and 2). It 
O O
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[BMIM]NTf2 
toluene, 40 °C, 3–72 h
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water, 130 °C, 16 h
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MeO
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was found that no conversion to 190a was observed in the absence of a ligand (entry 
3), demonstrating that a relatively high ligand loading (10 mol%) was necessary for 
activity. A reduction of the cyclisation temperature led to lower conversion to 
benzo[b]furan 190a, with yields of 35% and 13% at 110 and 90 °C, respectively, 
proving that a high reaction temperature was critical to overcome the energy penalty 
associated with oxidative addition (entries 4 and 5). Based on these results, the 
optimal ligand for cyclisation was DMEDA (89) and a reaction temperature of 130 
°C. 
Table 11: Optimisation of benzo[b]furan formation 
 
Entry Ligand Temperature 
(°C) 
Isolated 
Yield (%) 
1 94 130 24 
2 98 130 44 
3 none 130 0 
4 89 110 35 
5 89 90 13 
Next, the single step heterocyclisation of a 1-(2-haloaryl)ketone was performed, to 
verify that ppm quantities of copper could catalyse this transformation. To achieve 
this, aryl iodide 191 was prepared by the reaction of aryl ketone 157b with NIS using 
Fe(NTf2)3 (2.5 mol%) under standard conditions (Scheme 135). 
O O
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Scheme 135: Synthesis of aryl iodide 191 
The single step cyclisation of iodide 191 was then performed using CuI (0.001 
mol%), with a concentration of 14 ppm (Scheme 136). The 1H NMR spectrum of the 
crude reaction mixture after 24 h showed 74% conversion to benzo[b]furan 190a. 
On isolation, this gave 190a in 56% yield. 
 
Scheme 136: Ultra-low loading of CuI in the synthesis of benzo[b]furan 190a 
There was a concern that trace copper impurities may be introduced during the 
cyclisation step, through the addition of reagents or solvents (e.g. water), or already 
present from the glassware. To eliminate this possibility, a reaction was performed 
with aryl iodide 191 using DMEDA (10 mol%), cesium carbonate in toluene and 
water under standard cyclisation conditions (Scheme 137). This resulted in no 
conversion to 190a. These results confirmed that O-arylation reaction during the 
one-pot processes was catalysed by ultrapure iron(III) or the associated copper 
impurities of the lower grade iron(III) chloride salts and not via the introduction of 
trace quantities of copper salts during the second step. 
 
Scheme 137: Attempted synthesis of benzo[b]furan 190a with no metal catalysts 
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2.4.5 Substrate Scope of One-Pot Processes 
The optimised one-pot process involving iron(III) chloride (5 mol%, 99.9% purity) to 
catalyse the iodination step and the residual copper (31.1 ppm) to catalyse the 
intramolecular O-arylation step was applied to the series of arylketones (Scheme 
138). 1-Arylketone substrates with electron-deficient groups, as well as ortho-, meta- 
and para-substituents were tolerated in this process and gave benzo[b]furans 190a–
190f in 60–73% yield. Ketone substrates with electron-rich aryl groups were also 
efficient substrates of this process and allowed for the synthesis of benzo[b]furans 
190g–190k in 62–75% yield. Using mesityl substituted ketone 184a in the one-pot 
process required a longer reaction time (48 h) during the cyclisation step, due to the 
steric hindrance of the two ortho-methyl groups. Despite the more forcing conditions, 
this still led to the isolation of 190i in 75% yield. The one-pot process was also used 
for the efficient synthesis of corsifuran C (176), a stilbenoid natural product from 
Corsinia coriandrina,290 in 74% yield from aryl ketone 157a. The one-pot process 
was also performed with electron-deficient (p-CF3Ph, 181d) and electron-rich (p-
MeOPh, 157a) arylketone substrates using ultrapure iron(III) nitrate nonahydrate to 
catalyse both steps. Without the presence of trace copper impurities, benzo[b]furans 
190e and 176 were isolated in 55% and 41% yield, respectively. 
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Scheme 138: Scope of one-pot synthesis of benzo[b]furans using FeCl3 (99.9% purity); 
aIsolated yield using Fe(NO3)3•9H2O (5 mol%) 
The one-pot process was next used for the gram-scale synthesis of corsifuran C 
(176) (Scheme 139). Although the use of ppm loading of copper was sufficient to 
catalyse the heterocyclisation step of a small-scale reaction and gave 176 in 74% 
yield, it was necessary to use CuI (10 mol%) to increase the efficiency of the reaction 
of a larger scale process. This resulted in the isolation of corsifuran C in 84% yield. 
 
Scheme 139: Gram-scale synthesis of corsifuran C (176) 
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rings or alkyl side chains (Scheme 140). The synthesis of some of these 
benzo[b]furans were initially investigated using the one-pot process involving 
iron(III) chloride (5 mol%, 99.9% purity) with ppm loading of copper. However, this 
required longer reaction times (48–72 h) and resulted in low yields (26–32%). 
Consequently, the addition of copper(I) iodide during the cyclisation step was 
investigated for the efficient synthesis of these substrates. It was found that the use 
of FeCl3 (97% purity) at 5 mol% loading followed by CuI at 10 mol% loading was the 
most efficient catalytic system for these substrates. Amino-substituted 
benzo[b]furans 192a–192c bearing carbamate and acetyl protecting groups were 
prepared in 45–65% yield. The use of 3-amino substituted ketone 185 as a substrate 
gave benzo[b]furan 192d in only 28% yield. Analysis of the 1H NMR spectrum of the 
crude reaction mixture showed that this was due to competing iodination at the C-4 
position. 1-Methyl ketone 180c and aldehyde 188 were also tolerated in the one-pot 
process and gave benzo[b]furans 192e and 192f in 54% and 40%, respectively. 
Cyclic ketones 189a–189c were also submitted to the one-pot process and allowed 
for the efficient preparation of polycyclic benzo[b]furans 192g–192i in 53–61% yield. 
 
Scheme 140: Scope of the one-pot synthesis of benzo[b]furans using FeCl3 (97% purity) and 
CuI (10 mol%); aIodination step was performed at 50 °C for 6 h 
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It is worth noting that limitations were observed during the development of this 
methodology using unactivated 1-arylketones. In particular, halogenation of 3-
methylphenyl substituted aryl ketone 180b did not proceed under standard 
conditions, with NIS or NBS, using FeCl3 (5 mol%) and [BMIM]NTf2 (15 mol%) even 
at 70 °C with an extended reaction time (24 h) (Scheme 141). This substrate 
required the use of the ionic liquid as a solvent and harsh conditions (70 °C for 16 
h), which gave an inseparable 4:1 mixture of the desired 6-iodo and undesired 4-
iodo regioisomers (193:194). 
 
Scheme 141: Iodination with a methyl directing group 
After filtration through a short-pad of silica, this 4:1 mixture of regioisomers was 
submitted to a copper-catalysed cyclisation using CuI (10 mol%) and DMEDA (20 
mol%) (Scheme 142). This led to the isolation of benzo[b]furan 195 in 26% yield 
over the two steps. 
 
Scheme 142: Synthesis of benzo[b]furan 195 
2.4.6 Synthesis of Biologically Active Benzo[b]furans 
Having developed scalable, robust one-pot processes, attention shifted towards 
utilising this methodology for the total synthesis of a number of benzo[b]furan natural 
products. It should be noted that these one-pot processes were more efficient for 
the synthesis of electron-rich benzo[b]furans and the regioselectivity during the 
electrophilic aromatic substitution step was contingent on the presence of a strong 
methoxy or amino directing group. Fortunately, this type of benzannulated system 
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is widely found in pharmaceutically important compounds and natural products 
(Figure 9). 
 
Figure 9: Bioactive benzo[b]furan target compounds 
Compound 196 has nanomolar affinity of β-amyloid plaques and hence has potential 
utility as a PET tracer for patients with neurodegenerative diseases such as 
Alzheimer’s disease.362,363 The synthesis began with a Claisen condensation 
between 3-methoxyphenylacetic acid (128) and methyl 4-nitrobenzoate using 
LiHMDS and the conditions previously reported (Scheme 143). Analysis of the 1H 
NMR spectra of the crude reaction mixture showed a complex mixture of by-
products. It was believed that the lithium base can deprotonate the ortho-position 
relative to the nitro group and the resulting lithium species could react with the ester 
functionality, resulting in oligomerisation and other undesired side reactions. 
Furthermore, organolithium reagents can also attack the electrophilic nitrogen atom 
of the nitro group, in a similar manner to the Bartoli indole synthesis.364 By 
performing the addition of reagents at −78 °C, then warming to −20 °C in THF, 
allowed the isolation of arylketone 198 in 17% yield. To improve this process, 
different bases were screened, such as n-BuLi and NaH, however this did not 
improve the reaction outcome. Following this, alternative methods were trialled for 
the efficient synthesis of arylketone 198. Firstly, a Bamford-Stevens homologation 
of 4-nitrobenzaldehyde was attempted via the in situ formation of an 
aryldiazomethane of m-anisaldehyde using tosyl hydazone.365 As well as this, a 
palladium-catalysed α-arylation of 4-nitroacetophenone with 3-iodoanisole was 
attempted. However, both reactions resulted in a complex mixture with no formation 
of arylketone 198 evident. It was therefore decided to proceed with arylketone 198 
generated from the low yielding Claisen condensation. Treatment of 198 with NIS 
using iron(III) triflimide (5 mol%) resulted in full conversion to the aryl iodide 
intermediate in 3 h at 40 °C. Subsequent O-heterocyclisation, catalysed by the 
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homeopathic quantities of copper residues, allowed the isolation of benzo[b]furan 
199 in 63% overall yield. Finally, the nitro group of 199 was reduced with tin 
dichloride in 90% yield, which completed the total synthesis of biologically active 
benzo[b]furan 196. 
 
Scheme 143: Synthesis of β-amyloid plaque antagonist 196 
2.4.7 Total Synthesis of Caleprunin B 
This methodology was then used as the key step in the total synthesis of caleprunin 
B (177), a 2-acetylbenzo[b]furan natural product isolated from Eupatorium 
sternbergianum and various Calea species.366,367 Caleprunin B was also shown to 
have activity against a range of microorganisms, including several strains of E. 
coli.368 The synthesis began with formation of Weinreb amide 201 from 3,4-
dimethoxyphenylacetic acid (200) under standard conditions using EDCI and HOBt 
(Scheme 144). Weinreb amide 201 was then reacted with ethylmagnesium bromide 
to give ethylketone 202 in 94% yield. 
 
Scheme 144: Preparation of ethylketone 202 using the Weinreb amide approach 
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With ethylketone 202 in hand, the use of the one-pot process for the key cyclisation 
step was next investigated (Scheme 145). As alkylketones were previously shown 
to be better substrates for the one-pot process involving the addition of copper(I) 
iodide during the second step, this was also used for ethylketone 202. Activation of 
the aryl ring using the iron(III)-catalysed iodination led to the formation of a single 
regioisomer in 3 h at 40 °C. Following this, the intramolecular O-arylation step was 
carried out using copper iodide (10 mol%) and DMEDA (20 mol%), which gave 
benzo[b]furan 203 in 64% yield. 
 
Scheme 145: One-pot synthesis of benzo[b]furan 203 
To complete the synthesis of caleprunin B, an allylic oxidation of benzo[b]furan 203 
was required. There was very limited literature precedent for this transformation 
therefore a range of reagents and conditions were investigated (Table 12). 
Treatment of benzo[b]furan 203 with the 2KHSO5•KHSO4•K2SO4 triple salt, known 
as Oxone®, resulted in only decomposition of the starting material (entry 1).369 Using 
sodium dichromate in a mixture of concentrated acetic and sulfuric acids gave 
similar results, with only decomposition of 203 (entry 2).370 The reaction of 203 with 
m-CPBA also led to a complex mixture of side-products which could not be 
separated or characterised (entry 3).371 An attempt to selectively brominate, then 
hydrolyse, the allylic position via a radical halogenation using NBS and AIBN 
resulted in only bromination of the C-3 position of the benzo[b]furan ring (entry 4).372 
Selenium dioxide has previously been used in similar transformations, in particular, 
for the oxidation of the allylic position of pyrones.373 When using selenium dioxide 
(3 equiv.), the desired product could be observed by 1H NMR spectroscopy of the 
reaction mixture, however, this also resulted in the Riley oxidation374 of the α-
position giving a 1:1 mixture of 177 and the 1,2-dicarbonyl (entry 5). 
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Table 12: Screened conditions for allylic oxidation 
 
Entry Reagents and conditions Result 
1 Oxone® (2.2 equiv.), KBr (0.5 equiv.), MeCN (6:1) 
50 °C, 48 h 
Decomposition 
2 Na2Cr2O7, AcOH, H2SO4, 0 °C to rt, 16 h Decomposition 
3 m-CPBA, NaHCO3, CH2Cl2, 0 °C to rt, 16 h Decomposition 
4 NBS, AIBN, CaCO3, CHCl3, reflux, 2 h C-3 bromination 
5 SeO2 (3 equiv.), 1,4-dioxane, reflux, 20 h Not purified 
From these results, it was clear that the selenium dioxide mediated oxidation was 
the most promising method for this hitherto unprecedented step. To limit the 
undesired oxidation of the α-position of 177, fewer equivalents of selenium dioxide 
(1.5 equiv.) were used, the addition of reagents was performed at 0 °C and the 
reaction time was reduced to 6 h (Scheme 146). More specifically, SeO2 was added 
at 0 °C and then stirred at room temperature for 4 h. No conversion of the starting 
material was observed after this time therefore, the reaction mixture was stirred 
under reflux for 2 h. This allowed isolation of secondary alcohol 204 in 42% yield, 
with only traces of ketone 177 evident. Alcohol 204 was then treated with Dess-
Martin periodinane, however, this led to the formation of a complex mixture, possibly 
due to undesired oxidation of the electron rich aromatic system. 
 
Scheme 146: Attempted synthesis of caleprunin B via Dess-Martin oxidation 
Next, using SeO2 but heating under reflux from the beginning resulted in complete 
consumption of the starting material in 3 h, giving a 1.2:1 mixture of 184 and 157 
(Scheme 147). The crude mixture was submitted to a Swern oxidation conditions 
which gave caleprunin B (157) in 20% yield over the two-steps. 
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Scheme 147: Attempted synthesis of caleprunin B via Swern oxidation 
Finally, it was found that treating benzo[b]furan 203 with SeO2 (1.5 equiv.) and 
simply extending the reaction time to 22 h under reflux, allowed for full conversion 
to ketone 177, by way of intermediate alcohol 204 (Scheme 148). These conditions 
gave caleprunin B (177) in 56% yield, completing the total synthesis. 
 
Scheme 148: Allylic oxidation of benzo[b]furan 203 
2.4.8 Total Synthesis of Moracin F 
Moracin F (178), part of the larger family of moracin natural products, was first 
isolated from acetone extracts of mulberry shoots infected with Fusarium solani and 
has demonstrated promising antifungal activity.375,376 The only known total synthesis 
of moracin F was reported by Jun and co-workers who developed a diversity-
orientated method with four different approaches employed as key steps.377 It was 
proposed that the one-pot iodination and O-arylation process could be applied to 
ketone 205, for the rapid and efficient synthesis of moracin F (Scheme 149). 
 
Scheme 149: Proposed synthesis of moracin F using iron- and copper-catalysed one-pot 
process 
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To begin this synthesis, 3,5-dihydroxyphenol (206) was converted to the 
corresponding methyl ester 207 in 88% yield using catalytic quantities of 
concentrated sulfuric acid in methanol under reflux (Scheme 150). The hydroxyl 
groups were protected using TBDMSCl under standard conditions and gave 208 in 
81% yield. The Claisen condensation of ester 208 with carboxylic acid 200 using 
LiHMDS, gave arylketone 209 in 62% yield. 
 
Scheme 150: Synthesis of TBDMS protected ketone 209 
Cyclisation of arylketone 209 was then investigated using the optimal one-pot 
process for arylketones, specifically the use of iron(III) chloride for activation and 
copper residues for the cyclisation step. Initially, arylketone 209 was reacted with 
NIS using Fe(NTf2)3 (5 mol%) at 40 °C for 4 h (Scheme 151). Analysis of the 1H 
NMR spectrum of the crude reaction mixture revealed a 4:1 ratio of desired mono-
iodinated regioisomer 210 and di-iodinated material 211. The minor component of 
the mixture displayed two doublets with a 2.5 Hz meta coupling constant, showing 
that iodination had occurred para to one of the silyl ether groups. In addition, a mass 
ion equal to 791, corresponding to di-iodinated compound (211) plus a sodium ion, 
was detected by electrospray mass spectrometry analysis of the crude reaction 
mixture. Despite the formation of two compounds, the reaction mixture was then 
submitted to the cross-coupling step, catalysed by the trace copper impurities 
present in the iron(III) catalyst. This resulted in the formation of benzo[b]furan 212 
in only 36% yield. Alongside the selectivity issues experienced in the iodination step, 
the low yield was attributed to some mono-deprotection of the silyl ether. Attempts 
to prevent poly-iodination of ketone 209 by the reduction of the catalytic loading of 
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iron(III) triflimide to 2.5 mol% and a shorter reaction time of 3 h, resulted in no 
change to the product ratio and did not lead to an improvement in the yield of 212. 
 
Scheme 151: Synthesis of benzo[b]furan 212 using TBDMS protecting groups 
To overcome these selectivity and stability issues, a bulkier and less labile silyl 
protecting group, the TBDPS ether was used instead. To synthesise the required 
ketone substrate, methyl 3,5-dihydoxybenzoate (207) was reacted with TBDPSCl in 
the presence of imidazole and catalytic quantities of DMAP, which gave protected 
ester 213 in 60% yield (Scheme 152). A Claisen condensation between 3,4-
dimethoxyphenylacetic acid (200) and ester 213, followed by low temperature 
decarboxylation gave aryl ketone 214 in 55% yield. 
 
Scheme 152: Synthesis of TBDPS-protected arylketone 214 
O
MeO
MeO
OTBDMS
OTBDMS
MeO
MeO O
OTBDMS
OTBDMS
I
212
MeO
MeO O
OTBDMS
OTBDMS
209
[BMIM]NTf2 (15 mol%)
toluene, 40 °C, 4 h
DMEDA (10 mol%)
Cs2CO3, water
130 °C, 20 h, 36%
R
NIS, FeCl3 (5 mol%)
 4:1
210 (R = H): 211 (R = I)
HO
OH
CO2Me
207
TBDPSCl
imidazole
DMAP, THF
rt, 16 h, 60%
TBDPSO
OTBDPS
CO2Me
MeO
MeO O
OTBDPS
OTBDPS
214
213
LiHMDS, DMF
−10 °C, 3 h, 55%
200
MeO
MeO
CO2H
 
138 
The one-pot process was then performed using arylketone 214 (Scheme 153). The 
iodination step was catalysed using iron(III) chloride (5 mol%, 99.9% purity) and 
[BMIM]NTf2 (15 mol%), and was complete in 5 h at 40 °C. No iodination was 
observed of the sterically congested TBDPS-protected 3,5-disubstitued aryl ring, 
with reaction occurring exclusively at the C-6 position, para to the methoxy group. 
The following O-arylation was catalysed by the trace copper salts, assisted by 
DMEDA (10 mol%), and gave benzo[b]furan 215 in 55% yield. The total synthesis 
was completed with TBAF mediated removal of the silyl protecting groups, which 
gave moracin F (178) in 69% yield. 
 
Scheme 153: Final steps in the synthesis of moracin F 
2.4.9 Attempted Synthesis of Eupomatenoid 6 
The next target natural product containing the benzo[b]furan scaffold was 
eupomatenoid 6, a neolignan isolated from several plant species including Piper 
decurrens.378,379 A previous five-step synthesis of eupomatenoid 6 used a [3,3]-
sigmatropic rearrangement of an aryl oxime ether, derived from a simple 
aryloxyamine as the key step for the construction of the 2-arylbenzo[b]furan core.380 
The planned retrosynthesis of this project is shown in Scheme 154. This strategy 
involved the conversion of aniline 216 into the corresponding diazonium salt and 
then the employment of this for a cross-coupling reaction with a trans-
propenyltrifluoroborate potassium salt. Aniline 216 could be synthesised from α-
methyl phenyl ketone 217 using the one-pot iron(III)-catalysed iodination/copper(I)-
catalysed intramolecular O-arylation, with the amino group serving as a directing 
group. Ketone 217 could be synthesised in two-steps from 184b by methylation, 
followed by reduction of the nitro functionality. 
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Scheme 154: Retrosynthesis of eupomatenoid 6 (197) 
Ketone 184d, previously synthesised using a Friedel-Crafts acylation with 3-
nitrophenylacetic acid and anisole, was methylated using LiHMDS and methyl 
iodide, which gave 218 in 95% yield (Scheme 155). Tin dichloride was then used for 
the chemoselective reduction of the nitro group. This gave aniline 217 in 79% yield. 
 
Scheme 155: Synthesis of α-methylketone 217 
The key one-pot iron(III)-catalysed iodination and copper-catalysed C–O bond 
forming process was investigated using α-methylketone 197 (Table 13). Treatment 
of 217 with NIS, iron(III) chloride (5 mol%) and [BMIM]NTf2 (15 mol%) at 40 °C 
resulted in the formation of the 6-iodo regioisomer, 219 and the di-iodinated 
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compound, 221 in a 1.3:1 ratio (entry 1). The reaction conditions were optimised to 
minimise di-iodination of the very active aniline ring of 217. Reduction of the reaction 
temperature had no effect upon the ratio of 219 and 221 (entry 2). To slow the rate 
of reaction, the catalyst loading of FeCl3 was reduced to 2.5 mol% however, this 
only led to a marginal decrease in the observed di-iodination, with 219 and 221 
obtained in a 2:1 ratio (entry 3). The reaction was repeated but instead, the addition 
of reagents was performed at −10 °C and warmed to room temperature over 2 h. 
This resulted in the formation of the desired mono-regioisomer 219 and di-iodinated 
compound 221 in a 2.6:1 ratio (entry 4). As this aniline substrate was very active 
towards electrophilic aromatic substitution, the reaction was carried out without the 
Lewis acid catalyst. This prevented the formation of the di-iodinated compound 
however, the slower reaction led to the formation of a mixture of desired 6-iodo 
regioisomer 219 and undesired 4-regioisomer 220 in a 1.4:1 ratio (entry 5). It was 
clear that the Lewis acid catalyst was essential to increase the reaction rate and 
avoid the formation of the undesired 4-iodo regioisomer. The challenge now was to 
optimise the reaction conditions to achieve a reaction rate which, while not too slow, 
as to allow for formation of the undesired regioisomer, would not be too fast and 
result in the formation of di-iodinated compound 221. In an attempt to slow the 
reaction, iron(III) chloride (2.5 mol%) and [BMIM]NTf2 (7.5 mol%) were used and the 
reaction was stirred at −20 °C for 2 h. After this time, there was only 55% conversion 
of the starting material and a 10:1 ratio of desired compound 219 and di-iodinated 
compound 221. The reaction was warmed to room temperature and stirred for a 
further 2 h. However, this led to increased formation of both the 4-iodo and di-
iodinated and gave compounds 219, 220 and 221 in 6:1:1.4 ratio (entry 6). Finally, 
by using FeCl3 (5 mol%) and performing the reaction at −20 °C for 5 h, 75% 
conversion of the starting material was observed. This gave a 15:1 mixture of 
desired 6-iodo regioisomer 219 and the di-iodinated compound 221 (entry 7). 
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Table 13: Iodination of aryl ketone 217 
 
Entry FeCl3 
(mol%) 
[BMIM]NTf2 
(mol%) 
Temperature 
(°C) 
Time 
(h) 
Ratioa 
219 220 221 
1 5 15 40 4 1.3 n/a 1 
2 5 15 rt 2 1.3 n/a 1 
3 2.5 7.5 40 2 2 n/a 1 
4 2.5 7.5 −10 to rt 2 2.6 n/a 1 
5 n/a n/a −10 to rt 16 1.4 1 n/a 
6 2.5 7.5 −20 to rt 4 6 1 1.4 
7 5 15 −20 5 15 n/a 1 
aDetermined using 1H NMR spectroscopy 
Using these optimised iodination conditions (−20 °C for 5 h), allowed the isolation 
of aryl iodide 219 in 65% yield (Scheme 156). Next, the cyclisation was attempted 
using copper at ppm loadings and DMEDA (10 mol%). However, this resulted in no 
conversion from the aryl iodide intermediate, even at 150 °C. Using CuI (10 mol%) 
and trans-N,N′-dimethylcyclohexane-1,2-diamine (98) (20 mol%) for this more 
difficult cyclisation did not improve the outcome and only iodinated intermediate 219 
was recovered. It was proposed that the presence of a methyl group at the α-position 
of arylketone 219 did not allow for the cyclisation to occur due to steric hindrance. 
In addition, electron donation from the para-amino functionality increases the 
electron density of the C–I bond and hence, makes oxidative addition of the Cu(I)-
complex a higher energy process, hindering the cyclisation. Due to the difficulty of 
this cyclisation, the total synthesis of eupomatenoid 6 was not pursued any further. 
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Scheme 156: Attempted cyclisation of aryl iodide 219 
2.4.10 Conclusions 
New one-pot processes for the synthesis of benzo[b]furans directly from 1-aryl and 
1-alkylketones were developed using non-precious, earth-abundant metals to 
catalyse both the C–H iodination step and then the intramolecular O-arylation step 
(Scheme 157). It was shown that both steps could be catalysed by a single iron salt, 
iron(III) nitrate nonahydrate, in a tandem catalytic process. It was also demonstrated 
that the process was more efficient when using a copper catalyst, at either ppm or 
10 mol% loading, in combination with an ancillary ligand which led to the synthesis 
of a wide range of electron rich benzo[b]furan analogues. The electronic limitation 
for the synthesis of benzo[b]furans was investigated with a weakly activating methyl 
substituent. This substrate required harsher conditions and resulted in the formation 
of 4-iodo and 6-iodo regioisomers during the activation process. The O-cyclisation 
was then performed in a separate step to give the benzo[b]furan in 26% yield. As 
well as the gram-scale synthesis of corsifuran C, this methodology was then 
employed as the key step, for the total synthesis of several natural products 
including moracin F and caleprunin B. 
 
Scheme 157: One-Pot, Two-Step Synthesis of Benzo[b]furans 
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2.5 Synthesis of 2-Substituted Benzoxazoles and Benzothiazoles 
2.5.1 Introduction 
Benzoxazoles and benzothiazoles are important structural motifs with a wide range 
of applications throughout medicinal chemistry381–383 and material science.384,385 2-
Substituted analogues in particular have proven to be important pharmacophores 
with anticancer,386,387 antimicrobial,388 antiviral,389,390 antimalarial391 and anti-
inflammatory activity previously reported.392–394 This bioactivity arises as the 
benzoxazole and benzothiazole scaffold may engage in a diverse range of 
energetically favourable, non-covalent interactions with a range of receptors and 
enzymes.395 For example, the heteroatoms within the five-membered ring can act 
as hydrogen bond acceptors and also allow more efficient Lewis basic coordination 
to metal ions. Due to the extended, aromatic and planar nature of these 
benzannulated systems, both π-π stacking and π-cation interactions are also 
possible. Among the vast range of these biologically active heterocycles, Westwell 
and co-workers have developed a new series of 2-arylbenzothiazoles with in vitro 
antitumour properties when measured against several lung, colon and breast cancer 
cell lines.386 In particular, structure activity relationship (SAR) studies revealed that 
benzothiazole 222, with a 5-fluoro substituent, has remarkable antiproliferative 
activity, with a GI50 <0.1 nM for MCF-7 and MDA 468 breast cancer cell lines (Figure 
10).396 A series of novel benzoxazole and benzothiazole analogues of amodiaquine 
were synthesised and their antiplasmodial activity was determined.391 
Benzothiazole compound 223 was particularly effective against a chloroquine 
resistant Plasmodium falciparum W2 strain with an IC50 value of 11 nM and hence, 
has potential for the treatment of malaria. In a study by Hwang and co-workers, 
several benzoxazole derivatives were designed, synthesised and examined for their 
anti-inflammatory effects.392 Compound 224 was shown to effectively inhibit 
interferon-ɣ (IFN-ɣ), a critical inflammatory cytokine protein, and mitigate an 
inflammatory response induced by T-cells. Hence, 224 has the potential to be used 
for the treatment of chronic inflammatory bowel disease. 
 
144 
 
Figure 10: Biologically active benzoxazoles and benzothiazoles 
Due to this biological significance, there have been numerous synthetic efforts 
towards the rapid and efficient preparation of these heterocyclic scaffolds.397,398 The 
most common route remains cyclocondensation between 2-aminophenols/2-
aminothiophenols and readily available carboxylic acids under dehydrating 
conditions with reagents such as polyphosphoric acid399 and N,N-
dimethylchlorosulfitemethaniminium chloride (SOCl2-DMF).400 It addition to this, it 
has been reported that acyl chlorides can be used in combination with Lewis acids, 
such as indium(III) triflate, for the synthesis of 2-substituted benzoxazoles from 2-
aminophenols.401 The use of strong mineral acids and other corrosive reagents in 
these processes has led to the development of alternative procedures, which 
employ aldehydes directly in condensation reactions with 2-aminophenols and 2-
aminothiophenols (Scheme 158).402–409 The first-step involves the formation of the 
phenolic or thiophenolic Schiff base, which then undergoes intramolecular 
nucleophilic attack and results in the formation of a benzoxazoline intermediate. This 
intermediate is then oxidised to the benzoxazole or benzothiazole products with a 
suitable oxidising agent. Protocols have been developed using strongly oxidising 
agents including DDQ,402 barium manganate,403 PhI(OAc)2,404 PCC,405 cerium 
ammonium nitrate406 or under aerobic conditions, catalysed by 4-methoxy-
TEMPO.407 
 
Scheme 158: Oxidative cyclisation of phenolic/thiophenolic imine intermediates 
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A more elegant transition metal-catalysed cross-coupling strategy has emerged for 
the synthesis of benzoxazoles and benzothiazoles, exploiting the C7a–O/S bond 
disconnection. For instance, copper salts are most often used together with 
bidentate, chelating ligands, to catalyse intramolecular O- or S-arylation of ortho-
haloanilides or ortho-halothioanilides (Scheme 159). Despite requiring elevated 
temperatures to overcome the energy penalty associated with oxidative addition of 
the carbon-halide bond, this method can produce the corresponding benzoxazoles 
and benzothiazoles in good yields.410–416 Bonnamour and Bolm have shown that 
iron(III) chloride in combination with a diketone ligand could be used for the 
synthesis of benzoxazoles from N-haloaryl benzamides but as previously described 
(Chapter 2.4.1), copper impurities in the iron catalyst were most likely responsible 
for the observed catalytic activity.417 
 
Scheme 159: Transition metal-catalysed cyclisation of 2-haloanilides and 2-halothioanilides 
Influential work in the field of C–H activation was reported by the Nagasawa group 
in 2008 and demonstrated that benzoxazoles could be prepared directly from N-
arylbenzamides using an oxidative, copper(II) triflate-catalysed cyclisation 
procedure (Scheme 160).418,419 This methodology invokes the amide functionality of 
anilides to coordinate the copper catalyst and allow for activation of the ortho-C–H 
bond by directed metalation. Reductive elimination of the six-membered 
metallocycle then follows and can provide access to the benzoxazole scaffold in 
yields of up to 93%. Analogous to other copper(II)-mediated C–H functionalisation 
processes, molecular oxygen plays a critical role as a stoichiometric oxidant in the 
turnover of the catalytic cycle.64,158 Although there is a necessity for high reaction 
temperatures, this highly atom economical process does not require the use of pre-
functionalised halogenated starting materials and hence, avoids the production of 
the associated stoichiometric waste. 
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Scheme 160: Nagasawa's synthesis of benzoxazoles by C–H functionalisation 
In comparison, the synthesis of benzothiazoles by oxidative cyclisation of N-
arylthioanilides is a far more established method. First described by Jacobson in 
1886, the treatment of N-arylthiobenzamides with potassium ferricyanide in alkaline 
solution was shown to result in the preparation of the corresponding benzothiazole 
(Scheme 161).420 More than one hundred years later, a mechanism has been 
proposed by the groups of Stevens and Jackson where they indicate that potassium 
ferricyanide plays a role as a single electron oxidant, converting the thiolate ion to a 
sulfur radical which can attack the aromatic ring and form the C–S bond.421,422 
Another classical benzothiazole synthesis can be traced back to research by 
Hugerschoff at the turn of the 20th century.423,424 When investigating the reaction 
between arylthioureas and elemental bromine in chloroform, precipitation of the 
cyclised 2-aminobenzothiazole heterocycle was observed. It transpired that initial 
activation by bromination of the sulfur atom leads to the formation of an S-bromide 
intermediate that can then undergo intermolecular electrophilic aromatic 
substitution. Evidence for this mechanistic pathway has since been uncovered with 
the observation that weakly activated or electron deficient aryl thioamides do not 
readily cyclise and form the benzothiazole.425,426 In these cases, it was found that 
dimerisation of the starting materials occurred and thought to proceed via 
intermolecular nucleophilic attack of the S-bromide intermediate by the thioamide 
starting material. 
 
Scheme 161: Benzothiazole synthesis by the Jacobson and Hugerschoff methods 
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These two simple methods have found wide applicability, particularly in medicinal 
chemistry for the preparation of 2-substituted benzothiazoles.425,427–431 For example, 
the Hugerschoff reaction was employed in the synthesis of AMG-628 (225),425 a 
small molecule inhibitor of the vanilloid receptor-1, while the Jacobson method has 
been used for the synthesis of 226, a compound which has antimitotic properties 
(Figure 11).427 
 
Figure 11: Applications of the Hugerschoff and Jacobson reactions 
Since these initial findings, many similar synthetic procedures have been developed 
to achieve the oxidative cyclisation of N-arylthioanilides using reagents including the 
Dess-Martin periodinane,432 NBS,433 benzyltrimethylammonium tribromide434 or 
metal species such as manganese(III) acetate.435 
More recently, transition metal catalysts have found utility in the synthesis of 
benzothiazoles by efficient intramolecular C–S cross-coupling when used in 
combination with strong oxidants at high temperatures. The group of Doi developed 
an S-cyclisation procedure using palladium-catalysis in the presence of cesium 
fluoride under an oxygen atmosphere (Scheme 162).436 The first step involves 
coordination of the sulfur atom of thioanilide 227 to Pd(II), leading to the formation 
of intermediate 228. From this intermediate, six-membered palladacycle 229 is then 
formed either by σ-bond metathesis or base-assisted deprotonative metalation. The 
final step involves reductive elimination, whereby desired benzothiazole 230 is 
released and palladium(0) is generated, which is subsequently re-oxidised to Pd(II) 
by O2. In general, palladium catalysis has been widely applied to achieve this 
oxidative C–S coupling for the synthesis of a wide range of medicinally important 
benzothiazoles under thermal conditions.437–440 In a similar fashion, iron,441 
ruthenium442 and recently nickel443 catalysis, in conjunction with various oxidants 
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have also been utilised, allowing the transformation to be carried out at lower 
temperatures. 
 
Scheme 162: Palladium-catalysed, thermal cyclisation of N-thioanilide 227 
Related cyclisation processes under electrochemical444,445 and organocatalytic446 
conditions have been described for the synthesis of benzothiazoles via C–H 
thiolation. Over the past decade, photoredox catalysis has developed into an 
extremely powerful tool, particularly in the activation and functionalisation of C–H 
bonds.447 By exploiting visible light and converting it into chemical energy, reaction 
pathways that were previously very difficult or unattainable under thermal control 
can be achieved. In this regard, photoredox catalysis has been utilised in the 
synthesis of benzothiazoles directly from N-arylthiobenzamides using either 
transition metal448–450 or organic photocatalysts under very mild conditions.451,452 
One such method was reported by Li and co-workers in which they achieved room 
temperature C–H functionalisation of thioanilides for the synthesis of 2-substituted 
benzothiazoles (Scheme 163).448 They propose that the photocatalyst, Ru(bpy)32+, 
readily accepts a photon of visible light to generate the excited state catalyst 
*Ru(bpy)32+ which can then be oxidised by molecular oxygen, generating Ru(bpy)33+ 
alongside the superoxide radical anion (O2•−). Concurrently, thioanilide 227 is 
deprotonated with DBU to give the corresponding sulfur anion. Anion 231 is then 
reduced to sulfur radical species 232 through a single electron transfer by 
Ru(bpy)33+ which regenerates the Ru(bpy)32+, completing the photoredox catalytic 
cycle. Next, a 1,5-homolytic sulfur radical cyclisation produces aryl radical 233 while 
constructing the key C–S bond. Hydrogen atom transfer to the superoxide species 
instigates the rearomatisation of 233 and provides benzothiazole product 230 
alongside the hydroperoxyl anion. 
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Scheme 163: Photoredox catalysis in the synthesis of benzothiazoles 
In a similar process, Lang and co-workers have developed a method which utilises 
visible-light and TEMPO as an oxidant to promote C–H thiolation by a reverse 
hydrogen atom transfer (RHAT).453 Although operating through a comparable 
mechanism to the above mentioned photoredox procedures via the generation of 
sulfur radicals, this method avoids the use of expensive transition metal 
photocatalysts and occurs under base-free conditions at room temperature. 
2.5.2 Project Aims 
Following the successful development of one-pot processes for the synthesis of 
indolines, 2,3-dihydrobenzofurans and benzo[b]furans, the main aim of this project 
was the application of a similar strategy for the preparation of a wide range of 2-
arylbenzoxazoles and 2-arylbenzothiazoles (Scheme 164). This one-pot method 
would again employ the regioselective iron(III)-catalysed halogenation, applied to a 
series of N-arylbenzamides, followed by copper(I)-catalysed O-heterocyclisation to 
allow the synthesis of a small library of 2-arylbenzoxazoles. Similarly, it was planned 
to apply this one-pot procedure to a series of N-arylthiobenzamides for the 
preparation of benzothiazoles through C–S bond formation. The final aim of this 
project was to use these new one-pot methods for the synthesis of biologically active 
2-arybenzoxazoles and 2-arylbenzothiazoles. 
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Scheme 164: Proposed one-pot synthesis of benzoxazoles and benzothiazoles 
2.5.3 Synthesis of N-Arylbenzamide and N-Arylthiobenzamide Substrates 
Synthetic work began with the preparation of a series of N-arylbenzamides by the 
reaction of anilines with aryl acid chlorides under standard conditions (Scheme 165). 
This project, particularly the synthesis of N-arylbenzamides and the reaction 
optimisation was carried out with Vincenzo Mirco Abbinante, a visiting PhD student 
from the University of Insurbia, Italy. It should be noted N-arylbenzamides 234a, 
234b and 234k were synthesised by Vincenzo Abbinante. This was generally a high 
yielding, efficient reaction and gave N-arybenzamides in up to 99% yield. Only 4-
nitro and 4-fluoro analogues, 234d and 234l, were isolated in moderate yields owing 
to their poor solubility in dichloromethane, precipitating from solution as they formed. 
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Scheme 165: Synthesis of N-arylbenzamides 234a–234l 
Acetamide analogue 234m was synthesised in 80% yield by reaction of 3,4-
dimethoxyaniline with acetic anhydride at room temperature (Scheme 166). 
 
Scheme 166: Acetylation of 3,4-dimethoxyaniline 
Next, a range of N-arylthioamides 235a–235k were prepared by reaction of 
Lawesson’s reagent with the small library of N-arylbenzamides (Scheme 167).454 
This thionation reaction was very efficient and gave the N-arylthioamides in 
excellent yields of up to 94%, with the exception of compound 235e and 235i. The 
more modest yields observed for these compounds can be attributed to the difficultly 
in separating these from by-products generated by the decomposition of 
Lawesson’s reagent. 
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Scheme 167: Synthesis of thiobenzamides 235a–235k using Lawesson’s reagent 
The mechanism for the thionation of amides using Lawesson’s reagent is shown in 
scheme 168.455,456 In solution, Lawesson’s reagent is in equilibrium with a more 
reactive dithiophosphine ylide, which reacts with the carbonyl oxygen of the amide 
substrate.457 Attack of the sulfur nucleophile on the activated carbonyl carbon results 
in the formation of a thiaoxaphosphetane intermediate. This 4-membered ring 
decomposes to give the desired thioketone, thermodynamically driven by the 
formation of a stable P=O bond of the aryl phosphorus by-product, comparable to 
the Wittig reaction. 
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Scheme 168: Mechanism of thiolation of amides with Lawesson’s reagent 
2.5.4 One-Pot Synthesis of 2-Substituted Benzoxazoles 
N-(3,4-Dimethoxyphenyl)benzamide (234a) was initially used to investigate the 
development of the one-pot process (Table 14). Entries 1–4 of the optimisation 
study were carried out by Vincenzo Abbinante. Firstly, iron(III) chloride (5 mol%) and 
the ionic liquid [BMIM]NTf2 (15 mol%) were used for the activation of NIS and 
subsequent reaction with 234a which resulted in a slow iodination (8 h). O-
Cyclisation under standard conditions, using copper iodide (10 mol%) and DMEDA 
(20 mol%), then gave benzoxazole 236a in 36% yield over the two-steps (entry 1). 
The slow reaction of benzamide 234a with NIS was thought to be due to steric 
hindrance therefore, NBS, a less sterically encumbered reagent was next 
investigated. With NBS, halogenation was found to be faster overall and led to an 
improved yield of 236a (entry 2). It was proposed that the relatively poor solubility 
of amide 234a in toluene was responsible for the low isolated yield therefore, 
alternative solvents were sought in order to increase the efficiency of the 
bromination step. When using DMF, the reaction was more efficient overall, however 
difficulties in the isolation of final product 236a resulted in a lower yield (entry 3). By 
using a mixture of toluene and THF (5:1) and an increased reaction temperature of 
40 °C, led to a 51% yield over the two-steps (entry 4). The use of toluene and 
acetonitrile as co-solvents in a 5:1 ratio, resulted in complete conversion to the 
brominated intermediate. Following copper-catalysed cyclisation, benzoxazole 236a 
was isolated in 57% yield (entry 5). 
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Table 14: Optimisation of the one-pot halogenation and O-cyclisation of 234a 
 
Entry NXS Solvent Temp (°C) Time (h) Yield (%) 
1 NIS toluene rt 8 36 
2 NBS toluene rt 4 46 
3 NBS DMF rt 4 40 
4 NBS toluene/THF 40 4 51 
5 NBS toluene/MeCN 40 4 57 
With the optimised conditions for the bromination and O-cyclisation in hand, the 
scope of the transformation was investigated with a range of N-arylbenzamides 
234a–234k (Scheme 169). From previous chapters, it is clear that electron-rich 
arenes with activating groups are vital for the iron(III) triflimide-catalysed 
electrophilic aromatic halogenation to occur. N-(3,4-Dimethoxyphenyl)benzamides 
(234a–234e), featuring both electron-rich and electron-deficient 2-aryl systems, and 
N-(3,4-methylenedioxyphenyl)benzamide (234f) were investigated as substrates for 
the one-pot process and gave benzoxazoles 236a–236f in 45–69% yield. Following 
this, the methodology was then applied to the synthesis of benzoxazole 236g, a 
compound shown to possess potent activity as a potential upregulator of utrophin in 
a predictive screening assay.399,458 Increased levels of this protein has been linked 
with slower disease progression in patients with Duchenne muscular 
dystrophy.459,460 Starting from 4-chloro-N-(3,4-methylenedioxyphenyl)benzamide 
(234g), regioselective bromination followed by copper(I)-catalysed C–O cross-
coupling gave 236g in 75% yield. Benzamides 234h and 234i, with slightly less 
electron-rich aryl systems, were found to be successful substrates for the 
bromination/O-heterocyclisation process and gave 2-arylbenzoxazoles 236h and 
236i in 62% and 72% yield, respectively. 
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Scheme 169: Scope of the one-pot synthesis of benzoxazoles 
While developing this methodology, certain limitations were discovered with some 
classes of N-arylbenzamide substrates. In the initial stages of this project, N-(3-
methoxyphenyl)benzamide (234j) was reacted with NIS and iron(III) triflimide under 
the standard halogenation conditions (40 °C for 3 h), which led to full conversion of 
the starting material and a 95:5 mixture of regioisomers (Scheme 170). However, 
submitting this mixture to the copper(I)-catalysed O-cyclisation step failed to give 
any product. On closer inspection of the 1H NMR spectra of the mixture of aryl iodide 
regioisomers, as well as using 2D NMR experiments, the 4-iodo regioisomer was 
found to be the major component. It was believed that the tethered benzamide side 
chain sterically shields the C-6 position and prevents access of the large iodine 
atom. In addition, a less significant factor which may contribute to the observed 
regioselectivity is the electronic directing effect exerted by the nitrogen functionality. 
This slightly increases the orbital coefficient at the C-4 position. Taken together, 
these steric and electronic factors result in almost exclusive iodination at the C-4 
position. 
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Scheme 170: Iodination of N-(3-methoxyphenyl)benzamide (234j) 
Next, N-(3-methoxyphenyl)benzamide (234j) was instead reacted with NBS and 
iron(III) triflimide (Scheme 171). It was envisioned that the smaller atomic radius of 
the bromine atom would allow access to the hindered C-6 position and improve the 
regioselectivity of the halogenation step. This led to a better outcome, to an extent, 
with the formation of the 4- and 6-brominated regioisomers in a 1:1 ratio. This 
mixture was then submitted to the standard copper(I)-catalysed cyclisation which 
completed the one-pot process and gave benzoxazole 236j in 33% yield. 
 
Scheme 171: Bromination and O-cyclisation of N-(3-methoxyphenyl)benzamide (234j) 
Another limitation was noted, by Vincenzo Abbinante, when using N-(4-
methylphenyl)benzamide (234k) as a substrate in the one-pot process (Scheme 
172). As a consequence of the weakly activated aryl system, with only a mild 
inductive effect of the 4-methyl substituent, the electrophilic aromatic bromination 
step required a reaction temperature of 40 °C for 12 h. Benzoxazole 236k was 
isolated in only 22% yield as a result of this extended reaction time. 
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Scheme 172: Synthesis of benzoxazole 236k 
Alongside the synthesis of 2-arylbenoxazoles, the preparation of 2-alkyl analogues 
was also investigated as part of this project. The reaction of N-(3,4-
dimethoxyphenyl)acetamide (234m) with NBS under the standard iron(III)-catalysed 
halogenation conditions resulted in full conversion to the 6-bromo regioisomer of the 
brominated intermediate (Scheme 173). Next, the attempted cyclisation of this 
brominated intermediate with copper(I) iodide and DMEDA at 130 °C for 20 h, 
resulted in only traces of 2-methylbenzoxazole 236l. Instead, the 1H NMR spectra 
of the crude material revealed almost exclusively starting material, N-(3,4-
dimethoxyphenyl)acetamide (234m). This would suggest that despite oxidative 
addition of the aryl bromide, the acetamide functionality does not ligate to the copper 
metal centre, leaving protodecupration as the main reaction pathway. 
 
Scheme 173: Attempted synthesis of 2-alkylbenzoxazole 236l 
2.5.5 Synthesis of 2-Substituted Benzothiazoles 
The bromination and heterocyclisation one-pot process was next explored for the 
synthesis of 2-substituted benzothiazoles. Firstly, N-(3,4-
dimethoxyphenyl)thiobenzamide (235a) was reacted with NBS in the presence of 
iron(III) triflimide using the previously developed halogenation conditions in toluene 
and acetonitrile (5:1) (Table 15). Investigation of the crude reaction mixture after 4 
h, using 1H NMR spectroscopy, revealed direct formation of benzothiazole 237a, in 
contrast to the anticipated aryl ring bromination. From this, benzothiazole 237a was 
then isolated in 39% yield (entry 1). Following this unexpected result, the reaction 
conditions were briefly optimised using iron(III) triflimide at 5 mol% loading. A 
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change of the reaction solvent to acetonitrile resulted in complete consumption of 
the starting material after 2 h at 40 °C and 237a was obtained in 49% yield (entry 
2). The optimal conditions for this S-cyclisation were found to be a 2 h reaction time 
at 40 °C in acetonitrile using a slight excess of NBS (1.1 equiv.). This allowed the 
synthesis of benzothiazole 237a in 54% yield (entry 3). 
Table 15: Direct synthesis of benzothiazole 237a from N-arylthiobenzamide 235a 
 
Entry NBS 
(equiv.) 
Solvent Temperature 
(°C) 
Time (h) Isolated 
Yield (%) 
1 1.0 toluene/MeCN 40 4 39 
2 1.0 MeCN 40 2 49 
3 1.1 MeCN 40 2 54 
Following this short optimisation, the substrate scope of the single step 
transformation was investigated with a range of N-arylthiobenzamides 235a–235h 
(Scheme 174). This S-cyclisation process gave 2-aryl-substituted benzothiazoles 
237a–237h in 47–65% yield. Included in this substrate scope was the synthesis of 
2-(4′-fluorophenyl)-5,6-dimethoxy-1,3-benzothiazole (237d), a biologically active 
compound which binds effectively to the amyloid-beta protein and hence, is a 
prospective imaging agent in the diagnosis of Alzheimer’s disease.461,462 
Benzothiazole 237d was isolated in 59% yield from the single-step cyclisation of 4′-
fluoro-N-(3,4-dimethoxyphenyl)thiobenzamide (235d). Several limitations were 
noted for this one-step S-cyclisation. Electron-rich trimethoxyphenyl thioamide 235g 
was not an effective substrate and gave the corresponding benzothiazole 237g in 
only 36% yield. As expected, the greater steric hindrance associated with the 
ortho,ortho-substituted aryl position of trisubstituted substrate 235g resulted in a 
slower cyclisation and allowed competitive bromination of the electron-rich aromatic 
ring. In a similar manner, the application of thioacetamide analogue 235h in the one-
pot process gave benzothiazole in 17% yield. The low yield in this case was 
attributed to a less efficient cyclisation which allowed competing arene halogenation, 
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with a crude mixture of benzothiazole 237h and the mono-brominated compound 
obtained in a 2:1 ratio. 
 
Scheme 174: Scope of the S-cyclisation of N-arylthiobenzamides 
A mechanism for the benzothiazole cyclisation was proposed and is shown in 
scheme 175. The first step involves the in-situ generation of the iron(III) triflimide, 
which then coordinates to the carbonyl oxygen of NBS. This thiophilic iron(III)-
complexed NBS species undergoes nucleophilic attack by the thioamide sulfur 
atom, resulting in the formation of a reactive S-bromide intermediate. Next, 
intramolecular electrophilic aromatic substitution with the pendant activated sulfur 
electrophile followed by re-aromatisation completes the transformation. 
 
Scheme 175: Mechanism of cyclisation of N-arylthiobenzamides using iron(III) triflimide and 
NBS 
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Evidence for the mechanism of the S-cyclisation was elucidated through several 
experiments with less activated N-arylthiobenzamide substrates. Firstly, weakly-
activated N-(4-methylphenyl)thiobenzamide 235i was used in the single-step 
reaction (Scheme 176). In this instance, reaction of 235i with the iron(III)-complexed 
NBS species resulted in no formation of the desired benzothiazole but instead 
yielded the N-arylbenzamide 234k in 67% yield. This is due to the less activated aryl 
ring of S-bromide intermediate 238, which is unable to perform intramolecular 
electrophilic aromatic substitution and instead, is hydrolysed upon aqueous work-
up. 
 
Scheme 176: N-Arylbenzamide 235i formation by hydrolysis of S-bromide intermediate 238 
Additional evidence for this mechanism was gained with N-arylthiobenzamides 235j 
and 235k (Scheme 177). For example, on application of N-(3-methoxy-4-
methylphenyl)thiobenzamide (235j) to the S-cyclisation conditions, slow 
electrophilic aromatic substitution led to the formation of a 4:1 mixture of 
benzothiazole 237i and N-(3-methoxy-4-methylphenyl)benzamide (234h), formed 
through hydrolysis of the S-bromide intermediate. Purification of this mixture by 
recrystallisation then allowed for the isolation of benzothiazole 237i in 37% yield. 
Furthermore, when N-(3-methoxyphenyl)thiobenzamide (235k) was used, a 2.5:1 
mixture of benzothiazole 237j and a mono-brominated compound was obtained 
after 2 h at 40 °C. This mixture could not be separated by flash column 
chromatography or recrystallisation. 
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Scheme 177: S-Cyclisation with less reactive aryl systems 
2.5.6 Conclusions and Outlook 
The synthesis of 2-substituted benzoxazoles and benzothiazoles has been 
achieved by utilising the iron(III) triflimide-catalysed activation of NBS (Scheme 
178). The first protocol involved the activation of N-arylbenzanilides using 
regioselective iron(III)-catalysed bromination followed by a copper(I)-catalysed 
intramolecular O-arylation with the benzamide side chain. The scope and limitations 
of the procedure were explored and allowed the synthesis of a small library of 
benzoxazole analogues, including a pharmaceutically relevant compound with 
potential therapeutic applications in the treatment of Duchenne muscular dystrophy. 
This one-pot, two-step synthesis of benzoxazoles is juxtaposed with the synthesis 
of 2-arylbenzothiazoles, which operates via a distinct reaction pathway under milder 
conditions. The reaction of N-arylthiobenzamides with NBS and iron(III) triflimide 
resulted in the isolation of the corresponding electron-rich 2-arylbenzothiazoles by 
direct intramolecular C–S bond formation. Control experiments indicated that this 
one-step S-cyclisation occurs via a reactive brominated sulfur intermediate which 
can undergo intramolecular electrophilic aromatic substitution, similar to the 
Hugerschoff reaction. Using this methodology, several functionalised benzothiazole 
derivatives were prepared including an antagonist of the amyloid-beta protein in 
patients with Alzheimer’s disease. 
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Scheme 178: Synthesis of benzoxazoles and benzothiazoles via distinct reaction pathways 
As part of these projects, the synthesis of indoles and benzo[b]thiophenes from aryl 
imines and thioketones, respectively, using similar one-pot processes was briefly 
investigated (Scheme 179). 
 
Scheme 179: Proposed synthesis of indoles and benzo[b]thiophenes 
Karchava and co-workers developed a one-pot process for the synthesis of indoles 
directly from ortho-brominated α-arylketones.463 Their reaction sequence involved a 
titanium mediated reaction of the ketone with various amines followed by copper-
catalysed cyclisation of the resulting imine species. Our approach would incorporate 
this imine synthesis into the one-pot reaction and allow the synthesis of indoles 
directly from arylketones. In an initial attempt, imine 239 was prepared by reaction 
of arylketone 157b with p-toluidine using titanium(IV) butoxide (Scheme 180). This 
imine was not compatible with the conditions used in the iodination step of the one-
pot process and full conversion back to ketone 157b was observed via imine 
hydrolysis. Future work will focus on the optimisation of this process, by the 
synthesis of more stable imine substrates and by screening various solvents and 
conditions for the iodination step. Clearly, any imine substrate will be sensitive to 
water therefore it will be required to perform this one-pot process under strictly 
anhydrous conditions. 
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Scheme 180: Attempted one-pot indole synthesis 
The next aim was to synthesise benzo[b]thiophenes directly from thioketones using 
the one-pot process. This was not achieved due to the difficulty in accessing the α-
arylthioketone starting materials. Reaction of aryl ketone 157b with Lawesson’s 
reagent resulted in no conversion to thioketone 240, with only decomposition 
observed (Table 16, entry 1). Using 3 equivalents of Lawesson’s reagent and stirring 
under reflux for 24 h also resulted in no conversion to thioketone 240 (entry 2). 
Phosphorus pentasulfide was instead used as a thionating agent however, this 
resulted in decomposition of the starting material, perhaps due to undesired side 
reactions of the anisole ring (entry 3). In general, thioketones are unstable due to 
the high reactivity associated with the poor orbital overlap of the C–S π-bond. As a 
result, thiocarbonyls have a tendency to tautomerise and then undergo spontaneous 
oligomerisation unless there is significant electronic stabilisation.464 Curphey 
demonstrated that P2S5, used in combination with hexamethyldisiloxane (HMDSO), 
is an efficient method for the thionation of ketones.465 It is thought that HMDSO 
reacts with the highly electrophilic polythiophosphate by-products, converting these 
to innocuous, unreactive silylated phosphates and preventing side reactions. The 
thionation reaction was attempted using the combination of phosphorus 
pentasulfide and HMDSO however, this again resulted in only decomposition of the 
starting material (entry 4). 
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Table 16: Attempted α-arylthioketone synthesis 
 
Entry Reagent Equiv. Additive Result 
1 Lawesson’s reagent 0.6 n/a Decomposition 
2 Lawesson’s reagent 3 n/a Decomposition 
3 P2S5 2 n/a Decomposition 
4 P2S5 0.25 HMDSO Decomposition 
Alternative methods for the synthesis of thioketones will be explored, such as the 
reaction of dimethyl acetals with hydrogen sufide in the presence of zinc chloride466 
or by fragmentation of 1,3-dithiolane-derived sulfur ylides.467,468 Future work will also 
investigate the synthesis of 2-arylthioketones with significant electronic aromatic 
stabilisation which do not undergo tautomerisation or more stable, cyclic 
alkylthioketones.469 
The one-pot synthesis of 2-substituted benzimidazoles directly from amidines will 
also be examined (Scheme 181). After the development of efficient syntheses of 
aryl guanidines by the reaction of anilines with benzonitriles,470 these will then be 
investigated as substrates in the one-pot iron(III)-catalysed bromination and 
copper(I)-catalysed O-cyclisation. This one-pot process will be used for the 
preparation of a wide range of benzimidazoles, including 2-aryl, 2-alkyl and 2-amino 
analogues. Following this, the process will be applied to the rapid synthesis of broad 
spectrum anthelmintic compounds, albendazole (241) and mebendazole (242). 
 
Scheme 181: Proposed one-pot synthesis of benzimidazoles 
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2.6 Overall Conclusions 
The overall goal of this PhD was the development of novel one-pot processes for 
the conversion of aryl C–H bonds into aryl C–heteroatom bonds using inexpensive 
and earth-abundant transition metal-catalysis. This PhD began with the 
development of an electrophilic aromatic iodination procedure which relied upon the 
activation of NIS using iron(III) triflimide, generated from catalytic quantities of both 
iron(III) chloride and [BMIM]NTf2 (Scheme 182). It was clear that a strong, electron-
donating group on the aromatic ring was essential for both reactivity and selectivity. 
 
Scheme 182: Regioselective iron(III) triflimide-catalysed iodination 
This regioselective, iron(III) triflimide-catalysed electrophilic aromatic substitution 
was then combined with an intermolecular copper(I)-catalysed, ligand-assisted N-
arylation for the synthesis of a small library of para-aminated aromatic compounds 
in a one-pot process (Scheme 183). It was found that when the para-position was 
blocked, the ortho-C–H bond could selectively undergo iodination and copper(I)-
catalysed cross-coupling. This one-pot process was found to be applicable to a 
range of unprotected anilines, anisoles and phenols bearing activating and 
deactivating groups in combination with a variety of nitrogen nucleophiles such as 
N-heterocycles, benzamides and sulfonamides. The synthetic utility of this one-pot, 
two-step method for direct amination of ortho-C-H bonds was exemplified with the 
late-stage functionalisation of 3,4-dihydroquinolin-2-ones resulting in the 
preparation of a TRIM24 bromodomain inhibitor and a series of novel analogues. 
 
Scheme 183: One-pot, two-step intermolecular amination of C–H bonds 
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Another major objective of this PhD was the application of the one-pot, two-step 
amination procedure to the synthesis of functional heterocycles. This aim was 
realised when N-protected phenylethylamines were found to undergo regioselective 
iodination and intramolecular copper(I)-catalysed cross-coupling with the 
ethylamine side chain to give indolines in a high yielding one-pot process. Following 
this, it was demonstrated that this process could be used for the synthesis of a wide 
range of valuable heterocyclic building blocks including oxindoles, 2,3-
dihydrobenzofurans as well as 6- and 7-membered analogues (Scheme 184). The 
synthetic utility of this methodology was demonstrated with the 8-step total synthesis 
of (+)-obtusafuran, where the one-pot iron- and copper-catalysed process was used 
as the key step for the construction of the trans-substituted 2,3-dihydrobenzofuran 
ring system. As part of this project, DFT calculations using Fukui functions revealed 
the molecular orbital rationale responsible for the highly regioselective iodination 
step. 
 
Scheme 184: One-pot, two-step synthesis of N- and O-heterocycles 
In an extension of this methodology, the one-pot, two-step synthesis of 
benzo[b]furans was achieved via intramolecular O-arylation of aryl and alkyl ketones 
(Scheme 185). Iron(III)-catalysed electrophilic aromatic halogenation resulted in the 
formation of a single regioisomer of the aryl iodide intermediate which then 
underwent an intramolecular O-cyclisation of the ketone side chain without the 
addition of copper(I) iodide. In this project, it was shown that a single iron salt could 
perform both steps in a tandem catalytic process although the presence of copper 
salts at either ppm or 10 mol% loading was overall more effective and assisted the 
O-cyclisation step. This one-pot process was used as the key step in the preparation 
of a range of medicinally important benzo[b]furans and natural products such as 
corsifuran C, caleprunin B and moracin F. 
CuI (10 mol%)
 DMEDA (20 mol%)
Cs2CO3, water
130–150 °C
16–48 h
H
X = O, NPG
n = 0,1,2
NIS
Fe(NTf2)3 (2.5 mol%)
toluene, 40 °C, 4–7 h
DG DG
31 examples
19–93% yield
XH
X
n
I
DG XHn n
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Scheme 185: One-pot, two-step synthesis of benzo[b]furans 
Finally, the one-pot synthesis of benzoxazoles was achieved by applying 
regioselective iron(III)-catalysed bromination to a series of N-arylbenzamides 
followed by copper(I)-catalysed O-cyclisation with the benzamide side chain 
(Scheme 186). In contrast, it was found that the application of N-arylthiobenzamides 
to the iron(III)-catalysed bromination procedure led to the direct formation of the 
corresponding 2-arylbenzothiazoles. This divergence in reactivity was investigated 
with mechanistic experiments which suggested that bromination of the Lewis basic 
sulfur atom occurs leading to a reactive intermediate which then undergoes 
electrophilic aromatic substitution resulting in intramolecular C–S bond formation. 
These processes were then used to prepare a small library of benzoxazoles and 
benzothiazoles including pharmaceutically active compounds for the potential 
treatment of Duchenne muscular dystrophy and Alzheimer’s disease. 
 
Scheme 186: Synthesis of 2-substituted benzoxazoles and benzothiazoles 
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3.0 Experimental 
General Information 
All reagents and starting materials were obtained from commercial sources and 
used as received. N-Bromosuccinimide was recrystallised from water and dried 
under high vacuum before use. Lithium chloride was oven-dried (140 °C) for at least 
16 h before use. All reactions were performed in oven or flame dried glassware 
under an atmosphere of argon unless otherwise stated. All dry solvents were 
purified using a PureSolv 500 MD solvent purification system or by distillation. Brine 
refers to a saturated aqueous solution of sodium chloride. Flash column 
chromatography was performed using Merck Geduran silica gel 60. Merck 
aluminium-backed plates pre-coated with silica gel 60F254 were used for thin layer 
chromatography and were visualised with a UV lamp or by staining with potassium 
permanganate or ninhydrin. 1H NMR spectra were recorded on Bruker NMR 
spectrometers at either 400 or 500 MHz and data are reported as follows: chemical 
shifts in ppm relative to tetramethylsilane (δH 0.00 ppm) or the residual chloroform 
(δH 7.26 ppm) as internal standard, multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet or overlap of nonequivalent resonances). 13C NMR spectra 
were recorded on Bruker NMR spectrometers at either 101 or 126 MHz and data 
are reported as follows: chemical shift in ppm relative to tetramethylsilane (δC 0.0) 
or residual chloroform (δC 77.2 ppm) internal standard, multiplicity with respect to 
hydrogen (deduced from DEPT experiments, C, CH, CH2 or CH3). Assignments are 
based on 2-dimensional COSY, HSQC and HMBC experiments. Infrared spectra 
were recorded using a Shimadzu FTIR-84005 spectrometer; wavenumbers are 
indicated in cm−1. Mass spectra were recorded using electron impact or electrospray 
techniques. HRMS spectra were recorded using a dual-focusing magnetic analyser 
mass spectrometer. Melting points were determined on a Gallencamp melting point 
apparatus and are uncorrected. Where no solvent(s) are specified, the solids 
obtained in the procedure were melted directly without recrystallisation. Optical 
rotations were determined as solutions irradiating with the sodium D line (λ = 589 
nm) using an Autopol V polarimeter. [α]D values are given in units 10−1 deg cm2 g−1. 
Chiral HPLC methods were calibrated with the corresponding racemic mixtures. 
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4-Iodoanisole (82a)471 
 
Iron(III) chloride (4.00 mg, 0.0125 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (22.0 µL, 0.0375 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.225 g, 0.500 mmol) in dry toluene (1.0 mL). Anisole (0.108 mL, 
1.00 mmol) was added and the mixture was heated to 40 °C for 4 h. The reaction 
mixture was then cooled to room temperature, diluted with ethyl acetate (20 mL) 
and washed with a 1 M aqueous sodium thiosulfate solution (20 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 20 mL) and the combined organic 
extracts were washed with brine (40 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 4-iodoanisole (82a) (0.213 g, 91%) as a 
white solid. Mp 43–46 °C (lit.471 43–45 °C); δH (400 MHz, CDCl3) 3.78 (3H, s, OCH3), 
6.65–6.72 (2H, m, 2-H and 6-H), 7.52–7.58 (2H, m, 3-H and 5-H); δC (101 MHz, 
CDCl3) 55.3 (CH3), 82.7 (C), 116.4 (2 × CH), 138.2 (2 × CH), 159.5 (C); m/z (EI) 234 
(M+. 96%), 219 (35), 84 (28). 
4-Iodophenol (82b)472 
 
4-Iodophenol (82b) was synthesised as described for 4-iodoanisole (82a) using 
phenol (0.0510 g, 0.500 mmol). The reaction mixture was heated to 40 °C for 3 h. 
Purification by flash column chromatography (hexane/ethyl acetate, 19:1 to 
hexane/ethyl acetate, 9:1) gave 4-iodophenol (82b) (0.0867 g, 79%) as a colourless 
oil. Spectroscopic data were consistent with the literature.472 δH (400 MHz, CDCl3) 
4.68 (1H, s, OH), 6.63 (2H, d, J 8.8 Hz, 2-H and 6-H), 7.52 (2H, d, J 8.8 Hz, 3-H and 
5-H); δC (126 MHz, CDCl3) 82.7 (C), 117.8 (2 × CH), 138.5 (2 × CH), 155.3 (C); m/z 
(EI) 220 (M+. 100%), 191 (3), 127 (6), 110 (5), 93 (37), 65 (20). 
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N-Phenylacetamide473 
 
Aniline (0.978 mL, 10.7 mmol) was dissolved in dry dichloromethane (30 mL) and 
acetic anhydride (1.22 mL, 12.9 mmol) was added and the reaction mixture was 
stirred at room temperature for 1 h. The reaction mixture was washed with saturated 
aqueous sodium carbonate (20 mL) and the organic layer was dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave N-phenylacetamide (1.45 g, 100%) as a white solid. 
Mp 113–115 °C (from chloroform) (lit.473 114–116 °C); δH (400 MHz, CDCl3) 2.16 
(3H, s, CH3), 7.10 (1H, t, J 7.6 Hz, 4-H), 7.30 (2H, t, J 7.6 Hz, 2-H and 6-H), 7.50 
(2H, d, J 7.6 Hz, 3-H and 5-H), 7.62 (1H, br s, NH); δC (101 MHz, CDCl3) 24.5 (CH3), 
120.0 (CH), 124.3 (2 × CH), 129.2 (2 × CH), 137.9 (C), 168.6 (C); m/z (EI) 135 (M+. 
100%). 
N-(4-Iodophenyl)acetamide (82c)474  
 
N-(4-Iodophenyl)acetamide (82c) was synthesised as described for 4-iodoanisole 
(82a) using N-phenylacetamide (0.0340 g, 0.250 mmol). The reaction mixture was 
heated to 50 °C for 2 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 3:2) gave N-(4-iodophenyl)acetamide (82c) (0.0623 g, 96%) as 
a white solid. Mp 175–177 °C (lit.474 172–174 °C); δH (400 MHz, CDCl3) 2.17 (3H, s, 
CH3), 7.12 (1H, br s, NH), 7.29 (2H, d, J 8.7 Hz, 2-H and 6-H), 7.62 (2H, d, J 8.7 Hz, 
3-H and 5-H); δC (101 MHz, CDCl3) 24.7 (CH3), 87.4 (C), 121.6 (2 × CH), 137.6 (C), 
137.9 (2 × CH), 168.2 (C); m/z (EI) 261 (M+. 100%), 219 (93), 92 (26), 65 (12). 
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5-Iodo-2,3-dihydrobenzofuran (82d)475  
 
5-Iodo-2,3-dihydrobenzofuran (82d) was synthesised as described for 4-iodoanisole 
(82a) using 2,3-dihydrobenzofuran (0.0270 mL, 0.250 mmol). The reaction mixture 
was heated to 40 °C for 4 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 49:1 to 19:1) gave 5-iodo-2,3-dihydrobenzofuran (82d) (0.0547 
g, 92%) as a white solid. Mp 61–63 °C (lit.475 64–65 °C); δH (400 MHz, CDCl3) 3.20 
(2H, br t, J 8.7 Hz, 3-H2), 4.56 (2H, t, J 8.7 Hz, 2-H2), 6.57 (1H, d, J 8.4 Hz, 7-H), 
7.38 (1H, dd, J 8.4, 1.7 Hz, 6-H), 7.47 (1H, d, J 1.7 Hz, 4-H); δC (101 MHz, CDCl3) 
29.5 (CH2), 71.4 (CH2), 81.6 (C), 111.7 (CH), 130.1 (C), 133.7 (CH), 136.7 (CH), 
160.0 (C); m/z (EI) 246 (M+. 89%), 232 (10), 117 (20), 91 (40), 84 (39), 44 (100). 
2-Iodo-4-nitroaniline (82e)476  
 
2-Iodo-4-nitroaniline (82e) was synthesised as described for 4-iodoanisole (82a) 
using 4-nitroaniline (0.0340 g, 0.250 mmol). The reaction mixture was heated to 40 
°C for 6 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 4:1) gave 2-iodo-4-nitroaniline (82e) (0.0570 g, 74%) as a white solid. Mp 
99–101 °C (lit.476 103–104 °C); δH (400 MHz, CDCl3) 4.83 (2H, br s, NH2), 6.70 (1H, 
d, J 9.0 Hz, 6-H), 8.06 (1H, dd, J 9.0, 2.5 Hz, 5-H), 8.57 (1H, d, J 2.5 Hz, 3-H); δC 
(101 MHz, CDCl3) 80.5 (C), 112.3 (CH), 125.7 (CH), 135.5 (CH), 139.3 (C), 152.3 
(C); m/z (EI) 264 (M+. 100%), 234 (38), 218 (11), 127 (5), 91 (31).  
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6-[(4′-Iodo-2′,6′-dimethylphenyl)amino]-2-methoxy-3-methylbenzamide (80) 
 
To a stirred solution suspension of N-iodosuccinimide (0.142 g, 0.633 mmol) and 
silver bis(trifluoromethanesulfonyl)imide (0.0154 g, 0.0396 mmol) in toluene (0.5 
mL) was slowly added 6-[(2ʹ,6ʹ-dimethylphenyl)amino]-2-methoxy-3-
methylbenzamide (79) (0.150 g, 0.528 mmol) in dry toluene (2.0 mL). The reaction 
mixture was stirred at 70 °C for 5 h in the dark. A further portion of N-iodosuccinimide 
(0.0360 g, 0.158 mmol) was added and the mixture stirred at 70 °C for a subsequent 
2 h. After cooling to room temperature, the reaction mixture was filtered through a 
short pad of Celite®, washed with ethyl acetate and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 1:1) 
followed by recrystallisation from acetonitrile: water (9:1) gave 6-[(4′-iodo-2′,6′-
dimethylphenyl)amino]-2-methoxy-3-methylbenzamide (80) (0.0669 g, 31%) as a 
colourless crystalline solid. Mp 141–143 °C (from acetonitrile and water); νmax/cm−1 
(neat) 3447 (NH), 3202 (NH), 2934 (CH), 1645 (C=O), 1572, 1497, 1468, 1398, 
1366, 1265, 1215, 1047, 851, 733; δH (500 MHz, CDCl3) 2.13 (6H, s, 2′-CH3 and 6′-
CH3), 2.17 (3H, s, 3-CH3), 3.78 (3H, s, OCH3), 5.66 (1H, br s, NH), 5.92 (1H, d, J 
8.6 Hz, 5-H), 6.95 (1H, d, J 8.6 Hz, 4-H), 7.45 (2H, s, 3′-H and 5′-H), 7.92 (1H, br s, 
NH), 9.41 (1H, br s, NH); δC (126 MHz, CDCl3) 15.2 (CH3), 18.0 (2 × CH3), 61.2 
(CH3), 90.8 (C), 107.2 (C), 109.3 (CH), 118.1 (C), 135.0 (CH), 137.2 (2 × CH), 138.2 
(C), 139.0 (2 × C), 148.4 (C), 158.2 (C), 170.6 (C); m/z (ESI) 433.0385 (MNa+. 
C17H19IN2NaO2 requires 433.0383). 
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6-[(4′-(Trimethylstannyl)-2′,6′-dimethylphenyl)amino]-2-methoxy-3-
methylbenzamide (83) 
 
An oven-dried microwave vial was flushed with argon and charged with 6-[(4′-iodo-
2′,6′-dimethylphenyl)amino]-2-methoxy-3-methylbenzamide (80) (0.0666 g, 0.162 
mmol) in dry toluene (3.0 mL). Lithium chloride (0.0343 g, 0.810 mmol) was added 
and the mixture was degassed under argon, while stirring, for 0.2 h. 
Tetrakis(triphenylphosphine)palladium(0) (0.0374 g, 0.0324 mmol) and 
hexamethylditin (0.0670 mL, 0.325 mmol) were added under argon and the reaction 
mixture was stirred under reflux for 22 h. After cooling to room temperature, the 
reaction mixture was quenched by the addition of 30% aqueous potassium fluoride 
solution (2.0 mL) and stirred at room temperature for 0.5 h. The mixture was filtered 
through a short pad of Celite®, washed with ethyl acetate and concentrated in vacuo. 
Purification by neutral alumina (Brockmann grade V) flash column chromatography 
(hexane/diethyl ether, 1:1) gave 6-[(4′-(trimethylstannyl)-2′,6′-
dimethylphenyl)amino]-2-methoxy-3-methylbenzamide (83) (0.0475 g, 65%) as a 
colourless oil. νmax/cm−1 (neat) 3445 (NH), 3188 (NH), 2918 (CH), 1651 (C=O), 
1576, 1497, 1267, 1258, 1049, 765; δH (500 MHz, CDCl3) 0.29 (9H, s, Sn(CH3)3), 
2.16 (3H, s, 3-CH3), 2.19 (6H, s, 2′-CH3 and 6′-CH3), 3.78 (3H, s, OCH3), 5.68 (1H, 
br s, NH), 5.97 (1H, d, J 8.6 Hz, 5-H), 6.93 (1H, d, J 8.6 Hz, 4-H), 7.21 (2H, s, 3′-H 
and 5′-H), 7.92 (1H, br s, NH), 9.46 (1H, br s, NH); δC (126 MHz, CDCl3) −9.5 (3 × 
CH3), 15.2 (CH3), 18.3 (2 × CH3), 61.2 (CH3), 106.9 (C), 109.5 (CH), 117.5 (C), 
134.9 (CH), 135.8 (2 × CH), 136.0 (2 × C), 138.4 (C), 139.4 (C), 148.9 (C), 158.1 
(C), 170.8 (C); m/z (ESI) 471.1056 (MNa+. C20H28N2NaO2Sn requires 471.1065). 
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1-(4-Methoxyphenyl)-1H-pyrazole (88a)477 
 
Iron(III) chloride (2.03 mg, 0.0125 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (11.0 µL, 0.0375 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.113 g, 0.500 mmol) in dry toluene (0.5 mL). Anisole (0.0540 mL, 
0.500 mmol) was added and the mixture was heated to 40 °C for 4 h. Upon 
completion of the iodination step, the reaction mixture was cooled to room 
temperature and pyrazole (0.0510 g, 0.750 mmol), copper(I) iodide (9.52 mg, 0.0500 
mmol), cesium carbonate (0.326 g, 1.00 mmol), N,N′-dimethylethylenediamine (10.8 
µL, 0.100 mmol) and water (0.4 mL) were added. The reaction mixture was 
degassed under argon for 0.1 h and then heated to 130 °C for 22 h. The reaction 
mixture was cooled to room temperature, diluted with ethyl acetate (10 mL) and 
washed with a 1 M aqueous sodium thiosulfate solution (10 mL). The aqueous layer 
was extracted with ethyl acetate (3 × 10 mL) and the combined organic extracts 
were washed with brine (20 mL). The organic phase was dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 19:1 to petroleum ether/ethyl acetate, 9:1) gave 1-(4-
methoxyphenyl)-1H-pyrazole (88a) (0.0821 g, 94%) as a light brown oil. 
Spectroscopic data were consistent with the literature.477 δH (400 MHz, CDCl3) 3.84 
(3H, s, OCH3), 6.44 (1H, dd, J 2.1, 1.5 Hz, 4-H), 6.94–7.00 (2H, m, 3′-H and 5′-H), 
7.56–7.62 (2H, m, 2′-H and 6′-H), 7.69 (1H, d, J 1.5 Hz, ArH) 7.82 (1H, d, J 2.1 Hz, 
ArH); δC (101 MHz, CDCl3) 55.5 (CH3), 107.2 (CH), 114.5 (2 × CH), 120.8 (2 × CH), 
126.8 (CH), 134.0 (C), 140.6 (CH), 158.2 (C); m/z (ESI) 197 (MNa+. 100%). 
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1′-(4-Methoxy-5-methylphenyl)-1H-pyrazole (88b) 
 
1′-(4-Methoxy-5-methylphenyl)-1H-pyrazole (88b) was synthesised as described for 
1-(4-methoxyphenyl)-1H-pyrazole (88a) using 2-methylanisole (0.0620 mL, 0.500 
mmol) and pyrazole (0.0510 g, 0.750 mmol). The iodination step was carried out at 
40 °C for 4 h and the N-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1′-(4-methoxy-5-
methylphenyl)-1H-pyrazole (88b) (0.0859 g, 90%) as a colourless oil. νmax/cm−1 
(neat) 2928, 1519, 1504, 1239, 1046, 909, 730; δH (500 MHz, CDCl3) 2.28 (3H, s, 
CH3), 3.86 (3H, s, OCH3), 6.42 (1H, t, J 2.0 Hz, 4-H), 6.86 (1H, d, J 8.7 Hz, 3′-H), 
7.42 (1H, dd, J 8.7, 2.6 Hz, 2′-H), 7.48 (1H, d, J 2.6 Hz, 6′-H), 7.68 (1H, d, J 2.0 Hz, 
ArH), 7.81 (1H, d, J 2.0 Hz, ArH); δC (126 MHz, CDCl3) 16.4 (CH3), 55.6 (CH3), 107.0 
(CH), 110.2 (CH), 117.8 (CH), 122.3 (CH), 126.8 (CH), 127.8 (C), 133.5 (C), 140.5 
(CH), 156.4 (C); m/z (ESI) 211.0838 (MNa+, C11H12N2NaO requires 211.0842). 
1′-(2,3-Dihydrobenzofuran-5-yl)-1H-pyrazole (88c) 
 
1′-(2,3-Dihydrobenzofuran-5-yl)-1H-pyrazole (88c) was synthesised as described 
for 1-(4-methoxyphenyl)-1H-pyrazole (88a) using 2,3-dihydrobenzofuran (0.0570 
mL, 0.500 mmol) and pyrazole (0.0510 g, 0.750 mmol). The iodination step was 
carried out at 40 °C for 4 h and the N-arylation step at 150 °C for 22 h. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 19:1) gave 1′-(2,3-
dihydrobenzofuran-5-yl)-1H-pyrazole (88c) (0.0740 g, 79%) as a yellow oil. 
νmax/cm−1 (neat) 2974 (CH), 1516, 1492, 1394, 1228, 1029, 983, 942, 746; δH (400 
MHz, CDCl3) 3.25 (2H, t, J 8.7 Hz, 3′-H2), 4.62 (2H, t, J 8.7 Hz, 2′-H2), 6.41 (1H, t, J 
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2.3 Hz, 4-H), 6.81 (1H, d, J 8.5 Hz, 7′-H), 7.35 (1H, dd, J 8.5, 2.3 Hz, 6′-H), 7.51–
7.54 (1H, m, 4′-H), 7.67 (1H, d, J 2.1 Hz, ArH), 7.78 (1H, d, J 2.1 Hz, ArH); δC (101 
MHz, CDCl3) 29.7 (CH2), 71.7 (CH2), 107.0 (CH), 109.3 (CH), 117.2 (CH), 119.7 
(CH), 126.9 (CH), 128.3 (C), 134.1 (C), 140.4 (CH), 158.8 (C); m/z (ESI) 209.0682 
(MNa+. C11H10N2NaO requires 209.0685). 
N-[4-(1H-Pyrazol-1-yl)phenyl]acetamide (88d) 
 
N-[4-(1H-Pyrazol-1′-yl)phenyl]acetamide (88d) was synthesised as described for 1-
(4-methoxyphenyl)-1H-pyrazole (88a) using N-phenylacetamide (0.0680 g, 0.500 
mmol) and pyrazole (0.0510 g, 0.750 mmol). The iodination step was carried out at 
40 °C for 6 h and the N-arylation step at 130 °C for 16 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave N-[4-(1H-pyrazol-1′-
yl)phenyl]acetamide (88d) (0.0757 g, 76%) as a brown solid. Mp 134–136 °C; 
νmax/cm−1 (neat) 3304 (NH), 3062 (CH), 1667 (C=O), 1614 (C=C), 1555, 1525, 1398, 
1330, 1054, 1036, 940, 826; δH (500 MHz, CDCl3) 2.16 (3H, s, CH3), 6.45 (1H, t, J 
2.1 Hz, 4-H), 7.55–7.61 (4H, m, 2′-H, 3′-H, 5′-H and 6′-H), 7.70 (1H, d, J 2.1 Hz, 
ArH), 7.80 (1H, br s, NH), 7.86 (1H, d, J 2.1 Hz, ArH); δC (126 MHz, CDCl3) 24.4 
(CH3), 107.6 (CH), 119.9 (2 × CH), 120.9 (2 × CH), 127.0 (CH), 136.4 (C), 136.6 
(C), 141.0 (CH), 169.0 (C); m/z (ESI) 224.0791 (MNa+. C11H11N3NaO requires 
224.0794). 
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5-Fluoro-1-(1H-pyrazol-1′-yl)phenol (88e) 
 
2-Fluoro-4-(1H-pyrazol-1′-yl)phenol (88e) was synthesised as described for 1-(4-
methoxyphenyl)-1H-pyrazole (88a) using 2-fluorophenol (0.0450 mL, 0.500 mmol) 
and pyrazole (0.0510 g, 0.750 mmol). The iodination step was carried out at 40 °C 
for 5 h and the N-arylation step at 130 °C for 24 h. The reaction mixture was diluted 
with dichloromethane (10 mL) and extracted with 1 M aqueous sodium hydroxide 
(20 mL). The aqueous phase was separated and then acidified with 1 M aqueous 
hydrochloric acid then extracted with dichloromethane (3 × 30 mL). The combined 
organic extracts were washed with brine (100 mL), dried (MgSO4) and concentrated 
in vacuo. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave 2-fluoro-4-(1H-pyrazol-1′-yl)phenol (88e) (0.0453 g, 51%) as a 
viscous yellow oil. νmax/cm−1 (neat) 3123 (OH), 2970 (CH), 1526, 1516, 1401, 1288, 
1248, 1186, 1039, 753; δH (500 MHz, CDCl3) 6.45 (1H, t, J 2.0 Hz, 4-H), 6.49 (1H, 
s, OH), 7.02 (1H, t, J 8.9 Hz, 6′-H), 7.28 (1H, ddd, J 8.9, 2.5, 1.4 Hz, 5′-H), 7.44 (1H, 
dd, J 11.4, 2.5 Hz, 3′-H), 7.71 (1H, d, J 2.0 Hz, ArH), 7.80 (1H, d, J 2.0 Hz, ArH); δC 
(126 MHz, CDCl3) 107.6 (CH), 108.9 (CH, d, 2JCF 22.6 Hz), 116.2 (CH, d, 3JCF 3.3 
Hz), 118.1 (CH, d, 4JCF 3.1 Hz), 127.7 (CH), 133.0 (C, d, 3JCF 8.6 Hz), 140.9 (CH), 
143.2 (C, d, 2JCF 13.7 Hz), 151.3 (C, d, 1JCF 241.2 Hz); m/z (ESI) 177.0465 ([M–H]–
. C9H6FN2O requires 177.0470). 
1-(4-Methoxyphenyl)-1H-imidazole (88f)478 
 
1-(4-Methoxyphenyl)-1H-imidazole (88f) was synthesised as described for 1-(4-
methoxyphenyl)-1H-pyrazole (88a) using anisole (0.0540 mL, 0.500 mmol) and 
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imidazole (0.0510 g, 0.750 mmol). The iodination step was carried out at 40 °C for 
4 h and the N-arylation step at 150 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1 to dichloromethane/methanol, 
19:1) gave 1-(4-methoxyphenyl)-1H-imidazole (88f) (0.0685 g, 79%) as an off-white 
solid. Mp 60–62 °C (lit.478 61–63 °C); δH (500 MHz, CDCl3) 3.79 (3H, s, OCH3), 6.90–
6.95 (2H, m, 3-H and 5-H), 7.10–7.20 (2H, m, 4′-H and 5′-H), 7.21–7.27 (2H, m, 2-
H and 6-H), 7.72 (1H, br s, 2′-H); δC (126 MHz, CDCl3) 55.6 (CH3), 114.9 (2 × CH), 
118.8 (CH), 123.1 (2 × CH), 130.1 (CH), 130.7 (C), 135.8 (CH), 158.9 (C); m/z (ESI) 
175 (MH+. 100%). 
1-(4-Methoxyphenyl)pyrrolidin-2′-one (88g)479  
 
1-(4-Methoxyphenyl)pyrrolidin-2′-one (88g) was synthesised as described for 1-(4-
methoxyphenyl)-1H-pyrazole (88a) using anisole (0.0540 mL, 0.500 mmol) and 
pyrrolidin-2-one (0.0570 mL, 0.750 mmol). The iodination step was carried out at 40 
°C for 4 h and the N-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1 to methanol/dichloromethane, 
49:1) gave 1-(4-methoxyphenyl)pyrrolidin-2′-one (88g) (0.0772 g, 78%) as an off-
white solid. Mp 112–114 °C (lit.479 113–114 °C); δH (500 MHz, CDCl3) 2.14 (2H, 
quin., J 7.9 Hz, 4′-H2), 2.58 (2H, t, J 7.9 Hz, 3′-H2), 3.79 (3H, s, OMe), 3.81 (2H, t, J 
7.9 Hz, 5′-H2), 6.86–6.92 (2H, m, 3-H and 5-H), 7.46–7.51 (2H, m, 2-H and 6-H); δC 
(126 MHz, CDCl3) 18.0 (CH2), 32.5 (CH2), 49.2 (CH2), 55.5 (CH3), 114.0 (2 × CH), 
121.8 (2 × CH), 132.6 (C), 156.6 (C), 173.9 (C); m/z (ESI) 214 (MNa+. 100%). 
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N-(4-Methoxyphenyl)benzamide (88h)480 
 
N-(4-Methoxyphenyl)benzamide (88h) was synthesised as described for 1-(4-
methoxyphenyl)-1H-pyrazole (88a) using anisole (0.0540 mL, 0.500 mmol) and 
benzamide (0.0909 g, 0.750 mmol). The iodination step was carried out at 40 °C for 
4 h and the N-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave N-(4-
methoxyphenyl)benzamide (88h) (0.0920 g, 81%) as a white solid. Mp 152–154 °C 
(lit.480 149–152 °C); δH (500 MHz, CDCl3) 3.81 (3H, s, OCH3), 6.87–6.93 (2H, m, 3-
H and 5-H), 7.44–7.56 (5H, m, 2-H, 6-H and 3 × ArH), 7.80 (1H, br s, NH), 7.83–
7.88 (2H, m, 2 × ArH); δC (126 MHz, CDCl3) 55.5 (CH3), 114.3 (2 × CH), 122.1 (2 × 
CH), 127.0 (2 × CH), 128.7 (2 × CH), 131.0 (C), 131.7 (CH), 135.1 (C), 156.7 (C), 
165.6 (C); m/z (ESI) 250 (MNa+. 100%). 
4′-Fluoro-N-(4-methoxyphenyl)benzenesulfonamide (88i) 
 
4′-Fluoro-N-(4-methoxyphenyl)benzenesulfonamide (88i) was synthesised as 
described for 1-(4-methoxyphenyl)-1H-pyrazole (88a) using anisole (0.0540 mL, 
0.500 mmol) and 4-fluorobenzenesulfonamide (0.131 g, 0.750 mmol). The 
iodination step was carried out at 40 °C for 4 h and the N-arylation step at 130 °C 
for 18 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 4:1) gave 4′-fluoro-N-(4-methoxyphenyl)benzenesulfonamide (88i) (0.120 
g, 86%) as a white solid. Mp 102–104 °C; νmax/cm−1 (neat) 3262 (NH), 2937 (CH), 
1592 (C=C), 1508, 1495, 1247, 1241, 1165, 1153, 1090, 837, 754; δH (500 MHz, 
CDCl3) 3.76 (3H, s, OCH3), 6.74–6.79 (3H, m, 3-H, 5-H and NH), 6.95–7.00 (2H, m, 
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2-H and 6-H), 7.06–7.12 (2H, m, 3′-H and 5′-H), 7.69–7.74 (2H, m, 2′-H and 6′-H); 
δC (126 MHz, CDCl3) 55.4 (CH3), 114.5 (2 × CH), 116.2 (2 × CH, d, 2JCF 22.6 Hz), 
125.7 (2 × CH), 128.5 (C), 130.1 (2 × CH, d, 3JCF 9.4 Hz), 134.9 (C, d, 4JCF 3.2 Hz), 
158.2 (C), 165.2 (C, d, 1JCF 255.1 Hz); m/z (ESI) 304.0405 (MNa+. C13H12FNNaO3S 
requires 304.0414). 
Benzyl N-(4-Methoxyphenyl)carbamate (88j)481 
 
Benzyl N-(4-methoxyphenyl)carbamate (88j) was synthesised as described for 1-
(4-methoxyphenyl)-1H-pyrazole (88a) using anisole (0.0540 mL, 0.500 mmol) and 
benzyl carbamate (0.113 g, 0.750 mmol). The iodination step was carried out at 40 
°C for 4 h and the N-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/diethyl ether, 1:1) gave benzyl N-(4-
methoxyphenyl)carbamate (88j) (0.0550 g, 43%) as a white solid. Mp 95–97 °C 
(lit.481 98 °C); δH (400 MHz, CDCl3) 3.78 (3H, s, OCH3), 5.19 (2H, s, OCH2Ph), 6.53 
(1H, br s, NH), 6.85 (2H, d, J 8.6 Hz, 3-H and 5-H), 7.24–7.43 (7H, m, 2-H, 6-H and 
Ph); δC (101 MHz, CDCl3) 55.5 (CH3), 67.0 (CH2), 114.3 (2 × CH), 120.8 (C), 128.2 
(2 × CH), 128.3 (2 × CH), 128.6 (2 × CH), 130.8 (CH), 136.2 (C), 153.6 (C), 156.1 
(C); m/z (ESI) 280.0928 (MNa+. C15H15NNaO3 requires 280.0950). 
1′-(4-Methoxyphenyl)morpholine (88q)482 
 
Iron(III) chloride (1.60 mg, 0.0100 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (7.00 µL, 0.0250 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.113 g, 0.500 mmol) in dry toluene (0.5 mL). Anisole (0.0540 mL, 
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0.500 mmol) was added and the mixture was heated to 40 °C for 4 h. Upon 
completion of the iodination step, the reaction mixture was cooled to room 
temperature and copper(I) iodide (9.52 mg, 0.0500 mmol), cesium carbonate (0.326 
g, 1.00 mmol), 2-isobutyrylcyclohexanone (0.0253 mL, 0.150 mmol) and water (0.4 
mL) were added under argon. The resulting mixture was stirred at room temperature 
for 0.1 h then morpholine (0.0520 mL, 0.600 mmol) was added. The reaction mixture 
was degassed under argon for 0.1 h and then heated to 150 °C for 48 h. The reaction 
mixture was cooled to room temperature, diluted with ethyl acetate (10 mL) and 
washed with a 1 M aqueous sodium thiosulfate solution (10 mL). The aqueous layer 
was extracted with ethyl acetate (3 × 10 mL) and the combined organic extracts 
were washed with brine (20 mL). The organic phase was dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave 1′-(4-methoxyphenyl)morpholine (88q) (0.0480 g, 
50%) as a light brown oil. Spectroscopic data were consistent with the literature.482 
δH (400 MHz, CDCl3) 3.06 (4H, t, J 4.3 Hz, 3-H2 and 5-H2), 3.77 (3H, s, OCH3), 3.86 
(4H, t, J 4.3 Hz, 2-H2 and 6-H2), 6.85 (2H, d, J 8.6 Hz, 3-H and 5-H), 6.89 (2H, d, J 
8.6 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 50.9 (2 × CH2), 55.6 (CH3), 67.1 (2 × 
CH2), 114.5 (2 × CH), 117.8 (2 × CH), 145.7 (C), 154.0(C); m/z (EI) 193 (M+. 100%). 
(E)-4′-(4-Chlorophenyl)-1′,1′,1′-trifluorobut-3′-en-2′-one (97)483 
 
To a stirred solution of 4-chlorobenzaldehyde (96) (0.702 g, 5.00 mmol), acetic acid 
(0.430 mL, 7.50 mmol) and piperidine (0.500 mL, 5.00 mmol) in tetrahydrofuran (20 
mL) was added 1,1,1-trifluoroacetone (1.80 mL, 20.0 mmol) dropwise at 0 °C. The 
reaction mixture was stirred at 0 ° C for 1 h before being warmed to room 
temperature and stirred for 18 h. The reaction mixture was quenched with saturated 
aqueous ammonium chloride solution (15 mL) and extracted with ethyl acetate (2 × 
20 mL). The combined organic extracts were washed with brine (40 mL), dried 
(MgSO4) and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/dichloromethane, 9:1) gave (E)-4′-(4-chlorophenyl)-1′,1′,1′-
trifluorobut-3′-en-2′-one (97) (0.599 g, 51%) as a white solid. Mp 38–40°C (lit.483 42–
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45°C); δH (400 MHz, CDCl3) 6.98 (1H, d, J 15.6 Hz, 3′-H), 7.41 (2H, d, J 7.9 Hz, 3-
H and 5-H), 7.56 (2H, d, J 7.9 Hz, 2-H and 6-H), 7.89 (1H, d, J 15.6 Hz, 4′-H); δC 
(101 MHz, CDCl3) 116.3 (C, q, 1JCF 290.0 Hz), 117.1 (CH), 129.6 (2 × CH), 130.3 (2 
× CH), 131.8 (C), 138.5 (C), 148.5 (CH), 179.8 (C, q, 2JCF 36.0 Hz); m/z (ESI) 257 
(MNa+. 100%). 
5′-(4-Chlorophenyl)-3′-(trifluoromethyl)-1H-pyrazole (95)256 
 
A solution of (E)-4′-(4-chlorophenyl)-1′,1′,1′-trifluorobut-3′-en-2′-one (97) (0.425 g, 
1.82 mmol), p-tosylhydrazide (0.372 g, 2.00 mmol) and sodium acetate (0.164 g, 
2.00 mmol) in ethanol (20 mL) was stirred under reflux for 16 h. The reaction mixture 
was filtered and the solvent was removed in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave 5′-(4-chlorophenyl)-3′-
(trifluoromethyl)-1H-pyrazole (95) (0.296 g, 66%) as a white solid. Mp 149–151 °C 
(lit.256 150–153 °C); δH (400 MHz, CDCl3) 6.79 (1H, s, 4′-H), 7.45 (2H, d, J 8.4 Hz, 
2-H and 6-H), 7.51 (2H, d, J 8.4 Hz, 3-H and 5-H), 10.78 (1H, br s, NH); δC (101 
MHz, CDCl3) 101.3 (CH), 120.9 (C, q, 1JCF 263.0 Hz), 126.3 (C), 126.9 (2 × CH), 
129.5 (2 × CH), 135.6 (C), 143.4 (C, q, 2JCF 38.0 Hz), 144.4 (C); m/z (ESI) 247 (MH+. 
100%). 
5′-(4′′-Chlorophenyl)-1′-(4-methoxyphenyl)-3′-(trifluoromethyl)-1H-pyrazole 
(88r)257 
 
Iron(III) chloride (0.800 mg, 0.00500 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (4.36 µL, 0.0150 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
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iodosuccinimide (0.0450 g, 0.200 mmol) in dry toluene (0.2 mL). Anisole (0.0220 
mL, 0.200 mmol) was added and the mixture was heated to 40 °C for 4 h. Upon 
completion of the iodination step, the reaction mixture was cooled to room 
temperature and copper(I) iodide (3.80 mg, 0.0200 mmol), cesium carbonate (0.130 
g, 0.400 mmol) and trans-N,N′-dimethylcyclohexane-1,2-diamine (6.40 µL, 0.0400 
mmol) were added under argon. 5′-(4-Chlorophenyl)-3′-(trifluoromethyl)-1H-
pyrazole (95) (0.140 g, 0.600 mmol) in dry 1,4-dioxane (1.2 mL) was added, the 
reaction mixture was degassed under argon for 0.2 h and then heated to 150 °C for 
60 h. The reaction mixture was then cooled to room temperature, diluted with ethyl 
acetate, filtered through a short pad of silica and concentrated in vacuo. Purification 
by flash column chromatography (hexane/diethyl ether, 19:1) gave 1′-(4-
methoxyphenyl)-3′-(trifluoromethyl)-5′-(4′′-chlorophenyl)-1H-pyrazole (88r) (0.0160 
g, 23%) as a colourless oil. Spectroscopic data were consistent with the literature.257 
δH (500 MHz, CDCl3) 3.83 (3H, s, OCH3), 6.73 (1H, s, 4′-H), 6.88 (2H, d, J 9.2 Hz, 
3-H and 5-H), 7.15 (2H, d, J 8.9 Hz, 2′′-H and 6′′-H), 7.21 (2H, d, J 9.2 Hz, 2-H and 
6-H), 7.30 (2H, d, J 8.9 Hz, 3′′-H and 5′′-H); δC (126 MHz, CDCl3) 55.6 (CH3), 105.3 
(CH), 114.4 (2 × CH), 121.2 (C, q, 1JCF 270.1 Hz), 126.9 (2 × CH), 127.7 (C), 129.0 
(2 × CH), 130.0 (2 × CH), 132.1 (C), 135.1 (C), 143.0 (C, q, 2JCF 37.4 Hz), 143.4 (C), 
159.7 (C); m/z (ESI) 375 (MNa+. 100%). 
N-(2-Amino-5-cyanophenyl)-1H-pyrazole (101a)484 
 
Iron(III) chloride (4.03 mg, 0.0250 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (22.0 µL, 0.0750 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.112 g, 0.500 mmol) in toluene (0.5 mL). 4-Aminobenzonitrile (99) 
(0.0590 g, 0.500 mmol) was added and the mixture was stirred at 70 °C for 5 h. 
Upon the completion of the iodination step, the reaction mixture was cooled to room 
temperature and pyrazole (0.102 g, 1.50 mmol), copper(I) iodide (9.52 mg, 0.0500 
mmol), cesium carbonate (0.326 g, 1.00 mmol), trans-N,N′-dimethylcyclohexane-
3
4
5
6
1
2
NH2
CN
N N
3′
4′5′
 
184 
1,2-diamine (16.0 µL, 0.100 mmol) and water (0.25 mL) were added. The reaction 
mixture was degassed under argon for 0.1 h and then heated to 130 °C for 24 h. 
The reaction mixture was cooled to room temperature, diluted with ethyl acetate (10 
mL), washed with a 1 M aqueous sodium thiosulfate solution (10 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 10 mL) and the combined organic 
extracts were washed with brine (10 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 7:3) gave N-(2-amino-5-cyanophenyl)-1H-pyrazole 
(101a) (0.0550 g, 60%) as a colourless oil. Spectroscopic data were consistent with 
the literature.484 δH (500 MHz, CDCl3) 5.45 (2H, br s, NH2), 6.50 (1H, t, J 2.2 Hz, 4′-
H), 6.81 (1H, d, J 8.4 Hz, 3-H), 7.39 (1H, dd, J 8.4, 1.9 Hz, 4-H), 7.47 (1H, d, J 1.9 
Hz, 6-H), 7.75 (1H, d, J 2.2 Hz, ArH), 7.77 (1H, d, J 2.2 Hz, ArH); δC (126 MHz, 
CDCl3) 99.7 (C), 107.2 (CH), 117.0 (CH), 119.2 (C), 125.5 (C), 127.3 (CH), 129.7 
(CH), 132.2 (CH), 141.2 (CH), 145.0 (C); m/z (ESI) 207 (MNa+. 100%). 
N-(2-Amino-5-nitrophenyl)-1H-pyrazole (87) 
 
N-(2-Amino-5-nitrophenyl)-1H-pyrazole (87) was synthesised as described for N-(2-
amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-nitroaniline (86) (0.0700 g, 0.500 
mmol) and pyrazole (0.102 g, 1.50 mmol). The iodination step was carried out at 70 
°C for 5 h and the N-arylation step at 130 °C for 22 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave N-(2-amino-5-
nitrophenyl)-1H-pyrazole (87) (0.0730 g, 71%) as a yellow crystalline solid. Mp 137–
139 °C (from ethanol); νmax/cm−1 (neat) 3319 (NH), 3080 (CH), 1633, 1614, 1527 
(C=C), 1494, 1333, 1316, 707; δH (500 MHz, CDCl3) 5.84 (2H, br s, NH2), 6.52 (1H, 
t, J 2.0 Hz, 4′-H), 6.80 (1H, d, J 8.9 Hz, 3-H), 7.78 (1H, d, J 2.0 Hz, ArH), 7.86 (1H, 
d, J 2.0 Hz, ArH), 8.05 (1H, dd, J 8.9, 2.5 Hz, 4-H), 8.17 (1H, d, J 2.5 Hz, 6-H); δC 
(126 MHz, CDCl3) 107.4 (CH), 115.8 (CH), 119.4 (CH), 124.2 (C), 124.4 (CH), 129.8 
(CH), 138.1 (C), 141.2 (CH), 146.8 (C); m/z (EI) 204.0654 (M+. C9H8N4O2 requires 
204.0647), 174 (20%), 159 (19), 149 (20), 131 (15), 83 (100), 77 (23), 69 (28), 57 
(46). 
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3-Pyrazol-1′-yl-4-aminobenzophenone (101b) 
 
3-Pyrazol-1′-yl-4-aminobenzophenone (101b) was synthesised as described for N-
(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-aminobenzophenone (0.0986 
g, 0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). The iodination step was carried 
out at 70 °C for 20 h and the N-arylation step at 130 °C for 20 h. Purification by flash 
column chromatography (dichloromethane/petroleum ether, 9:1 to 
dichloromethane/petroleum ether, 4:1) gave 3-pyrazol-1′-yl-4-aminobenzophenone 
(101b) (0.0760 g, 64%) as a colourless oil. νmax/cm−1 (neat) 3360 (NH), 1611 (C=O), 
1518, 1396, 1269, 1148; δH (500 MHz, CDCl3) 5.44 (2H, br s, NH2), 6.47 (1H, t, J 
2.2 Hz, 4′-H), 6.82 (1H, d, J 8.4 Hz, 5-H), 7.44–7.50 (2H, m, 3′′-H and 5′′-H), 7.56 
(1H, tt, J 7.4, 1.3 Hz, 4′′-H), 7.65 (1H, dd, J 8.4, 1.9 Hz, 6-H), 7.72–7.77 (3H, m, 2-
H, 2′′-H and 6′′-H), 7.79 (1H, d, J 2.2 Hz, ArH), 7.81 (1H, d, J 2.2 Hz, ArH); δC (126 
MHz, CDCl3) 106.8 (CH), 115.9 (CH), 125.3 (C), 126.1 (CH), 126.9 (C), 128.3 (2 × 
CH), 129.5 (2 × CH), 129.9 (CH), 131.5 (CH), 131.7 (CH), 138.4 (C), 140.8 (CH), 
145.3 (C), 194.6 (C); m/z (ESI) 286.0944 (MNa+. C16H13N3NaO requires 286.0951). 
N-(2-Amino-5-chlorophenyl)-1H-pyrazole (101c)484 
 
N-(2-Amino-5-chlorophenyl)-1H-pyrazole (101c) was synthesised as described for 
N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-chloroaniline (0.0640 g, 
0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). The iodination step was carried out 
at 70 °C for 5 h and the N-arylation step at 130 °C for 20 h. Purification by flash 
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column chromatography (dichloromethane) gave N-(2-amino-5-chlorophenyl)-1H-
pyrazole (101c) (0.0610 g, 63%) as a brown oil. Spectroscopic data were consistent 
with the literature.484 δH (500 MHz, CDCl3) 4.75 (2H, br s, NH2), 6.44 (1H, t, J 2.2 
Hz, 4′-H), 6.74 (1H, d, J 8.5 Hz, 3-H), 7.08 (1H, dd, J 8.5, 2.4 Hz, 4-H), 7.18 (1H, d, 
J 2.4 Hz, 6-H), 7.70 (1H, d, J 2.2 Hz, ArH), 7.73 (1H, d, J 2.2 Hz, ArH); δC (126 MHz, 
CDCl3) 106.8 (CH), 118.2 (CH), 122.2 (C), 123.7 (CH), 126.8 (C), 128.2 (CH), 129.8 
(CH), 139.7 (C), 140.9 (CH); m/z (ESI) 216 (MNa+. 100%). 
N-(2-Amino-5-methylphenyl)-1H-pyrazole (101d)484 
 
N-(2-Amino-5-methylphenyl)-1H-pyrazole (101d) was synthesised as described for 
N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methylaniline (0.0540 g, 
0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). The iodination step was carried out 
at 40 °C for 5 h and the N-arylation step at 130 °C for 21 h. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 7:3) gave N-(2-amino-5-
methylphenyl)-1H-pyrazole (101d) (0.0510 g, 58%) as an orange oil. Spectroscopic 
data were consistent with the literature.484 δH (400 MHz, CDCl3) 2.27 (3H, s, 5-CH3), 
4.48 (2H, br s, NH2), 6.42 (1H, t, J 2.1 Hz, 4′-H), 6.74 (1H, d, J 8.1 Hz, 3-H), 6.96 
(1H, dd, J 8.1, 1.3 Hz, 4-H), 7.00 (1H, d, J 1.3 Hz, 6-H), 7.70 (1H, d, J 2.1 Hz, ArH), 
7.73 (1H, d, J 2.1 Hz, ArH); δC (101 MHz, CDCl3) 20.3 (CH3), 106.3 (CH), 117.4 
(CH), 124.7 (CH), 126.6 (C), 127.6 (C), 129.1 (CH), 129.8 (CH), 138.5 (C), 140.5 
(CH); m/z (ESI) 174 (MNa+. 100%). 
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N-(2-Methoxy-5-methylphenyl)-1H-pyrazole (101e) 
 
N-(2-Methoxy-5-methylphenyl)-1H-pyrazole (101e) was synthesised as described 
for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methylanisole (103) 
(0.0630 mL, 0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). The iodination step 
was carried out at 70 °C for 20 h and the N-arylation step at 130 °C for 21 h. 
Purification by flash column chromatography (hexane/diethyl ether, 4:1) gave N-(2-
methoxy-5-methylphenyl)-1H-pyrazole (101e) (0.0670 g, 71%) as a colourless oil. 
νmax/cm−1 (neat) 2936 (CH), 1524 (C=C), 1504, 1462, 1283, 1242, 1036, 804, 744; 
δH (400 MHz, CDCl3) 2.33 (3H, br s, 5-CH3), 3.83 (3H, s, OCH3), 6.41 (1H, dd, J 2.4, 
1.9 Hz, 4′-H), 6.92 (1H, d, J 8.4 Hz, 3-H), 7.05–7.10 (1H, m, 4-H), 7.55 (1H, d, J 2.3 
Hz, 6-H), 7.69 (1H, dd, J 2.4, 0.4 Hz, ArH), 8.03 (1H, dd, J 1.9, 0.4 Hz, ArH); δC (101 
MHz, CDCl3) 20.4 (CH3), 56.1 (CH3), 106.1 (CH), 112.3 (CH), 125.6 (CH), 128.3 
(CH), 129.4 (C), 130.8 (C), 131.5 (CH), 139.9 (CH), 149.1 (C); m/z (EI) 188.0942 
(M+. C11H12N2O requires 188.0950), 159 (55%), 144 (34). 
N-(2-Methoxy-4,5-dimethylphenyl)-1H-pyrazole (101f) 
 
N-(2-Methoxy-4,5-dimethylphenyl)-1H-pyrazole (101f) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 3,4-
dimethylanisole (0.0700 mL, 0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). The 
iodination step was carried out at 70 °C for 5 h and the N-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (hexane/diethyl ether, 9:1) 
gave N-(2-methoxy-4,5-dimethylphenyl)-1H-pyrazole (101f) (0.0680 g, 67%) as a 
colourless oil. νmax/cm−1 (neat) 2932 (CH), 1520, 1466, 1396, 1242, 1188, 1034, 
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748; δH (400 MHz, CDCl3) 2.23 (3H, s, CH3), 2.29 (3H, s, CH3), 3.82 (3H, s, OCH3), 
6.39 (1H, dd, J 2.3, 1.7 Hz, 4′-H), 6.81 (1H, s, 3-H), 7.47 (1H, s, 6-H), 7.67 (1H, d, J 
1.7 Hz, ArH), 7.97 (1H, d, J 2.3 Hz, ArH); δC (101 MHz, CDCl3) 18.7 (CH3), 19.9 
(CH3), 56.1 (CH3), 105.9 (CH), 113.9 (CH), 126.1 (CH), 127.2 (C), 129.2 (C), 131.4 
(CH), 136.4 (C), 139.7 (CH), 149.1 (C); m/z (ESI) 225.0994 (MNa+. C12H14N2NaO 
requires 225.0998). 
N-(5-Acetyl-2,4-dimethoxyphenyl)-1H-pyrazole (101g) 
 
N-(5-Acetyl-2,4-dimethoxyphenyl)-1H-pyrazole (101g) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 2,4-
dimethoxyacetophenone (0.0900 g, 0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). 
The iodination step was carried out at 70 °C for 5 h and the N-arylation step at 150 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 4:1) followed by trituration with diethyl ether gave N-(5-acetyl-2,4-
dimethoxyphenyl)-1H-pyrazole (101g) (0.0590 g, 48%) as a white solid. Mp 122–
124 °C (Et2O); νmax/cm−1 (neat) 2931 (CH), 1659 (C=O), 1605, 1520, 1265, 1227, 
1026, 741; δH (500 MHz, CDCl3) 2.60 (3H, s, COMe), 3.93 (3H, s, OCH3), 3.99 (3H, 
s, OCH3), 6.41 (1H, dd, J 2.3, 1.8 Hz, 4′-H), 6.57 (1H, s, 3-H), 7.69 (1H, d, J 1.8 Hz, 
ArH), 7.78 (1H, d, J 2.3 Hz, ArH), 8.08 (1H, s, 6-H); δC (126 MHz, CDCl3) 31.7 (CH3), 
56.0 (CH3), 56.2 (CH3), 95.8 (CH), 106.1 (CH), 120.6 (C), 123.4 (C), 128.8 (CH), 
131.3 (CH), 140.2 (CH), 156.7 (C), 159.9 (C), 196.8 (C); m/z (ESI) 269.0889 (MNa+. 
C13H14N2NaO3 requires 269.0897). 
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N-(5-Formyl-2,4-dimethoxyphenyl)-1H-pyrazole (101h) 
 
N-(5-Formyl-2,4-dimethoxyphenyl)-1H-pyrazole (101h) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 2,4-
dimethoxybenzaldehyde (0.0830 g, 0.500 mmol) and pyrazole (0.0510 g, 0.750 
mmol). The iodination step was carried out at 70 °C for 5 h and the N-arylation step 
at 130 °C for 30 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 1:1) gave N-(5-formyl-2,4-dimethoxyphenyl)-1H-pyrazole 
(101h) (0.0470 g, 42%) as a colourless oil. νmax/cm−1 (neat) 2937 (CH), 1664 (C=O), 
1614 (C=C), 1523, 1478, 1332, 1277, 1209, 1152, 1038, 1020, 818; δH (400 MHz, 
CDCl3) 3.95 (3H, s, OCH3), 3.99 (3H, s, OCH3), 6.41 (1H, dd, J 2.3, 1.8 Hz, 4′-H), 
6.56 (1H, s, 3-H), 7.69 (1H, d, J 1.8 Hz, ArH), 7.80 (1H, d, J 2.3 Hz, ArH), 8.08 (1H, 
s, 5-H), 10.3 (1H, s, CHO); δC (101 MHz, CDCl3) 56.1 (CH3), 56.3 (CH3), 95.5 (CH), 
106.3 (CH), 118.3 (C), 123.8 (C), 126.6 (CH), 131.3 (CH), 140.3 (CH), 158.3 (C), 
162.5 (C), 187.5 (CH); m/z (EI) 232.0855 (M+. C12H12N2O3 requires 232.0848), 188 
(22%), 73 (28). 
3-Pyrazol-1′-yl-4-methoxybiphenyl (101i) 
 
3-Pyrazol-1′-yl-4-methoxybiphenyl (101i) was synthesised as described for N-(2-
amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methoxybiphenyl (0.0920 g, 
0.500 mmol) and pyrazole (0.0510 g, 0.750 mmol). The iodination step was carried 
out at 70 °C for 8 h and the N-arylation step at 130 °C for 26 h. Purification by flash 
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column chromatography (hexane/diethyl ether, 7:3) gave 3-pyrazol-1′-yl-4-
methoxybiphenyl (101i) (0.0770 g, 61%) as a white solid. Mp 52–54 °C; νmax/cm−1 
(neat) 2940 (CH), 1528 (C=C), 1489, 1404, 1281, 1250, 1018, 756; δH (500 MHz, 
CDCl3) 3.92 (3H, s, OCH3), 6.45 (1H, dd, J 2.3, 1.8 Hz, 4′-H), 7.11 (1H, d, J 8.6 Hz, 
5-H), 7.32 (1H, tt, J 7.4, 1.2 Hz, 4′′-H), 7.38–7.44 (2H, m, 3′′-H and 5′′-H), 7.52 (1H, 
dd, J 8.6, 2.4 Hz, 6-H), 7.58–7.63 (2H, m, 2′′-H and 6′′-H), 7.73 (1H, d, J 1.8 Hz, 
ArH), 7.99 (1H, d, J 2.4 Hz, 2-H), 8.08 (1H, d, J 2.3 Hz, ArH); δC (126 MHz, CDCl3) 
56.1 (CH3), 106.3 (CH), 112.7 (CH), 123.9 (CH), 126.3 (CH), 126.8 (2 × CH), 127.1 
(CH), 128.8 (2 × CH), 129.9 (C), 131.6 (CH), 134.5 (C), 139.8 (C), 140.2 (CH), 150.7 
(C); m/z (ESI) 273.0992 (MNa+. C16H14N2NaO requires 273.0998). 
N-(2,5-Dimethoxyphenyl)-1H-pyrazole (101j) 
 
N-(2,5-Dimethoxyphenyl)-1H-pyrazole (101j) was synthesised as described for N-
(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 1,4-dimethoxybenzene (0.0690 
g, 0.500 mmol) and pyrazole (0.102 g, 1.50 mmol). The iodination step was carried 
out at 70 °C for 5 h and the N-arylation step at 150 °C for 24 h. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 9:1) gave N-(2,5-
dimethoxyphenyl)-1H-pyrazole (101j) (0.0670 g, 66%) as a colourless oil. νmax/cm−1 
(neat) 2940 (CH), 1597, 1520, 1504, 1211, 1042, 748; δH (400 MHz, CDCl3) 3.82 
(6H, br s, 2 × OCH3), 6.42 (1H, dd, J 2.4, 1.9 Hz, 4′-H), 6.83 (1H, dd, J 9.0, 3.1 Hz, 
4-H), 6.98 (1H, d, J 9.0 Hz, 3-H), 7.36 (1H, d, J 3.1 Hz, 6-H), 7.70 (1H, d, J 1.9 Hz, 
ArH), 8.10 (1H, d, J 2.4 Hz, ArH); δC (101 MHz, CDCl3) 55.9 (CH3), 56.7 (CH3), 106.3 
(CH), 110.0 (CH), 113.6 (CH), 114.0 (CH), 130.2 (C), 131.6 (CH), 140.1 (CH), 145.1 
(C), 154.1 (C); m/z (ESI) 227.0785 (MNa+. C11H12N2NaO2 requires 227.0791). 
  
3
4
5
6
1
2
OMe
OMe
N N
3′
4′5′
 
191 
2′′-(4-Methoxy-3-pyrazol-1′-ylphenyl)acetic acid (101k) 
 
2′′-(4-Methoxy-3-pyrazol-1′-ylphenyl)acetic acid (101k) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-
methoxyphenylacetic acid (0.0830 g, 0.500 mmol) and pyrazole (0.102 g, 1.50 
mmol). The iodination step was carried out at 70 °C for 4 h and the N-arylation step 
at 150 °C for 24 h. The reaction mixture was cooled to room temperature, diluted 
with dichloromethane (10 mL) and extracted with 1 M aqueous sodium hydroxide 
solution (10 mL). The aqueous layer was separated and acidified with 1 M aqueous 
hydrochloric acid and extracted into dichloromethane (3 × 30 mL). The combined 
organic extracts were dried (MgSO4) and concentrated in vacuo. Trituration with 
hexane gave 2′′-(4-methoxy-3-pyrazol-1′-ylphenyl)acetic acid (101k) (0.0621 g, 
53%) as a white crystalline solid. Mp 94–96 °C (from hexane); νmax/cm−1 (neat) 2940 
(CH), 1713 (C=O), 1526 (C=C), 1462, 1410, 1287, 1248, 1180, 1152, 1022, 760; δH 
(400 MHz, CDCl3) 3.62 (2H, s, CH2), 3.86 (3H, s, OCH3), 6.42 (1H, dd, J 2.3, 1.8 
Hz, 4′-H), 6.99 (1H, d, J 8.5 Hz, 5-H), 7.21 (1H, dd, J 8.5, 2.1 Hz, 6-H), 7.67 (1H, d, 
J 2.1 Hz, 2-H), 7.73 (1H, d, J 1.8 Hz, ArH), 8.02 (1H, d, J 2.3 Hz, ArH); δC (101 MHz, 
CDCl3) 40.1 (CH2), 56.0 (CH3), 106.3 (CH), 112.4 (CH), 126.4 (CH), 126.9 (C), 129.1 
(CH), 129.2 (C), 131.9 (CH), 139.9 (CH), 150.2 (C), 175.5 (C); m/z (ESI) 255.0738 
(MNa+. C12H12N2NaO3 requires 255.0740). 
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N-(2-Methoxy-5-methylphenyl)benzamide (104a)485 
 
N-(2-Methoxy-5-methylphenyl)benzamide (104a) was synthesised as described for 
N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methylanisole (103) 
(0.0630 mL, 0.500 mmol) and benzamide (0.182 g, 1.50 mmol). The iodination step 
was carried out at 70 °C for 7 h and the N-arylation step at 150 °C for 20 h. 
Purification by flash column chromatography (hexane/diethyl ether, 4:1) gave N-(2-
methoxy-5-methylphenyl)benzamide (104a) (0.0910 g, 75%) as a colourless oil. 
Spectroscopic data were consistent with the literature.485 δH (500 MHz, CDCl3) 2.33 
(3H, s, 5-CH3), 3.87 (3H, s, OCH3), 6.78 (1H, d, J 8.3 Hz, 3-H), 6.86 (1H, dd, J 8.3 
Hz, 2.1 Hz, 4-H), 7.44–7.55 (3H, m, 3′-H, 4′-H and 5′-H), 7.86–7.90 (2H, m, 2′-H and 
6′-H), 8.38 (1H, d, J 2.1 Hz, 6-H), 8.52 (1H, br s, NH); δC (126 MHz, CDCl3) 21.0 
(CH3), 55.9 (CH3), 109.8 (CH), 120.5 (CH), 124.1 (CH), 127.0 (2 × CH), 127.5 (C), 
128.7 (2 × CH), 130.6 (C), 131.6 (CH), 135.3 (C), 146.1 (C), 165.1 (C); m/z (ESI) 
264 (MNa+. 100%). 
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzamide (104b) 
 
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzamide (104b) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-
methylanisole (103) (0.0630 mL, 0.500 mmol) and p-toluamide (0.203 g, 1.50 
mmol). The iodination step was carried out at 70 °C for 5 h and the N-arylation step 
at 150 °C for 20 h. Purification by flash column chromatography (hexane/diethyl 
ether, 4:1) gave N-(2-methoxy-5-methylphenyl)-4′-methylbenzamide (104b) (0.0980 
g, 77%) as a white solid. Mp 56–58 °C; νmax/cm−1 (neat) 3429 (NH), 2920 (CH), 1670 
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(C=O), 1530 (C=C), 1477, 1423, 1248, 1223, 1138, 1030, 799; δH (500 MHz, CDCl3) 
2.33 (3H, s, 5-CH3), 2.41 (3H, s, 4′-CH3), 3.87 (3H, s, OCH3), 6.78 (1H, d, J 8.2 Hz, 
3-H), 6.85 (1H, dd, J 8.2, 2.0 Hz, 4-H), 7.27 (2H, d, J 8.1 Hz, 3′-H and 5′-H), 7.78 
(2H, d, J 8.1 Hz, 2′-H and 6′-H), 8.38 (1H, d, J 2.0 Hz, 6-H), 8.50 (1H, br s, NH); δC 
(126 MHz, CDCl3) 21.0 (CH3), 21.5 (CH3), 55.9 (CH3), 109.8 (CH), 120.4 (CH), 123.9 
(CH), 127.0 (2 × CH), 127.6 (C), 129.4 (2 × CH), 130.6 (C), 132.5 (C), 142.1 (C), 
146.1 (C), 165.1 (C); m/z (ESI) 278.1146 (MNa+. C16H17NNaO2 requires 278.1151). 
N-(2-Methoxy-5-methylphenyl)benzenesulfonamide (104c) 
 
N-(2-Methoxy-5-methylphenyl)benzenesulfonamide (104c) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-
methylanisole (103) (0.0630 mL, 0.500 mmol) and benzene sulfonamide (0.236 g, 
1.50 mmol). The iodination step was carried out at 70 °C for 7 h and the N-arylation 
step at 150 °C for 20 h. Purification by flash column chromatography (hexane/diethyl 
ether, 1:1) gave N-(2-methoxy-5-methylphenyl)benzenesulfonamide (104c) (0.0840 
g, 61%) as a white solid. Mp 134–136 °C; νmax/cm−1 (neat) 3011 (CH), 1506, 1389, 
1327, 1256, 1165, 1090, 1030, 907, 727; δH (400 MHz, CDCl3) 2.25 (3H, s, 5-CH3), 
3.54 (3H, s, OCH3), 6.59 (1H, d, J 8.3 Hz, 3-H), 6.82 (1H, dd, J 8.3, 1.6 Hz, 4-H), 
6.98 (1H, br s, NH), 7.34 (1H, d, J 1.6 Hz, 6-H), 7.36–7.43 (2H, m, 3′-H and 5′-H), 
7.48 (1H, t, J 7.4 Hz, 4′-H), 7.71–7.77 (2H, m, 2′-H and 6′-H); δC (101 MHz, CDCl3) 
20.7 (CH3), 55.7 (CH3), 110.5 (CH), 122.4 (CH), 125.4 (C), 125.9 (CH), 127.2 (2 × 
CH), 128.7 (2 × CH), 130.6 (C), 132.8 (CH), 139.2 (C), 147.7 (C); m/z (ESI) 
300.0653 (MNa+. C14H15NNaO3S requires 300.0665). 
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N-(2-Methoxy-5-methylphenyl)-4′-methylbenzenesulfonamide (104d) 
 
N-(2-Methoxy-5-methylphenyl)-4′-methylbenzenesulfonamide (104d) was 
synthesised as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 
4-methylanisole (103) (0.0630 mL, 0.500 mmol) and p-toluenesulfonamide (0.257 
g, 1.50 mmol). The iodination step was carried out at 70 °C for 7 h and the N-
arylation step at 150 °C for 20 h. Purification by flash column chromatography 
(hexane/diethyl ether, 1:1) gave N-(2-methoxy-5-methylphenyl)-4′-
methylbenzenesulfonamide (104d) (0.113 g, 78%) as a white solid. Mp 68–70 °C; 
νmax/cm−1 (neat) 3400 (NH), 2936 (CH), 1595 (C=C), 1508, 1389, 1330, 1252, 1163, 
1123, 1090, 808; δH (400 MHz, CDCl3) 2.25 (3H, s, 4′-CH3), 2.35 (3H, s, 5-CH3), 
3.58 (3H, s, OCH3), 6.60 (1H, d, J 8.4 Hz, 3-H), 6.81 (1H, dd, J 8.4, 2.1 Hz, 4-H), 
6.95 (1H, br s, NH), 7.18 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 7.34 (1H, d, J 2.1 Hz, 6-
H), 7.63 (2H, d, J 8.2 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 20.8 (CH3), 21.5 
(CH3), 55.7 (CH3), 110.5 (CH), 121.8 (CH), 125.6 (CH), 125.7 (C), 127.2 (2 × CH), 
129.3 (2 × CH), 130.6 (C), 136.4 (C), 143.5 (C), 147.5 (C); m/z (ESI) 314.0809 
(MNa+. C15H17NNaO3S requires 314.0821). 
N-(2-Methoxy-5-methylphenyl)-4′-chlorobenzenesulfonamide (104e) 
 
N-(2-Methoxy-5-methylphenyl)-4′-chlorobenzenesulfonamide (104e) was 
synthesised as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 
4-methylanisole (103) (0.0630 mL, 0.500 mmol) and p-chlorobenzenesulfonamide 
(0.288 g, 1.50 mmol). The iodination step was carried out at 70 °C for 5 h and the 
N-arylation step at 150 °C for 20 h. Purification by flash column chromatography 
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(hexane/diethyl ether, 1:1) gave N-(2-methoxy-5-methylphenyl)-4′-
chlorobenzenesulfonamide (104e) (0.0890 g, 55%) as a yellow oil. νmax/cm−1 (neat) 
3273 (NH), 2932 (CH), 1585 (C=C), 1508, 1335, 1252, 1165, 1123, 1086, 752; δH 
(400 MHz, CDCl3) 2.27 (3H, s, 5-CH3), 3.58 (3H, s, OCH3), 6.61 (1H, d, J 8.3 Hz, 3-
H), 6.85 (1H, dd, J 8.3, 2.0 Hz, 4-H), 6.97 (1H, br s, NH), 7.32–7.38 (3H, m, 6-H, 3′-
H and 5′-H), 7.67 (2H, d, J 8.9 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 20.7 (CH3), 
55.7 (CH3), 110.5 (CH), 122.6 (CH), 125.0 (C), 126.3 (CH), 128.7 (2 × CH), 129.0 
(2 × CH), 130.7 (C), 137.8 (C), 139.2 (C), 147.8 (C); m/z (ESI) 334.0265 (MNa+. 
C14H1435ClNNaO3S requires 334.0275). 
N-(2-Methoxy-5-methylphenyl)methanesulfonamide (104f) 
 
N-(2-Methoxy-5-methylphenyl)methanesulfonamide (104f) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-
methylanisole (103) (0.0630 mL, 0.500 mmol) and methanesulfonamide (0.143 g, 
1.50 mmol). The iodination step was carried out at 70 °C for 5 h and the N-arylation 
step at 150 °C for 24 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave N-(2-methoxy-5-methylphenyl)methanesulfonamide 
(104f) (0.0610 g, 57%) as a colourless oil. νmax/cm−1 (neat) 3267 (NH), 2934 (CH), 
1508 (C=C), 1387, 1323, 1252, 1161, 1121, 1028, 970, 760; δH (500 MHz, CDCl3) 
2.30 (3H, s, 5-CH3), 2.94 (3H, s, SO2CH3), 3.85 (3H, s, OCH3), 6.74 (1H, br s, NH), 
6.80 (1H, d, J 8.3 Hz, 3-H), 6.92 (1H, dd, J 8.3, 1.9 Hz, 4-H), 7.33 (1H, d, J 1.9 Hz, 
6-H); δC (126 MHz, CDCl3) 20.8 (CH3), 39.0 (CH3), 55.9 (CH3), 110.6 (CH), 121.7 
(CH), 125.7 (C), 125.9 (CH), 131.0 (C), 147.5 (C); m/z (ESI) 238.0502 (MNa+. 
C9H13NNaO3S requires 238.0508). 
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N-(2-Methoxy-5-methylphenyl)pyrrolidin-2′-one (104g)486 
 
N-(2-Methoxy-5-methylphenyl)pyrrolidin-2′-one (104g) was synthesised as 
described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-
methylanisole (103) (0.0630 mL, 0.500 mmol) and pyrrolidin-2-one (0.114 mL, 1.50 
mmol). The iodination step was carried out at 70 °C for 5 h and the N-arylation step 
at 150 °C for 20 h. Purification by flash column chromatography (ethyl acetate) gave 
N-(2-methoxy-5-methylphenyl)pyrrolidin-2′-one (104g) (0.0530 g, 52%) as a 
colourless oil. Spectroscopic data were consistent with the literature.486 δH (500 
MHz, CDCl3) 2.12–2.20 (2H, m, 4′-H2), 2.28 (3H, s, 5-CH3), 2.54 (2H, t, J 7.8 Hz, 3′-
H2) 3.73 (2H, t, J 7.0 Hz, 5′-H2), 3.79 (3H, s, OCH3), 6.84 (1H, d, J 8.9 Hz, 3-H), 
7.04–7.07 (2H, m, 4-H and 6-H); δC (126 MHz, CDCl3) 18.9 (CH2), 20.4 (CH3), 31.2 
(CH2), 50.0 (CH2), 55.8 (CH3), 112.1 (CH), 126.9 (C), 129.1 (CH), 129.2 (CH), 130.4 
(C), 152.7 (C), 175.2 (C); m/z (ESI) 228 (MNa+. 100%). 
N-(2-Methoxy-5-methylphenyl)pyrrole (104h) 
 
N-(2-Methoxy-5-methylphenyl)pyrrole (104h) was synthesised as described for N-
(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methylanisole (103) (0.0630 
mL, 0.500 mmol) and pyrrole (0.104 mL, 1.50 mmol). The iodination step was 
carried out at 70 °C for 5 h and the N-arylation step at 150 °C for 36 h. Purification 
by flash column chromatography (hexane/diethyl ether, 9:1) gave N-(2-methoxy-5-
methylphenyl)pyrrole (104h) (0.0350 g, 37%) as a colourless oil. νmax/cm−1 (neat) 
2931 (CH), 1512 (C=C), 1483, 1327, 1242, 1070, 1024, 723; δH (400 MHz, CDCl3) 
2.32 (3H, s, 5-CH3), 3.79 (3H, s, OCH3), 6.30 (2H, t, J 2.2 Hz, 3′-H and 4′-H), 6.91 
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(1H, d, J 8.2 Hz, 3-H), 6.97 (2H, t, J 2.2 Hz, 2′-H and 5′-H), 7.05 (1H, dd, J 8.2, 2.1 
Hz, 4-H), 7.10 (1H, d, J 2.1 Hz, 6-H); δC (101 MHz, CDCl3) 20.4 (CH3), 56.0 (CH3), 
108.7 (2 × CH), 112.4 (CH), 122.0 (2 × CH), 126.4 (CH), 127.7 (CH), 130.0 (C), 
130.5 (C), 150.6 (C); m/z (ESI) 210.0892 (MNa+. C12H13NNaO requires 210.0889). 
1-(2-Methoxy-5-methylphenyl)-1H-indole (104i) 
 
1-(2-Methoxy-5-methylphenyl)-1H-indole (104i) was synthesised as described for 
N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methylanisole (103) 
(0.0630 mL, 0.500 mmol) and indole (0.0879 g, 0.750 mmol). The iodination step 
was carried out at 70 °C for 20 h and the N-arylation step at 130 °C for 20 h. 
Purification by flash column chromatography (hexane/dichloromethane, 9:1) gave 
1-(2-methoxy-5-methylphenyl)-1H-indole (104i) (0.0303 g, 25%) as a colourless oil. 
νmax/cm−1 (neat) 2928 (CH), 1514 (C=C), 1462, 1254, 741; δH (500 MHz, CDCl3) 
2.34 (3H, s, 5-CH3), 3.72 (3H, s, OCH3), 6.63 (1H, dd, J 3.2, 0.7 Hz, 3′-H), 6.97 (1H, 
d, J 8.2 Hz, 3-H), 7.10–7.24 (5H, m, 6-H, 4′-H, 5′-H, 6′-H and 7′-H), 7.26 (1H, d, J 
3.2 Hz, 2′-H), 7.66 (1H, dd, J 8.2, 1.2 Hz, 4-H); δC (126 MHz, CDCl3) 20.4 (CH3), 
55.9 (CH3), 102.4 (CH), 110.9 (CH), 112.5 (CH), 119.8 (CH), 120.7 (CH), 121.8 
(CH), 127.9 (C), 128.5 (C), 128.6 (CH), 128.8 (CH), 129.3 (CH), 130.4 (C), 136.8 
(C), 152.3 (C); m/z (ESI) 260.1040 (MNa+. C16H15NNaO requires 260.1046). 
N-(2-Methoxy-5-methylphenyl)imidazole (104j)487 
 
N-(2-Methoxy-5-methylphenyl)imidazole (104j) was synthesised as described for N-
(2-amino-5-cyanophenyl)-1H-pyrazole (101a) using 4-methylanisole (103) (0.0630 
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mL, 0.500 mmol) and imidazole (0.102 g, 1.50 mmol). The iodination step was 
carried out at 70 °C for 5 h and the N-arylation step at 150 °C for 36 h. Purification 
by flash column chromatography (ethyl acetate/methanol, 9:1) gave N-(2-methoxy-
5-methylphenyl)imidazole (104j) (0.0490 g, 51%) as a colourless oil. Spectroscopic 
data were consistent with the literature.487 δH (500 MHz, CDCl3) 2.33 (3H, s, 5-CH3), 
3.80 (3H, s, OCH3), 6.94 (1H, d, J 8.4 Hz, 3-H), 7.09 (1H, d, J 1.8 Hz, 6-H), 7.14 
(1H, dd, J 8.4, 1.8 Hz, 4-H), 7.15–7.24 (2H, m, 5′-H and 4′-H), 7.79 (1H, br s, 2′-H); 
δC (126 MHz, CDCl3) 20.4 (CH3), 55.9 (CH3), 112.4 (CH), 120.3 (CH), 126.1 (CH), 
126.2 (C), 128.7 (CH), 129.2 (CH), 130.7 (C), 137.8 (CH), 150.4 (C); m/z (ESI) 189 
(MH+. 100%). 
N-(2-Hydroxy-5-methylphenyl)-1H-pyrazole (106) 
 
An oven-dried microwave vial was flushed with argon and charged with N-
iodosuccinimide (0.113 g, 0.500 mmol) and dry toluene (3.0 mL). To this suspension 
was added silver bis(trifluoromethanesulfonyl)imide (0.0150 g, 0.0375 mmol) and p-
cresol (105) (0.0530 mL, 0.500 mmol). The reaction mixture was stirred at 40 °C for 
5 h in the dark. The reaction mixture was cooled to room temperature and pyrazole 
(0.102 g, 1.50 mmol), copper(I) iodide (9.52 mg, 0.0500 mmol), cesium carbonate 
(0.326 g, 1.00 mmol), trans-N,N′-dimethylcyclohexane-1,2-diamine (16.0 µL, 0.100 
mmol) and water (0.5 mL) were added. The reaction mixture was degassed under 
argon for 0.1 h and then heated to 130 °C for 24 h. The reaction mixture was then 
cooled to room temperature, diluted with ethyl acetate (10 mL), washed with a 1 M 
aqueous sodium thiosulfate solution (10 mL). The aqueous layer was extracted with 
ethyl acetate (3 × 10 mL) and the combined organic extracts were washed with brine 
(10 mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (hexane/diethyl ether, 4:1) gave N-(2-
hydroxy-5-methylphenyl)-1H-pyrazole (106) (0.0315 g, 37%) as a colourless oil. 
νmax/cm−1 (neat) 3036 (OH), 2920 (CH), 1518 (C=C), 1333, 1279, 1250, 750; δH (400 
MHz, CDCl3) 2.33 (3H, s, 5-CH3), 6.49 (1H, dd, J 2.4, 2.1 Hz, 4′-H), 6.95–7.01 (2H, 
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m, 3-H and 4-H), 7.18 (1H, br s, 6-H), 7.72 (1H, d, J 2.1 Hz, ArH), 7.99 (1H, d, J 2.4 
Hz, ArH), 11.11 (1H, s, OH); δC (101 MHz, CDCl3) 20.6 (CH3), 106.7 (CH), 118.3 
(CH), 118.7 (CH), 124.5 (C), 126.6 (CH), 128.2 (CH), 128.9 (C), 138.9 (CH), 147.0 
(C); m/z (ESI) 197.0684 (MNa+. C10H10N2NaO requires 197.0685). 
N-Methyl-6-benzenesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one 
(108a) 
 
N-Methyl-6-benzenesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one (108a) 
was synthesised as described for N-(2-amino-5-cyanophenyl)-1H-pyrazole (101a) 
using N-methyl-7-methoxy-3,4-dihydro-1H-quinolin-2-one (107) (0.0500 g, 0.262 
mmol) and benzenesulfonamide (0.122 g, 0.780 mmol), iron(III) chloride (1.01 mg, 
0.00625 mmol) and [BMIM]NTf2 (6.00 µL, 0.0196 mmol). The iodination step was 
carried out at 40 °C for 4 h and the N-arylation step at 150 °C for 20 h. Purification 
by flash column chromatography (ethyl acetate/hexane, 7:3) gave N-methyl-6-
benzenesulfonamide-7-methoxy-3,4-dihydro-1H-quinolin-2-one (108a) (0.0510 g, 
56%) as a white solid. Mp 185–188 °C; νmax/cm−1 (neat) 3252 (NH), 2967 (CH), 1665 
(C=O), 1616, 1518, 1332, 1171, 1146, 1115, 1092, 1061, 934, 763; δH (400 MHz, 
CDCl3) 2.61 (2H, dd, J 9.2, 6.8 Hz, 4-H2), 2.83 (2H, dd, J 7.6, 6.8 Hz, 3-H2), 3.29 
(3H, s, NCH3), 3.55 (3H, s, OCH3), 6.33 (1H, s, 8-H), 6.76 (1H, br s, NH), 7.35 (1H, 
s, 5-H), 7.39–7.44 (2H, m, 3′-H and 5′-H), 7.52 (1H, tt, J 7.2, 1.2 Hz, 4′-H), 7.70–
7.74 (2H, m, 2′-H and 6′-H); δc (101 MHz, CDCl3) 24.6 (CH2), 29.6 (CH3), 31.8 (CH2), 
55.8 (CH3), 98.7 (CH), 118.6 (C), 120.0 (C), 122.5 (CH), 127.2 (2 × CH), 128.7 (2 × 
CH), 132.8 (CH), 138.8 (C), 139.3 (C), 149.8 (C), 170.4 (C); m/z (ESI) 369.0873 
(MNa+. C17H18N2NaO4S requires 369.0879). 
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N-Methyl-6-(4′-methylbenzamide)-7-methoxy-3,4-dihydro-1H-quinolin-2-one 
(108c) 
 
N-Methyl-6-(4′-methylbenzamide)-7-methoxy-3,4-dihydro-1H-quinolin-2-one (108c) 
was synthesised as described for N-methyl-6-benzenesulfonamide-7-methoxy-3,4-
dihydro-1H-quinolin-2-one (108a) using N-methyl-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (107) (0.0500 g, 0.262 mmol) and p-toluamide (0.106 g, 0.783 mmol). 
The iodination step was carried out at 40 °C for 4 h and the N-arylation step at 150 
°C for 20 h. Purification by flash column chromatography (dichloromethane/diethyl 
ether, 3:2) gave N-methyl-6-(4′-methylbenzamide)-7-methoxy-3,4-dihydro-1H-
quinolin-2-one (108c) (0.0520 g, 61%) as a white solid. Mp 164–166 °C; νmax/cm−1 
(neat) 3428 (NH), 2955 (CH), 1663 (C=O), 1614, 1533, 1472, 1427, 1350, 1265, 
1244, 1206, 1126, 1061, 745; δH (500 MHz, CDCl3) 2.43 (3H, s, 4′-CH3), 2.62–2.66 
(2H, m, 4-H2), 2.86–2.90 (2H, m, 3-H2), 3.37 (3H, s, NCH3), 3.94 (3H, s, OCH3), 6.56 
(1H, s, 8-H), 7.29 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 7.78 (2H, d, J 8.2 Hz, 2′-H and 6′-
H), 8.36 (1H, s, 5-H), 8.39 (1H, br s, NH); δc (126 MHz, CDCl3) 21.5 (CH3), 24.9 
(CH2), 29.6 (CH3), 32.0 (CH2), 56.2 (CH3), 98.3 (CH), 118.3 (C), 119.4 (CH), 122.7 
(C), 127.0 (2 × CH), 129.4 (2 × CH), 132.3 (C), 136.6 (C), 142.3 (C), 147.6 (C), 
165.1 (C), 170.5 (C); m/z (ESI) 347.1364 (MNa+. C19H20N2NaO3 requires 347.1366). 
4-(Phenylethynyl)anisole (111)488 
 
Iron(III) chloride (2.03 mg, 0.0125 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (11.0 µL, 0.0375 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
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iodosuccinimide (0.113 g, 0.500 mmol) in toluene (1.0 mL). Anisole (0.0540 mL, 
0.500 mmol) was then added and the mixture was stirred at 40 °C for 4 h. Upon the 
completion of the iodination, phenylacetylene (0.110 mL, 1.00 mmol), copper(I) 
iodide (9.52 mg, 0.0500 mmol), cesium carbonate (0.325 g, 1.00 mmol), N,N′-
dimethylethylenediamine (10.8 µL, 0.100 mmol) and water (0.5 mL) were added. 
The reaction mixture was degassed under argon for 0.1 h then heated to 150 °C for 
48 h. The reaction mixture was then cooled to room temperature, diluted with ethyl 
acetate (10 mL), washed with a 10% sodium thiosulfate solution (10 mL) and brine 
(10 mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (hexane/dichloromethane, 9:1) gave 
4-(phenylethynyl)anisole (111) (0.0410 g, 39%) as a brown solid. Mp 61–63 °C 
(lit.488 57–59 °C); δH (400 MHz, CDCl3) 3.82 (3H, s, OCH3), 6.87 (2H, d, J 8.9 Hz, 3-
H and 5-H), 7.29–7.36 (3H, m, 3′-H, 4′-H and 5′-H), 7.47 (1H, d, J 8.9 Hz, 2-H and 
6-H), 7.49–7.54 (2H, m, 2′-H and 6′-H); δC (101 MHz, CDCl3) 55.3 (CH3), 88.1 (C), 
89.4 (C), 114.0 (CH), 115.4 (C), 123.6 (C), 128.0 (2 × CH), 128.3 (2 × CH), 131.5 
(2 × CH), 133.1 (2 × CH), 159.6 (C); m/z (ESI) 231 (MNa+. 100%). 
2′-(4-Methoxyphenyl)-4′,4′,5′,5′-tetramethyl-1′,3′,2′-dioxaborolane (113)269 
 
An oven-dried microwave vial was flushed with argon and charged with 
bis(pinacolato)diboron (0.191 g, 0.750 mmol), 4-iodoanisole (0.0585 g, 0.250 
mmol), copper(I) iodide (0.00476 g, 0.0250 mmol) and dry tetrahydrofuran (2.0 mL). 
n-Tributylphosphine (0.00800 mL, 0.0325 mmol) was added followed by potassium 
tert-butoxide (0.0840 g, 0.750 mmol) under argon. The mixture was degassed under 
argon for 0.1 h and the reaction mixture was stirred at 70 °C for 20 h. After cooling 
to room temperature, the reaction mixture was diluted with ethyl acetate, filtered 
through a short-pad of Celite® then concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/diethyl ether, 9:1) gave 2′-(4-
methoxyphenyl)-4′,4′,5′,5′-tetramethyl-1′,3′,2′-dioxaborolane (113) (0.0192 g, 33%) 
as a colourless oil. Spectroscopic data were consistent with the literature.269 δH (400 
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MHz, CDCl3) 1.33 (12 H, s, 4 × CH3), 3.82 (3H, s, OCH3), 6.89 (2H, d, J 8.7 Hz, 3-
H and 5-H), 7.75 (2H, d, J 8.7 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 24.9 (4 × 
CH3), 55.1 (CH3), 83.5 (C), 113.3 (2 × CH), 136.5 (2 × CH), 162.2 (C); m/z (ESI) 257 
(MNa+. 100%). 
3-Methoxy-1-[(E)-2′-nitrovinyl]benzene (120a)489 
 
To a solution of m-anisaldehyde (119a) (0.890 mL, 7.30 mmol) in toluene (30 mL) 
was added nitromethane (2.00 mL, 37.0 mmol) and ammonium acetate (0.560 g, 
7.30 mmol). The resulting solution was heated under reflux for 18 h. The reaction 
mixture was washed with water (2 × 30 mL), followed by brine (2 × 30 mL). 
Purification by flash column chromatography (dichloromethane) gave 3-methoxy-1-
[(E)-2′-nitrovinyl]benzene (120a) (1.21 g, 97%) as a yellow solid. Mp 91–92 °C (lit.489 
92–94 °C); δH (400 MHz, CDCl3) 3.85 (3H, s, OCH3), 7.02–7.08 (2H, m, 2-H and 6-
H), 7.14 (1H, d, J 7.6 Hz, 4-H), 7.37 (1H, t, J 7.6 Hz, 5-H), 7.57 (1H, d, J 13.6 Hz, 
2′-H), 7.97 (1H, d, J 13.6 Hz, 1′-H); δC (101 MHz, CDCl3) 55.4 (CH3), 114.0 (CH), 
118.0 (CH), 121.7 (CH), 130.4 (CH), 131.4 (C), 137.4 (CH), 139.0 (CH), 160.2 (C); 
m/z (EI) 179 (M+. 100%), 136 (82), 135 (72), 84 (86), 77 (50). 
3,4-Dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120b)490 
 
3,4-Dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120b) was synthesised as described for 
3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using 3,4-dimethoxybenzaldehyde 
(119b) (1.00 g, 6.00 mmol). Purification by flash column chromatography 
(dichloromethane) gave 3,4-dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120b) (1.04 g, 
83%) as a yellow solid. Mp 134–136 °C (lit.490 135–137 °C); δH (400 MHz, CDCl3) 
3.93 (3H, s, OCH3), 3.95 (3H, s, OCH3), 6.91 (1H, d, J 8.3 Hz, 5-H), 7.01 (1H, d, J 
1.7 Hz, 2-H), 7.18 (1H, dd, J 8.3, 1.7 Hz, 6-H), 7.53 (1H, d, J 13.6 Hz, 2′-H), 7.96 
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(1H, d, J 13.6 Hz, 1′-H); δC (101 MHz, CDCl3) 56.0 (CH3), 56.1 (CH3), 110.3 (CH), 
111.4 (CH), 122.8 (C), 124.6 (CH), 135.2 (CH), 139.3 (CH), 149.6 (C), 152.9 (C); 
m/z (ESI) 232 (MNa+. 100%). 
3,5-Dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120c)491 
 
3,5-Dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120c) was synthesised as described for 
3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using 3,5-dimethoxybenzaldehyde 
(119c) (0.350 g, 2.10 mmol). The residue was recrystallised from diethyl ether which 
gave 3,5-dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120c) (0.357 g, 81%) as a yellow 
crystalline solid. Mp 81–83 °C (from diethyl ether) (lit.491 78 °C); δH (400 MHz, CDCl3) 
3.83 (6H, s, 2 × OCH3), 6.59 (1H, t, J 2.2 Hz, 4-H), 6.66 (2H, d, J 2.2 Hz, 2-H and 
6-H), 7.54 (1H, d, J 13.6 Hz, 2′-H), 7.92 (1H, d, J 13.6 Hz, 1′-H); δC (101 MHz, CDCl3) 
55.5 (CH3), 55.6 (CH3), 102.8 (CH), 104.2 (CH), 107.0 (CH), 107.6 (CH), 133.4 (CH), 
139.2 (C), 160.7 (C), 161.3 (C); m/z (EI) 209 (M+. 100%), 189 (48), 165 (90), 135 
(34), 84 (100). 
1-[(E)-2′-Nitrovinyl]-3,4,5-Trimethoxybenzene (120d)490 
 
1-[(E)-2′-Nitrovinyl]-3,4,5-trimethoxybenzene (120d) was synthesised as described 
for 3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using 3,4,5-
trimethoxybenzaldehyde (119d) (1.00 g, 5.10 mmol). The residue was recrystallised 
from hexane, which gave 1-[(E)-2′-nitrovinyl]-3,4,5-trimethoxybenzene (120d) (1.14 
g, 94%) as a yellow crystalline solid. Mp 119–121 °C (from hexane) (lit.490 122–124 
°C); δH (400 MHz, CDCl3) 3.91 (6H, s, 2 × OCH3), 3.92 (3H, s, OCH3), 6.76 (2H, s, 
2-H and 6-H), 7.52 (1H, d, J 13.6 Hz, 2′-H), 7.94 (1H, d, J 13.6 Hz, 1′-H); δC (101 
MHz, CDCl3) 56.3 (2 × CH3), 61.1 (CH3), 106.5 (2 × CH), 125.3 (C), 136.4 (CH), 
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139.3 (CH), 141.8 (C), 153.7 (2 × C); m/z (ESI) 262 (MNa+. 100%). 
3-Methoxy-4-methylbenzaldehyde (119e)492 
 
To a stirred solution of lithium aluminium hydride (0.425 g, 11.1 mmol) in dry 
tetrahydrofuran (20 mL) was added a solution of methyl 3-methoxy-4-
methylbenzoate (1.00 g, 5.55 mmol) in dry tetrahydrofuran (10 mL) dropwise at 0 
°C. The resulting suspension was warmed to room temperature and stirred for 4 h 
after which, the solution was cooled to 0 °C and diluted with tetrahydrofuran (20 
mL). Water (0.5 mL) was added slowly followed by 15% aqueous sodium hydroxide 
solution (0.5 mL) and water (1.5 mL). The resulting solution was warmed to room 
temperature, magnesium sulfate (0.50 g) was added and stirred for 0.5 h. The 
suspension was filtered and the filtrate was concentrated in vacuo to give 3-
methoxy-4-methylbenzyl alcohol (0.767 g, 91%) as a colourless oil which was used 
without further purification. To a stirred solution of 3-methoxy-4-methylbenzyl 
alcohol (0.737 g, 4.85 mmol) in chloroform (25 mL) was added manganese dioxide 
(4.22 g, 48.5 mmol). The resulting suspension was stirred at room temperature for 
18 h. The crude reaction mixture was filtered through Celite® and concentrated in 
vacuo to give 3-methoxy-4-methylbenzaldehyde (119e) (0.621 g, 75%) as a white 
solid. Mp 34–36 °C (lit.492 39–41 °C); δH (400 MHz, CDCl3) 2.29 (3H, s, 4-CH3), 3.90 
(3H, s, OCH3), 7.29 (1H, d, J 7.5 Hz, 5-H), 7.34 (1H, d, J 1.4 Hz, 2-H), 7.36 (1H, dd, 
J 7.5, 1.4 Hz, 6-H), 9.93 (1H, s, CHO); δC (101 MHz, CDCl3) 16.9 (CH3), 55.5 (CH3), 
107.9 (CH), 124.5 (CH), 130.9 (C), 134.9 (CH), 135.9 (C), 158.3 (C), 192.0 (CH); 
m/z (EI) 150 (M+. 100%), 121 (19), 91 (28), 84 (21). 
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3-Methoxy-4-methyl-1-[(E)-2′-nitrovinyl]benzene (120e)  
 
3-Methoxy-4-methyl-1-[(E)-2′-nitrovinyl]benzene (120e) was synthesised as 
described for 3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using 3-methoxy-4-
methylbenzaldehyde (119e) (0.624 g, 4.16 mmol). The residue was recrystallised 
from hexane which gave 3-methoxy-4-methyl-1-[(E)-2′-nitrovinyl]benzene (120e) 
(0.585 g, 73%) as a yellow solid. Mp 142–143 °C (from hexane); νmax/cm−1 (neat) 
3119, 2945 (CH), 1629, 1602 (C=C), 1573, 1494, 1414, 1343, 1328, 1248, 1159, 
1035, 976, 814; δH (400 MHz, CDCl3) 2.26 (3H, s, 4-CH3), 3.87 (3H, s, OCH3), 6.92 
(1H, s, 2-H), 7.06 (1H, d, J 7.6 Hz, 6-H), 7.19 (1H, d, J 7.6 Hz, 5-H), 7.57 (1H, d, J 
13.6 Hz, 2′-H), 7.97 (1H, d, J 13.6 Hz, 1′-H); δC (101 MHz, CDCl3) 16.6 (CH3), 55.4 
(CH3), 109.3 (CH), 122.2 (CH), 128.8 (C), 131.4 (CH), 132.4 (C), 136.3 (CH), 139.6 
(CH), 158.3 (C); m/z (ESI) 216.0626 (MNa+. C10H11NNaO3 requires 216.0631). 
3,4-Methylenedioxy-1-[(E)-2′-nitrovinyl]benzene (120f)493 
 
3,4-Methylenedioxy-1-[(E)-2′-nitrovinyl]benzene (120f) was synthesised as 
described for 3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using piperonal (119f) 
(1.00 g, 6.66 mmol). The residue was recrystallised from hexane which gave 3,4-
methylenedioxy-1-[(E)-2′-nitrovinyl]benzene (120f) (1.03 g, 80%) as a yellow solid. 
Mp 142–143 °C (from hexane) (lit.493 148 °C); δH (400 MHz, CDCl3) 6.06 (2H, s, 
OCH2O), 6.87 (1H, d, J 8.0 Hz, 5-H), 7.00 (1H, d, J 1.8 Hz, 2-H), 7.08 (1H, dd, J 8.0, 
1.8 Hz, 6-H), 7.47 (1H, d, J 13.6 Hz, 2′-H), 7.92 (1H, d, J 13.6 Hz, 1′-H); δC (101 
MHz, CDCl3) 102.1 (CH2), 107.0 (CH), 109.1 (CH), 124.2 (CH), 126.6 (CH), 135.5 
(C), 139.1 (CH), 148.8 (C), 151.4 (C); m/z (EI) 193 (M+. 100%), 146 (100), 89 (65), 
84 (51), 63 (44). 
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3-Nitro-1-[(E)-2′-nitrovinyl]benzene (120g)494 
 
3-Nitro-1-[(E)-2′-nitrovinyl]benzene (120g) was synthesised as described for 3-
methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using 3-nitrobenzaldehyde (119g) 
(1.00 g, 6.62 mmol). Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 9:1) gave 3-nitro-1-[(E)-2′-nitrovinyl]benzene (120g) (0.406 g, 
31%) as a yellow solid. Mp 119–121 °C (lit.494 125–126 °C); δH (400 MHz, CDCl3) 
7.68 (1H, d, J 13.7 Hz, 2′-H), 7.69 (1H, t, J 8.0 Hz, 5-H), 7.88 (1H, dt, J 8.0, 1.6 Hz, 
6-H), 8.05 (1H, d, J 13.7 Hz, 1′-H), 8.35 (1H, dt, J 8.0, 1.6 Hz, 4-H), 8.43 (1H, t, J 
1.6 Hz, 2-H); δC (101 MHz, CDCl3) 123.5 (CH), 126.2 (CH), 130.6 (CH), 131.9 (C), 
134.4 (CH), 136.2 (CH), 139.3 (CH), 148.9 (C); m/z (EI) 194 (M+. 100%), 147 (48), 
118 (38), 102 (100), 84 (82), 76 (36). 
4-Chloro-3-nitro-1-[(E)-2′-nitrovinyl]benzene (120h) 
 
4-Chloro-3-nitro-1-[(E)-2′-nitrovinyl]benzene (120h) was synthesised as described 
for 3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) using 4-chloro-3-
nitrobenzaldehyde (119h) (2.00 g, 10.8 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave 4-chloro-3-nitro-1-[(E)-2′-
nitrovinyl]benzene (120h) (0.620 g, 26%) as a yellow solid. Mp 142–143 °C; 
νmax/cm−1 (neat) 3109, 2945 (CH), 2361, 1605 (C=C), 1540, 1342, 1049, 833; δH 
(400 MHz, CDCl3) 7.61 (1H, d, J 13.7 Hz, 2′-H), 7.66–7.72 (2H, m, 5-H and 6-H), 
7.96 (1H, d, J 13.7 Hz, 1′-H), 8.06 (1H, d, J 1.2 Hz, 2-H); δC (101 MHz, CDCl3) 125.6 
(CH), 130.1 (C), 130.4 (C), 132.6 (CH), 133.2 (CH), 133.8 (C), 135.1 (CH), 139.4 
(CH); m/z (EI) 227.9929 (M+. C8H535ClN2O4 requires 227.9938), 181 (100%), 152 
(38), 136 (95), 115 (38), 101 (48), 89 (41), 75 (54). 
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1′-(3-Methoxyphenyl)ethyl-2′-amine (121a)495 
 
To a suspension of sodium borohydride (0.180 g, 4.80 mmol) in dry tetrahydrofuran 
(10 mL) was added boron trifluoride diethyl etherate (0.750 mL, 6.00 mmol) 
dropwise at 0 °C and the contents were stirred at room temperature for 0.25 h. A 
solution of 3-methoxy-1-[(E)-2′-nitrovinyl]benzene (120a) in tetrahydrofuran (3.0 mL) 
was added dropwise into the reaction mixture which was then heated under reflux 
for 6.5 h. After cooling to room temperature, the reaction was quenched by the slow 
addition of ice water (12 mL). The reaction mixture was acidified with 1 M aqueous 
hydrochloric acid (12 mL) and heated to 85 °C for 2 h. The reaction mixture was 
cooled to room temperature, washed with dichloromethane (2 × 10 mL), then 1 M 
aqueous sodium hydroxide was added until basic (ca. pH 12). The aqueous layer 
was extracted with dichloromethane (3 × 20 mL), dried (MgSO4) and concentrated 
in vacuo to give 1′-(3-methoxyphenyl)ethyl-2′-amine (121a) (0.137 g, 92%) as a 
yellow oil which was used without further purification. Spectroscopic data were 
consistent with the literature.495 δH (400 MHz, CDCl3) 1.99 (2H, br s, NH2), 2.72 (2H, 
t, J 6.8 Hz, 1′-H2), 2.96 (2H, t, J 6.8 Hz, 2′-H2), 3.78 (3H, s, OCH3), 6.73–6.80 (3H, 
m, 2-H, 4-H and 6-H), 7.21 (1H, t, J 7.6 Hz, 5-H); δC (101 MHz, CDCl3) 39.0 (CH2), 
43.0 (CH2), 55.2 (CH3), 111.6 (CH), 114.6 (CH), 121.2 (CH), 129.5 (CH), 140.9 (C), 
159.8 (C); m/z (ESI) 152 (MH+. 100%). 
N-[(3-Methoxyphenyl)ethyl]benzamide (122a)496 
 
1′-(3-Methoxyphenyl)ethyl-2′-amine (121a) (0.0500 g, 0.331 mmol) was dissolved in 
dry dichloromethane (5.0 mL) and triethylamine (0.0700 mL, 0.500 mmol) was 
added. The reaction mixture was cooled to 0 °C and benzoyl chloride (0.0390 mL, 
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0.331 mmol) was added dropwise. The reaction mixture was stirred at 0 °C for 0.5 
h, warmed to room temperature and stirred for 20 h. The reaction mixture was 
diluted with dichloromethane (10 mL), washed with 1 M aqueous hydrochloric acid 
(10 mL) then brine (10 mL), dried (MgSO4) and concentrated in vacuo. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 7:3) gave N-[(3-
methoxyphenyl)ethyl]benzamide (122a) (0.0765 g, 91% yield) as a white solid. Mp 
64–66 °C (lit.496 65–66 °C); δH (400 MHz, CDCl3) 2.91 (2H, t, J 6.9 Hz, 1′-H2), 3.71 
(2H, q, J 6.9 Hz, 2′-H2), 3.78 (3H, s, OCH3), 6.24 (1H, br s, NH), 6.76–6.84 (3H, m, 
2-H, 4-H and 6-H), 7.20–7.26 (1H, m, 5-H), 7.36–7.42 (2H, m, 3′′-H and 5′′-H), 7.44–
7.50 (1H, m, 4′′-H), 7.67–7.72 (2H, m, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 35.8 
(CH2), 41.1 (CH2), 55.2 (CH3), 112.1 (CH), 114.4 (CH), 121.1 (CH), 126.8 (2 × CH), 
128.6 (2 × CH), 129.7 (CH), 131.4 (CH), 134.7 (C), 140.5 (C), 159.9 (C), 167.5 (C); 
m/z (EI) 255 (M+. 25%), 134 (100), 105 (62), 77 (25). 
N-[(3-Methoxyphenyl)ethyl]acetamide (122b)497 
 
1′-(3-Methoxyphenyl)ethyl-2′-amine (121a) (0.0500 g, 0.331 mmol) was dissolved in 
dry dichloromethane (10 mL) and acetic anhydride (0.0380 mL, 0.400 mmol) was 
added while stirring. The reaction mixture was stirred at room temperature for 20 h. 
The reaction mixture was diluted with dichloromethane (15 mL), washed with 1 M 
aqueous sodium carbonate (15 mL), then brine (15 mL), dried (MgSO4) and 
concentrated in vacuo to give N-[(3-methoxyphenyl)ethyl]acetamide (122b) (0.0600 
g, 94%) as a yellow oil which was used without further purification. Spectroscopic 
data were consistent with the literature.497 δH (400 MHz, CDCl3) 1.94 (3H, s, 
CH3CO), 2.79 (2H, t, J 6.8 Hz, 1′-H2), 3.51 (2H, q, J 6.8 Hz, 2′-H2), 3.80 (3H, s, 
OCH3), 5.44 (1H, br s, NH), 6.72–6.82 (3H, m, 2-H, 4-H and 6-H), 7.23 (1H, t, J 7.9 
Hz, 5-H); δC (101 MHz, CDCl3) 23.4 (CH3), 35.7 (CH2), 40.5 (CH2), 50.2 (CH3), 111.9 
(CH), 114.5 (CH), 121.1 (CH), 129.7 (CH), 140.5 (C), 159.9 (C), 170.0 (C); m/z (ESI) 
216 (MNa+. 100%). 
  
3
4
5
6
1
2 1′
2′
H
NMeO
O
Me
 
209 
Benzyl N-[(3-methoxyphenyl)ethyl]carbamate (122c)498 
 
1′-(3-Methoxyphenyl)ethyl-2′-amine (121a) (0.100 g, 0.660 mmol) was dissolved in 
dry dichloromethane (10 mL) and triethylamine (0.142 mL, 1.00 mmol) was added 
while stirring. The reaction mixture was cooled to 0 °C and benzyl chloroformate 
(0.114 mL, 0.800 mmol) was added dropwise. The reaction mixture was stirred at 0 
°C for 0.5 h, warmed to room temperature and stirred for 5 h. The reaction mixture 
was diluted with dichloromethane (15 mL), washed with 1 M aqueous hydrochloric 
acid (15 mL), then brine (15 mL), dried (MgSO4) and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 4:1) 
gave benzyl N-[(3-methoxyphenyl)ethyl]carbamate (122c) (0.134 g, 72%) as a 
colourless oil. Spectroscopic data were consistent with the literature.498 δH (400 
MHz, CDCl3) 2.79 (2H, t, J 6.6 Hz, 1′-H2), 3.45 (2H, q, J 6.6 Hz, 2′-H2), 3.78 (3H, s, 
OCH3), 4.76 (1H, br s, NH), 5.09 (2H, s, OCH2), 6.69–6.81 (3H, m, 2-H, 4-H and 6-
H), 7.21 (1H, t, J 7.9 Hz, 5-H), 7.28–7.38 (5H, m, Ph); δC (101 MHz, CDCl3) 36.1 
(CH2), 42.1 (CH2), 55.2 (CH3), 66.7 (CH2), 111.9 (CH), 114.5 (CH), 121.1 (CH), 
128.1 (2 × CH), 128.5 (2 × CH), 128.6 (CH), 129.6 (CH), 136.6 (C), 140.3 (C), 156.3 
(C), 159.8 (C); m/z (ESI) 308 (MNa+. 100%). 
tert-Butyl-N-[(3-methoxyphenyl)ethyl]carbamate (122d)499 
 
1′-(3-Methoxyphenyl)ethyl-2′-amine (121a) (0.200 g, 1.32 mmol) was dissolved in 
dry dichloromethane (10 mL) and triethylamine (0.370 mL, 2.64 mmol) was added 
with stirring. Di-tert-butyl dicarbonate (0.870 g, 3.97 mmol) was added and the 
resulting solution was stirred at room temperature for 16 h. The reaction mixture 
was concentrated in vacuo and the residue was purified by column chromatography 
(petroleum ether/ethyl acetate, 4:1) to give tert-butyl-N-[(3-
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methoxyphenyl)ethyl]carbamate (122d) (0.253 g, 76%) as a yellow oil. 
Spectroscopic data were consistent with the literature.499 δH (400 MHz, CHCl3) 1.44 
(9H, s, C(CH3)3), 2.77 (2H, t, J 6.9 Hz, 1′-H2), 3.38 (2H, q, J 6.9 Hz, 2′-H2), 3.80 (3H, 
s, OCH3), 4.55 (1H, br s, NH), 6.72–6.89 (3H, m, 2-H, 4-H and 6-H), 7.22 (1H, t, J 
7.9 Hz, 5-H); δC (101 MHz, CHCl3) 28.4 (3 × CH3), 36.3 (CH2), 41.7 (CH2), 55.2 
(CH3), 80.5 (C), 111.8 (CH), 114.5 (CH), 121.1 (CH), 129.6 (CH), 140.6 (C), 155.9 
(C), 159.8 (C); m/z (EI) 251 (M+. 12%), 195 (32), 134 (100), 121 (48), 91 (24). 
N-[(3-Methoxyphenyl)ethyl]methanesulfonamide (122e) 
 
1′-(3-Methoxyphenyl)ethyl-2′-amine (121a) (0.198 g, 1.32 mmol) was dissolved in 
dry dichloromethane (10 mL) and triethylamine (0.370 mL, 2.64 mmol) was added 
with stirring. The reaction mixture was cooled to 0 °C and methanesulfonyl chloride 
(0.120 mL, 1.59 mmol) was added. The reaction mixture was stirred at 0 °C for 0.5 
h, warmed to room temperature and stirred for 4 h. The reaction mixture was diluted 
with dichloromethane (15 mL), washed with 1 M aqueous hydrochloric acid (15 mL), 
brine (15 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 1:1) gave N-[(3-
methoxyphenyl)ethyl]methanesulfonamide (122e) (0.184 g, 60%) as a yellow oil. 
νmax/cm−1 (neat) 3287 (NH), 2936 (CH), 1586 (C=C), 1489, 1312, 1258, 1146, 783; 
δH (500 MHz, CDCl3) 2.82–2.87 (5H, m, SO2CH3 and 1′-H2), 3.39 (2H, q, J 6.4 Hz, 
2′-H2), 3.80 (3H, s, OCH3), 4.44 (1H, br s, NH), 6.74–6.81 (3H, m, 2-H, 4-H and 6-
H), 7.24 (1H, t, J 7.9 Hz, 5-H); δC (126 MHz, CDCl3) 36.5 (CH2), 40.3 (CH3), 44.3 
(CH2), 55.2 (CH3), 112.2 (CH), 114.7 (CH), 121.1 (CH), 129.9 (CH), 139.4 (C), 159.9 
(C); m/z (EI) 229.0780 (M+. C10H15NO3S requires 229.0773), 134 (100%), 122 (76), 
108 (62), 91 (25). 
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N-[(3-Methoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (122f)500 
 
1′-(3-Methoxyphenyl)ethyl-2′-amine (121a) (0.200 g, 1.32 mmol) was dissolved in 
dry dichloromethane (10 mL) and triethylamine (0.280 mL, 1.98 mmol) was added 
with stirring. The reaction mixture was cooled to 0 °C and p-toluenesulfonyl chloride 
(0.302 g, 1.58 mmol) was added. The reaction mixture was stirred at 0 °C for 0.5 h, 
warmed to room temperature and stirred for 6 h. The reaction mixture was diluted 
with dichloromethane (15 mL), washed with 1 M aqueous hydrochloric acid (15 mL), 
brine (15 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 4:1) gave N-[(1-
methoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (122f) (0.327 g, 81%) as a 
yellow oil. Spectroscopic data were consistent with the literature.500 δH (400 MHz, 
CDCl3) 2.45 (3H, s, 4′′-CH3), 2.75 (2H, t, J 6.9 Hz, 1′-H2), 3.23 (2H, q, J 6.9 Hz, 2′-
H2), 3.79 (3H, s, OCH3), 4.54 (1H, br s, NH), 6.63 (1H, br s, 2-H), 6.69 (1H, br d, J 
7.9 Hz, 4-H), 6.78 (1H, dd, J 7.9, 2.5 Hz, 6-H), 7.20 (1H, t, J 7.9 Hz, 5-H), 7.31 (2H, 
d, J 8.2 Hz, 3′′-H and 5′′-H), 7.71 (2H, d, J 8.2 Hz, 2′′-H and 6′′-H); δC (101 MHz, 
CDCl3) 21.5 (CH3), 35.8 (CH2), 44.1 (CH2), 55.1 (CH3), 112.1 (CH), 114.4 (CH), 
121.0 (CH), 127.1 (2 × CH), 129.7 (2 × CH), 129.8 (CH), 136.9 (C), 139.2 (C), 143.4 
(C), 159.9 (C); m/z (ESI) 328 (MNa+. 100%). 
N-[(3,4-Dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123a)501 
 
To a suspension of sodium borohydride (0.817 g, 21.6 mmol) in dry tetrahydrofuran 
(50 mL) was added boron trifluoride diethyl etherate (3.37 mL, 27.3 mmol) dropwise 
at 0 °C and the mixture was stirred at room temperature for 0.25 h. A solution of 3,4-
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dimethoxy-1-[(E)-2′-nitrovinyl]benzene (120b) (0.950 g, 4.55 mmol) in 
tetrahydrofuran (15 mL) was added dropwise into the reaction mixture which was 
then heated under reflux for 6.5 h. After cooling to room temperature, the reaction 
was quenched by the slow addition of ice water (30 mL). The reaction mixture was 
acidified with 1 M aqueous hydrochloric acid (30 mL) and heated to 85 °C for 2 h. 
The reaction mixture was cooled to room temperature, washed with 
dichloromethane (2 × 40 mL), then 1 M aqueous sodium hydroxide was added until 
basic (ca. pH 12). The aqueous layer was extracted with dichloromethane (3 × 40 
mL), dried (MgSO4) and concentrated in vacuo to give 1′-(3,4-
dimethoxyphenyl)ethyl-2′-amine (121b) (0.582 g, 71%) as a yellow oil which was 
used without further purification. 1′-(3,4-Dimethoxyphenyl)ethyl-2′-amine (121b) 
(0.509 g, 2.81 mmol) was dissolved in dry dichloromethane (20 mL) and 
triethylamine (0.588 mL, 4.22 mmol) was added while stirring. The reaction mixture 
was cooled to 0 °C and p-toluenesulfonyl chloride (0.643 g, 3.37 mmol) was added. 
The reaction mixture was stirred at 0 °C for 0.5 h, warmed to room temperature and 
stirred for 6 h. The reaction mixture was diluted with dichloromethane (30 mL), 
washed with 1 M aqueous hydrochloric acid (30 mL), brine (30 mL), dried (MgSO4) 
and concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave N-[(3,4-dimethoxyphenyl)ethyl]-4′′-
methylbenzenesulfonamide (123a) (0.716 g, 76%) as a yellow oil. Spectroscopic 
data were consistent with the literature.501 δH (400 MHz, CDCl3) 2.42 (3H, s, 4′′-
CH3), 2.71 (2H, t, J 6.8 Hz, 1′-H2), 3.19 (2H, q, J 6.8 Hz, 2′-H2), 3.81 (3H, s, OCH3), 
3.86 (3H, s, OCH3), 4.31 (1H, t, J 6.8 Hz, NH), 6.55 (1H, d, J 2.0 Hz, 2-H), 6.62 (1H, 
dd, J 8.1, 2.0 Hz, 6-H), 6.76 (1H, d, J 8.1 Hz, 5-H), 7.28 (2H, d, J 8.2 Hz, 3′′-H and 
5′′-H), 7.67 (2H, d, J 8.2 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 35.3 
(CH2), 44.3 (CH2), 55.8 (CH3), 56.0 (CH3), 111.5 (CH), 111.8 (CH), 120.8 (CH), 
127.1 (2 × CH), 129.7 (2 × CH), 130.1 (C), 136.9 (C), 143.4 (C), 148.0 (C), 149.2 
(C); m/z (EI) 335 (M+. 60%), 184 (17), 164 (38), 151 (100), 107 (17), 91 (48). 
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N-[(3,5-Dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123b)502 
 
N-[(3,5-Dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123b) was 
synthesised as described for N-[(3,4-dimethoxyphenyl)ethyl]-4′′-
methylbenzenesulfonamide (123a) using 3,5-dimethoxy-1-[(E)-2′-
nitrovinyl]benzene (120c). Reduction of 3,5-dimethoxy-1-[(E)-2′-nitrovinyl]benzene 
(120c) (0.330 g, 1.58 mmol) using sodium borohydride (0.285 g, 7.51 mmol) and 
boron trifluoride diethyl etherate (1.17 mL, 9.48 mmol) gave 1′-(3,5-
dimethoxyphenyl)ethyl-2′-amine (121c) (0.165 g, 58%) which was used without 
further purification. The N-protection step was carried out at room temperature for 
18 h. Purification by flash column chromatography (petroleum ether/ethyl acetate, 
4:1) gave N-[(3,5-dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123b) 
(0.114 g, 50% yield) as a colourless oil. Spectroscopic data were consistent with the 
literature.502 δH (400 MHz, CDCl3) 2.42 (3H, s, 4′′-CH3), 2.69 (2H, t, J 6.9 Hz, 1′-H2), 
3.19 (2H, q, J 6.9 Hz, 2′-H2), 3.74 (6H, s, 2 × OCH3), 4.48 (1H, t, J 6.9 Hz, NH), 6.21 
(2H, d, J 2.2 Hz, 2-H and 6-H), 6.31 (1H, t, J 2.2 Hz, 4-H), 7.27 (2H, d, J 8.2 Hz, 3′′-
H and 5′′-H), 7.68 (2H, d, J 8.2 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 
36.0 (CH2), 44.0 (CH2), 55.3 (2 × CH3), 98.7 (CH), 106.7 (2 × CH), 127.1 (2 × CH), 
129.7 (2 × CH), 136.9 (C), 140.0 (C), 143.4 (C), 161.1 (2 × C); m/z (ESI) 358 (MNa+. 
100%). 
4′′-Methyl-N-[(3,4,5-trimethoxyphenyl)ethyl]benzenesulfonamide (123c)503 
 
4′′-Methyl-N-[(3,4,5-trimethoxyphenyl)ethyl]benzenesulfonamide (123c) was 
synthesised as described for N-[(3,4-dimethoxyphenyl)ethyl]-4′′-
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methylbenzenesulfonamide (123a) using 1-[(E)-2′-nitrovinyl]-3,4,5-
trimethoxybenzene (120d). Reduction of 1-[(E)-2′-nitrovinyl]-3,4,5-
trimethoxybenzene (120d) (1.09 g, 4.56 mmol) using sodium borohydride (0.821 g, 
21.7 mmol) and boron trifluoride diethyl etherate (3.90 mL, 27.4 mmol) gave 1′-
(3,4,5-trimethoxyphenyl)ethyl-2′-amine (121d) (0.748 g, 78%) which was used 
without further purification. The N-protection step was carried out at room 
temperature for 6 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 3:2) gave 4′′-methyl-N-[(3,4,5-
trimethoxyphenyl)ethyl]benzenesulfonamide (123c) (0.903 g, 71%) as a yellow oil. 
Spectroscopic data were consistent with the literature.503 δH (400 MHz, CDCl3) 2.42 
(3H, s, 4′′-CH3), 2.71 (2H, t, J 6.8 Hz, 1′-H2), 3.21 (2H, q, J 6.8 Hz, 2′-H2), 3.80 (6H, 
s, 2 × OCH3), 3.81 (3H, s, OCH3), 4.48 (1H, t, J 6.8 Hz, NH), 6.28 (2H, s, 2-H and 
6-H), 7.28 (2H, d, J 8.3 Hz, 3′′-H and 5′′-H), 7.69 (2H, d, J 8.3 Hz, 2′′-H and 6′′-H); 
δC (101 MHz, CDCl3) 21.5 (CH3), 36.1 (CH2), 44.2 (CH2), 56.1 (2 × CH3), 60.8 (CH3), 
105.7 (2 × CH), 127.1 (2 × CH), 129.7 (2 × CH), 133.3 (C), 136.9 (C), 137.0 (C), 
143.5 (C), 153.4 (2 × C); m/z (ESI) 388 (MNa+. 100%). 
N-[(3-Methoxy-4-methylphenyl)ethyl]-4′′-methylbenzenesulfonamide (123d) 
 
N-[(3-Methoxy-4-methylphenyl)ethyl]-4′′-methylbenzenesulfonamide (123d) was 
synthesised as described for N-[(3,4-dimethoxyphenyl)ethyl]-4′′-
methylbenzenesulfonamide (123a) using 3-methoxy-4-methyl-1-[(E)-2′-
nitrovinyl]benzene (120e). Reduction of 3-methoxy-4-methyl-1-[(E)-2′-
nitrovinyl]benzene (120e) (0.585 g, 3.03 mmol) using sodium borohydride (0.757 g, 
20.5 mmol) and boron trifluoride diethyl etherate (3.42 mL, 26.5 mmol) gave 1′-(3-
methoxy-4-methylphenyl)ethyl-2′-amine (121e) (0.356 g, 71%) which was used 
without further purification. The N-protection step was carried out at room 
temperature for 24 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 4:1) gave N-[(3-methoxy-4-methylphenyl)ethyl]-4′′-
methylbenzenesulfonamide (123d) (0.278 g, 45% yield) as a yellow oil. νmax/cm−1 
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(neat) 3264 (NH), 2924 (CH), 1586 (C=C), 1512, 1464, 1414, 1323, 1256, 1155, 
1094, 814; δH (400 MHz, CDCl3) 2.17 (3H, s, 4-CH3), 2.42 (3H, s, 4′′-CH3), 2.72 (2H, 
t, J 6.8 Hz, 1′-H2), 3.20 (2H, q, J 6.8, Hz, 2′-H2), 3.76 (3H, s, OCH3), 4.34 (1H, t, J 
6.8 Hz, NH), 6.51 (1H, d, J 1.4 Hz, 2-H), 6.51 (1H, dd, J 7.5, 1.4 Hz, 6-H), 7.01 (1H, 
d, J 7.5 Hz, 5-H), 7.27 (2H, d, J 8.2 Hz, 3′′-H and 5′′-H), 7.67 (2H, d, J 8.2 Hz, 2′′-H 
and 6′′-H); δC (101 MHz, CDCl3) 15.8 (CH3), 21.5 (CH3), 35.7 (CH2), 44.2 (CH2), 55.2 
(CH3), 110.4 (CH), 120.4 (CH), 125.2 (C), 127.1 (2 × CH), 129.7 (2 × CH), 130.8 
(CH), 136.3 (C), 137.0 (C), 143.4 (C), 158.0 (C); m/z (ESI) 342.1125 (MNa+. 
C17H21NNaO3S requires 342.1134). 
4′′-Methyl-N-[(3,4-methylenedioxyphenyl)ethyl]benzenesulfonamide (123e)504 
 
4′′-Methyl-N-[(3,4-methylenedioxyphenyl)ethyl]benzenesulfonamide (123e) was 
synthesised as described for N-[(3,4-dimethoxyphenyl)ethyl]-4′′-
methylbenzenesulfonamide (123a) using 3,4-methylenedioxy-1-[(E)-2′-
nitrovinyl]benzene (120f). Reduction of 3,4-methylenedioxy-1-[(E)-2′-
nitrovinyl]benzene (120f) (1.03 g, 5.32 mmol) using sodium borohydride (0.957 g, 
25.3 mmol) and boron trifluoride diethyl etherate (3.90 mL, 31.9 mmol) gave 1′-(3,4-
methylenedioxyphenyl)ethyl-2′-amine (121f) (0.587 g, 66%) which was used without 
further purification. The N-protection step was carried out at room temperature for 6 
h. Purification by flash column chromatography (petroleum ether/ethyl acetate, 4:1) 
gave 4′′-methyl-N-[(3,4-methylenedioxyphenyl)ethyl]benzenesulfonamide (123e) 
(0.679 g, 76% yield) as a white solid. Mp 86–88 °C (lit.504 89–90 °C); δH (400 MHz, 
CDCl3) 2.43 (3H, s, 4′′-CH3), 2.67 (2H, t, J 6.8 Hz, 1′-H2), 3.16 (2H, q, J 6.8 Hz, 2′-
H2), 4.34 (1H, br s, NH), 5.92 (2H, s, OCH2O), 6.49–6.54 (2H, m, 2-H and 5-H), 6.70 
(1H, dd, J 7.1, 1.3 Hz, 6-H), 7.29 (2H, d, J 8.4 Hz, 3′′-H and 5′′-H), 7.69 (2H, d, J 8.4 
Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 35.5 (CH2), 44.3 (CH2), 101.0 
(CH2), 108.5 (CH), 109.0 (CH), 121.8 (CH), 127.1 (2 × CH), 129.7 (2 × CH), 131.3 
(C), 137.0 (C), 143.5 (C), 146.5 (C), 147.9 (C); m/z (ESI) 342 (MNa+. 100%). 
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4′′-Methyl-N-[(3-nitrophenyl)ethyl]benzenesulfonamide (123f) 
 
4′′-Methyl-N-[(3-nitrophenyl)ethyl]benzenesulfonamide (123f) was synthesised as 
described for N-[(3,4-dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123a) 
using 3-nitro-1-[(E)-2′-nitrovinyl]benzene (120g). Reduction of 3-nitro-1-[(E)-2′-
nitrovinyl]benzene (120g) (0.281 g, 1.45 mmol) using sodium borohydride (0.363 g, 
9.78 mmol) and boron trifluoride diethyl etherate (1.59 mL, 12.3 mmol) gave 1′-(3-
nitrophenyl)ethyl-2′-amine (121g) (0.186 g, 77%) which was used without further 
purification. The N-protection step was carried out at room temperature for 6 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 1:1) 
gave 4′′-methyl-N-[(3-nitrophenyl)ethyl]benzenesulfonamide (123f) (0.142 g, 82%) 
as a yellow oil. νmax/cm−1 (neat) 3285 (NH), 1597 (C=C), 1526, 1348, 1325, 1155, 
1094, 814; δH (400 MHz, CDCl3) 2.42 (3H, s, 4′′-CH3), 2.88 (2H, t, J 7.0 Hz, 1′-H2), 
3.25 (2H, q, J 7.0 Hz, 2′-H2), 5.03 (1H, br s, NH), 7.27 (2H, d, J 7.9 Hz, 3′′-H and 5′′-
H), 7.42 (1H, t, J 7.8 Hz, 5-H), 7.47 (1H, dt, J 7.8, 1.5 Hz, 6-H), 7.68 (2H, d, J 7.9 
Hz, 2′′-H and 6′′-H), 7.90 (1H, t, J 1.5 Hz, 2-H), 8.03 (1H, dt, J 7.8, 1.5 Hz, 4-H); δC 
(101 MHz, CDCl3) 21.5 (CH3), 35.5 (CH2), 43.8 (CH2), 121.8 (CH), 123.6 (CH), 127.0 
(2 × CH), 129.5 (CH), 129.8 (2 × CH), 135.2 (CH), 136.7 (C), 140.0 (C), 143.7 (C), 
148.3 (C); m/z (ESI) 343.0712 (MNa+. C15H16N2NaO4S requires 343.0723). 
N-[(4-Chloro-3-nitrophenyl)ethyl]-4′′-methylbenzenesulfonamide (123g) 
 
N-[(4-Chloro-3-nitrophenyl)ethyl]-4′′-methylbenzenesulfonamide (123g) was 
synthesised as described for N-[(3,4-dimethoxyphenyl)ethyl]-4′′-
methylbenzenesulfonamide (123a) using 4-chloro-3-nitro-1-[(E)-2′-
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nitrovinyl]benzene (120h). Reduction of 4-chloro-3-nitro-1-[(E)-2′-nitrovinyl]benzene 
(120h) (0.255 g, 1.12 mmol) using sodium borohydride (0.280 g, 7.55 mmol) and 
boron trifluoride diethyl etherate (1.23 mL, 9.52 mmol) gave 1′-(4-chloro-3-
nitrophenyl)ethyl-2′-amine (121h) (0.174 g, 78%) which was used without further 
purification. The N-protection step was carried out at room temperature for 6 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave N-[(4-chloro-3-nitrophenyl)ethyl]-4′′-methylbenzenesulfonamide (123g) (0.238 
g, 79% yield) as a yellow soild. Mp 84–86 °C; νmax/cm−1 (neat) 3271 (NH), 2922 
(CH), 2361, 1532, 1327, 1157, 1088, 810; δH (400 MHz, CDCl3) 2.43 (3H, s, 4′′-
CH3), 2.82 (2H, t, J 6.8 Hz, 1′-H2), 3.22 (2H, q, J 6.8 Hz, 2′-H2), 5.13 (1H, t, J 6.8 Hz, 
NH), 7.24–7.30  (3H, m, 6-H, 3′′-H and 5′′-H), 7.38 (1H, d, J 8.2 Hz, 5-H), 7.55 (1H, 
d, J 2.0 Hz, 2-H), 7.65 (2H, d, J 8.2 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.6 
(CH3), 34.9 (CH2), 43.6 (CH2), 125.2 (C), 125.8 (CH), 127.0 (2 × CH), 129.8 (2 × 
CH), 131.9 (CH), 133.8 (CH), 136.5 (C), 138.6 (C), 143.9 (C), 147.7 (C); m/z (ESI) 
377.0326 (MNa+. C15H1535ClN2NaO4S requires 377.0333). 
N-[(3-Aminophenyl)ethyl]-4′′-methylbenzenesulfonamide (124a) 
 
To a stirred solution of 4′′-methyl-N-[(3-nitrophenyl)ethyl]benzenesulfonamide 
(123f) (0.142 g, 0.443 mmol) in ethanol (20 mL) was added tin dichloride dihydrate 
(0.758 g, 3.36 mmol) and the resulting solution was heated under reflux for 18 h. 
After cooling to room temperature, the reaction mixture was diluted with saturated 
aqueous sodium hydrogen carbonate solution (20 mL) and extracted with 
dichloromethane (4 × 50 mL). The combined extracts were washed with brine (2 × 
200 mL), dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1) gave N-[(3-
aminophenyl)ethyl]-4′′-methylbenzenesulfonamide (124a) (0.102 g, 79%) as a white 
solid. Mp 80–82 °C; νmax/cm−1 (neat) 3268 (NH), 2922 (CH), 1601 (C=C), 1495, 
1460, 1319, 1153, 1093, 814; δH (400 MHz, CDCl3) 2.42 (3H, s, 4′′-CH3), 2.66 (2H, 
t, J 6.8 Hz, 1′-H2), 3.17 (2H, q, J 6.8 Hz, 2′-H2), 3.62 (2H, br s, NH2), 4.38 (1H, br s, 
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NH), 6.39 (1H, t, J 1.7 Hz, 2-H), 6.42–6.48 (1H, m, 4-H), 6.53 (1H, dd, J 7.6, 1.7 Hz, 
6-H), 7.04 (1H, t, J 7.6 Hz, 5-H), 7.29 (2H, d, J 7.9 Hz, 3′′-H and 5′′-H), 7.69 (2H, d, 
J 7.9 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 35.7 (CH2), 44.1 (CH2), 
113.6 (CH), 115.3 (CH), 118.8 (CH), 127.1 (2 × CH), 129.7 (2 × CH), 129.8 (CH), 
137.0 (C), 138.8 (C), 143.4 (C), 146.8 (C); m/z (ESI) 313.0984 (MNa+. 
C15H18N2NaO2S requires 313.0981). 
N-[(3-Amino-4-chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (124b) 
 
N-[(3-Amino-4-chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (124b) was 
synthesised as described for N-[(3-aminophenyl)ethyl]-4′′-
methylbenzenesulfonamide (124a) using 4′′-methyl-N-[(3-nitro-4-
chlorophenyl)ethyl]benzenesulfonamide (123g) (0.278 g, 0.790 mmol). Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 7:3) gave N-[(3-
amino-4-chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (124b) (0.226 g, 89%) 
as a colourless oil. νmax/cm−1 (neat) 3372 (NH), 3279 (NH), 2924 (CH), 2361, 1620 
(C=C), 1497, 1435, 1319, 1156, 1088, 810; δH (400 MHz, CDCl3) 2.41 (3H, s, 4′′-
CH3), 2.62 (2H, t, J 6.8 Hz, 1′-H2), 3.13 (2H, q, J 6.8 Hz, 2′-H2), 4.00 (2H, br s, NH2), 
4.88 (1H, t, J 6.8 Hz, NH), 6.36 (1H, dd, J 8.1, 2.0 Hz, 6-H), 6.49 (1H, d, J 2.0 Hz, 
2-H), 7.06 (1H, d, J 8.1 Hz, 5-H), 7.26 (2H, d, J 8.3 Hz, 3′′-H and 5′′-H), 7.67 (2H, d, 
J 8.3 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.6 (CH3), 35.3 (CH2), 44.0 (CH2), 
116.1 (CH), 117.7 (C), 119.2 (CH), 127.1 (2 × CH), 129.6 (CH), 129.7 (2 × CH), 
136.8 (C), 137.5 (C), 143.0 (C), 143.5 (C); m/z (ESI) 347.0582 (MNa+. 
C15H1735ClN2NaO2S requires 347.0591). 
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N-[(3-Acetamidophenyl)ethyl]-4′′-methylbenzenesulfonamide (125a) 
 
Acetic anhydride (0.110 mL, 1.17 mmol) was added to a stirred solution of N-[(3-
aminophenyl)ethyl]-4′′-methylbenzenesulfonamide (124a) (0.225 g, 0.780 mmol) in 
dry dichloromethane (10 mL) and stirred at room temperature for 16 h. The reaction 
mixture was washed with saturated sodium carbonate (15 mL) and brine (15 mL). 
The organic layer was dried (MgSO4) and concentrated in vacuo. Purification by 
flash column chromatography (petroleum ether/ethyl acetate, 3:7) gave N-[(3-
acetamidophenyl)ethyl]-4′′-methylbenzenesulfonamide (125a) (0.245 g, 95%) as a 
colourless oil. νmax/cm−1 (neat) 3282 (NH), 2921 (CH), 1669 (C=O), 1613 (C=C), 
1595, 1549, 1489, 1440, 1319, 1153, 1094, 814; δH (400 MHz, CDCl3) 2.14 (3H, s, 
CH3CO), 2.42 (3H, s, 4′′-CH3), 2.72 (2H, t, J 6.8 Hz, 1′-H2), 3.18 (2H, q, J 6.8 Hz, 2′-
H2), 4.69 (1H, t, J 6.8 Hz, NH), 6.81 (1H, d, J 7.5 Hz, 4-H), 7.20 (1H, t, J 7.5 Hz, 5-
H), 7.25–7.30 (3H, m, 2-H, 3′′-H and 5′′-H), 7.39 (1H, d, J 7.5 Hz, 6-H), 7.46 (1H, br 
s, NH), 7.69 (2H, d, J 7.9 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 24.6 
(CH3), 35.8 (CH2), 44.1 (CH2), 118.3 (CH), 120.2 (CH), 124.5 (CH), 127.1 (2 × CH), 
129.3 (CH), 129.8 (2 × CH), 136.8 (C), 138.3 (C), 138.8 (C), 143.5 (C), 168.6 (C); 
m/z (ESI) 355.1080 (MNa+. C17H20N2NaO3S requires 355.1087). 
N-[(3-Acetamido-4-chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (125b) 
 
N-[(3-Acetamido-4-chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (125b) was 
synthesised as described for N-[(3-acetamidophenyl)ethyl]-4′′-
methylbenzenesulfonamide (125a) using N-[(3-amino-4-chlorophenyl)ethyl]-4′′-
methylbenzenesulfonamide (124b) (0.109 g, 0.340 mmol). Purification by flash 
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column chromatography (petroleum ether/ethyl acetate, 1:1) gave N-[(3-acetamido-
4-chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (125b) (0.121 g, 99%) as a 
colourless oil. νmax/cm−1 (neat) 3279 (NH), 2932 (CH), 2361, 1674 (C=O), 1582, 
1528, 1427, 1319, 1157, 1096; δH (400 MHz, CDCl3) 2.22 (3H, s, CH3CO), 2.42 (3H, 
s, 4′′-CH3), 2.72 (2H, t, J 6.9 Hz, 1′-H2), 3.19 (2H, q, J 6.9 Hz, 2′-H2), 4.73 (1H, t, J 
6.9 Hz, NH), 6.78 (1H, dd, J 8.2, 1.7 Hz, 6-H), 7.23 (1H, d, J 8.2 Hz, 5-H), 7.27 (2H, 
d, J 8.2 Hz, 3′′-H and 5′′-H), 7.59 (1H, br s, 2-H), 7.69 (2H, d, J 8.2 Hz, 2′′-H and 6′′-
H), 8.11 (1H, br s, NH); δC (101 MHz, CDCl3) 21.5 (CH3), 24.9 (CH3), 35.6 (CH2), 
44.0 (CH2), 121.0 (C), 121.8 (CH), 125.1 (CH), 127.1 (2 × CH), 129.0 (CH), 129.7 
(2 × CH), 134.6 (C), 136.9 (C), 137.9 (C), 143.4 (C), 168.4 (C); m/z (ESI) 389.0685 
(MNa+. C17H1935ClN2NaO3S requires 389.0697). 
1′-(3-Methoxyphenyl)acrylonitrile (126)505 
 
To a solution of m-anisaldehyde (119a) (1.79 mL, 14.7 mmol) in dry 
dichloromethane (25 mL) was added cyanomethylene triphenylphosphorane (4.88 
g, 16.2 mmol) and the resulting mixture was stirred at room temperature for 16 h. 
After this time, the reaction mixture was concentrated in vacuo and the residue was 
purified by flash column chromatography (petroleum ether/ethyl acetate, 9:1) to give 
1′-(3-methoxyphenyl)acrylonitrile (126) (3:1 ratio of E to Z isomers) (1.81 g, 79%) as 
a colourless oil. Spectroscopic data is reported for the major E isomer. 
Spectroscopic data were consistent with the literature.505 δH (400 MHz, CDCl3) 3.84 
(3H, s, OCH3), 5.87 (1H, t, J 16.6 Hz, 2′-H), 6.93–7.05 (3H, m, 3 × ArH), 7.30–7.43 
(2H, m, ArH and 1′-H); δC (101 MHz, CDCl3) 55.4 (CH3), 96.7 (CH), 112.5 (CH), 
116.9 (CH), 117.1 (C), 120.0 (CH), 130.2 (CH), 134.8 (C), 150.5 (CH), 160.0 (C); 
m/z (EI) 159 (M+. 100%), 116 (20), 89 (20). 
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N-[(3-Methoxyphenyl)propyl]-4′′-methylbenzenesulfonamide (127)506 
 
To a solution of 1′-(3-methoxyphenyl)acrylonitrile (126) (1.00 mL, 6.29 mmol) in 
ethanol (25 mL) was added 37% aqueous hydrochloric acid (3 mL) and 10% 
palladium on charcoal (0.073 g). The reaction mixture was hydrogenated at 2.5 bar 
for 72 h. The reaction mixture was filtered through Celite® and concentrated in 
vacuo. The crude hydrochloride salt was dissolved in dichloromethane (25 mL) and 
triethylamine (0.700 mL, 5.00 mmol) was added. p-Toluenesulfonyl chloride (0.572 
g, 3.00 mmol) was added at 0 °C and the resulting solution was stirred at room 
temperature overnight. The reaction mixture was diluted with dichloromethane (20 
mL) and washed with 1 M aqueous hydrochloric acid (30 mL) and brine (30 mL), 
dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave N-[(3-
methoxyphenyl)propyl]-4′′-methylbenzenesulfonamide (127) (0.499 g, 63% over 
two-steps) as a colourless oil. Spectroscopic data were consistent with the 
literature.506 δH (400 MHz, CDCl3) 1.70–1.80 (2H, m, 2′-H2), 2.40 (3H, s, 4′′-CH3), 
2.56 (2H, t, J 7.7 Hz, 1′-H2), 2.94 (2H, q, J 6.7 Hz, 3′-H2), 3.75 (3H, s, OCH3), 5.04 
(1H, t, J 6.7 Hz, NH), 6.62–6.68 (2H, m, 2-H and 4-H), 6.70 (1H, ddd, J 8.0, 2.5, 0.8 
Hz, 6-H), 7.14 (1H, t, J 8.0 Hz, 5-H), 7.28 (2H, d, J 8.3 Hz, 3′′-H and 5′′-H), 7.74 (2H, 
d, J 8.3 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 31.0 (CH2), 32.8 (CH2), 
42.6 (CH2), 55.2 (CH3), 111.5 (CH), 114.1 (CH), 120.8 (CH), 127.1 (2 × CH), 129.4 
(CH), 129.8 (2 × CH), 137.0 (C), 142.7 (C), 143.4 (C), 159.7 (C); m/z (ESI) 342 
(MNa+. 100%). 
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3-Methoxyphenylacetamide (129)507 
 
To a stirred solution of 3-methoxyphenylacetic acid (128) (0.500 g, 3.00 mmol) in 
dry dichloromethane (15 mL) was added thionyl chloride (2.63 mL, 63.0 mmol) at 0 
°C. The reaction mixture was heated under reflux for 2.5 h after which the solvent 
was removed in vacuo. The residue was dissolved in tetrahydrofuran (20 mL) and 
25% aqueous ammonium hydroxide (4 mL) was added slowly at 0 °C. The reaction 
mixture was then stirred at room temperature for 16 h. The mixture was 
concentrated in vacuo and water (15 mL) was added. The solution was heated for 
0.5 h. The suspension was cooled to 0 °C and the resulting white powder was 
collected by vacuum filtration and washed with ice-water to give 3-
methoxyphenylacetamide (129) (0.209 g, 42%) as a colourless crystalline solid. Mp 
139–141 °C (from water) (lit.507 137–139 °C); δH (400 MHz, CDCl3) 3.56 (2H, s, 1′-
H2), 3.81 (3H, s, OCH3), 5.41 (1H, br s, NH), 5.52 (1H, br s, NH), 6.80–6.88 (3H, m, 
3 × ArH), 7.28 (1H, t, J 7.8 Hz, 5-H); δC (101 MHz, CDCl3) 43.4 (CH2), 55.2 (CH3), 
113.0 (CH), 115.0 (CH), 121.6 (CH), 130.1 (CH), 136.3 (C), 160.1 (C), 173.2 (C); 
m/z (ESI) 188 (MNa+. 100%). 
(3,4-Methylenedioxy)phenethan-2′-ol (131a)508 
 
To a stirred suspension of lithium aluminium hydride (0.211 g, 5.55 mmol) in dry 
tetrahydrofuran (15 mL) was added 3,4-(methylenedioxy)phenylacetic acid (130a) 
(0.500 g, 2.78 mmol) in tetrahydrofuran (5 mL) dropwise under a constant stream of 
argon at 0 °C. The suspension was stirred at room temperature for 5 h, cooled to 0 
°C and quenched with water (0.20 mL). To this solution was added 15% aqueous 
sodium hydroxide (0.20 mL), followed by water (0.60 mL). Magnesium sulfate was 
added and the suspension was stirred for 0.5 h, filtered, then concentrated in vacuo. 
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Purification by flash column chromatography (petroleum ether/ethyl acetate, 1:1) 
gave (3,4-methylenedioxy)phenethan-2′-ol (131a) (0.308 g, 67%) as a colourless 
oil. Spectroscopic data were consistent with the literature.508 δH (400 MHz, CDCl3) 
1.50 (1H, br s, OH), 2.78 (2H, t, J 6.6 Hz, 1′-H2), 3.79 (2H, br s, 2′-H2), 5.93 (2H, s, 
OCH2O), 6.67 (1H, dd, J 7.9, 1.6 Hz, 6-H), 6.72 (1H, d, J 1.6 Hz, 2-H), 6.75 (1H, d, 
J 7.9 Hz, 5-H); δC (101 MHz, CDCl3) 38.9 (CH2), 63.7 (CH2), 100.9 (CH2), 108.3 
(CH), 109.3 (CH), 121.9 (CH), 132.2 (C), 146.2 (C), 147.8 (C); m/z (EI) 166 (M+. 
30%), 135 (100). 
1′-(Dihydro-3,4-benzodioxinyl)ethan-2′-ol (131b)509 
 
1′-(Dihydro-3,4-benzodioxinyl)ethan-2′-ol (131b) was synthesised as described for 
(3,4-methylenedioxy)phenethan-2′-ol (131a) using 1,4-benzodioxane-6-acetic acid 
(130b) (0.487 g, 2.51 mmol). Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 1:1) gave 1′-(dihydro-3,4-benzodioxinyl)ethan-2′-ol 
(131b) (0.425 g, 94%) as a colourless oil. Spectroscopic data were consistent with 
the literature.509 δH (400 MHz, CDCl3) 1.78 (1H, br s, OH), 2.74 (2H, t, J 6.5 Hz, 1′-
H2), 3.78 (2H, br s, 2′-H2), 4.22 (4H, s, OCH2CH2O), 6.68 (1H, dd, J 8.2, 2.0 Hz, 6-
H), 6.73 (1H, d, J 2.0 Hz, 2-H), 6.79 (1H, d, J 8.2 Hz, 5-H); δC (101 MHz, CDCl3) 
38.4 (CH2), 63.6 (CH2), 64.3 (CH2), 64.4 (CH2), 117.3 (CH), 117.6 (CH), 121.9 (CH), 
131.7 (C), 142.1 (C), 143.4 (C); m/z (ESI) 203 (MNa+. 100%). 
Methyl (3-methoxyphenyl)acetate (132)510 
 
To a stirred solution of 3-methoxyphenylacetic acid (128) (2.00 g, 12.0 mmol) in 
methanol (20 mL) was added a few drops of concentrated sulfuric acid. The resulting 
mixture was heated under reflux for 16 h. The methanol was removed in vacuo and 
the residue was diluted with dichloromethane (50 mL). The solution was washed 
3
4
5
6
1
2 1′
2′
OHO
O
3
4
5
6
1
2
MeO
1′
O
OMe
 
224 
with water (4 × 50 mL) and brine (50 mL), dried (MgSO4) and concentrated to give 
methyl (3-methoxyphenyl)acetate (132) (2.12 g, 99%) as a colourless oil. 
Spectroscopic data were consistent with the literature.510 δH (400 MHz, CDCl3) 3.59 
(2H, s, 1′-H2), 3.67 (3H, s, OCH3), 3.78 (3H, s, OCH3), 6.76–6.88 (3H, m, 2-H, 4-H 
and 6-H), 7.21 (1H, t, J 7.8 Hz, 5-H); δC (101 MHz, CDCl3) 41.2 (CH2), 52.0 (CH3), 
55.2 (CH3), 112.6 (CH), 114.9 (CH), 121.6 (CH), 129.6 (CH), 135.4 (C), 159.8 (C), 
171.9 (C); m/z (ESI) 203 (MNa+. 100%). 
2′,2′-Dimethyl-1′-(3-methoxyphenyl)ethan-2′-ol (133) 
 
Methylmagnesium bromide (2.20 mL, 6.50 mmol; 3.0 M in diethyl ether) was added 
dropwise to a 0 °C solution of methyl (3-methoxyphenyl)acetate (132) (0.390 g, 2.17 
mmol) in dry tetrahydrofuran (20 mL). The yellow solution was warmed to room 
temperature and stirred for 5 h. The reaction mixture was quenched with saturated 
aqueous ammonium chloride (30 mL) and diluted with diethyl ether (30 mL). The 
layers were separated and the aqueous layer was extracted with diethyl ether (3 × 
30 mL). The combined organic extracts were washed with brine (30 mL), dried 
(MgSO4) and concentrated. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 4:1) gave 2′,2′-dimethyl-1′-(3-methoxyphenyl)ethan-
2′-ol (133) (0.301 g, 77%) as a colourless oil. νmax/cm−1 (neat) 3426 (OH), 2969 (CH), 
1601 (C=C), 1489, 1261, 1153, 1047; δH (400 MHz, CDCl3) 1.23 (6H, s, 2 × 2′-CH3), 
2.74 (2H, s, 1′-H2), 3.79 (3H, s, OCH3), 6.75–6.81 (3H, m, 2-H, 4-H and 6-H), 7.21 
(1H, t, J 7.9 Hz, 5-H); δC (101 MHz, CDCl3) 29.2 (2 × CH3), 49.8 (CH2), 55.2 (CH3), 
70.7 (C), 111.8 (CH), 116.3 (CH), 122.9 (CH), 129.2 (CH), 139.4 (C), 159.5 (C); m/z 
(ESI) 203.1044 (MNa+. C11H16NaO2 requires 203.1043). 
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Methyl 1′,1′-dimethyl-(3-methoxyphenyl)acetate511 
 
To a stirred solution of methyl (3-methoxyphenyl)acetate (132) (1.10 g, 6.07 mmol) 
in dry tetrahydrofuran (30 mL) was added sodium hydride (60 % in mineral oil, 0.701 
g, 29.2 mmol) at 0 °C. The suspension was stirred at 0 °C for 1 h, then methyl iodide 
(1.14 mL, 18.2 mmol) was added. The reaction mixture was warmed to room 
temperature, then stirred for 16 h. The reaction mixture was quenched with water 
(30 mL) and extracted with ethyl acetate (3 × 50 mL). The combined organic extracts 
were washed with 1 M aqueous sodium thiosulfate solution (50 mL) and brine (100 
mL), dried (MgSO4) and concentrated to give methyl 1′,1′-dimethyl-(3-
methoxyphenyl)acetate (0.639 g, 55%) as a colourless oil.511 δH (400 MHz, CDCl3) 
1.56 (6H, s, 2 × 1′-CH3), 3.64 (3H, s, OCH3), 3.79 (3H, s, OCH3), 6.77 (1H, ddd, J 
7.9, 2.2, 0.8 Hz, 4-H), 6.88 (1H, t, J 2.2 Hz, 2-H), 6.91 (1H, ddd, J 7.9, 2.2, 0.8 Hz, 
6-H), 7.25 (1H, t, J 7.9 Hz, 5-H); δC (101 MHz, CDCl3) 26.5 (2 × CH3), 46.5 (C), 52.2 
(CH3), 55.2 (CH3), 111.5 (CH), 112.1 (CH), 118.1 (CH), 129.4 (CH), 146.3 (C), 159.6 
(C), 177.1 (C); m/z (ESI) 231 (MNa+. 100%). 
1′,1′-Dimethyl-1′-(3-methoxyphenyl)ethan-2′-ol (134)512 
 
1′,1′-Dimethyl-1′-(3-methoxyphenyl)ethan-2′-ol (134) was synthesised as described 
for (3,4-methylenedioxy)phenethan-2′-ol (131a) using 1′,1′-dimethyl-(3-
methoxyphenyl)acetate (0.640 g, 3.08 mmol). The reaction was quenched after 3 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave 1′,1′-dimethyl-1′-(3-methoxyphenyl)ethan-2′-ol (134) (0.352 g, 64%) as a 
colourless oil. Spectroscopic data were consistent with the literature.512 δH (400 
MHz, CDCl3) 1.29–1.34 (7H, m, 2 × 1′-CH3 and OH), 3.59 (2H, d, J 6.2 Hz, 2′-H2), 
3.81 (3H, s, OCH3), 6.76 (1H, ddd, J 8.0, 2.4, 0.7 Hz, 4-H), 6.93 (1H, t, J 2.4 Hz, 2-
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H), 6.97 (1H, ddd, J 8.0, 2.4, 0.7 Hz, 6-H), 7.26 (1H, t, J 8.0 Hz, 5-H); δC (101 MHz, 
CDCl3) 25.4 (2 × CH3), 40.2 (C), 55.2 (CH3), 73.1 (CH2), 110.8 (CH), 113.0 (CH), 
118.7 (CH), 129.4 (CH), 148.2 (C), 159.7 (C); m/z (ESI) 203 (MNa+. 100%). 
1′-(3-Aminophenyl)ethan-2′-ol (136)513 
 
To a stirred solution of 1′-(3-nitrophenyl)ethan-2′-ol (135) (0.350 g, 2.09 mmol) in 
ethanol (25 mL) was added tin dichloride dihydrate (2.40 g, 10.5 mmol) and the 
resulting solution was heated under reflux for 18 h. After cooling to room 
temperature, the reaction mixture was diluted with saturated aqueous sodium 
hydrogen carbonate solution (20 mL) and extracted with dichloromethane (5 × 50 
mL). The combined extracts were washed with brine (2 × 200 mL), dried (MgSO4) 
and concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 3:7) gave 1′-(3-aminophenyl)ethan-2′-ol (136) (0.090 g, 32%) as 
a colourless oil. Spectroscopic data were consistent with the literature.513 δH (400 
MHz, CDCl3) 1.54 (1H, br s, OH), 2.78 (2H, t, J 6.5 Hz, 1′-H2), 3.64 (2H, br s, NH2), 
3.83 (2H, t, J 6.5 Hz, 2′-H2), 6.54–6.58 (2H, m, 2 × ArH), 6.60–6.65 (1H, m, ArH), 
7.07–7.13 (1H, m, ArH); δC (101 MHz, CDCl3) 39.2 (CH2), 63.6 (CH2), 113.3 (CH), 
115.7 (CH), 119.2 (CH), 129.6 (CH), 139.7 (C), 146.6 (C); m/z (EI) 137 (M+. 70%), 
106 (100), 84 (38), 78 (37), 63 (42). 
1′-(3-Acetamidophenyl)ethan-2′-ol (137)  
 
Acetic anhydride (0.085 mL, 0.900 mmol) was added to a stirred solution of 1′-(3-
aminophenyl)ethan-2′-ol (136) (0.082 g, 0.600 mmol) in dichloromethane (10 mL) 
and stirred for 24 h at room temperature. The reaction mixture was washed with 
aqueous saturated sodium carbonate (15 mL) and brine (15 mL). The organic layer 
was dried (MgSO4) and concentrated in vacuo. Recrystallisation from diethyl ether 
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gave 1′-(3-acetamidophenyl)ethan-2′-ol (137) (0.042 g, 42%) as a white crystalline 
solid. Mp 102–104 °C (from diethyl ether); νmax/cm−1 (neat) 3294 (NH), 2924 (CH), 
1667 (C=O), 1612 (C=C), 1551, 1489, 1435, 1319, 1041, 787; δH (400 MHz, CDCl3) 
1.67 (1H, br s, OH), 2.16 (3H, s, CH3CO), 2.84 (2H, t, J 6.6 Hz, 1′-H2), 3.85 (2H, t, 
J 6.6 Hz, 2′-H2), 6.95–7.00 (1H, m, ArH), 7.23–7.45 (4H, m, 3 × ArH and NH); δC 
(101 MHz, CDCl3) 24.6 (CH3), 39.1 (CH2), 63.5 (CH2), 118.1 (CH), 120.5 (CH), 125.0 
(CH), 129.2 (CH), 138.1 (C), 139.6 (C), 168.4 (C); m/z (ESI) 202.0838 (MNa+. 
C10H13NNaO2 requires 202.0838). 
Ethyl (E)-1′-(3-methoxyphenyl)acrylate (138a)514 
 
A solution of lithium chloride (0.310 g, 7.30 mmol), triethyl phosphonoacetate (1.45 
mL, 7.30 mmol) and 1,8-diazabicyclo[5,4,0]undec-7-ene (1.09 mL, 7.30 mmol) in 
dry acetonitrile (30 mL) was stirred for 0.5 h. m-Anisaldehyde (119a) (0.890 mL, 
7.30 mmol) was added and the solution was stirred at room temperature for 18 h. 
The reaction mixture was quenched with brine (30 mL), concentrated and the 
residue was extracted with diethyl ether (5 × 50 mL). The combined ethereal extracts 
were dried (MgSO4) and concentrated. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave ethyl (E)-1′-(3-methoxyphenyl)acrylate 
(138a) (1.36 g, 91%) as a colourless oil. Spectroscopic data were consistent with 
the literature.514 δH (400 MHz, CDCl3) 1.33 (3H, t, J 7.2 Hz, OCH2CH3), 3.82 (3H, s, 
OCH3), 4.26 (2H, q, J 7.2 Hz, OCH2CH3), 6.42 (1H, d, J 15.9 Hz, 2′-H), 6.91 (1H, 
ddd, J 8.1, 2.5, 0.8 Hz, 4-H), 7.04 (1H, t, J 2.5 Hz, 2-H), 7.10 (1H, br d, J 8.1 Hz, 6-
H), 7.29 (1H, t, J 8.1 Hz, 5-H), 7.64 (1H, d, J 15.9 Hz, 1′-H); δC (101 MHz, CDCl3) 
14.3 (CH3), 55.3 (CH3), 60.5 (CH2), 112.9 (CH), 116.1 (CH), 118.6 (CH), 120.7 (CH), 
129.9 (CH), 135.8 (C), 144.5 (CH), 159.9 (C), 166.9 (C); m/z (ESI) 207 (MH+. 100%). 
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Ethyl (E)-1′-(3,4,5-trimethoxyphenyl)acrylate (138b)515 
 
Ethyl (E)-1′-(3,4,5-trimethoxyphenyl)acrylate (138b) was synthesised as described 
for ethyl (E)-1′-(3-methoxyphenyl)acrylate (138a) using 3,4,5-
trimethoxybenzaldehyde (119d) (1.00 g, 5.10 mmol). The resulting off-white solid 
was recrystallised from hot hexane which gave ethyl (E)-1′-(3,4,5-
trimethoxyphenyl)acrylate (138b) (0.713 g, 53%) as a colourless crystalline solid. 
Mp 50–52 °C (from hexane) (lit.515 53–55 °C); δH (500 MHz, CDCl3) 1.34 (3H, t, J 
7.2 Hz, OCH2CH3), 3.88 (3H, s, 4-OCH3), 3.89 (6H, s, 2 × OCH3), 4.26 (2H, q, J 7.2 
Hz, OCH2CH3), 6.35 (1H, d, J 15.9 Hz, 2′-H), 6.76 (2H, s, 2-H and 6-H), 7.60 (1H, 
d, J 15.9 Hz, 1′-H); δC (126 MHz, CDCl3) 14.3 (CH3), 56.1 (2 × CH3), 60.5 (CH2), 
61.0 (CH3), 105.2 (2 × CH), 117.5 (CH), 130.0 (C), 140.1 (C), 144.5 (CH), 153.4 (2 
× C), 166.9 (C); m/z (ESI) 289 (MH+. 100%). 
1′-(3-Methoxyphenyl)propan-3′-ol (139a)516 
 
To a stirred suspension of lithium aluminium hydride (0.150 g, 3.94 mmol) in dry 
tetrahydrofuran (10 mL) was added ethyl (E)-1′-(3-methoxyphenyl)acrylate (138a) 
(0.325 g, 1.58 mmol) in tetrahydrofuran (10 mL) dropwise under a constant stream 
of argon at 0 °C. The suspension was stirred at room temperature for 5 h, then 
cooled to 0 °C and quenched with a saturated aqueous solution of potassium 
sodium tartrate (20 mL) and stirred overnight. The suspension was extracted with 
diethyl ether (5 × 50 mL) and the combined organic extracts were dried (MgSO4) 
and concentrated. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave 1′-(3-methoxyphenyl)propan-3′-ol (139a) (0.179 g, 
69%) as a colourless oil. Spectroscopic data were consistent with the literature.516 
δH (400 MHz, CDCl3) 1.85–1.94 (2H, m, 2′-H2), 2.69 (2H, t, J 7.9 Hz, 1′-H2), 3.68 
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(2H, t, J 6.5 Hz, 3′-H2), 3.80 (3H, s, OCH3), 6.72–6.77 (2H, m, 2 × ArH), 6.78–6.82 
(1H, m, ArH), 7.21 (1H, t, J 7.6 Hz, 5-H); δC (101 MHz, CDCl3) 32.1 (CH2), 34.1 
(CH2), 55.1 (CH3), 62.3 (CH2), 111.1 (CH), 114.2 (CH), 120.8 (CH), 129.4 (CH), 
143.5 (C), 159.7 (C); m/z (ESI) 189 (MNa+. 100%). 
1′-(3,4,5-Trimethoxyphenyl)propan-3′-ol (139b)517 
 
1′-(3,4,5-Trimethoxyphenyl)propan-3′-ol (139b) was synthesised as described for 1′-
(3-methoxyphenyl)propan-3′-ol (139a) using ethyl (E)-1′-(3,4,5-
trimethoxyphenyl)acrylate (138b) (0.596 g, 2.24 mmol). The suspension was stirred 
at room temperature for 5 h, cooled to 0 °C and quenched with water (0.25 mL). To 
this solution was added 15% aqueous sodium hydroxide (0.25 mL), followed by 
water (0.75 mL). Magnesium sulfate was added and the suspension was stirred for 
0.5 h, filtered and concentrated in vacuo. Purification by flash column 
chromatography (ethyl acetate/petroleum ether, 3:2) gave 1′-(3,4,5-
trimethoxyphenyl)propan-3′-ol (139b) (0.228 g, 45%) as a colourless oil. 
Spectroscopic data were consistent with the literature.517 δH (400 MHz, CDCl3) 1.42 
(1H, br s, OH), 1.85–1.95 (2H, m, 2′-H2), 2.63–2.69 (2H, m, 1′-H2), 3.68 (2H, t, J 6.5 
Hz, 3′-H2), 3.83 (3H, s, OCH3), 3.85 (6H, s, 2 × OCH3), 6.42 (2H, s, 2-H and 6-H); 
δC (101 MHz, CDCl3) 32.6 (CH2), 34.3 (CH2), 56.1 (2 × CH3), 60.9 (CH3), 62.3 (CH2), 
105.3 (2 × CH), 136.1 (C), 137.7 (C), 153.2 (2 × C); m/z (ESI) 249 (MNa+. 100%). 
1′-(3,4-Dimethoxyphenyl)butan-4′-ol (141)518  
 
1′-(3,4-Dimethoxyphenyl)butan-4′-ol (141) was synthesised as described for (3,4-
methylenedioxy)phenethan-2′-ol (131a) using 3,4-dimethoxyphenylbutyric acid 
(140) (0.500 g, 2.23 mmol). The reaction was quenched after 4.5 h. Purification by 
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flash column chromatography (dichloromethane/ethyl acetate, 4:1) gave 1′-(3,4-
dimethoxyphenyl)butan-4′-ol (141) (0.429 g, 92%) as a colourless oil. Spectroscopic 
data were consistent with the literature.518 δH (500 MHz, CDCl3) 1.31 (1H, br s, OH), 
1.57–1.73 (4H, m, 2′-H2 and 3′-H2), 2.59 (2H, t, J 7.9 Hz, 1′-H2), 3.66 (2H, t, J 6.4 
Hz, 4′-H2), 3.85 (3H, s, OCH3), 3.87 (3H, s, OCH3), 6.70–6.74 (2H, m, 2-H and 6-H), 
6.78 (1H, d, J 8.1 Hz, 5-H); δC (126 MHz, CDCl3) 27.3 (CH2), 32.3 (CH2), 35.3 (CH2), 
55.8 (CH3), 55.9 (CH3), 62.8 (CH2), 111.2 (CH), 111.7 (CH), 120.2 (CH), 135.0 (C), 
147.1 (C), 148.8 (C); m/z (ESI) 233 (MNa+. 100%). 
6-Iodo-N-[(3-methoxyphenyl)ethyl]benzamide (142) 
 
6-Iodo-N-[(3-methoxyphenyl)ethyl]benzamide (142) was synthesised as described 
for 4-iodoanisole (82a) using N-[(3-methoxyphenyl)ethyl]benzamide (122a) (0.0500 
g, 0.200 mmol). The reaction mixture was stirred at 40 °C for 5 h. After cooling to 
room temperature, the solvent was removed in vacuo and the crude residue was 
filtered through a short-pad of silica, eluting with ethyl acetate. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 4:1) gave 6-iodo-N-[(3-
methoxyphenyl)ethyl]benzamide (142) (0.0663 g, 89%) as a colourless oil. 
νmax/cm−1 (neat) 3310 (NH), 2910 (CH), 1638 (C=O), 1595 (C=C), 1537, 1467, 1410, 
1352, 1294, 1236, 1190, 1057, 802; δH (400 MHz, CDCl3) 3.04 (2H, t, J 7.0 Hz, 1′-
H2), 3.66–3.75 (5H, m, 2′-H2 and OCH3), 6.37 (1H, br s, NH), 6.54 (1H, dd, J 8.7, 
3.0 Hz, 4-H), 6.82 (1H, d, J 3.0 Hz, 2-H), 7.36–7.50 (3H, m, 3′′-H, 4′′-H and 5′′-H), 
7.67 (1H, d, J 8.7 Hz, 5-H), 7.71–7.76 (2H, m, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 
40.1 (CH2), 40.2 (CH2), 55.4 (CH3), 89.0 (C), 114.8 (CH), 115.7 (CH), 126.9 (2 × 
CH), 128.6 (2 × CH) 131.5 (CH), 134.5 (C), 140.0 (CH), 142.7 (C), 160.2 (C), 167.7 
(C); m/z (EI) 381.0223 (M+. C16H16INO2 requires 381.0226), 260 (46%), 254 (100), 
253 (12), 105 (85), 77 (36). 
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1-Benzoyl-5-methoxyindoline (143a) 
 
Iron(III) chloride (0.550 mg, 3.40 µmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (3.00 µL, 10.2 µmol) and 
stirred for 0.5 h at room temperature and then added to a solution of N-
iodosuccinimide (0.0306 g, 0.136 mmol) in toluene (1.0 mL). N-[(3-
Methoxyphenyl)ethyl]benzamide (122a) (0.0348 g, 0.136 mmol) was then added 
and the mixture was stirred at 40 °C for 5 h. Upon completion of the iodination step, 
the reaction mixture was cooled to room temperature and copper(I) iodide (3.00 mg, 
14.0 µmol), cesium carbonate (0.0886 g, 0.272 mmol), N,N′-
dimethylethylenediamine (3.00 µL, 27.2 µmol) and water (0.25 mL) were added. The 
reaction mixture was degassed under argon for 0.1 h and then heated to 130 °C for 
24 h. The reaction mixture was then cooled to room temperature, diluted with ethyl 
acetate (10 mL) and washed with a 1 M aqueous sodium thiosulfate solution (10 
mL). The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the 
combined organic extracts were washed with brine (10 mL). The organic phase was 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave 1-benzoyl-5-
methoxyindoline (143a) (0.0271 g, 79%) as a brown solid. Mp 102–104 °C; 
νmax/cm−1 (neat) 2922 (CH), 1624 (C=O), 1595 (C=O), 1487, 1400, 1294, 1140, 
1026, 833; δH (500 MHz, DMSO-d6, 100 °C) 3.08 (2H, t, J 8.2 Hz, 3-H2), 3.76 (3H, 
s, OCH3), 4.00 (2H, t, J 8.2 Hz, 2-H2), 6.71 (1H, dd, J 8.7, 2.4 Hz, 6-H), 6.88 (1H, d, 
J 2.4 Hz, 4-H), 7.46–7.62 (6H, m, 6 × ArH); δC (126 MHz, DMSO-d6, 100 °C) 28.4 
(CH2), 50.8 (CH2), 56.1 (CH3), 111.6 (CH), 112.6 (CH), 117.4 (CH), 127.3 (2 × CH), 
128.8 (2 × CH) 130.2 (CH), 134.7 (C), 137.0 (C), 137.9 (C), 156.8 (C), 167.9 (C); 
m/z (EI) 253.1114 (M+. C16H15NO2 requires 253.1103), 148 (18%), 105 (100), 77 
(30). 
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1-Acetyl-5-methoxyindoline (143b)519 
 
1-Acetyl-5-methoxyindoline (143b) was synthesised as described for 1-benzoyl-5-
methoxyindoline (143a) using N-[(3-methoxyphenyl)ethyl]acetamide (122b) (0.0490 
g, 0.250 mmol). The iodination step was carried out at 40 °C for 5 h and the N-
arylation step at 130 °C for 24 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 1:1) gave 1-acetyl-5-methoxyindoline (143b) 
(0.0420 g, 87%) as a colourless oil. Spectroscopic data were consistent with the 
literature.519 NMR spectra showed a 5:1 mixture of rotamers. Only signals for the 
major rotamer are recorded. δH (400 MHz, CDCl3) 2.20 (3H, s, CH3CO), 3.17 (2H, t, 
J 8.4 Hz, 3-H2), 3.78 (3H, s, OCH3), 4.04 (2H, t, J 8.4 Hz, 2-H2), 6.68–6.76 (2H, m, 
4-H and 6-H), 8.12 (1H, d, J 8.6 Hz, 7-H); δC (101 MHz, CDCl3) 24.0 (CH3), 28.2 
(CH2), 48.9 (CH2), 55.6 (CH3), 110.9 (CH), 111.9 (CH), 117.5 (CH), 132.7 (C), 136.7 
(C), 156.2 (C), 167.9 (C); m/z (EI) 191 (M+. 80%), 149 (60), 134 (100). 
1-(Benzyloxycarbonyl)-5-methoxyindoline (143c) 
 
1-(Benzyloxycarbonyl)-5-methoxyindoline (143c) was synthesised as described for 
1-benzoyl-5-methoxyindoline (143a) using benzyl N-[(3-
methoxyphenyl)ethyl]carbamate (122c) (0.0480 g, 0.170 mmol). The iodination step 
was carried out at 40 °C for 5 h and the N-arylation step at 130 °C for 24 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 9:1) 
gave 1-(benzyloxycarbonyl)-5-methoxyindoline (143c) (0.0302 g, 63%) as a 
colourless oil. νmax/cm−1 (neat) 2953 (CH), 1701 (C=O), 1493, 1406, 1325, 1263, 
1132, 1024, 756; δH (500 MHz, DMSO-d6, 100 °C) 3.09 (2H, t, J 8.6 Hz, 3-H2), 3.74 
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(3H, s, OCH3), 4.01 (2H, t, J 8.6 Hz, 2-H2), 5.25 (2H, s, OCH2Ph), 6.72 (1H, dd, J 
8.7, 2.6 Hz, 6-H), 6.84 (1H, d, J 2.6 Hz, 4-H), 7.31–7.45 (5H, m, Ph), 7.56 (1H, d, J 
8.7 Hz, 7-H); δC (126 MHz, DMSO-d6, 100 °C) 27.7 (CH2), 48.0 (CH2), 56.2 (CH3), 
66.8 (CH2), 112.0 (CH), 112.9 (CH), 115.2 (CH), 128.1 (2 × CH), 128.3 (CH), 128.8 
(2 × CH), 133.4 (C), 136.3 (C), 137.3 (C), 152.9 (C), 156.2 (C); m/z (ESI) 306.1095 
(MNa+. C17H17NNaO3 requires 306.1101). 
1-(tert-Butoxycarbonyl)-5-methoxyindoline (143d)520 
 
1-(tert-Butoxycarbonyl)-5-methoxyindoline (143d) was synthesised as described for 
1-benzoyl-5-methoxyindoline (143a) using tert-butyl-N-[(3-
methoxyphenyl)ethyl]carbamate (122d) (0.0630 g, 0.250 mmol). The iodination step 
was carried out at 40 °C for 4 h and the N-arylation step at 130 °C for 16 h. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 9:1) 
gave 1-(tert-butoxycarbonyl)-5-methoxyindoline (143d) (0.0349 g, 56%) as a white 
solid. Mp 84–86 °C (lit.520 Mp 87–89 °C); δH (500 MHz, DMSO-d6, 100 °C) 1.53 (9H, 
s, C(CH3)3), 3.04 (2H, t, J 8.6 Hz, 3-H2), 3.73 (3H, s, OCH3), 3.91 (2H, J 8.6 Hz, 2-
H2), 6.71 (1H, dd, J 8.7, 2.5 Hz, 6-H), 6.81 (1H, d, J 2.5 Hz, 4-H), 7.50 (1H, d, J 8.7 
Hz, 7-H); δC (126 MHz, DMSO-d6, 100 °C) 27.5 (CH2), 28.7 (3 × CH3), 48.1 (CH2), 
56.2 (CH3), 80.4 (C), 111.9 (CH), 112.8 (CH), 115.1 (CH), 133.3 (C), 136.6 (C), 
152.3 (C), 155.8 (C); m/z (EI) 249 (M+. 15%), 193 (100), 149 (28), 134 (62), 84 (30). 
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1-(Methanesulfonyl)-5-methoxyindoline (143e) 
 
1-(Methanesulfonyl)-5-methoxyindoline (143e) was synthesised as described for 1-
benzoyl-5-methoxyindoline (143a) using N-[(3-
methoxyphenyl)ethyl]methanesulfonamide (122e) (0.0570 g, 0.250 mmol). The 
iodination step was carried out at 40 °C for 4 h and the N-arylation step at 130 °C 
for 22 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 1:1) gave 1-(methanesulfonyl)-5-methoxyindoline (143e) (0.0410 g, 73%) 
as a colourless oil. νmax/cm−1 (neat) 2932 (CH), 1489, 1343, 1157, 1030, 818; δH 
(400 MHz, CDCl3) 2.81 (3H, s, SO2CH3), 3.12 (2H, t, J 8.5 Hz, 3-H2), 3.78 (3H, s, 
OCH3), 3.97 (2H, t, J 8.5 Hz, 2-H2), 6.72 (1H, dd, J 8.8, 2.5 Hz, 6-H), 6.79 (1H, d, J 
2.5 Hz, 4-H), 7.32 (2H, d, J 8.8 Hz, 7-H); δC (101 MHz, CDCl3) 28.4 (CH2), 33.9 
(CH3), 50.7 (CH2), 55.7 (CH3), 111.6 (CH), 112.8 (CH), 115.1 (CH), 133.1 (C), 135.4 
(C), 156.8 (C); m/z (EI) 227.0617 (M+. C10H13NO3S requires 227.0616), 148 (100%), 
133 (69), 117 (38), 77 (33). 
5-Methoxy-1-(4′-methylbenzenesulfonyl)indoline (143f) 
 
5-Methoxy-1-(4′-methylbenzenesulfonyl)indoline (143f) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3-
methoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (122f) (0.0765 g, 0.250 
mmol). The iodination step was carried out at 40 °C for 4 h and the N-arylation step 
at 130 °C for 24 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 4:1) gave 5-methoxy-1-(4′-methylbenzenesulfonyl)indoline 
(143f) (0.0703 g, 93%) as a yellow oil. νmax/cm−1 (neat) 2943 (CH), 1597 (C=C), 
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1485, 1350, 1163, 1032, 814; δH (400 MHz, CDCl3) 2.39 (3H, s, 4′-CH3), 2.77 (2H, 
t, J 8.2 Hz, 3-H2), 3.77 (3H, s, OCH3), 3.92 (2H, t, J 8.2 Hz, 2-H2), 6.64 (1H, d, J 2.5 
Hz, 4-H), 6.75 (1H, dd, J 8.8, 2.5 Hz, 6-H), 7.22 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 
7.58 (1H, d, J 8.8 Hz, 7-H), 7.63 (2H, d, J 8.2 Hz, 2′-H and 6′-H); δC (101 MHz, 
CDCl3) 21.5 (CH3), 28.3 (CH2), 50.4 (CH2), 55.6 (CH3), 111.0 (CH), 112.6 (CH), 
116.7 (CH), 127.4 (2 × CH), 129.6 (2 × CH), 133.9 (C), 134.0 (C), 135.5 (C), 143.9 
(C), 156.9 (C); m/z (ESI) 326.0810 (MNa+. C16H17NNaO3S requires 326.0821). 
5,6-Dimethoxy-1-(4′-methylbenzenesulfonyl)indoline (146a) 
 
5,6-Dimethoxy-1-(4′-methylbenzenesulfonyl)indoline (146a) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3,4-
dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123a) (0.0840 g, 0.250 
mmol). The iodination step was carried out at 40 °C for 4 h and the N-arylation step 
at 130 °C for 21 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 4:1) gave 5,6-dimethoxy-1-(4′-methylbenzenesulfonyl)indoline 
(146a) (0.0654 g, 78%) as a white solid. Mp 116–118 °C; νmax/cm−1 (neat) 2955 
(CH), 1597 (C=C), 1505, 1456, 1348, 1211, 1159, 1089, 814; δH (400 MHz, CDCl3) 
2.37 (3H, s, 4′-CH3), 2.70 (2H, t, J 8.2 Hz, 3-H2), 3.80 (3H, s, OCH3), 3.90 (,), 3.94 
(3H, s, OCH3), 6.60 (1H, s, 4-H), 7.20 (2H, d, J 8.7 Hz, 3′-H and 5′-H), 7.32 (1H, s, 
7-H), 7.59 (2H, d, J 8.7 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 28.1 
(CH2), 50.7 (CH2), 56.3 (CH3), 56.3 (CH3), 101.2 (CH), 108.2 (CH), 123.6 (C), 127.4 
(2 × CH), 129.6 (2 × CH), 133.9 (C), 135.4 (C), 143.9 (C), 146.4 (C), 148.7 (C); m/z 
(ESI) 356.0918 (MNa+. C17H19NNaO4S requires 356.0927). 
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5,7-Dimethoxy-1-(4′-methylbenzenesulfonyl)indoline (146b) 
 
5,7-Dimethoxy-1-(4′-methylbenzenesulfonyl)indoline (146b) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3,5-
dimethoxyphenyl)ethyl]-4′′-methylbenzenesulfonamide (123b) (0.0820 g, 0.250 
mmol). The iodination step was carried out at 40 °C for 4 h and the N-arylation step 
at 130 °C for 21 h. Purification by flash column chromatography 
(dichloromethane/diethyl ether, 19:1) gave 5,7-dimethoxy-1-(4′-
methylbenzenesulfonyl)indoline (146b) (0.0610 g, 75%) as a colourless oil. 
νmax/cm−1 (neat) 2361 (CH), 1558 (C=C), 1350, 1165, 813; δH (400 MHz, CDCl3) 
2.32 (2H, t, J 7.4 Hz, 3-H2), 2.40 (3H, s, 4′-CH3), 3.77 (3H, s, OCH3), 3.85 (3H, s, 
OCH3), 4.02 (2H, t, J 7.4 Hz, 2-H2), 6.25 (1H, d, J 2.2 Hz, 6-H), 6.38 (1H, d, J 2.2 
Hz, 4-H), 7.19 (2H, d, J 8.6 Hz, 3′-H and 5′-H), 7.54 (2H, d, J 8.6 Hz, 2′-H and 6′-H); 
δC (101 MHz, CDCl3) 21.6 (CH3), 29.9 (CH2), 53.1 (CH2), 55.6 (CH3), 56.2 (CH3), 
99.1 (CH), 101.7 (CH), 124.5 (C), 127.7 (2 × CH), 129.3 (2 × CH), 135.6 (C), 139.6 
(C), 143.6 (C), 152.9 (C), 152.6 (C); m/z (ESI) 356.0917 (MNa+. C17H19NNaO4S 
requires 356.0927). 
1-(4′-Methylbenzenesulfonyl)-5,6,7-trimethoxyindoline (146c) 
 
1-(4′-Methylbenzenesulfonyl)-5,6,7-trimethoxyindoline (146c) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using 4′-methyl-N-[(3,4,5-
trimethoxyphenyl)ethyl]benzenesulfonamide (123c) (0.0920 g, 0.250 mmol). The 
iodination step was carried out at 40 °C for 4 h and the N-arylation step at 130 °C 
for 22 h. Purification by flash column chromatography (petroleum ether/ethyl 
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acetate, 7:3) gave 1-(4′-methylbenzenesulfonyl)-5,6,7-trimethoxyindoline (146c) 
(0.0668 g, 73%) as a white solid. Mp 126–128 °C; νmax/cm−1 (neat) 2940 (CH), 1597 
(C=C), 1470, 1418, 1350, 1236, 1163, 1125, 1067, 816; δH (400 MHz, CDCl3) 2.30 
(2H, t, J 7.6 Hz, 3-H2), 2.40 (3H, s, 4′-CH3), 3.80 (3H, s, OCH3), 3.87 (3H, s, OCH3), 
4.00 (3H, s, OCH3), 4.02 (2H, t, J 7.6 Hz, 2-H2), 6.38 (1H, s, 4-H), 7.18 (2H, d, J 8.3 
Hz, 3′-H and 5′-H), 7.53 (2H, d, J 8.3 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 21.6 
(CH3), 29.6 (CH2), 53.1 (CH2), 56.3 (CH3), 60.3 (CH3), 61.2 (CH3), 102.9 (CH), 127.6 
(C), 127.7 (2 × CH), 129.3 (2 × CH), 132.5 (C), 135.5 (C), 141.5 (C), 143.7 (C), 
146.9 (C), 152.4 (C); m/z (ESI) 386.1022 (MNa+. C18H21NNaO5S requires 
386.1033). 
5-Methoxy-6-methyl-1-(4′-methylbenzenesulfonyl)indoline (146d) 
 
5-Methoxy-6-methyl-1-(4′-methylbenzenesulfonyl)indoline (146d) was synthesised 
as described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3-methoxy-4-
methylphenyl)ethyl]-4′′-methylbenzenesulfonamide (123d) (0.0580 g, 0.180 mmol). 
The iodination step was carried out at 40 °C for 5 h and the N-arylation step at 130 
°C for 24 h. Purification by flash column chromatography (hexane/ethyl acetate, 7:3) 
gave 5-methoxy-6-methyl-1-(4′-methylbenzenesulfonyl)indoline (146d) (0.0424 g, 
74%) as a colourless oil; νmax/cm−1 (neat) 2947 (CH), 1597 (C=C), 1497, 1350, 1157, 
1088, 1026, 810; δH (400 MHz, CDCl3) 2.23 (3H, s, 6-CH3), 2.36 (3H, s, 4′-CH3), 
2.71 (2H, t, J 8.2 Hz, 3-H2), 3.75 (3H, s, OCH3), 3.88 (2H, t, J 8.2 Hz, 2-H2), 6.55 
(1H, s, 4-H), 7.19 (2H, d, J 8.1 Hz, 3′-H and 5′-H), 7.46 (1H, s, 7-H), 7.59 (2H, d, J 
8.1 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 16.7 (CH3), 21.5 (CH3), 28.3 (CH2), 
50.4 (CH2), 55.6 (CH3), 107.0 (CH), 118.3 (CH), 126.0 (C), 127.4 (2 × CH), 129.6 (2 
× CH), 130.6 (C), 134.0 (C), 134.8 (C), 143.8 (C), 155.0 (C); m/z (ESI) 340.0970 
(MNa+. C17H19NNaO3S requires 340.0978). 
  
5
6
7
4
N
2
3
S
2′ 3′
4′
5′6′
MeO
OO Me
Me
 
238 
1-(4′-Methylbenzenesulfonyl)-(5,6-methylenedioxy)indoline (146e) 
 
1-(4′-Methylbenzenesulfonyl)-(5,6-methylenedioxy)indoline (146e) was synthesised 
as described for 1-benzoyl-5-methoxyindoline (143a) using 4′′-methyl-N-[(3,4-
methylenedioxyphenyl)ethyl]benzenesulfonamide (123e) (0.0780 g, 0.250 mmol). 
The iodination step was carried out at 40 °C for 4 h and the N-arylation step at 130 
°C for 21 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave 1-(4′-methylbenzenesulfonyl)-(5,6-methylenedioxy)indoline 
(146e) (0.0534 g, 69%) as a white solid. Mp 139–141 °C; νmax/cm−1 (neat) 2955 
(CH), 1597 (C=C), 1476, 1454, 1352, 1306, 1163, 1038, 937; δH (400 MHz, CDCl3) 
2.38 (3H, s, 4′-CH3), 2.66 (2H, t, J 8.2 Hz, 3-H2), 3.90 (2H, t, J 8.2 Hz, 2-H2), 5.94 
(2H, s, OCH2O), 6.51 (1H, s, 4-H), 7.22 (2H, d, J 8.3 Hz, 3′-H and 5′-H), 7.24 (1H, 
s, 7-H), 7.62 (2H, d, J 8.3 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 28.0 
(CH2), 50.9 (CH2), 99.0 (CH), 101.4 (CH2), 105.2 (CH), 124.7 (C), 127.4 (2 × CH), 
129.6 (2 × CH), 134.0 (C), 136.0 (C), 144.0 (C), 144.6 (C), 147.2 (C); m/z (ESI) 
340.0603 (MNa+. C16H15NNaO4S requires 340.0614). 
5-Amino-1-(4′-methylbenzenesulfonyl)indoline (146f) 
 
5-Amino-1-(4′-methylbenzenesulfonyl)indoline (146f) was synthesised as described 
for 1-benzoyl-5-methoxyindoline (143a) using N-[(3-aminophenyl)ethyl]-4′′-
methylbenzenesulfonamide (124a) (0.0798 g, 0.280 mmol). The iodination step was 
carried out at 40 °C for 4 h and the N-arylation step at 130 °C for 21 h. Purification 
by flash column chromatography (hexane/ethyl acetate, 1:1) gave 5-amino-1-(4′-
methylbenzenesulfonyl)indoline (146f) (0.0550 g, 70%) as a colourless oil. νmax/cm−1 
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(neat) 3475 (NH), 3365 (NH), 1624, 1597 (C=C), 1488, 1343, 1161, 1091, 814; δH 
(400 MHz, CDCl3) 2.36 (3H, s, 4′-CH3), 2.64 (2H, t, J 8.2 Hz, 3-H2), 3.53 (2H, br s, 
NH2), 3.86 (2H, t, J 8.2 Hz, 2-H2), 6.41 (1H, d, J 2.3 Hz, 4-H), 6.53 (1H, dd, J 8.5, 
2.3 Hz, 6-H), 7.19 (2H, d, J 8.1 Hz, 3′-H and 5′-H), 7.45 (1H, d, J 8.5 Hz, 7-H), 7.58 
(2H, d, J 8.1 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 28.3 (CH2), 50.3 
(CH2), 111.9 (CH), 114.3 (CH), 117.3 (CH), 127.4 (2 × CH), 129.5 (2 × CH), 133.9 
(C), 134.0 (2 × C), 143.4 (C), 143.7 (C); m/z (ESI) 311.0826 (MNa+. C15H16N2NaO2S 
requires 311.0825). 
5-Amino-6-chloro-1-(4′-methylbenzenesulfonyl)indoline (146g) 
 
5-Amino-6-chloro-1-(4′-methylbenzenesulfonyl)indoline (146g) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3-amino-4-
chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (124b) (0.0590 g, 0.180 mmol). 
The iodination step was carried out at 40 °C for 4 h and the N-arylation step at 130 
°C for 24 h. Purification by flash column chromatography (hexane/ethyl acetate, 1:1) 
gave 5-amino-6-chloro-1-(4′-methylbenzenesulfonyl)indoline (146g) (0.0320 g, 
55%) as a colourless oil. νmax/cm−1 (neat) 3472 (NH), 3372 (NH), 2924 (CH), 2361, 
1620, 1597 (C=C), 1481, 1342, 1159, 1088, 810; δH (400 MHz, CDCl3) 2.38 (3H, s, 
4′-CH3), 2.66 (2H, t, J 8.2 Hz, 3-H2), 3.71–3.96 (4H, m, 2-H2 and NH2), 6.49 (1H, s, 
4-H), 7.22 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 7.58 (1H, s, 7-H), 7.61 (2H, d, J 8.2 Hz, 
2′-H and 6′-H); δC (101 MHz, CDCl3) 21.5 (CH3), 28.0 (CH2), 50.3 (CH2), 112.1 (CH), 
117.0 (CH), 118.1 (C), 127.4 (2 × CH), 129.7 (2 × CH), 132.4 (C), 133.7 (C), 134.2 
(C), 139.7 (C), 144.0 (C); m/z (ESI) 345.0422 (MNa+. C15H1535ClN2NaO2S requires 
345.0435). 
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5-Acetamido-1-(4′-methylbenzenesulfonyl)indoline (146h) 
 
5-Acetamido-1-(4′-methylbenzenesulfonyl)indoline (146h) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3-
acetamidophenyl)ethyl]-4′′-methylbenzenesulfonamide (125a) (0.148 g, 0.450 
mmol) in tolunene (1.0 mL) and acetonitrile (0.2 mL). The iodination step was carried 
out at 40 °C for 4 h and the N-arylation step at 130 °C for 21 h. Purification by flash 
column chromatography (hexane/ethyl acetate, 7:3) gave 5-acetamido-1-(4′-
methylbenzenesulfonyl)indoline (146h) (0.0940 g, 64%) as a white solid. Mp 168–
170 °C; νmax/cm−1 (neat) 3320 (NH), 2924 (CH), 1675 (C=O), 1546 (C=C), 1487, 
1351, 1163, 1091, 815; δH (400 MHz, CDCl3) 2.13 (3H, s, CH3CO), 2.37 (3H, s, 4′-
CH3), 2.83 (2H, t, J 8.1 Hz, 3-H2), 3.89 (2H, t, J 8.1 Hz, 2-H2), 7.05 (1H, dd, J 8.3, 
1.6 Hz, 6-H), 7.21 (2H, d, J 7.7 Hz, 3′-H and 5′-H), 7.24 (1H, br s, NH), 7.49 (1H, br 
s, 4-H), 7.54 (1H, d, J 8.3 Hz, 7-H), 7.62 (2H, d, J 7.7 Hz, 2′-H and 6′-H); δC (101 
MHz, CDCl3) 21.5 (CH3), 24.4 (CH3), 28.1 (CH2), 50.2 (CH2), 115.4 (CH), 117.6 
(CH), 119.3 (CH), 127.3 (2 × CH), 129.7 (2 × CH), 133.0 (C), 133.7 (C), 134.2 (C), 
138.4 (C), 144.2 (C), 168.3 (C); m/z (ESI) 353.0925 (MNa+. C17H18N2NaO3S 
requires 353.0930). 
5-Acetamido-6-chloro-1-(4′-methylbenzenesulfonyl)indoline (146i) 
 
5-Acetamido-6-chloro-1-(4′-methylbenzenesulfonyl)indoline (146i) was synthesised 
as described for 1-benzoyl-5-methoxyindoline (143a) using N-[(3-acetamido-4-
chlorophenyl)ethyl]-4′′-methylbenzenesulfonamide (125b) (0.0420 g, 0.110 mmol) 
and N-bromosuccinimide (0.0200 g, 0.110 mmol). The bromination step was carried 
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out at 40 °C for 4 h and the N-arylation step at 130 °C for 21 h. Purification by flash 
column chromatography (hexane/ethyl acetate, 2:3) gave 5-acetamido-6-chloro-1-
(4′-methylbenzenesulfonyl)indoline (146i) (0.0170 g, 43%) as a white solid. Mp 138–
140 °C; νmax/cm−1 (neat) 3350 (NH), 2925 (CH), 1653 (C=O), 1356, 1162; δH (400 
MHz, CDCl3) 2.21 (3H, s, CH3CO), 2.39 (3H, s, 4′-CH3), 2.85 (2H, t, J 8.4 Hz, 3-H2), 
3.90 (2H, t, J 8.4 Hz, 2-H2), 7.25 (2H, d, J 8.5 Hz, 3′-H and 5′-H), 7.49 (1H, s, 4-H), 
7.65 (2H, d, J 8.5 Hz, 2′-H and 6′-H), 7.68 (1H, s, 7-H), 8.05 (1H, br s, NH); δC (101 
MHz, CDCl3) 21.5 (CH3), 24.7 (CH3), 27.9 (CH2), 50.3 (CH2), 115.4 (CH), 118.4 
(CH), 121.9 (C), 127.3 (2 × CH), 129.8 (2 × CH), 130.5 (C), 131.6 (C), 133.6 (C), 
138.6 (C), 144.4 (C), 168.2 (C); m/z (ESI) 387.0527 (MNa+. C17H1735ClN2NaO3S 
requires 387.0541). 
6-Methoxy-1-(4′-methylbenzenesulfonyl)-2,3,4-tetrahydroquinoline (146j) 
 
6-Methoxy-1-(4′-methylbenzenesulfonyl)-2,3,4-tetrahydroquinoline (146j) was 
synthesised as described for 1-benzoyl-5-methoxyindoline (143a) using N-[(1-
methoxyphenyl)propyl]-4′′-methylbenzenesulfonamide (127) (0.0840 g, 0.260 
mmol). The iodination step was carried out at 40 °C for 5 h and the N-arylation step 
at 130 °C for 23 h. Purification by flash column chromatography (hexane/ethyl 
acetate, 4:1) gave 6-methoxy-1-(4′-methylbenzenesulfonyl)-2,3,4-
tetrahydroquinoline (146j) (0.0710 g, 85%) as a colourless oil. νmax/cm−1 (neat) 2943 
(CH), 1609, 1597 (C=C), 1493, 1339, 1162, 1090, 812; δH (400 MHz, CDCl3) 1.51–
1.59 (2H, m, 3-H2), 2.33 (2H, t, J 6.8 Hz, 4-H2), 2.38 (3H, s, 4′-CH3), 3.73–3.77 (2H, 
m, 2-H2), 3.78 (3H, s, OCH3), 6.52 (1H, d, J 2.8 Hz, 5-H), 6.75 (1H, dd, J 9.0, 2.8 
Hz, 7-H), 7.18 (2H, d, J 8.3 Hz, 3′-H and 5′-H), 7.42 (2H, d, J 8.3 Hz, 2′-H and 6′-H), 
7.70 (1H, d, J 9.0 Hz, 8-H); δC (101 MHz, CDCl3) 21.3 (CH2), 21.5 (CH3), 26.6 (CH2), 
46.4 (CH2), 55.4 (CH3), 112.1 (CH), 113.7 (CH), 127.0 (CH), 127.2 (2 × CH), 129.5 
(2 × CH), 129.9 (C), 132.7 (C), 136.7 (C), 143.4 (C), 157.0 (C); m/z (ESI) 340.0965 
(MNa+. C17H19NNaO3S requires 340.0978). 
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5-Methoxyindolin-2-one (146k)521 
 
5-Methoxyindolin-2-one (146k) was synthesised as described for 1-benzoyl-5-
methoxyindoline (143a) using 3-methoxyphenylacetamide (129) (0.0420 g, 0.250 
mmol). The iodination step was carried out at 40 °C for 5 h and the N-arylation step 
at 130 °C for 21 h. Purification by flash column chromatography (hexane/ethyl 
acetate, 1:1) gave 5-methoxyindolin-2-one (146k) (0.0269 g, 65%) as a white solid. 
Mp 128–130 °C (lit.521 132–134 °C); δH (400 MHz, CDCl3) 3.53 (2H, s, 3-H2), 3.78 
(3H, s, OCH3), 6.75 (1H, dd, J 8.5, 2.4 Hz, 6-H), 6.79 (2H, d, J 8.5 Hz, 7-H), 6.85 
(1H, br s, 4-H), 8.53 (1H, br s, NH); δC (101 MHz, CDCl3) 36.7 (CH2), 55.8 (CH3), 
110.0 (CH), 111.8 (CH), 112.5 (CH), 126.7 (C), 135.9 (C), 155.7 (C), 177.5 (C); m/z 
(ESI) 186 (MNa+. 100%). 
5,6-dimethoxyindoline (147)522 
 
5,6-Dimethoxy-1-(4′-methylbenzenesulfonyl)indoline (146a) (0.0500 g, 0.150 mmol) 
was dissolved in methanol (10 mL) and dichloromethane (1.0 mL) and magnesium 
turnings (0.109 g, 4.50 mmol) were added under argon. The reaction mixture was 
stirred under reflux for 16 h. The reaction mixture was cooled to 0 °C, 1 M aqueous 
hydrochloric acid solution (10 mL) was added dropwise and the solution was 
washed with ethyl acetate (10 mL). The aqueous layer was separated and 
neutralised with 1 M aqueous sodium hydroxide (10 mL) and extracted into 
dichloromethane (3 × 30 mL). The combined organic extracts were washed with 
brine (50 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by 
flash column chromatography (petroleum ether/ethyl acetate, 1:1) gave 5,6-
dimethoxyindoline (147) (0.0181 g, 67%) as yellow oil. Spectroscopic data were 
consistent with the literature.522 δH (400 MHz, CDCl3) 2.98 (2H, t, J 8.2 Hz, 3-H2), 
3.34 (1H, br s, NH), 3.53 (2H, t, J 8.2 Hz, 2-H2), 3.81 (3H, s, OCH3), 3.82 (3H, s, 
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OCH3), 6.35 (1H, s, 7-H), 6.76 (1H, s, 4-H); δC (101 MHz, CDCl3) 30.1 (CH2), 48.0 
(CH2), 56.1 (CH3), 57.1 (CH3), 96.2 (CH), 110.1 (CH), 120.4 (C), 142.7 (C), 145.3 
(C), 148.9 (C); m/z (ESI) 202 (MNa+. 100%). 
2,3-Dihydro-5-methoxybenzofuran (149a)284 
 
2,3-Dihydro-5-methoxybenzofuran (149a) was synthesised as described for 1-
benzoyl-5-methoxyindoline (143a) using 3-methoxyphenylethan-2′-ol (0.0710 mL, 
0.500 mmol). The iodination step was carried out at 40 °C for 4 h and the O-arylation 
step at 150 °C for 21 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 19:1) gave 2,3-dihydro-5-methoxybenzofuran (149a) (0.0460 g, 
65%) as a colourless oil. Spectroscopic data were consistent with the literature.284 
δH (400 MHz, CDCl3) 3.17 (2H, t, J 8.6 Hz, 3-H2), 3.75 (3H, s, OCH3), 4.53 (2H, t, J 
8.6 Hz, 2-H2), 6.64 (1H, dd, J 8.6, 2.6 Hz, 6-H), 6.68 (1H, d, J 8.6 Hz, 7-H), 6.78 
(1H, d, J 2.6 Hz, 4-H); δC (101 MHz, CDCl3) 30.3 (CH2), 56.1 (CH3), 71.3 (CH2), 
109.1 (CH), 111.4 (CH), 112.8 (CH), 128.0 (C), 154.1 (C), 154.2 (C); m/z (ESI) 173 
(MNa+. 100%). 
2,3-Dihydro-5,6-dimethoxybenzofuran (149b) 
 
2,3-Dihydro-5,6-dimethoxybenzofuran (149b) was synthesised as described for 1-
benzoyl-5-methoxyindoline (143a) using 3,4-dimethoxyphenylethan-2′-ol (0.0910 g, 
0.500 mmol). The iodination step was carried out at 40 °C for 4 h and the O-arylation 
step at 130 °C for 21 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 9:1) gave 2,3-dihydro-5,6-dimethoxybenzofuran (149b) (0.0650 
g, 72%) as a white solid. Mp 58–60 °C; νmax/cm−1 (neat) 2940 (CH), 1614, 1502, 
1446, 1304, 1208, 1186, 1169, 1095, 1003, 828; δH (400 MHz, CDCl3) 3.15 (2H, t, 
J 8.7 Hz, 3-H2), 3.82 (3H, s, OCH3), 3.83 (3H, s, OCH3), 4.54 (2H, t, J 8.7 Hz, 2-H2), 
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6.45 (1H, s, 7-H), 6.78 (1H, s, 4-H); δC (101 MHz, CDCl3) 30.0 (CH2), 56.1 (CH3), 
57.0 (CH3), 71.7 (CH2), 94.9 (CH), 109.3 (CH), 116.6 (C), 143.2 (C), 149.2 (C), 154.3 
(C); m/z (ESI) 203.0679 (MNa+. C10H12NaO3 requires 203.0679). 
2,3-Dihydro-5,6-methylenedioxybenzofuran (149c) 
 
2,3-Dihydro-5,6-methylenedixoybenzofuran (149c) was synthesised as described 
for 1-benzoyl-5-methoxyindoline (143a) using (3,4-methylenedioxy)phenethan-2′-ol 
(131a) (0.0830 g, 0.500 mmol). The iodination step was carried out at 40 °C for 5 h 
and the O-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 2,3-dihydro-5,6-
methylenedixoybenzofuran (149c) (0.0520 g, 63%) as a white solid. Mp 54–56 °C; 
νmax/cm−1 (neat) 2893 (CH), 2361, 1620 (C=C), 1474, 1296, 1142, 1034, 941; δH 
(400 MHz, CDCl3) 3.10 (2H, t, J 8.7 Hz, 3-H2), 4.54 (2H, t, J 8.7 Hz, 2-H2), 5.87 (2H, 
s, OCH2O), 6.37 (1H, s, 7-H), 6.65 (1H, s, 4-H); δC (101 MHz, CDCl3) 30.0 (CH2), 
72.0 (CH2), 93.0 (CH), 101.1 (CH2), 105.0 (CH), 117.7 (C), 141.4 (C), 147.1 (C), 
154.6 (C); m/z (EI) 164.0469 (M+. C9H8O3 requires 164.0473), 133 (18%), 84 (48), 
78 (20). 
2,3-Dihydro-5,6-ethylenedioxybenzofuran (149d) 
 
2,3-Dihydro-5,6-ethylenedioxybenzofuran (149d) was synthesised as described for 
1-benzoyl-5-methoxyindoline (143a) using 1′-(dihydro-3,4-benzodioxinyl)ethan-2′-ol 
(131b) (0.106 g, 0.590 mmol). The iodination step was carried out at 40 °C for 4 h 
and the O-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 2,3-dihydro-5,6-
ethylenedioxybenzofuran (149d) (0.0618 g, 60%) as a white solid. Mp 64–66 °C; 
νmax/cm−1 (neat) 2992 (CH), 1607 (C=C), 1486, 1327, 1185, 1060, 931; δH (400 MHz, 
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CDCl3) 3.10 (2H, t, J 8.3 Hz, 3-H2), 4.15–4.23 (4H, m, OCH2CH2O), 4.50 (2H, t, J 
8.3 Hz, 2-H2), 6.34 (1H, s, 7-H), 6.70 (1H, s, 4-H); δC (101 MHz, CDCl3) 29.6 (CH2), 
64.1 (CH2), 64.5 (CH2), 71.6 (CH2), 98.4 (CH), 113.2 (CH), 119.2 (C), 137.3 (C), 
142.8 (C), 154.3 (C); m/z (EI) 178.0625 (M+. C10H10O3 requires 178.0630), 122 
(92%), 69 (25). 
5-Acetamido-2,3-dihydrobenzofuran (149e)523 
 
5-Acetamido-2,3-dihydrobenzofuran (149e) was synthesised as described for 1-
benzoyl-5-methoxyindoline (143a) using 1′-(3-acetamidophenyl)ethan-2′-ol (137) 
(0.0270 g, 0.150 mmol) in toluene (1.0 mL) and acetonitrile (0.2 mL). The iodination 
step was carried out at 40 °C for 4 h and the O-arylation step at 130 °C for 24 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 1:1) 
gave 5-acetamido-2,3-dihydrobenzofuran (149e) (0.0140 g, 56%) as a white solid. 
Mp 94–96 °C (lit.523 93–95 °C); δH (400 MHz, CDCl3) 2.12 (3H, s, CH3CO), 3.17 (2H, 
t, J 8.4 Hz, 3-H2), 4.54 (2H, t, J 8.4 Hz, 2-H2), 6.69 (1H, d, J 8.5 Hz, 7-H), 7.00 (1H, 
dd, J 8.5, 2.2 Hz, 6-H) 7.44–7.49 (2H, m, 4-H and NH); δC (101 MHz, CDCl3) 24.2 
(CH3), 29.9 (CH2), 71.5 (CH2), 109.0 (CH), 118.6 (CH), 120.7 (CH), 127.6 (C), 130.8 
(C), 157.0 (C), 168.6 (C); m/z (ESI) 200 (MNa+. 100%). 
2,3-Dihydro-2,2-dimethyl-5-methoxybenzofuran (149f)284 
 
2,3-Dihydro-2,2-dimethyl-5-methoxybenzofuran (149f) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using 2′,2′-dimethyl-1′-(3-
methoxyphenyl)ethan-2′-ol (133) (0.120 g, 0.670 mmol). The iodination step was 
carried out at 40 °C for 5 h and the O-arylation step at 130 °C for 24 h. Purification 
by flash column chromatography (petroleum ether/diethyl ether, 19:1) gave 2,3-
dihydro-2,2-dimethyl-5-methoxybenzofuran (149f) (0.0821 g, 69%) as a colourless 
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oil. Spectroscopic data were consistent with the literature.284 δH (400 MHz, CDCl3) 
1.45 (6H, s, 2 × 2-CH3), 2.98 (2H, s, 3-H2), 3.74 (3H, s, OCH3), 6.60–6.67 (2H, m, 
4-H and 6-H), 6.71–6.75 (1H, m, 7-H); δC (101 MHz, CDCl3) 28.1 (2 × CH3), 43.3 
(CH2), 56.0 (CH3), 86.5 (C), 109.3 (CH), 111.6 (CH), 112.8 (CH), 128.1 (C), 153.1 
(C), 153.8 (C); m/z (ESI) 201 (MNa+. 100%). 
2,3-Dihydro-6-methoxy-1-benzopyran (149i)284 
 
2,3-Dihydro-6-methoxybenzopyran (149i) was synthesised as described for 1-
benzoyl-5-methoxyindoline (143a) using 1′-(3-methoxyphenyl)propan-3′-ol (139a) 
(0.0830 g, 0.500 mmol). The iodination step was carried out at 40 °C for 4 h and the 
O-arylation step at 150 °C for 24 h. Purification by flash column chromatography 
(hexane/dichloromethane, 1:1) gave 2,3-dihydro-6-methoxy-1-benzopyran (149i) 
(0.0460 g, 57%) as a colourless oil. Spectroscopic data were consistent with the 
literature.284 δH (400 MHz, CDCl3) 1.94–2.02 (2H, m, 3-H2), 2.77 (2H, t, J 6.5 Hz, 4-
H2), 3.74 (3H, s, OCH3), 4.13 (2H, t, J 5.2 Hz, 2-H2), 6.58 (1H, d, J 2.9 Hz, 5-H), 
6.66 (1H, dd, J 8.8, 2.9 Hz, 7-H), 6.71 (1H, d, J 8.8 Hz, 8-H); δC (101 MHz, CDCl3) 
22.5 (CH2), 25.2 (CH2), 55.7 (CH3), 66.3 (CH2), 113.3 (CH), 114.4 (CH), 117.2 (CH), 
122.7 (C), 149.0 (C), 153.2 (C); m/z (EI) 164 (M+. 100%), 149 (42), 136 (22), 108 
(14), 84 (28), 77 (11). 
2,3-Dihydro-6,7-dimethoxy-1-benzopyran (149j)524 
 
2,3-Dihydro-6,7-dimethoxybenzopyran (149j) was synthesised as described for 1-
benzoyl-5-methoxyindoline (143a) using 1′-(3,4-dimethoxyphenyl)propan-3′-ol 
(0.0490 g, 0.250 mmol). The iodination step was carried out at 40 °C for 4 h and the 
O-arylation step at 150 °C for 22 h. Purification by flash column chromatography 
(hexane/ethyl acetate, 4:1) gave 2,3-dihydro-6,7-dimethoxy-1-benzopyran (149j) 
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(0.0273 g, 56%) as a colourless oil. Spectroscopic data were consistent with the 
literature.524 δH (500 MHz, CDCl3) 1.95–2.02 (2H, m, 3-H2), 2.70 (2H, t, J 6.6 Hz, 4-
H2), 3.81 (3H, s, OCH3), 3.81 (3H, s, OCH3), 4.10–4.14 (2H, m, 2-H2), 6.38 (1H, s, 
8-H), 6.53 (1H, s, 5-H); δC (126 MHz, CDCl3) 22.6 (CH2), 24.3 (CH2), 55.9 (CH3), 
56.5 (CH3), 66.3 (CH2), 100.9 (CH), 112.6 (C), 112.7 (CH), 143.0 (C), 148.3 (C), 
148.7 (C); m/z (EI) 194 (M+. 100%), 179 (86), 149 (25), 123 (15), 57 (25). 
2,3-Dihydro-6,7,8-trimethoxy-1-benzopyran (149k) 
 
2,3-Dihydro-6,7-trimethoxy-1-benzopyran (149k) was synthesised as described for 
1-benzoyl-5-methoxyindoline (143a) using 1′-(3,4,5-trimethoxyphenyl)propan-3′-ol 
(139b) (0.0570 g, 0.250 mmol). The iodination step was carried out at 40 °C for 4 h 
and the O-arylation step at 150 °C for 22 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave 2,3-dihydro-6,7,8-
trimethoxy-1-benzopyran (149k) (0.0290 g, 51%) as a colourless oil. νmax/cm−1 
(neat) 2932 (CH), 1489, 1462, 1420, 1277, 1219, 1126, 1099, 1072, 1011; δH (400 
MHz, CDCl3) 1.95–2.03 (2H, m, 3-H2), 2.73 (2H, t, J 6.5 Hz, 4-H2), 3.79 (3H, s, 
OCH3), 3.87 (3H, s, OCH3), 3.89 (3H, s, OCH3), 4.16–4.21 (2H, m, 2-H2), 6.34 (1H, 
s, 5-H); δC (101 MHz, CDCl3) 22.4 (CH2), 24.8 (CH2), 56.4 (CH3), 61.1 (CH3), 61.3 
(CH3), 66.4 (CH2), 107.5 (CH), 117.1 (C), 141.4 (C), 142.3 (C), 142.6 (C), 146.6 (C); 
m/z (ESI) 247.0932 (MNa+. C12H16NaO4 requires 247.0941). 
2,3,4,5-Dihydro-7,8-dimethoxy-1-benzoxepin (150)289 
 
2,3,4,5-Dihydro-7,8-dimethoxy-1-benzoxepin (150) was synthesised as described 
for 1-benzoyl-5-methoxyindoline (143a) using 1′-(3,4-dimethoxyphenyl)butan-4′-ol 
(141) (0.111 g, 0.528 mmol). The iodination step was carried out at 40 °C for 4 h 
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and the O-arylation step at 150 °C for 48 h. Purification by flash column 
chromatography (hexane/diethyl ether, 7:3) gave 2,3,4,5-dihydro-7,8-dimethoxy-1-
benzoxepin (150) (0.0210 g, 19%) as a colourless oil. Spectroscopic data were 
consistent with the literature.289 δH (400 MHz, CDCl3) 1.66–1.74 (2H, m, 4-H2), 1.91–
1.98 (2H, m, 3-H2), 2.72–2.76 (2H, m, 5-H2), 3.83 (3H, s, OCH3), 3.84 (3H, s, OCH3), 
3.94–3.99 (2H, m, 2-H2), 6.59 (1H, s, 9-H), 6.62 (1H, s, 6-H); δC (101 MHz, CDCl3) 
26.6 (CH2), 32.7 (CH2), 34.1 (CH2), 56.0 (CH3), 56.3 (CH3), 73.8 (CH2), 105.6 (CH), 
113.3 (CH), 126.6 (C), 144.4 (C), 147.4 (C), 154.0 (C); m/z (EI) 208 (M+. 100%), 
193 (45).  
Methyl 1′-(3,4-dimethoxyphenyl)butanoate (151)525  
 
Methyl 1′-(3,4-dimethoxyphenyl)butanoate (151) was synthesised as described 
methyl (3-methoxyphenyl)acetate (132) using 3,4-dimethoxyphenylbutyric acid 
(140) (0.700 g, 3.12 mmol). This gave methyl 1′-(3,4-dimethoxyphenyl)butanoate 
(151) (0.715 g, 96%) as a yellow oil. Spectroscopic data were consistent with the 
literature.525 δH (500 MHz, CDCl3) 1.93 (2H, quin. J 7.5 Hz, 3′-H2), 2.32 (2H, t, J 7.5 
Hz, 2′-H2), 2.59 (2H, t, J 7.5 Hz, 4′-H2), 3.66 (3H, s, COOCH3), 3.84 (3H, s, OCH3), 
3.86 (3H, s, OCH3), 6.68–6.73 (2H, m, 2-H and 6-H), 6.78 (1H, d, J 8.7 Hz, 5-H); δC 
(126 MHz, CDCl3) 26.7 (CH2), 33.3 (CH2), 34.7 (CH2), 51.5 (CH3), 55.8 (CH3), 55.9 
(CH3), 111.3 (CH), 111.8 (CH), 120.3 (CH), 134.0 (C), 147.3 (C), 148.9 (C), 174.0 
(C); m/z (ESI) 261 (MNa+. 100%).  
1′-(3,4-Dimethoxyphenyl)-5′-methylpentan-5-ol (152) 
 
To a stirred solution of methyl 1′-(3,4-dimethoxyphenyl)butanoate (151) (0.715 g, 
3.00 mmol) in dry tetrahydrofuran (25 mL) was added methylmagnesium bromide 
(9.00 mL, 9.00 mmol; 1.0 M in dibutyl ether) dropwise at 0 °C. The reaction mixture 
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was warmed to room temperature and stirred for 2 h. The reaction mixture was 
quenched with saturated aqueous ammonium chloride solution (30 mL) at 0 °C and 
extracted with diethyl ether (4 × 40 mL). The combined organic extracts were 
washed with brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 1:1) 
gave 1′-(3,4-dimethoxyphenyl)-5′-methylpentan-5-ol (152) (0.569 g, 80%) as a 
colourless oil. νmax/cm−1 (neat) 3418 (OH), 2940 (CH), 1589, 1512, 1458, 1258, 
1234, 1142, 1026, 810, 764; δH (500 MHz, CDCl3) 1.20 (6H, s, 2 × CH3), 1.29 (1H, 
br s, OH), 1.47–1.53 (2H, m, 2′-H2), 1.63–1.72 (2H, m, 3′-H2), 2.56 (2H, t, J 7.7 Hz, 
4′-H2), 3.84 (3H, s, OCH3), 3.86 (3H, s, OCH3), 6.70–6.74 (2H, m, 2-H and 6-H), 
6.78 (1H, d, J 8.6 Hz, 5-H); δC (126 MHz, CDCl3) 26.4 (CH2), 29.3 (2 × CH3), 35.9 
(CH2), 43.5 (CH2), 55.8 (CH3), 55.9 (CH3), 70.9 (C), 111.3 (CH), 111.8 (CH), 120.2 
(CH), 135.1 (C), 147.2 (C), 148.8 (C); m/z (ESI) 261.1452 (MNa+. C14H22NaO3 
requires 261.1461).  
N-Methoxy-1′-(3-methoxyphenyl)-N-methylacetamide (158)526  
 
To a solution of 3-methoxyphenylacetic acid (128) (2.00 g, 12.0 mmol) in 
dichloromethane (100 mL) was added 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (2.31 g, 12.0 mmol), 1-
hydroxybenzotriazole hydrate (1.79 g, 13.2 mmol), N,O-dimethyhydroxylamine 
hydrochloride (1.17 g, 12.0 mmol) and N,N-diisopropylethylamine (8.60 mL, 48.2 
mmol). The mixture was stirred at room temperature for 20 h. Water (100 mL) was 
added and the mixture was extracted with dichloromethane (3 × 100 mL). The 
combined organic extracts were washed with 1 M aqueous hydrochloric acid (200 
mL) and brine (200 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 1:1) 
gave N-methoxy-1′-(3-methoxyphenyl)-N-methylacetamide (158) (1.91 g, 76%) as 
a yellow oil. Spectroscopic data were consistent with the literature.526 δH (400 MHz, 
CDCl3) 3.19 (3H, s, N-CH3), 3.60 (3H, s, OCH3), 3.74 (2H, s, 1′-H2), 3.79 (3H, s, 
OCH3), 6.79 (1H, dd, J 8.0, 2.6 Hz, 4-H), 6.83–6.92 (2H, m, 2-H and 6-H), 7.23 (1H, 
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t, J 8.0 Hz, 5-H); δC (101 MHz, CDCl3) 32.2 (CH3), 39.4 (CH2), 55.2 (CH3), 61.3 
(CH3), 112.4 (CH), 114.8 (CH), 121.7 (CH), 129.4 (CH), 136.4 (C), 159.7 (C), 172.3 
(C); m/z (ESI) 232 (MNa+. 100%). 
1′-(3-Methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (157a)291 
 
An oven-dried three-neck flask was flushed with argon and charged with magnesium 
turnings (0.0700 g, 2.30 mmol), a crystal of iodine and dry tetrahydrofuran (12 mL). 
4-Bromoanisole (0.290 mL, 2.30 mmol) was added and the solution was heated 
under reflux for 1 h. This solution was then transferred via cannula to a solution of 
N-methoxy-1′-(3-methoxyphenyl)-N-methylacetamide (158) (0.400 g, 1.91 mmol) in 
dry tetrahydrofuran (15 mL). The resulting suspension was stirred at room 
temperature for 16 h. The reaction mixture was quenched with saturated ammonium 
chloride solution (30 mL) and extracted with ethyl acetate (2 × 30 mL). The 
combined organic extracts were washed with brine (30 mL), dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 4:1 to petroleum ether/ethyl acetate, 1:1) gave 1′-(3-
methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (157a) (0.192 g, 45%) as a 
yellow oil. Spectroscopic data were consistent with the literature.291 δH (400 MHz, 
CDCl3) 3.77 (3H, s, OCH3), 3.85 (3H, s, OCH3), 4.19 (2H, s, 1′-H2), 6.78 (1H, dd, J 
8.0, 2.4 Hz, 4-H), 6.80–6.83 (1H, m, 2-H), 6.85–6.88 (1H, m, 6-H), 6.91 (2H, d, J 9.0 
Hz, 3′′-H and 5′′-H), 7.22 (1H, t, J 8.0 Hz, 5-H), 7.99 (2H, d, J 9.0 Hz, 2′′-H and 6′′-
H); δC (101 MHz, CDCl3) 45.4 (CH2), 55.2 (CH3), 55.5 (CH3), 112.3 (CH), 113.8 (2 
× CH), 115.0 (CH), 121.8 (CH), 129.6 (CH), 131.0 (2 × CH), 136.5 (2 × C), 159.8 
(C), 163.5 (C), 196.1 (C); m/z (ESI) 279 (MNa+. 100%). 
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1′-(3-Methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) 
 
An oven-dried two-neck flask was flushed with argon and charged with N-methoxy-
1′-(3-methoxyphenyl)-N-methylacetamide (158) (1.91 g, 9.12 mmol) in dry 
tetrahydrofuran (80 mL). 4-Chlorophenylmagnesium bromide (13.7 mL, 13.7 mmol; 
1.0 M in 2-methyltetrahydrofuran) was added dropwise at 0 °C and the solution was 
warmed to room temperature and stirred for 2.5 h. The reaction mixture was 
quenched with saturated aqueous ammonium chloride solution (80 mL) at 0 °C and 
extracted with diethyl ether (4 × 100 mL). The combined organic extracts were 
washed with brine (200 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 9:1) 
gave 1′-(3-methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) (2.21 g, 93%) 
as a colourless oil. νmax/cm−1 (neat) 2940 (CH), 2361, 1682 (C=O), 1589 (C=C), 
1489, 1265, 1157, 1088, 1049, 772; δH (400 MHz, CDCl3) 3.78 (3H, s, OCH3), 4.22 
(2H, s, 1′-H2), 6.78–6.85 (3H, m, 2-H, 4-H and 6-H), 7.24 (1H, t, J 7.6 Hz, 5-H), 7.42 
(2H, d, J 8.6 Hz, 3′′-H and 5′′-H), 7.94 (2H, d, J 8.6 Hz, 2′′-H and 6′′-H); δC (101 MHz, 
CDCl3) 45.6 (CH2), 55.2 (CH3), 112.5 (CH), 115.1 (CH), 121.7 (CH), 129.0 (2 × CH), 
129.8 (CH), 130.1 (2 × CH), 134.8 (C), 135.6 (C), 139.6 (C), 159.9 (C), 196.3 (C); 
m/z (ESI) 283.0500 (MNa+. C15H1335ClNaO2 requires 283.0496). 
1′-(3-Methoxyphenyl)-2′-phenylethan-2′-one (157c)527  
 
1′-(3-Methoxyphenyl)-2′-phenylethan-2′-one (157c) was synthesised as described 
for 1′-(3-methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) using N-methoxy-
1′-(3-methoxyphenyl)-N-methylacetamide (158) (0.349 g, 1.67 mmol) and 
3
4
5
6
1
2
MeO
1′
O 2′′
3′′
4′′
5′′
6′′ Cl
3
4
5
6
1
2
MeO
1′
O 2′′
3′′
4′′
5′′
6′′
 
252 
phenylmagnesium bromide (1.84 mL, 1.84 mmol; 1.0 M in tetrahydrofuran). 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 19:1) 
gave 1′-(3-methoxyphenyl)-2′-phenylethan-2′-one (157c) (0.210 g, 56%) as a 
colourless oil. Spectroscopic data were consistent with the literature.527 δH (400 
MHz, CDCl3) 3.78 (3H, s, OCH3), 4.25 (2H, s, 1′-H2), 6.78–6.83 (2H, m, 2-H and 6-
H), 6.86 (1H, br d, J 7.6 Hz, 4-H), 7.24 (1H, t, J 7.6 Hz, 5-H), 7.45 (2H, t, J 7.8 Hz, 
3′′-H and 5′′-H), 7.55 (1H, t, J 7.8 Hz, 4′′-H), 8.01 (2H, d, J 7.8 Hz, 2′′-H and 6′′-H); 
δC (101 MHz, CDCl3) 45.6 (CH2), 55.2 (CH3), 112.4 (CH), 115.1 (CH), 121.8 (CH), 
128.6 (4 × CH), 129.7 (CH), 133.2 (CH), 136.0 (C), 136.6 (C), 159.8 (C), 197.5 (C); 
m/z (ESI) 249 (MNa+. 100%). 
1′-(3-methoxyphenyl)-2′-(4′′-Methoxyphenyl)ethan-2′-ol (156a)291 
 
To a stirred solution of 1′-(3-methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one 
(157a) (0.530 g, 2.07 mmol) in methanol (15 mL) was added sodium borohydride 
(0.196 g, 5.17 mmol). The resulting suspension was stirred at room temperature for 
4 h after which time the reaction was quenched with water (15 mL) and extracted 
with dichloromethane (3 × 30 mL). The combined organic extracts were washed with 
water (2 × 60 mL), brine (60 mL), dried (MgSO4) and concentrated in vacuo to give 
1′-(3-methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-ol (156a) (0.508 g, 95%) as a 
colourless oil. Spectroscopic data were consistent with the literature.291 δH (400 
MHz, CDCl3) 1.97 (1H, br s, OH), 2.94 (1H, dd, J 13.5, 8.0 Hz, 1′-HH), 2.99 (1H, dd, 
J 13.5, 5.6 Hz, 1′-HH), 3.76 (3H, s, OCH3), 3.80 (3H, s, OCH3), 4.84 (1H, ddd, J 8.0, 
5.6, 2.7 Hz, 2′-H), 6.70–6.73 (1H, m, 2-H), 6.75–6.80 (2H, m, 4-H and 6-H), 6.87 
(2H, d, J 8.7 Hz, 3′′-H and 5′′-H), 7.21 (1H, t, J 7.9 Hz, 5-H), 7.27 (2H, d, J 8.7 Hz, 
2′′-H and 6′′-H); δC (101 MHz, CDCl3) 46.1 (CH2), 55.2 (CH3), 55.3 (CH3), 74.9 (CH), 
112.1 (CH), 113.8 (2 × CH), 115.1 (CH), 121.9 (CH), 127.2 (2 × CH), 129.5 (CH), 
136.0 (C), 139.8 (C), 159.1 (C), 159.7 (C); m/z (ESI) 281 (MNa+. 100%). 
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2′-(4′′-Chlorophenyl)-1′-(3-methoxyphenyl)ethan-2′-ol (156b) 
 
The reaction was carried out as described for 1′-(3-methoxyphenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-ol (156a) using 2′-(4′′-chlorophenyl)-1′-(3-
methoxyphenyl)ethan-2′-one (157b) (0.243 g, 0.930 mmol), except that the reaction 
mixture was stirred at room temperature for 2 h. This gave 2′-(4′′-chlorophenyl)-1′-
(3-methoxyphenyl)ethan-2′-ol (156b) (0.210 g, 86%) as a colourless oil. νmax/cm−1 
(neat) 3402 (OH), 2940 (CH), 2361, 1597 (C=C), 1489, 1258, 1157, 1088, 1049, 
833, 779; δH (400 MHz, CDCl3) 1.98 (1H, d, J 2.9 Hz, OH), 2.91 (1H, dd, J 13.7, 8.5 
Hz, 1′-HH), 2.99 (1H, dd, J 13.7, 5.0 Hz, 1′-HH), 3.78 (3H, s, OCH3), 4.88 (1H, ddd, 
J 8.5, 5.0, 2.9 Hz, 2′-H), 6.71 (1H, t, J 2.0 Hz, 2-H), 6.74–6.82 (2H, m, 4-H and 6-
H), 7.22 (1H, t, J 8.0 Hz, 5-H), 7.27 (2H, d, J 8.8 Hz, 2′′-H and 6′′-H), 7.32 (2H, d, J 
8.8 Hz, 3′′-H and 5′′-H); δC (101 MHz, CDCl3) 46.2 (CH2), 55.2 (CH3), 74.5 (CH), 
112.2 (CH), 115.1 (CH), 121.8 (CH), 127.3 (2 × CH), 128.5 (2 × CH), 129.6 (CH), 
133.2 (C), 139.1 (C), 142.2 (C), 159.8 (C); m/z (ESI) 285.0646 (MNa+. 
C15H1535ClNaO2 requires 285.0653). 
1′-(3-Methoxyphenyl)-2′-phenylethan-2′-ol (156c)528 
 
The reaction was carried out as described for 1′-(3-methoxyphenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-ol (156a) using 1′-(3-methoxyphenyl)-2′-phenylethan-2-
one (157c) (0.188 g, 0.830 mmol), except that the reaction mixture was stirred at 
room temperature for 1 h. This gave 1′-(3-methoxyphenyl)-2′-phenylethan-2′-ol 
(156c) (0.169 g, 89%) as a colourless oil. Spectroscopic data were consistent with 
the literature.528 δH (400 MHz, CDCl3) 1.97 (1H, d, J 3.0 Hz, OH), 2.96 (1H, dd, J 
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13.7, 8.4 Hz, 1′-HH), 3.03 (1H, dd, J 13.7, 5.0 Hz, 1′-HH), 3.77 (3H, s, OCH3), 4.89 
(1H, ddd, J 8.4, 5.0, 3.0 Hz, 2′-H), 6.71–6.74 (1H, m, 2-H), 6.76–6.83 (2H, m, 4-H 
and 6-H), 7.22 (1H, t, J 7.9 Hz, 5-H), 7.26–7.40 (5H, m, Ph); δC (101 MHz, CDCl3) 
46.2 (CH2), 55.2 (CH3), 75.2 (CH), 112.2 (CH), 115.1 (CH), 121.8 (CH), 125.9 (2 × 
CH), 127.6 (CH), 128.4 (2 × CH), 129.5 (CH), 139.6 (C), 143.8 (C), 159.7 (C); m/z 
(ESI) 251 (MNa+. 100%). 
2,3-Dihydro-2-(4′-methoxyphenyl)-5-methoxybenzofuran (155)291 
 
2,3-Dihydro-2-(4′-methoxyphenyl)-5-methoxybenzofuran (155) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using 1′-(3-methoxyphenyl)-2′-
(4′′-methoxyphenyl)ethan-2′-ol (156a) (0.0500 g, 0.190 mmol). The iodination step 
was carried out at 40 °C for 5 h and the O-arylation step at 130 °C for 18 h. 
Purification by flash column chromatography (hexane/dichloromethane, 1:1) gave 
2,3-dihydro-2-(4′-methoxyphenyl)-5-methoxybenzofuran (155) (0.0130 g, 29%) as a 
colourless oil. Spectroscopic data were consistent with the literature.291 δH (400 
MHz, CDCl3) 3.19 (1H, dd, J 15.7, 8.3 Hz, 3-HH), 3.55 (1H, dd, J 15.7, 9.0 Hz, 3-
HH), 3.77 (3H, s, OCH3), 3.81 (3H, s, OCH3), 5.68 (1H, dd, J 9.0, 8.3 Hz, 2-H), 6.65–
6.84 (3H, m, 4-H, 6-H and 7-H), 6.89 (2H, d, J 8.7 Hz, 3′-H and 5′-H), 7.33 (2H, d, J 
8.7 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 38.7 (CH2), 55.3 (CH3), 56.1 (CH3), 
84.2 (CH), 109.2 (CH), 111.2 (CH), 113.0 (CH), 114.0 (2 × CH), 127.3 (2 × CH), 
127.7 (C), 133.9 (C), 153.7 (C), 154.2 (C), 159.5 (C); m/z (ESI) 279 (MNa+. 100%). 
2-(4′-Chlorophenyl)-2,3-dihydro-5-methoxybenzofuran (159a)529 
 
2-(4′-Chlorophenyl)-2,3-dihydro-5-methoxybenzofuran (159a) was synthesised as 
described for 1-benzoyl-5-methoxyindoline (143a) using 2′-(4′′-chlorophenyl)-1′-(3-
methoxyphenyl)ethan-2′-ol (156b) (0.154 g, 0.590 mmol). The iodination step was 
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carried out at 40 °C for 4 h and the O-arylation step at 130 °C for 22 h. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 19:1) gave 2-(4′-
chlorophenyl)-2,3-dihydro-5-methoxybenzofuran (159a) (0.0958 g, 63%) as a white 
solid. Mp 58–60 °C (lit.529 60–61 °C); δH (400 MHz, CDCl3) 3.13 (1H, dd, J 15.7, 8.0 
Hz, 3-HH), 3.60 (1H, dd, J 15.7, 9.4 Hz, 3-HH), 3.76 (3H, s, OCH3), 5.70 (1H, dd, J 
9.4, 8.0 Hz, 1-H), 6.70 (1H, dd, J 8.7, 2.6 Hz, 6-H), 6.74–6.80 (2H, m, 4-H and 7-H), 
7.33 (4H, br s, 2′-H, 3′-H, 5′-H and 6′-H); δC (101 MHz, CDCl3) 38.9 (CH2), 56.0 
(CH3), 83.4 (CH), 109.3 (CH), 111.2 (CH), 113.1 (CH), 127.1 (2 × CH), 127.1 (C), 
128.8 (2 × CH), 133.7 (C), 140.6 (C), 153.6 (C), 154.4 (C); m/z (ESI) 283 (MNa+. 
100%). 
2,3-Dihydro-5-methoxy-2-phenylbenzofuran (159b)284 
 
2,3-Dihydro-5-methoxy-2-phenylbenzofuran (159b) was synthesised as described 
for 1-benzoyl-5-methoxyindoline (143a) using 1′-(3-methoxyphenyl)-2′-
phenylethan-2′-ol (156c) (0.0840 g, 0.370 mmol). The iodination step was carried 
out at 40 °C for 4 h and the O-arylation step at 130 °C for 22 h. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 19:1) gave 2,3-dihydro-5-
methoxy-2-phenylbenzofuran (159b) (0.0530 g, 64%) as a colourless oil. 
Spectroscopic data were consistent with the literature.284 δH (400 MHz, CDCl3) 3.18 
(1H, dd, J 15.7, 8.2 Hz, 3-HH), 3.59 (1H, dd, J 15.7, 9.4 Hz, 3-HH), 3.76 (3H, s, 
OCH3), 5.72 (1H, dd, J 9.4, 8.2 Hz, 2-H), 6.69 (1H, dd, J 8.7, 2.6 Hz, 6-H), 6.74–
6.80 (2H, m, 4-H and 7-H), 7.26–7.43 (5H, m, Ph); δC (101 MHz, CDCl3) 38.9 (CH2), 
56.1 (CH3), 84.3 (CH), 109.2 (CH), 111.2 (CH), 113.1 (CH), 125.8 (2 × CH), 127.5 
(C), 128.0 (CH), 128.7 (2 × CH), 142.1 (C), 153.8 (C), 154.3 (C); m/z (ESI) 249 
(MNa+. 100%). 
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1′-(3-Hydroxy-4-methoxyphenyl)-N-methoxy-N-methylacetamide (164) 
 
The reaction was carried out as described for N-methoxy-1′-(3-methoxyphenyl)-N-
methylacetamide (158) using 3-hydroxy-4-methoxyphenylacetic acid (163) (1.00 g, 
5.49 mmol), except that the solvent used was acetonitrile (30 mL). Purification by 
flash column chromatography (petroleum ether/ ethyl acetate, 3:7) gave 1′-(3-
hydroxy-4-methoxyphenyl)-N-methoxy-N-methylacetamide (164) (0.831 g, 68%) as 
a white solid. Mp 62–64 °C; νmax/cm−1 (neat) 3323 (OH), 2939 (CH), 1642 (C=O), 
1590, 1511, 1440, 1271, 1131, 1006, 761; δH (400 MHz, CDCl3) 3.18 (3H, s, N-CH3), 
3.61 (3H, s, N-OCH3), 3.67 (2H, s, 1′-H2), 3.85 (3H, s, OCH3), 5.85 (1H, s, OH), 
6.73–6.82 (2H, m, 5-H and 6-H), 6.87 (1H, d, J 1.3 Hz, 2-H); δC (101 MHz, CDCl3) 
32.3 (CH3), 38.7 (CH2), 56.0 (CH3), 61.3 (CH3), 110.8 (CH and C), 115.7 (CH), 120.7 
(CH), 128.1 (C), 145.6 (C), 172.7 (C); m/z (ESI) 248.0889 (MNa+. C11H15NNaO4 
requires 248.0893). 
1′-(3-tert-Butyldimethylsilyloxy-4-methoxyphenyl)-N-methoxy-N-
methylacetamide (165) 
 
To a solution of 1′-(3-hydroxy-4-methoxyphenyl)-N-methoxy-N-methylacetamide 
(164) (1.23 g, 5.46 mmol) and imidazole (0.744 g, 10.9 mmol) in dry 
dichloromethane (40 mL) was added tert-butyldimethylsilyl chloride (0.99 g, 6.56 
mmol) portionwise. 4-Dimethylaminopyridine (0.070 g, 0.55 mmol) was added and 
the resulting suspension was stirred at room temperature for 16 h. The reaction was 
quenched with water (30 mL) and the mixture was extracted with dichloromethane 
(4 × 50 mL). The combined organic extracts were washed with aqueous sodium 
hydrogen carbonate (100 mL) and brine (100 mL), dried (MgSO4) and concentrated 
in vacuo. Purification by flash column chromatography (petroleum ether/ethyl 
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acetate, 4:1) gave 1′-(3-tert-butyldimethylsilyloxy-4-methoxyphenyl)-N-methoxy-N-
methylacetamide (165) (1.87 g, 100%) as a colourless oil. νmax/cm−1 (neat) 2932 
(CH), 1663 (C=O), 1512, 1271, 1136, 988, 839; δH (400 MHz, CDCl3) 0.15 (6H, s, 
Si(CH3)2), 0.99 (9H, s, SiC(CH3)3), 3.18 (3H, s, N-CH3), 3.58 (3H, s, N-OCH3), 3.65 
(2H, s, 1′-H2), 3.78 (3H, s, OCH3), 6.78 (1H, d, J 8.2 Hz, 5-H), 6.80 (1H, d, J 2.0 Hz, 
2-H), 6.83 (1H, dd, J 8.2, 2.0 Hz, 6-H); δC (101 MHz, CDCl3) −4.6 (2 × CH3), 18.4 
(C), 25.8 (3 × CH3), 32.8 (CH3), 38.8 (CH2), 55.6 (CH3), 61.3 (CH3), 112.2 (CH), 
122.1 (CH), 122.3 (CH), 127.5 (C), 144.9 (C), 149.9 (C), 172.7 (C); m/z (ESI) 
362.1745 (MNa+. C17H29NNaO4Si requires 362.1758). 
1′-(3-tert-Butyldimethylsilyloxy-4-methoxyphenyl)-2′-phenylethan-2′-one (166) 
 
1′-(3-tert-Butyldimethylsilyloxy-4-methoxyphenyl)-2′-phenylethan-2′-one (166) was 
synthesised as described for 1′-(3-methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-
one (157b) using 1′-(3-tert-butyldimethylsilyloxy-4-methoxyphenyl)-N-methoxy-N-
methylacetamide (165) (1.71 g, 5.03 mmol) and phenylmagnesium bromide (7.54 
mL, 7.54 mmol; 1.0 M in tetrahydrofuran), except the reaction mixture was stirred 
for 5 h. Purification by flash column chromatography (petroleum ether/ethyl acetate, 
4:1) gave 1′-(3-tert-butyldimethylsilyloxy-4-methoxyphenyl)-2′-phenylethan-2′-one 
(166) (1.32 g, 74%) as a white solid. Mp 60–62 °C; νmax/cm−1 (neat) 2930 (CH), 1680 
(C=O), 1510, 1271, 1136, 984, 839; δH (500 MHz, CDCl3) 0.12 (6H, s, Si(CH3)2), 
0.97 (9H, s, SiC(CH3)3), 3.77 (3H, s, OCH3), 4.16 (2H, s, 1′-H2), 6.76 (1H, d, J 1.4 
Hz, 2H), 6.77–6.82 (2H, m, 5-H and 6-H), 7.40–7.46 (2H, m, 3′′-H and 5′′-H), 7.50–
7.55 (1H, m, 4′′-H), 7.94–8.01 (2H, m, 2′′-H and 6′′-H); δC (126 MHz, CDCl3) −4.6 (2 
× CH3), 18.4 (C), 25.7 (3 × CH3), 45.0 (CH2), 55.5 (CH3), 112.4 (CH), 122.2 (CH), 
122.5 (CH), 127.0 (C), 128.6 (2 × CH), 128.7 (2 × CH), 133.0 (CH), 136.7 (C), 145.1 
(C), 149.9 (C), 197.9 (C); m/z (ESI) 379.1686 (MNa+. C21H28NaO3Si requires 
379.1700). 
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1′-(3-tert-Butyldimethylsilyloxy-4-methoxyphenyl)-1′-methyl-2′-phenylethan-
2′-one (167) 
 
An oven dried three-neck flask was flushed with argon and charged with 1′-(3-tert-
butyldimethylsilyloxy-4-methoxyphenyl)-2′-phenylethan-2′-one (166) (1.32 g, 3.69 
mmol) in dry tetrahydrofuran (30 mL). To this solution was added lithium 
bis(trimethylsilyl)amide (4.06 mL, 4.06 mmol; 1.0 M in tetrahydrofuran) dropwise at 
–78 °C. The reaction mixture was stirred at –78 °C for 0.5 h before methyl iodide 
(0.690 mL, 11.1 mmol) was added dropwise. The resulting solution was stirred for 
1 h at –78 °C, then slowly warmed to 0 °C and stirred for a further 1 h. A saturated 
solution of ammonium chloride (30 mL) was added at 0 °C and the solution was 
extracted with diethyl ether (3 × 50 mL). The combined ethereal extracts were 
washed with brine (100 mL), dried (MgSO4) and concentrated in vacuo. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 19:1) gave 1′-(3-
tert-butyldimethylsilyloxy-4-methoxyphenyl)-1′-methyl-2′-phenylethan-2′-one (167) 
(1.19 g, 87%) as a colourless oil. νmax/cm−1 (neat) 2930 (CH), 1684 (C=O), 1506, 
1275, 1138, 970, 837; δH (400 MHz, CDCl3) 0.09 (6H, s, Si(CH3)2), 0.96 (9H, s, 
SiC(CH3)3), 1.48 (3H, d, J 6.8 Hz, 1′-CH3), 3.73 (3H, s, OCH3), 4.53 (2H, q, J 6.8 
Hz, 1′-H), 6.74 (1H, d, J 8.5 Hz, 5-H), 6.75 (1H, d, J 2.0 Hz, 2-H), 6.79 (1H, dd, J 
8.5, 2.0 Hz, 6-H), 7.32–7.39 (2H, m, 3′′-H and 5′′-H), 7.42–7.48 (1H, m, 4′′-H), 7.89–
7.94 (2H, m, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) −4.6 (2 × CH3), 18.5 (C), 19.3 
(CH3), 25.7 (3 × CH3), 47.3 (CH), 55.5 (CH3), 112.6 (CH), 120.7 (CH), 120.8 (CH), 
128.4 (2 × CH), 128.8 (2 × CH), 132.6 (CH), 134.1 (C), 136.6 (C), 145.3 (C), 149.9 
(C), 200.4 (C); m/z (ESI) 393.1848 (MNa+. C22H30NaO3Si requires 393.1856). 
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(1′R,2′R)-1′-(3-tert-Butyldimethylsilyloxy-4-methoxyphenyl)-1′-methyl-2′-
phenylethan-2′-ol (168) 
 
To an oven-dried conical flask was added potassium tert-butoxide (0.0182 g, 0.162 
mmol) and ˙dichloro[(S)-(–)-5,5′-bis[di-(3,5-xylyl)phosphino]-4,4′-bi-1,3-
benzodioxole][(2S-(+)-1,1-bis(4-methoxyphenyl)-3-methyl-1,2-
butanediamine]ruthenium(II) (0.0200 g, 0.0162 mmol). Freshly distilled 2-propanol 
(1.0 mL) was added and the resulting yellow solution was stirred at room 
temperature for 2 h under a constant stream of argon. 1′-(3-tert-
Butyldimethylsilyloxy-4-methoxyphenyl)-1′-methyl-2′-phenylethan-2′-one (167) 
(0.300 g, 0.810 mmol) in 2-propanol (2.0 mL) was added to the conical flask 
containing the catalyst solution and hydrogenated at 10 bar for 48 h. The reaction 
mixture was treated with activated carbon and stirred for 1 h. The mixture was 
filtered through Celite® and concentrated in vacuo. Purification by flash column 
chromatography (hexane/diethyl ether, 7:3) gave (1′R,2′R)-1′-(3-tert-
butyldimethylsilyloxy-4-methoxyphenyl)-1′-methyl-2′-phenylethan-2′-ol (168) (0.192 
g, 64%) as a colourless oil. νmax/cm−1 (neat) 3454 (OH), 2929 (CH), 1508, 1275, 
1139, 962, 836; [α]D23 +34.4 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.15 (6H, s, 
Si(CH3)2), 1.00 (9H, s, SiC(CH3)3), 1.03 (3H, d, J 7.2 Hz, 1′-CH3), 1.90 (1H, d, J 1.4 
Hz, OH), 2.89 (1H, dq, J 8.6, 7.2 Hz, 1′-H), 3.80 (3H, s, OCH3), 4.55 (1H, dd, J 8.6, 
1.4 Hz, 2′-H), 6.73–6.77 (1H, m, 2-H), 6.80–6.84 (2H, m, 5-H and 6-H), 7.24–7.36 
(5H, m, Ph); δC (101 MHz, CDCl3) −4.5 (2 × CH3), 18.3 (CH3), 18.5 (C), 25.8 (3 × 
CH3), 47.5 (CH), 55.6 (CH3), 79.7 (CH), 112.2 (CH), 120.6 (CH), 121.2 (CH), 127.0 
(2 × CH), 127.7 (CH), 128.2 (2 × CH), 135.6 (C), 142.5 (C), 145.2 (C), 149.9 (C); 
m/z (ESI) 395.2023 (MNa+. C22H32NaO3Si requires 395.2013). Enantiomeric 
excess was determined by HPLC analysis, using a chiralpak AD-H column 
(hexane:i-propanol 98:2, flow rate 1.0 mL min−1); tminor = 10.65 min, tmajor = 14.55 
min, er = 2.5:97.5. 
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(2R,3R)-5-(tert-Butyldimethylsilyloxy)-2,3-dihydro-6-methoxy-3-methyl-2-
phenylbenzofuran (169) 
 
(2R,3R)-5-(tert-Butyldimethylsilyloxy)-2,3-dihydro-6-methoxy-3-methyl-2-
phenylbenzofuran (169) was synthesised as described for 1-benzoyl-5-
methoxyindoline (143a) using (1′R,2′R)-1′-(3-tert-butyldimethylsilyloxy-4-
methoxyphenyl)-1′-methyl-2′-phenylethan-2′-ol (168) (0.0600 g, 0.160 mmol). The 
iodination step was carried out at 50 °C for 7 h and the O-arylation step at 130 °C 
for 22 h. Purification by flash column chromatography (hexane/dichloromethane, 
3:2) gave (2R,3R)-5-(tert-butyldimethylsilyloxy)-2,3-dihydro-6-methoxy-3-methyl-2-
phenylbenzofuran (169) (0.0378 g, 63%) as a colourless oil. νmax/cm−1 (neat) 2929 
(CH), 1493, 1449, 1215, 1188, 1169, 904, 837; [α]D20 +23.0 (c 1.0, CHCl3); δH (400 
MHz, CDCl3) 0.14 (3H, s, Si(CH3)), 0.14 (3H, s, Si(CH3)), 1.00 (9H, s, SiC(CH3)3), 
1.37 (3H, d, J 6.7 Hz, 3-CH3), 3.36 (1H, dq, J 8.9, 6.7 Hz, 3-H), 3.77 (3H, s, OCH3), 
5.11 (1H, d, J 8.9, 2-H), 6.46 (1H, s, 7-H), 6.61 (1H, s, 4-H), 7.27–7.45 (5H, m, Ph); 
δC (101 MHz, CDCl3) −4.7 (CH3), −4.6 (CH3), 18.4 (CH3), 18.5 (C), 25.8 (3 × CH3), 
45.6 (CH), 55.7 (CH3), 92.9 (CH), 95.0 (CH), 115.7 (CH), 122.4 (C), 126.1 (2 × CH), 
128.1 (CH), 128.6 (2 × CH), 139.0 (C), 141.1 (C), 150.8 (C), 153.6 (C); m/z (EI) 
370.1955 (M+. C22H30O3Si requires 370.1964), 313 (48%), 298 (100), 91 (36), 73 
(40). 
(2R,3R)-2,3-Dihydro-5-hydroxyl-6-methoxy-3-methyl-2-phenylbenzofuran, (+)-
obtusafuran (118)299 
 
To a stirred solution of (2R,3R)-5-(tert-butyldimethylsilyloxy)-2,3-dihydro-6-
methoxy-3-methyl-2-phenylbenzofuran (169) (0.0380 g, 0.100 mmol) in dry 
tetrahydrofuran (10 mL) was added tetrabutylammonium fluoride solution (0.150 
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mL, 0.150 mmol; 1.0 M in tetrahydrofuran) at 0 °C. The resulting solution was stirred 
at room temperature for 2 h. The reaction mixture was diluted with diethyl ether (10 
mL), washed with water (2 × 10 mL), dried (MgSO4) and concentrated in vacuo. 
Purification by flash column chromatography (hexane/diethyl ether, 7:3) gave 
(2R,3R)-2,3-dihydro-5-hydroxyl-6-methoxy-3-methyl-2-phenylbenzofuran (118) 
(0.0230 g, 88%) as a white solid. Mp 108–110 °C (lit.299 Mp 111–113 °C); [α]D23 
+48.2 (c 0.5, MeOH), lit.299 [α]D25 +50.0 (c 0.33, MeOH); δH (400 MHz, CDCl3) 1.37 
(3H, d, J 6.9 Hz, 3-CH3), 3.38 (1H, dq, J 8.6, 6.9 Hz, 3-H), 3.87 (3H, s, OCH3), 5.11 
(1H, d, J 8.6 Hz, 2-H), 5.24 (1H, s, OH), 6.50 (1H, s, 7-H), 6.72 (1H, s, 4-H), 7.29–
7.44 (5H, m, Ph); δC (101 MHz, CDCl3) 18.4 (CH3), 45.7 (CH), 56.2 (CH3), 92.8 (CH), 
94.2 (CH), 109.5 (CH), 122.9 (C), 126.0 (2 × CH), 128.1 (CH), 128.6 (2 × CH), 139.9 
(C), 141.0 (C), 146.2 (C), 152.4 (C); m/z (EI) 256 (M+. 100%), 239 (11), 165 (12), 91 
(10). 
N-Methoxy-1′-(3-methylphenyl)-N-methylacetamide (179)530 
 
N-Methoxy-1′-(3-methylphenyl)-N-methylacetamide (179) was synthesised as 
described for N-methoxy-1′-(3-methylphenyl)-N-methylacetamide (158) using 3-
methylphenylacetic acid (0.500 g, 3.33 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave N-methoxy-1′-(3-
methylphenyl)-N-methylacetamide (179) (0.411 g, 64%) as a colourless oil. 
Spectroscopic data were consistent with the literature.530 δH (500 MHz, CDCl3) 2.32 
(3H, s, 3-CH3), 3.17 (3H, s, N-CH3), 3.58 (3H, s, OCH3), 3.72 (2H, s, 1′-H2), 7.04 
(1H, d, J 7.6 Hz, 4-H), 7.07 (1H, d, J 7.6 Hz, 6-H), 7.11 (1H, br s, 2-H), 7.19 (1H, t, 
J 7.6 Hz, 5-H); δC (126 MHz, CDCl3) 21.4 (CH3), 32.2 (CH3), 39.3 (CH2), 61.2 (CH3), 
126.3 (CH), 127.5 (CH), 128.3 (CH), 130.0 (CH), 134.8 (C), 138.0 (C), 172.5 (C); 
m/z (ESI) 216 (MNa+. 100%). 
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1′-(3-Methoxyphenyl)-2′-(4′′-methylphenyl)ethan-2′-one (180a)531 
 
1′-(3-Methoxyphenyl)-2′-(4′′-methylphenyl)ethan-2′-one (180a) was synthesised as 
described for 1′-(3-methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) using 
N-methoxy-1′-(3-methoxyphenyl)-N-methylacetamide (158) (0.0950 g, 0.450 mmol) 
and 4-methylphenylmagnesium bromide (2.70 mL, 1.35 mmol; 0.5 M in diethyl 
ether). Purification by flash column chromatography (hexane/diethyl ether, 4:1) gave 
1′-(3-methoxyphenyl)-2′-(4′′-methylphenyl)ethan-2′-one (180a) (0.0760 g, 70%) as a 
colourless oil. Spectroscopic data were consistent with the literature.531 δH (500 
MHz, CDCl3) 2.39 (3H, s, 4′′-CH3), 3.77 (3H, s, OCH3), 4.22 (2H, s, 1′-H2), 6.78 (1H, 
dd, J 7.9, 2.5 Hz, 6-H), 6.81 (1H, br s, 2-H), 6.85 (1H, br d, J 7.9 Hz, 4-H), 7.22 (1H, 
t, J 7.9 Hz, 5-H), 7.24 (2H, d, J 8.3 Hz, 3′′-H and 5′′-H), 7.90 (2H, d, J 8.3 Hz, 2′′-H 
and 6′′-H); δC (126 MHz, CDCl3) 21.7 (CH3), 45.5 (CH2), 55.2 (CH3), 112.4 (CH), 
115.1 (CH), 121.8 (CH), 128.8 (2 × CH), 129.3 (2 × CH), 129.6 (CH), 134.1 (C), 
136.3 (C), 144.0 (C), 159.8 (C), 197.2 (C); m/z (ESI) 263 (MNa+. 100%). 
1′-(3-Methylphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (180b) 
 
1′-(3-Methylphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (180b) was synthesised as 
described for 1′-(3-methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) using 
N-methoxy-1′-(3-methylphenyl)-N-methylacetamide (179) (0.294 g, 1.52 mmol) and 
4-chlorophenylmagnesium bromide (1.83 mL, 1.83 mmol; 1.0 M in 2-
methyltetrahydrofuran). Purification by flash column chromatography 
(hexane/diethyl ether, 9:1) gave 1′-(3-methylphenyl)-2′-(4′′-chlorophenyl)ethan-2′-
one (180b) (0.173 g, 47%) as a colourless oil. νmax/cm−1 (neat) 2920 (CH), 1678 
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(C=O), 1587, 1398, 1271, 1206, 1090, 1011, 988, 762; δH (500 MHz, CDCl3) 2.32 
(3H, s, 3-CH3), 4.20 (2H, s, 1′-H2), 7.02–7.08 (3H, m, 2-H, 4-H and 6-H), 7.21 (1H, 
t, J 7.6 Hz, 5-H), 7.41 (2H, d, J 8.6 Hz, 3′′-H and 5′′-H), 7.93 (2H, d, J 8.6 Hz, 2′′-H 
and 6′′-H); δC (126 MHz, CDCl3) 21.4 (CH3), 45.5 (CH2), 126.4 (CH), 127.8 (CH), 
128.6 (CH), 128.9 (2 × CH), 130.1 (3 × CH), 134.1 (C), 134.9 (C), 138.4 (C), 139.6 
(C), 196.5 (C); m/z (ESI) 267.0542 (MNa+. C15H1335ClNaO requires 267.0547). 
1′-(3-Methoxyphenyl)propan-2′-one (180c)532 
 
1′-(3-Methoxyphenyl)propan-2′-one (180c) was synthesised as described for 1′-(3-
methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) using N-methoxy-1′-(3-
methoxyphenyl)-N-methylacetamide (158) (0.300 g, 1.43 mmol) and 
methylmagnesium bromide (2.15 mL, 2.15 mmol; 1.0 M in dibutyl ether). Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 4:1) gave 1′-(3-
methoxyphenyl)propan-2′-one (180c) (0.200 g, 85%) as a yellow oil. Spectroscopic 
data were consistent with the literature.532 δH (400 MHz, CDCl3) 2.15 (3H, s, 3′-H3), 
3.66 (2H, s, 1′-H2), 3.80 (3H, s, OCH3), 6.74 (1H, t, J 2.0 Hz, 2-H), 6.77–6.84 (2H, 
m, 4-H and 6-H), 7.25 (1H, t, J 7.9 Hz, 5-H); δC (101 MHz, CDCl3) 29.2 (CH3), 51.1 
(CH2), 55.2 (CH3), 112.6 (CH), 115.1 (CH), 121.8 (CH), 129.8 (CH), 135.7 (C), 159.9 
(C), 206.3 (C); m/z (ESI) 187 (MNa+. 100%). 
1′-(3-Methoxyphenyl)-2′-(3′′-chlorophenyl)ethan-2′-one (181a) 
 
An oven-dried two-neck flask was flushed with argon and charged with 3-
methoxyphenylacetic acid (128) (0.300 g, 1.81 mmol), methyl 3-chlorobenzoate 
(0.252 mL, 1.81 mmol) and anhydrous N,N-dimethylformamide (6 mL). The solution 
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was cooled to –10 °C and lithium bis(trimethylsilyl)amide (7.22 mL, 7.22 mmol; 1.0 
M in tetrahydrofuran) was added dropwise. The resulting reaction mixture was 
stirred at –10 °C for 3 h. A saturated aqueous solution of ammonium chloride (10 
mL) was added and the solution was extracted with ethyl acetate (3 × 20 mL). The 
combined organic extracts were washed with water (4 × 100 mL), brine (100 mL), 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (hexane/diethyl ether, 9:1) gave 1′-(3-methoxyphenyl)-2′-(3′′-
chlorophenyl)ethan-2′-one (181a) (0.278 g, 59%) as a colourless oil. νmax/cm−1 
(neat) 2938 (CH), 1682 (C=O), 1584, 1491, 1258, 1204, 1152, 1042, 781, 758, 709, 
691, 679; δH (400 MHz, CDCl3) 3.76 (3H, s, OCH3), 4.20 (2H, s, 1′-H2), 6.77–6.85 
(3H, m, 2-H, 4-H and 6-H), 7.20–7.26 (1H, m, 5-H), 7.36 (1H, t, J 7.9 Hz, 5′′-H), 7.48 
(1H, ddd, J 7.9, 2.0, 1.2 Hz, 4′′-H), 7.85 (1H, dt, J 7.9, 1.2 Hz, 6′′-H), 7.96 (1H, br t, 
J 2.0 Hz, 2′′-H); δC (101 MHz, CDCl3) 45.6 (CH2), 55.1 (CH3), 112.5 (CH), 115.1 
(CH), 121.7 (CH), 126.7 (CH), 128.6 (CH), 129.7 (CH), 130.0 (CH), 133.1 (CH), 
134.9 (C), 135.4 (C), 138.1 (C), 159.8 (C), 196.1 (C); m/z (ESI) 283.0490 (MNa+. 
C15H1335ClNaO2 requires 283.0496). 
1′-(3-Methoxyphenyl)-2′-(2′′-chlorophenyl)ethan-2′-one (181b) 
 
1′-(3-Methoxyphenyl)-2′-(2′′-chlorophenyl)ethan-2′-one (181b) was synthesised as 
described for 1′-(3-methoxyphenyl)-2′-(3′′-chlorophenyl)ethan-2′-one (181a) using 
3-methoxyphenylacetic acid (128) (0.100 g, 0.600 mmol) and methyl 2-
chlorobenzoate (0.102 g, 0.600 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 9:1) gave 1′-(3-methoxyphenyl)-2′-(2′′-
chlorophenyl)ethan-2′-one (181b) (0.0620 g, 40%) as a colourless oil. νmax/cm−1 
(neat) 2941 (CH), 1697 (C=O), 1585, 1491, 1433, 1258, 1152, 1060, 772, 756; δH 
(500 MHz, CDCl3) 3.77 (3H, s, OCH3), 4.22 (2H, s, 1′-H2), 6.76–6.83 (3H, m, 2-H, 
4-H and 6-H), 7.21 (1H, t, J 7.8 Hz, 5-H), 7.26 (1H, td, J 7.5, 1.3 Hz, 5′′-H), 7.33–
7.42 (3H, m, 3′′-H, 4′′-H and 6′′-H); δC (126 MHz, CDCl3) 49.6 (CH2), 55.2 (CH3), 
112.7 (CH), 115.2 (CH), 122.0 (CH), 126.9 (CH), 129.1 (CH), 129.6 (CH), 130.4 
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(CH), 130.8 (C), 131.6 (CH), 135.0 (C), 139.2 (C), 159.7 (C), 200.8 (C); m/z (ESI) 
283.0501 (MNa+. C15H1335ClNaO2 requires 283.0496). 
1′-(3-Methoxyphenyl)-2′-(4′′-fluorophenyl)ethan-2′-one (181c)533 
 
1′-(3-Methoxyphenyl)-2′-(4′′-fluorophenyl)ethan-2′-one (181c) was synthesised as 
described for 1′-(3-methoxyphenyl)-2′-(3′′-chlorophenyl)ethan-2′-one (181a) using 
3-methoxyphenylacetic acid (128) (0.500 g, 3.01 mmol) and methyl 4-
fluorobenzoate (0.464 g, 3.01 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 9:1) gave 1′-(3-methoxyphenyl)-2′-(4′′-
fluorophenyl)ethan-2′-one (181c) (0.540 g, 73%) as a colourless oil. Spectroscopic 
data were consistent with the literature.533 δH (400 MHz, CDCl3) 3.76 (3H, s, OCH3), 
4.20 (2H, s, 1′-H2), 6.76–6.86 (3H, m, 2-H, 4-H and 6-H), 7.09 (2H, t, J 8.7 Hz, 3′′-H 
and 5′′-H), 7.22 (1H, td, J 7.6, 0.9 Hz, 5-H), 8.01 (2H, dd, J 8.7, 5.5 Hz, 2′′-H and 6′′-
H); δC (101 MHz, CDCl3) 45.6 (CH2), 55.2 (CH3), 112.4 (CH), 115.1 (CH), 115.1 (2 
× CH, d, 2JCF 21.8 Hz), 121.7 (CH), 129.8 (CH), 131.3 (2 × CH, d, 3JCF 9.2 Hz), 133.0 
(C, d, 4JCF 3.0 Hz), 135.9 (C), 159.9 (C), 165.8 (C, d, 1JCF 255.7 Hz), 195.9 (C); m/z 
(ESI) 267 (MNa+. 100%). 
1′-(3-Methoxyphenyl)-2′-(4′′-trifluoromethylphenyl)ethan-2′-one (181d) 
 
1′-(3-Methoxyphenyl)-2′-(4′′-trifluoromethylphenyl)ethan-2′-one (181d) was 
synthesised as described for 1′-(3-methoxyphenyl)-2′-(3′′-chlorophenyl)ethan-2′-
one (181a) using 3-methoxyphenylacetic acid (128) (0.300 g, 1.81 mmol) and 
methyl 4-trifluoromethylbenzoate (0.291 mL, 1.81 mmol). Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 9:1) gave 1′-(3-
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methoxyphenyl)-2′-(4′′-trifluoromethylphenyl)ethan-2′-one (181d) (0.266 g, 50%) as 
a white solid. Mp 32–34 °C; νmax/cm−1 (neat) 2941 (CH), 1688 (C=O), 1585, 1491, 
1410, 1321, 1263, 1165, 1125, 1109, 1065, 1015, 1001, 993, 766; δH (400 MHz, 
CDCl3) 3.78 (3H, s, OCH3), 4.27 (2H, s, 1′-H2), 6.78–6.86 (3H, m, 2-H, 4-H and 6-
H), 7.24 (1H, dd, J 9.0, 7.5 Hz, 5-H), 7.70 (2H, d, J 7.9 Hz, 3′′-H and 5′′-H), 8.09 (2H, 
d, J 7.9 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 45.9 (CH2), 55.2 (CH3), 112.5 
(CH), 115.2 (CH), 121.7 (CH), 123.6 (C, q, 1JCF 274.6 Hz), 125.7 (2 × CH, q, 3JCF 
3.8 Hz), 129.0 (2 × CH), 129.9 (CH), 134.4 (C, q, 2JCF 32.8 Hz), 135.3 (C), 139.2 
(C), 159.9 (C), 196.5 (C); m/z (ESI) 317.0747 (MNa+. C16H13F3NaO2 requires 
317.0760). 
1′-(3-Methoxyphenyl)-2′-(4′′-cyanophenyl)ethan-2′-one (181e) 
 
1′-(3-Methoxyphenyl)-2′-(4′′-cyanophenyl)ethan-2′-one (181e) was synthesised as 
described for 1′-(3-methoxyphenyl)-2′-(3′′-chlorophenyl)ethan-2′-one (181a) using 
3-methoxyphenylacetic acid (128) (0.300 g, 1.81 mmol) and methyl 4-
cyanobenzoate (0.292 g, 1.81 mmol). Purification by flash column chromatography 
(dichloromethane) gave 1′-(3-methoxyphenyl)-2′-(4′′-cyanophenyl)ethan-2′-one 
(181e) (0.274 g, 60%) as a white solid. Mp 96–98 °C; νmax/cm−1 (neat) 2968 (CH), 
2224 (CN), 1699 (C=O), 1584, 1489, 1329, 1261, 1209, 1157, 1047, 887, 833, 764; 
δH (400 MHz, CDCl3) 3.78 (3H, s, OCH3), 4.26 (2H, s, 1′-H2), 6.76–6.84 (3H, m, 2-
H, 4-H and 6-H), 7.25 (1H, t, J 7.8 Hz, 5-H), 7.74 (2H, d, J 8.2 Hz, 3′′-H and 5′′-H), 
8.07 (2H, d, J 8.2 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 45.9 (CH2), 55.2 (CH3), 
112.6 (CH), 115.2 (CH), 116.4 (C), 117.9 (C), 121.6 (CH), 129.0 (2 × CH), 129.9 
(CH), 132.5 (2 × CH), 134.9 (C), 139.5 (C), 160.0 (C), 196.1 (C); m/z (ESI) 274.0840 
(MNa+. C16H13NNaO2 requires 274.0838). 
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1′-(3-Methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (157a)291  
 
3-Methoxyphenylacetic acid (128) (1.00 g, 6.02 mmol) was dissolved in thionyl 
chloride (5.20 mL, 72.2 mmol) and heated under reflux for 1 h. After cooling to room 
temperature, the excess thionyl chloride was removed in vacuo. The crude residue 
was dissolved in dry dichloromethane (25 mL) and anisole (0.650 mL, 6.02 mmol) 
was added. The solution was cooled to −5 °C and aluminium trichloride (0.803 g, 
6.02 mmol) was slowly added. The reaction mixture was stirred at −5 °C for 0.5 h, 
warmed to room temperature and stirred for 1.5 h. After this time, the reaction 
mixture was quenched by the slow addition of ice-cold water (20 mL) and the 
aqueous layer was extracted with dichloromethane (4 × 50 mL). The combined 
organic extracts were washed with 1 M aqueous hydrochloric acid (100 mL), brine 
(100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 4:1) gave 1′-(3-
methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (157a) (1.24 g, 80%) as a 
yellow oil. Characterisation data previously reported for 1′-(3-methoxyphenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (157a). 
1′-(3-Methoxyphenyl)-2′-(2′′,4′′,6′′-trimethylphenyl)ethan-2′-one (184a) 
 
3-Methoxyphenylacetic acid (128) (0.500 g, 3.01 mmol) was dissolved in thionyl 
chloride (2.60 mL, 36.3 mmol) and heated under reflux for 1 h. After cooling to room 
temperature, the excess thionyl chloride was removed in vacuo. The crude residue 
was dissolved in dry dichloromethane (20 mL) and mesitylene (0.505 mL, 3.61 
mmol) was added. The solution was cooled to −5 °C and aluminium trichloride 
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(0.482 g, 3.61 mmol) was slowly added. The reaction mixture was stirred at −5 °C 
for 0.5 h, warmed to room temperature and stirred for 1.5 h. After this time, the 
reaction mixture was quenched by the slow addition of ice-cold water (20 mL) and 
the aqueous layer was extracted with dichloromethane (4 × 30 mL). The combined 
organic extracts were washed with 1 M aqueous hydrochloric acid (100 mL), brine 
(100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (hexane/diethyl ether, 19:1) gave 1′-(3-methoxyphenyl)-2′-
(2′′,4′′,6′′-trimethylphenyl)ethan-2′-one (184a) (0.220 g, 27%) as a colourless oil. 
νmax/cm−1 (neat) 2922 (CH), 1695 (C=O), 1599, 1489, 1258, 1150, 770; δH (400 
MHz, CDCl3) 2.13 (6H, s, 2′′-CH3 and 6′′-CH3), 2.28 (3H, s, 4′′-CH3), 3.77 (3H, s, 
OCH3), 3.96 (2H, s, 1’-H2), 6.74–6.76 (1H, m, 2-H), 6.77–6.84 (4H, m, 4-H, 6-H, 3′′-
H and 5′′-H), 7.22 (1H, t, J 7.9 Hz, 5-H); δC (101 MHz, CDCl3) 19.2 (2 × CH3), 21.1 
(CH3), 51.8 (CH2), 55.2 (CH3), 112.6 (CH), 115.5 (CH), 122.3 (CH), 128.5 (2 × CH), 
129.5 (CH), 132.8 (2 × C), 134.7 (C), 138.5 (C), 139.1 (C), 159.7 (C), 207.4 (C); m/z 
(ESI) 291.1344 (MNa+. C18H20NaO2 requires 291.1356). 
1′-(3,4-Dimethoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184b)534  
 
1′-(3,4-Dimethoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184b) was 
synthesised as described for 1′-(3-methoxyphenyl)-2′-(2′′,4′′,6′′-
trimethylphenyl)ethan-2′-one (184a) using 3,4-dimethoxyphenylacetic acid (200) 
(0.500 g, 2.55 mmol) and anisole (0.280 mL, 2.55 mmol). The crude residue was 
filtered through a short pad of silica eluting with ethyl acetate to give a brown solid. 
Purification by recrystallisation from hexane gave 1′-(3,4-dimethoxyphenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (184b) (0.425 g, 58%) as a yellow solid. Spectroscopic 
data were consistent with the literature.534 Mp 135–137 °C (from hexane); δH (400 
MHz, CDCl3) 3.84–3.86 (9H, m, 3 × OCH3), 4.17 (2H, s, 1′-H2), 6.78–6.82 (3H, m, 
2-H, 5-H and 6-H), 6.93 (2H, d, J 9.0 Hz, 3′′-H and 5′′-H), 7.99 (2H, d, J 9.0 Hz, 2′′-
H and 6′′-H); δC (101 MHz, CDCl3) 44.9 (CH2), 55.5 (CH3), 55.9 (CH3), 55.9 (CH3), 
111.4 (CH), 112.6 (CH), 113.8 (2 × CH), 121.5 (CH), 127.5 (C), 129.7 (C), 130.9 (2 
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× CH), 148.0 (C), 149.1 (C), 163.5 (C), 196.4 (C); m/z (ESI) 309 (MNa+. 100%). 
1′-(3,4-Methylenedioxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184c)527 
 
1′-(3,4-Methylenedioxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184c) was 
synthesised as described for 1′-(3-methoxyphenyl)-2′-(2′′,4′′,6′′-
trimethylphenyl)ethan-2′-one (184a) using 3,4-methylenedioxyphenylacetic acid 
(130a) (0.500 g, 2.78 mmol) and anisole (0.360 mL, 3.34 mmol). Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 4:1) gave 1′-(3,4-
methylenedioxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184c) (0.247 g, 33%) 
as a white solid. Mp 96–98 °C (lit.527 100–102 °C); δH (500 MHz, CDCl3) 3.86 (3H, 
s, OCH3), 4.13 (2H, 1′-CH2), 5.92 (2H, s, OCH2O), 6.70 (1H, dd, J 8.0, 1.8 Hz, 6-H), 
6.73–6.77 (2H, m, 2-H and 5-H), 6.92 (2H, d, J 9.0 Hz, 3′′-H and 5′′-H), 7.98 (2H, d, 
J 9.0 Hz, 2′′-H and 6′′-H); δC (126 MHz, CDCl3) 44.8 (CH2), 55.5 (CH3), 101.0 (CH2), 
108.4 (CH), 109.8 (CH), 113.8 (2 × CH), 122.4 (CH), 128.5 (C), 129.6 (C), 130.9 (2 
× CH), 146.5 (C), 147.8 (C), 163.5 (C), 196.2 (C); m/z (ESI) 293 (MNa+. 100%). 
1′-(3-Nitrophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184d)535 
 
1′-(3-Nitrophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184d) was synthesised as 
described for 1′-(3-methoxyphenyl)-2′-(2′′,4′′,6′′-trimethylphenyl)ethan-2′-one (184a) 
using 3-nitrophenylacetic acid (0.500 g, 2.76 mmol) and anisole (0.330 mL, 3.04 
mmol). The reaction mixture was stirred at –5 °C for 0.5 h, warmed to room 
temperature and stirred for 3 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 7:3) gave 1′-(3-nitrophenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (184d) (0.544 g, 73%) as a white solid. Spectroscopic 
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data were consistent with the literature.535 Mp 66–68 °C; δH (400 MHz, CDCl3) 3.88 
(3H, s, OCH3), 4.36 (2H, s, 1′-H2), 6.96 (2H, d, J 9.0 Hz, 3′′-H and 5′′-H), 7.50 (1H, 
td, J 7.6, 1.0 Hz, 5-H), 7.60 (1H, br d, J 7.6 Hz, 6-H), 8.00 (2H, d, J 9.0 Hz, 2′′-H and 
6′′-H), 8.09–8.15 (2H, m, 2-H and 4-H); δC (101 MHz, CDCl3) 44.3 (CH2), 55.6 (CH3), 
114.0 (2 × CH), 122.0 (CH), 124.7 (CH), 129.2 (C), 129.3 (CH), 130.8 (2 × CH), 
136.0 (CH), 136.8 (C), 148.3 (C), 164.0 (C), 194.6 (C); m/z (ESI) 294 (MNa+. 100%). 
1′-(3-Aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (185) 
 
To a stirred solution of 1′-(3-nitrophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184d) 
(0.777 g, 2.86 mmol) in ethanol (40 mL) was added tin dichloride dihydrate (3.23 g, 
14.2 mmol) and the resulting mixture was stirred under reflux for 16 h. After cooling 
to room temperature, sodium bicarbonate (40 mL) was added and the suspension 
was stirred for 0.1 h. The suspension was diluted with ethyl acetate (60 mL), filtered 
through Celite® and concentrated in vacuo. The crude residue was dissolved in ethyl 
acetate (50 mL) and washed with water (50 mL) and brine (50 mL). The organic 
phase was dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (dichloromethane/diethyl ether 19:1) gave 1′-(3-
aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (185) (0.596 g, 86%) as a beige 
solid. Mp 112–114 °C; νmax/cm−1 (neat) 3350 (NH), 2950 (CH), 1667 (C=O), 1601, 
1258, 1217, 995, 837, 766; δH (500 MHz, CDCl3) 3.62 (2H, br s, NH2), 3.85 (3H, s, 
OCH3), 4.12 (2H, s, 1′-H2), 6.55 (1H, br dd, J 7.8, 2.0 Hz, 4-H), 6.59 (1H, br t, J 2.0 
Hz, 2-H), 6.66 (1H, br d, J 7.8 Hz, 6-H), 6.91 (2H, d, J 8.9 Hz, 3′′-H and 5′′-H), 7.09 
(1H, t, J 7.8 Hz, 5-H), 7.98 (2H, d, J 8.9 Hz, 2′′-H and 6′′-H); δC (126 MHz, CDCl3) 
45.4 (CH2), 55.5 (CH3), 113.7 (CH), 113.8 (2 × CH), 115.9 (CH), 119.6 (CH), 129.6 
(CH), 129.7 (C), 131.0 (2 × CH), 136.2 (C), 146.7 (C), 163.5 (C), 196.4 (C); m/z 
(ESI) 264.0985 (MNa+. C15H15NNaO2 requires 264.0995). 
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1′-(3-Benzyloxycarbonylaminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one 
(186a) 
 
To a stirred solution of 1′-(3-aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (185) 
(0.0500 g, 0.210 mmol) in tetrahydrofuran (10 mL) was added sodium bicarbonate 
(0.0350 g, 0.420 mmol). The resulting suspension was cooled to 0 °C and benzyl 
chloroformate (0.0360 mL, 0.250 mmol) was slowly added. The reaction mixture 
was warmed to room temperature and stirred for 20 h. The solvent was removed in 
vacuo and the residue was dissolved in ethyl acetate (50 mL). The organic layer 
was washed with water (50 mL), brine (50 mL), dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave 1′-(3-benzyloxycarbonylaminophenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (186a) (0.0700 g, 90%) as a yellow oil. νmax/cm−1 (neat) 
3323 (NH), 2936 (CH), 1730 (C=O), 1668 (C=O), 1595, 1493, 1443, 1258, 1211, 
1167, 1061, 1028, 764, 696; δH (400 MHz, CDCl3) 3.85 (3H, s, OCH3), 4.19 (2H, s, 
1′-H2), 5.17 (2H, s, CH2O), 6.74 (1H, br s, NH), 6.91 (2H, d, J 9.0 Hz, 3′′-H and 5′′-
H), 6.95 (1H, br d, J 7.6 Hz, 6-H), 7.23 (1H, t, J 7.6 Hz, 5-H), 7.26–7.41 (7H, m, 2-
H, 4-H and Ph), 7.97 (2H, d, J 9.0 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 45.2 
(CH2), 55.5 (CH3), 67.0 (CH2), 113.8 (2 × CH), 117.2 (CH), 119.6 (CH), 124.5 (CH), 
128.2 (2 × CH), 128.3 (CH), 128.6 (2 × CH), 129.3 (CH), 129.5 (C), 130.9 (2 × CH), 
136.0 (C), 136.1 (C), 138.1 (C), 153.3 (C), 163.6 (C), 196.0 (C); m/z (ESI) 398.1353 
(MNa+. C23H21NNaO4 requires 398.1363). 
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1′-(3-N-[tert-Butyloxycarbonyl]aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-
one (186b) 
 
To a stirred solution of 1′-(3-aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (185) 
(0.0500 g, 0.210 mmol) in tetrahydrofuran (10 mL) was added sodium bicarbonate 
(0.0350 g, 0.420 mmol). The resulting suspension was cooled to 0 °C and di-tert-
butyl dicarbonate (0.0570 mL, 0.250 mmol) was slowly added. The reaction mixture 
was warmed to room temperature then stirred under reflux for 96 h. After cooling to 
room temperature, the solvent was removed in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave 1′-(3-N-[tert-
butyloxycarbonyl]aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (186b) (0.0570 
g, 81%) as a yellow oil. νmax/cm−1 (neat) 3333 (NH), 2976 (CH), 1724 (C=O), 1672 
(C=O), 1599, 1539, 1315, 1260, 1236, 1159; δH (500 MHz, CDCl3) 1.50 (9H, s, 
C(CH3)3), 3.86 (3H, s, OCH3), 4.19 (2H, s, 1′-H2), 6.48 (1H, br s, NH), 6.88–6.96 
(3H, m, 6-H, 3′′-H and 5′′-H), 7.19–7.33 (3H, m, 2-H, 4-H and 5-H), 7.98 (2H, d, J 
8.9 Hz, 2′′-H and 6′′-H); δC (126 MHz, CDCl3) 28.3 (3 × CH3), 45.2 (CH2), 55.5 (CH3), 
80.5 (C), 113.8 (2 × CH), 117.0 (CH), 119.4 (CH), 124.0 (CH), 129.2 (CH), 129.6 
(C), 131.0 (2 × CH), 135.9 (C), 138.7 (C), 152.7 (C), 163.5 (C), 196.1 (C); m/z (ESI) 
364.1513 (MNa+. C20H23NNaO4 requires 364.1519). 
1′-(3-Acetamidophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (186c) 
 
To a stirred solution of 1′-(3-aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (185) 
(0.150 g, 0.622 mmol) in dichloromethane (20 mL) was added acetic anhydride 
(0.0880 mL, 0.932 mmol) and the resulting solution was stirred at room temperature 
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for 2 h. The reaction mixture was diluted with dichloromethane (20 mL) then washed 
with 1 M aqueous sodium carbonate (30 mL), brine (30 mL), dried (MgSO4), filtered 
and concentrated in vacuo. Purification by flash column chromatography (ethyl 
acetate/ petroleum ether, 3:2) gave 1′-(3-acetamidophenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (186c) (0.142 g, 81%) as a colourless oil. νmax/cm−1 
(neat) 3321 (NH), 2936, 1667 (C=O), 1597, 1553, 1317, 1260, 1171; δH (400 MHz, 
CDCl3) 2.11 (3H, s, NHCOCH3), 3.86 (3H, s, OCH3), 4.21 (2H, s, 1′-H2), 6.94 (2H, 
d, J 8.9 Hz, 3′′-H and 5′′-H), 6.99 (1H, br d, J 7.8 Hz, 4-H), 7.24 (1H, t, J 7.8 Hz, 5-
H), 7.33–7.43 (3H, m, 2-H, 6-H and NH), 7.99 (2H, d, J 8.9 Hz, 2′′-H and 6′′-H); δC 
(126 MHz, CDCl3) 24.6 (CH3), 45.1 (CH2), 55.5 (CH3), 113.9 (2 × CH), 118.4 (CH), 
120.8 (CH), 125.3 (CH), 129.2 (CH), 129.5 (C), 130.9 (2 × CH), 135.7 (C), 138.3 
(C), 163.7 (C), 168.3 (C), 196.3 (C); m/z (ESI) 306.1093 (MNa+. C17H17NNaO3 
requires 306.1101). 
3,4-Dimethoxyphenylacetaldehyde (188)536 
 
To a stirred solution of 1′-(3,4-dimethoxyphenyl)ethanol (187) (0.150 g, 0.823 mmol) 
in dry dichloromethane (10 mL) at 0 °C was slowly added Dess-Martin periodinane 
(0.419 g, 0.988 mmol). The reaction mixture was warmed to room temperature and 
stirred for 3 h. A saturated aqueous solution of sodium thiosulfate (5 mL) and a 
saturated aqueous solution of sodium bicarbonate (5 mL) were added and the 
mixture was extracted with dichloromethane (3 × 20 mL). The combined organic 
extracts were washed with brine (60 mL), dried (MgSO4), filtered and concentrated 
in vacuo. Purification by flash column chromatography (hexane/ethyl acetate, 4:1) 
gave 3,4-dimethoxyphenylacetaldehyde (188) (0.0960 g, 65%) as a colourless oil. 
Spectroscopic data were consistent with the literature.536 δH (400 MHz, CDCl3) 3.62 
(2H, d, J 2.4 Hz, 1′-H2), 3.87 (6H, s, 2 × OCH3), 6.71 (1H, d, J 2.0 Hz, 2-H), 6.76 
(1H, dd, J 8.0, 2.0 Hz, 6-H), 6.86 (1H, d, J 8.0 Hz, 5-H), 9.72 (1H, t, J 2.4 Hz, CHO); 
δC (101 MHz, CDCl3) 50.1 (CH2), 55.9 (CH3), 55.9 (CH3), 111.6 (CH), 112.6 (CH), 
121.9 (CH), 124.1 (C), 148.4 (C), 149.3 (C), 199.5 (CH); m/z (EI) 180 (M+. 82%), 
151 (100), 107 (48), 91 (24), 65 (28). 
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2′-(3-Methoxyphenyl)cyclohexanone (189a)537 
 
An oven-dried microwave vial was flushed with argon and charged with 
tris(dibenzylideneacetone)dipalladium (0.00920 g, 0.0100 mmol), 4,5-
bis(diphenylphosphino)-9,9-dimethylxanthene (0.0140 g, 0.0240 mmol), cesium 
carbonate (1.43 g, 4.40 mmol) and anhydrous 1,4-dioxane (4.0 mL). Cyclohexanone 
(0.415 mL, 4.00 mmol) and 3-iodoanisole (0.238 mL, 2.00 mmol) were added to this 
suspension under argon and the resulting reaction mixture was stirred at 80 °C for 
24 h. After cooling to room temperature, the reaction mixture was diluted with diethyl 
ether (30 mL), washed with water (30 mL) and the aqueous layer was extracted with 
diethyl ether (3 × 30 mL). The combined organic extracts were washed with brine 
(100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 4:1) gave 2′-(3-
methoxyphenyl)cyclohexanone (189a) (0.188 g, 46%) as a colourless oil. 
Spectroscopic data were consistent with the literature.537 δH (500 MHz, CDCl3) 1.75–
1.88 (2H, m, 5′-H2), 1.95–2.17 (3H, m, 3’-HH and 4′-H2), 2.23–2.31 (1H, m, 3′-HH), 
2.40–2.53 (2H, m, 6′-H2), 3.58 (1H, dd, J 12.1, 5.5 Hz, 2′-H), 3.79 (3H, s, OCH3), 
6.69 (1H, t, J 2.4 Hz, 2-H), 6.73 (1H, br d, J 7.9 Hz, 6-H), 6.80 (1H, dd, J 7.9, 2.4 
Hz, 4-H), 7.24 (1H, t, J 7.9 Hz, 5-H); δC (126 MHz, CDCl3) 25.2 (CH2), 27.8 (CH2), 
34.9 (CH2), 42.2 (CH2), 55.1 (CH3), 57.4 (CH), 112.1 (CH), 114.5 (CH), 120.9 (CH), 
129.3 (CH), 140.3 (C), 159.6 (C), 210.2 (C); m/z (ESI) 227 (MNa+. 100%). 
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2′-(3-Methoxyphenyl)-3′,4′-dihydronaphthalen-1′(2H)-one (189b)538 
 
2′-(3-Methoxyphenyl)-3′,4′-dihydronaphthalen-1′(2H)-one (189b) was synthesised 
as described for 2′-(3-methoxyphenyl)cyclohexanone (189a) using 3-iodoanisole 
(0.238 mL, 2.00 mmol), α-tetralone (0.320 mL, 2.40 mmol), 
tris(dibenzylideneacetone)dipalladium (0.00920 g, 0.0100 mmol), 4,5-
bis(diphenylphosphino)-9,9-dimethylxanthene (0.0140 g, 0.0240 mmol), cesium 
carbonate (1.43 g, 4.40 mmol) in anhydrous 1,4-dioxane (3.0 mL). The reaction 
mixture was stirred at 100 °C for 20 h. Purification by flash column chromatography 
(hexane/diethyl ether, 19:1 to hexane/diethyl ether, 9:1) gave 2′-(3-methoxyphenyl)-
3′,4′-dihydronaphthalen-1′(2H)-one (189b) (0.292 g, 58%) as a brown solid. 
Spectroscopic data were consistent with the literature.538 Mp 70–72 °C; δH (500 
MHz, CDCl3) 2.40–2.49 (2H, m, 3′-H2), 3.01–3.15 (2H, m, 4′-H2), 3.76–3.80 (4H, m, 
2′-H and OCH3), 6.74 (1H, t, J 2.5 Hz, 2-H), 6.78 (1H, br d, J 7.5 Hz, 6-H), 6.81 (1H, 
dd, J 8.3, 2.5 Hz, 4-H), 7.24–7.30 (2H, m, 5-H and 5′-H), 7.34 (1H, t, J 7.6 Hz, 7′-H), 
7.50 (1H, td, J 7.6, 1.2 Hz, 6′-H), 8.10 (1H, dd, J 7.6, 1.2 Hz, 8′-H); δC (126 MHz, 
CDCl3) 28.7 (CH2), 31.1 (CH2), 54.4 (CH), 55.2 (CH3), 112.2 (CH), 114.5 (CH), 120.8 
(CH), 126.8 (CH), 127.8 (CH), 128.8 (CH), 129.5 (CH), 132.8 (C), 133.4 (CH), 141.2 
(C), 144.0 (C), 159.7 (C), 198.0 (C); m/z (ESI) 275 (MNa+. 100%). 
2′-(3-Methoxyphenyl)cycloheptanone (189c) 
 
2′-(3-Methoxyphenyl)cycloheptanone (189c) was synthesised as described for 2′-
(3-methoxyphenyl)cyclohexanone (189a) using 3-iodoanisole (0.238 mL, 2.00 
mmol), cycloheptanone (0.473 mL, 4.00 mmol), 
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tris(dibenzylideneacetone)dipalladium (0.00920 g, 0.0100 mmol), 4,5-
bis(diphenylphosphino)-9,9-dimethylxanthene (0.0140 g, 0.0240 mmol), cesium 
carbonate (1.43 g, 4.40 mmol) in anhydrous 1,4-dioxane (4.0 mL). Purification by 
flash column chromatography (hexane/diethyl ether, 19:1 to hexane/diethyl ether, 
9:1) gave 2′-(3-methoxyphenyl)cycloheptanone (189c) (0.218 g, 50%) as a 
colourless oil. νmax/cm−1 (neat) 2928 (CH), 1699 (C=O), 1597, 1584, 1452, 1260, 
1146, 1045, 770, 694; δH (500 MHz, CDCl3) 1.38–1.50 (2H, m, 5′-H2), 1.57–1.67 
(1H, m, 6′-HH), 1.86–2.17 (5H, m, 3′-H2, 4′-H2 and 6′-HH), 2.47–2.54 (1H, m, 7′-HH), 
2.68 (1H, td, J 13.0, 3.2 Hz, 7′-HH), 3.67 (1H, dd, J 11.5, 4.2 Hz, 2′-H), 3.78 (3H, s, 
OCH3), 6.76–6.79 (2H, m, 2-H and 4-H), 6.81 (1H, br d, J 7.7 Hz, 6-H), 7.22 (1H, 
dd, J 8.8, 7.7 Hz, 5-H); δC (126 MHz, CDCl3) 25.4 (CH2), 28.5 (CH2), 30.0 (CH2), 
31.8 (CH2), 42.7 (CH2), 55.2 (CH3), 58.8 (CH), 112.1 (CH), 113.9 (CH), 120.1 (CH), 
129.4 (CH), 141.9 (C), 159.7 (C), 213.3 (C); m/z (ESI) 241.1190 (MNa+. C14H18NaO2 
requires 241.1199). 
1′-(3-Methoxy-6-iodophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (191)  
 
1′-(3-methoxy-6-iodophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (191) was 
synthesised as described for 4-iodoanisole (82a) using 1′-(3-Methoxyphenyl)-2′-(4′′-
chlorophenyl)ethan-2′-one (157b) (0.300 g, 1.15 mmol) in toluene (1.5 mL). The 
reaction mixture was stirred at 40 °C for 3 h. Purification by flash column 
chromatography (hexane/diethyl ether, 9:1) gave 1′-(3-methoxy-6-iodophenyl)-2′-
(4′′-methoxyphenyl)ethan-2′-one (191) (0.257 g, 58%) as a yellow oil. νmax/cm−1 
(neat) 2957 (CH), 1686 (C=O), 1587, 1568, 1466, 1398, 1296, 1277, 1250, 1238, 
1209, 1090, 1009, 993, 812; δH (500 MHz, CDCl3) 3.76 (3H, s, OCH3), 4.37 (2H, s, 
1′-H2), 6.59 (1H, dd, J 8.8, 3.0 Hz, 4-H), 6.80 (1H, d, J 3.0 Hz, 2-H), 7.46 (2H, d, J 
8.6 Hz, 3′′-H and 5′′-H), 7.72 (1H, d J 8.8 Hz, 5-H), 7.98 (2H, d, J 8.6 Hz, 2′′-H and 
6′′-H); δC (126 MHz, CDCl3) 50.5 (CH2), 55.4 (CH3), 89.8 (C), 115.0 (CH), 116.9 
(CH), 129.1 (2 × CH), 129.8 (2 × CH), 135.0 (C), 139.2 (C), 139.8 (C), 139.9 (CH), 
160.0 (C), 195.2 (C); m/z (ESI) 408.9459 (MNa+. C15H1235ClINaO2 requires 
408.9463). 
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Method A: Synthesis of 2-(4′-chlorophenyl)-5-methoxybenzo[b]furan (190a) 
using iron(III) chloride (99.9%) 
 
Iron(III) chloride (2.10 mg, 0.0130 mmol, 99.9% purity) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (11.0 µL, 0.0390 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.0600 g, 0.260 mmol) in toluene (0.5 mL). 1′-(3-Methoxyphenyl)-
2′-(4′′-chlorophenyl)ethan-2′-one (157b) (0.0670 g, 0.260 mmol) in toluene (0.5 mL) 
was then added and the mixture was stirred at 40 °C for 3 h. Upon completion of 
the iodination step, the reaction mixture was cooled to room temperature, diluted 
with toluene (1.0 mL) and cesium carbonate (0.170 g, 0.520 mmol), N,N′-
dimethylethylenediamine (3.00 µL, 0.0260 mmol) and water (0.5 mL) were added. 
The reaction mixture was degassed under argon for 0.1 h and then heated to 130 
°C for 16 h. The reaction mixture was then cooled to room temperature, diluted with 
ethyl acetate (10 mL) and washed with a 1 M aqueous sodium thiosulfate solution 
(10 mL). The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the 
combined organic extracts were washed with brine (30 mL). The organic phase was 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 2-(4′-chlorophenyl)-5-
methoxybenzo[b]furan (190a) (0.0400 g, 60%) as a white solid. Mp 108–110 °C; 
νmax/cm−1 (neat) 2965 (CH), 1613, 1599, 1471, 1271, 833, 800; δH (500 MHz, CDCl3) 
3.85 (3H, s, OCH3), 6.89 (1H, dd, J 8.9, 2.6 Hz, 6-H), 6.92 (1H, d, J 0.9 Hz, 3-H), 
7.01 (1H, br d, J 2.6 Hz, 4-H), 7.35–7.42 (3H, m, 7-H, 3′-H and 5′-H), 7.74 (2H, d, J 
8.5 Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 55.9 (CH3), 101.9 (CH), 103.3 (CH), 
111.6 (CH), 113.3 (CH), 126.0 (2 × CH), 129.0 (2 × CH), 129.1 (C), 129.6 (C), 134.2 
(C), 150.0 (C), 155.5 (C), 156.2 (C); m/z (EI) 258.0440 (M+. C15H1135ClO2 requires 
258.0448), 215 (12%), 152 (42). 
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Method B: Synthesis of 2-(4′-chlorophenyl)-5-methoxybenzo[b]furan (190a) 
using iron(III) nitrate nonahydrate (99.999%)  
 
Iron(III) nitrate nonahydrate (2.40 mg, 0.0100 mmol, 99.999% purity) was 
suspended in 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide (8.70 
µL, 0.0300 mmol) and stirred for 0.5 h at room temperature and then added to a 
suspension of N-iodosuccinimide (0.0450 g, 0.200 mmol) in toluene (0.5 mL). 1′-(3-
Methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) (0.0521 g, 0.200 mmol) in 
toluene (0.5 mL) was then added and the mixture was stirred at 40 °C for 5 h. Upon 
completion of the iodination step, the reaction mixture was cooled to room 
temperature, diluted with toluene (1.0 mL) and cesium carbonate (0.170 g, 0.520 
mmol), N,N′-dimethylethylenediamine (3.00 µL, 0.0260 mmol) and water (0.5 mL) 
were added. The reaction mixture was degassed under argon for 0.1 h and then 
heated to 130 °C for 22 h. The reaction mixture was then cooled to room 
temperature, diluted with ethyl acetate (10 mL) and washed with a 1 M aqueous 
sodium thiosulfate solution (10 mL). The aqueous layer was extracted with ethyl 
acetate (3 × 10 mL) and the combined organic extracts were washed with brine (30 
mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 19:1) 
gave 2-(4′-chlorophenyl)-5-methoxybenzo[b]furan (190a) (0.0278 g, 54%) as a 
white solid. Characterisation data as previously reported for 2-(4′-chlorophenyl)-5-
methoxybenzo[b]furan (190a). 
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Synthesis of 2-(4′-chlorophenyl)-5-methoxybenzo[b]furan (190a) from 1′-(3-
methoxy-6-iodophenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (191) using copper(I) 
iodide (ppm loading) 
 
To a solution of 1′-(3-methoxy-6-iodophenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (191) 
(0.0771 g, 0.200 mmol) in toluene (1.0 mL) was added cesium carbonate (0.130 g, 
0.400 mmol), N,N′-dimethylethylenediamine (2.15 µL, 0.0200 mmol) and water (0.4 
mL). Copper(I) iodide (0.0038 mg, 0.001 mol%, 14 ppm) in acetonitrile (10 µL) was 
added (stock solution prepared by dissolving 3.80 mg of copper(I) iodide in 10 mL 
of acetonitrile). The reaction mixture was degassed under argon for 0.1 h and then 
heated to 130 °C for 24 h. The reaction mixture was then cooled to room 
temperature, diluted with ethyl acetate (10 mL) and washed with a 1 M aqueous 
sodium thiosulfate solution (10 mL). The aqueous layer was extracted with ethyl 
acetate (3 × 10 mL) and the combined organic extracts were washed with brine (30 
mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 19:1) 
gave 2-(4′-chlorophenyl)-5-methoxybenzo[b]furan (190a) (0.0289 g, 56%) as a 
white solid. Characterisation data as previously reported for 2-(4′-chlorophenyl)-5-
methoxybenzo[b]furan (190a). 
2-(3′-Chlorophenyl)-5-methoxybenzo[b]furan (190b) 
 
2-(3′-Chlorophenyl)-5-methoxybenzo[b]furan (190b) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(3′′-chlorophenyl)ethan-2′-one (181a) 
(0.0500 g, 0.190 mmol). The iodination step was carried out at 40 °C for 3 h and the 
O-arylation at 130 °C for 36 h. Purification by flash column chromatography 
(hexane/diethyl ether, 19:1) gave 2-(3′-chlorophenyl)-5-methoxybenzo[b]furan 
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(190b) (0.0310 g, 62%) as a white solid. Mp 80–82 °C; νmax/cm−1 (neat) 2932 (CH), 
1599, 1470, 1215, 1205, 1148, 1034, 837, 802, 785, 737; δH (400 MHz, CDCl3) 3.86 
(3H, s, OCH3), 6.91 (1H, dd, J 8.8, 2.6 Hz, 6-H), 6.98 (1H, d, J 0.7 Hz, 3-H), 7.04 
(1H, br d, J 2.6 Hz, 4-H), 7.31 (1H, ddd, J 8.0, 1.9, 1.3 Hz, 4′-H), 7.36 (1H, dd, J 8.0, 
7.7 Hz, 5′-H), 7.41 (1H, d, J 8.8 Hz, 7-H), 7.70 (1H, dt, J 7.7, 1.3 Hz, 6′-H), 7.83 (1H, 
br t, J 1.9 Hz, 2′-H); δC (101 MHz, CDCl3) 55.9 (CH3), 102.5 (CH), 103.4 (CH), 111.7 
(CH), 113.6 (CH), 122.9 (CH), 124.8 (CH), 128.4 (CH), 129.5 (C), 130.0 (CH), 132.2 
(C), 134.8 (C), 150.0 (C), 155.1 (C), 156.2 (C); m/z (EI) 258.0450 (M+. C15H1135ClO2 
requires 258.0448), 215 (12%), 152 (28). 
2-(2′-Chlorophenyl)-5-methoxybenzo[b]furan (190c) 
 
2-(2′-Chlorophenyl)-5-methoxybenzo[b]furan (190c) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(2′′-chlorophenyl)ethan-2′-one (181b) 
(0.0523 g, 0.200 mmol). The iodination step was carried out at 40 °C for 3 h and the 
O-arylation at 130 °C for 24 h. Purification by flash column chromatography 
(hexane/diethyl ether, 19:1) gave 2-(2′-chlorophenyl)-5-methoxybenzo[b]furan 
(190c) (0.0311 g, 60%) as a colourless oil. νmax/cm−1 (neat) 2934 (CH), 1614, 1466, 
1213, 1207, 1184, 1148, 1030, 1018, 835, 799, 752, 733; δH (500 MHz, CDCl3) 3.85 
(3H, s, OCH3), 6.93 (1H, dd, J 8.9, 2.6 Hz, 6-H), 7.08 (1H, br d, J 2.6 Hz, 4-H), 7.26 
(1H, td, J 7.8, 1.6 Hz, 4′-H), 7.36 (1H, td, J 7.8, 1.2 Hz, 5′-H), 7.40 (1H, d, J 8.9 Hz, 
7-H), 7.46 (1H, d, J 0.6 Hz, 3-H), 7.48 (1H, dd, J 7.8, 1.2 Hz, 3′-H), 8.02 (1H, dd, J 
7.8, 1.6 Hz, 6′-H); δC (126 MHz, CDCl3) 55.9 (CH3), 103.6 (CH), 107.6 (CH), 111.6 
(CH), 113.9 (CH), 127.0 (CH), 128.9 (CH), 129.0 (CH), 129.0 (C), 129.6 (C), 130.9 
(CH), 131.2 (C), 149.2 (C), 152.7 (C), 156.1 (C); m/z (ESI) 281.0333 (MNa+. 
C15H1135ClNaO2 requires 281.0340). 
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2-(4′-Fluorophenyl)-5-methoxybenzo[b]furan (190d)539  
 
2-(4′-Fluorophenyl)-5-methoxybenzo[b]furan (190d) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(4′′-fluorophenyl)ethan-2′-one (181c) 
(0.0610 g, 0.250 mmol). The iodination step was carried out at 40 °C for 3 h and the 
O-arylation at 130 °C for 20 h. Purification by flash column chromatography 
(hexane/diethyl ether, 9:1) gave 2-(4′-fluorophenyl)-5-methoxybenzo[b]furan (190d) 
(0.0440 g, 72%) as a white solid. Spectroscopic data were consistent with the 
literature.539 Mp 98–100 °C; δH (500 MHz, CDCl3) 3.83 (3H, s, OCH3), 6.85 (1H, d, 
J 0.7 Hz, 3-H), 6.87 (1H, dd, J 8.9, 2.6 Hz, 6-H), 7.00 (1H, br d, J 2.6 Hz, 4-H), 7.10 
(2H, t, J 8.8 Hz, 3′-H and 5′-H), 7.37 (1H, d, J 8.9 Hz, 7-H), 7.78 (2H, dd, J 8.8, 5.4 
Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 55.9 (CH3), 101.2 (CH), 103.3 (CH), 111.6 
(CH), 113.0 (CH), 115.8 (2 × CH, d, 2JCF 22.0 Hz), 126.7 (2 × CH, d, 3JCF 8.1 Hz), 
126.9 (C, d, 4JCF 3.2 Hz), 129.8 (C), 149.9 (C), 155.8 (C), 156.1 (C), 162.9 (C, d, 
1JCF 248.0 Hz); m/z (EI) 242 (M+. 100%), 198 (15), 172 (15), 170 (15). 
2-(4′-Trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e) 
 
2-(4′-Trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e) was synthesised 
according to method A using 1′-(3-methoxyphenyl)-2′-(4′′-
trifluoromethylphenyl)ethan-2′-one (181d) (0.0500 g, 0.170 mmol). The iodination 
step was carried out at 40 °C for 3 h and the O-arylation step at 130 °C for 36 h. 
Purification by flash column chromatography (hexane/diethyl ether, 9:1) gave 2-(4′-
trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e) (0.0364 g, 73%) as a white 
solid. Mp 126–128 °C; νmax/cm−1 (neat) 2938 (CH), 1618, 1477, 1333, 1171, 1134, 
1117, 1109, 1072, 1026, 1012, 839, 804; δH (400 MHz, CDCl3) 3.86 (3H, s, OCH3), 
6.93 (1H, dd, J 9.0, 2.7 Hz, 6-H), 7.03–7.06 (2H, m, 3-H and 4-H), 7.42 (1H, d, J 9.0 
Hz, 7-H), 7.67 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 7.91 (2H, d, J 8.2 Hz, 2′-H and 6′-H); 
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δC (101 MHz, CDCl3) 55.9 (CH3), 103.4 (CH), 103.4 (CH), 111.9 (CH), 114.1 (CH), 
124.1 (C, q, 1JCF 272.0 Hz), 124.9 (2 × CH), 125.8 (2 × CH, q, 3JCF 3.9 Hz), 129.4 
(C), 130.0 (C, q, 2JCF 32.5 Hz), 133.8 (C), 150.2 (C), 154.9 (C), 156.3 (C); m/z (EI) 
292.0708 (M+. C16H11F3O2 requires 292.0711), 248 (18%), 201 (17), 154 (20). 
2-(4′-Trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e) 
 
2-(4′-Trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e) was synthesised 
according to method B using 1′-(3-methoxyphenyl)-2′-(4′′-
trifluoromethylphenyl)ethan-2′-one (181d) (0.0588 g, 0.200 mmol). The iodination 
step was carried out at 70 °C for 24 h and the O-arylation step at 130 °C for 24 h. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 9:1) 
gave 2-(4′-trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e) (0.0319 g, 55%) 
as a white solid. Characterisation data as previously reported for 2-(4′-
trifluoromethylphenyl)-5-methoxybenzo[b]furan (190e). 
2-(4′-Cyanophenyl)-5-methoxybenzo[b]furan (190f) 
 
2-(4′-Cyanophenyl)-5-methoxybenzo[b]furan (190f) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(4′′-cyanophenyl)ethan-2′-one (181e) 
(0.0520 g, 0.210 mmol). The iodination step was carried out at 40 °C for 4 h and the 
O-arylation step at 130 °C for 36 h. Purification by flash column chromatography 
(petroleum ether/dichloromethane, 1:1) gave 2-(4′-cyanophenyl)-5-
methoxybenzo[b]furan (190f) (0.0370 g, 72%) as a white solid. Mp 144–146 °C; 
νmax/cm−1 (neat) 2945 (CH), 2220 (CN), 1608, 1472, 1227, 1196, 1144, 1030, 914, 
799, 748; δH (400 MHz, CDCl3) 3.86 (3H, s, OCH3), 6.95 (1H, dd, J 8.9, 2.5 Hz, 6-
H), 7.05 (1H, d, J 2.5 Hz, 4-H), 7.09 (1H, s, 3-H), 7.42 (1H, d, J 8.9 Hz, 7-H), 7.69 
(2H, d, J 8.4 Hz, 3′-H and 5′-H), 7.89 (2H, d, J 8.4 Hz, 2′-H and 6′-H); δC (101 MHz, 
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CDCl3) 55.9 (CH3), 103.5 (CH), 104.5 (CH), 111.4 (C), 111.9 (CH), 114.7 (CH), 
118.8 (C), 125.0 (2 × CH), 129.2 (C), 132.6 (2 × CH), 134.5 (C), 150.3 (C), 154.3 
(C), 156.4 (C); m/z (ESI) 272.0673 (MNa+. C16H11NNaO2 requires 272.0682). 
2-Phenyl-5-methoxybenzo[b]furan (190g)540 
 
2-Phenyl-5-methoxybenzo[b]furan (190g) was synthesised according to method A 
using 1′-(3-methoxyphenyl)-2′-phenylethan-2′-one (157c) (0.0480 g, 0.212 mmol). 
The iodination step was carried out at 40 °C for 4 h and the O-arylation step at 130 
°C for 20 h. Purification by flash column chromatography (hexane/diethyl ether, 
19:1) gave 2-phenyl-5-methoxybenzo[b]furan (190g) (0.0310 g, 65%) as a white 
solid. Mp 125–127 °C (lit.540 128–130 °C); δH (400 MHz, CDCl3) 3.85 (3H, s, OCH3), 
6.88 (1H, dd, J 8.9, 2.6 Hz, 6-H), 6.96 (1H, d, J 0.7 Hz, 3-H), 7.04 (1H, br d, J 2.6 
Hz, 4-H), 7.34 (1H, tt, J 7.4, 1.2 Hz, 4′-H), 7.38–7.48 (3H, m, 7-H, 3′-H and 5′-H), 
7.81–7.87 (2H, m, 2′-H and 6′-H); δC (101 MHz, CDCl3) 55.9 (CH3), 101.5 (CH), 
103.3 (CH), 111.6 (CH), 113.0 (CH), 124.8 (2 × CH), 128.5 (CH), 128.8 (2 × CH), 
129.8 (C), 130.5 (C), 149.9 (C), 156.1 (C), 156.7 (C); m/z (EI) 224 (M+. 100%), 181 
(18), 153 (16), 152 (20). 
2-(4′-Methylphenyl)-5-methoxybenzo[b]furan (190h)349 
 
2-(4′-Methylphenyl)-5-methoxybenzo[b]furan (190h) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(4′′-methylphenyl)ethan-2′-one (180a) 
(0.0550 g, 0.229 mmol). The iodination step was carried out at 40 °C for 4 h and the 
O-arylation step at 130 °C for 18 h. Purification by flash column chromatography 
(hexane/diethyl ether, 19:1) gave 2-(4′-methylphenyl)-5-methoxybenzo[b]furan 
(190h) (0.0370 g, 68%) as a white solid. Mp 119–121 °C (lit.349 123–124 °C); δH 
(500 MHz, CDCl3) 2.38 (3H, s, 4′-CH3), 3.83 (3H, s, OCH3), 6.86 (1H, dd, J 8.9, 2.6 
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Hz, 6-H), 6.88 (1H, d, J 0.6 Hz, 3-H), 7.01 (1H, br d, J 2.6 Hz, 4-H), 7.23 (2H, d, J 
8.1 Hz, 3′-H and 5′-H), 7.38 (1H, d, J 8.9 Hz, 7-H), 7.71 (2H, d, J 8.1 Hz, 2′-H and 
6′-H); δC (126 MHz, CDCl3) 21.4 (CH3), 55.9 (CH3), 100.8 (CH), 103.3 (CH), 111.5 
(CH), 112.7 (CH), 124.8 (2 × CH), 127.8 (C), 129.5 (2 × CH), 129.9 (C), 138.6 (C), 
149.8 (C), 156.1 (C), 157.0 (C); m/z (ESI) 261 (MNa+. 100%). 
2-(2′,4′,6′-Trimethylphenyl)-5-methoxybenzo[b]furan (190i)349 
 
2-(2′,4′,6′-Trimethylphenyl)-5-methoxybenzo[b]furan (190i) was synthesised 
according to method A using 1′-(3-methoxyphenyl)-2′-(2′′,4′′,6′′-
trimethylphenyl)ethan-2′-one (184a) (0.0670 g, 0.250 mmol). The iodination step 
was carried out at 40 °C for 3 h and the O-arylation step at 130 °C for 48 h. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 19:1) 
gave 2-(2′,4′,6′-trimethylphenyl)-5-methoxybenzo[b]furan (190i) (0.0513 g, 75%) as 
a colourless oil. Spectroscopic data were consistent with the literature.349 δH (400 
MHz, CDCl3) 2.22 (6H, s, 2′-CH3 and 6′-CH3), 2.33 (3H, s, 4′-CH3), 3.86 (3H, s, 
OCH3), 6.57 (1H, d, J 0.7 Hz, 3-H), 6.88 (1H, dd, J 8.8, 2.5 Hz, 6-H), 6.95 (2H, s, 3′-
H and 5′-H), 7.07 (1H, br d, J 2.5 Hz, 4-H), 7.38 (1H, d, J 8.8 Hz, 7-H); δC (101 MHz, 
CDCl3) 20.5 (2 × CH3), 21.2 (CH3), 56.0 (CH3), 103.2 (CH), 106.2 (CH), 111.6 (CH), 
112.3 (CH), 127.8 (C), 128.3 (2 × CH), 129.4 (C), 138.3 (2 × C), 139.0 (C), 149.7 
(C), 155.9 (C), 155.9 (C); m/z (ESI) 289 (MNa+. 100%). 
2-(4′-Methoxyphenyl)-5,6-dimethoxybenzo[b]furan (190j) 
 
2-(4′-Methoxyphenyl)-5,6-dimethoxybenzo[b]furan (190j) was synthesised 
according to method A except 1′-(3,4-dimethoxyphenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (184b) (0.0810 g, 0.280 mmol) was added to the 
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reaction mixture as a solution in toluene (1.0 mL) and acetonitrile (0.1 mL). The 
iodination step was carried out at 40 °C for 4 h and the O-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (dichloromethane) gave 2-(4′-
methoxyphenyl)-5,6-dimethoxybenzo[b]furan (190j) (0.0492 g, 62%) as a white 
solid. Mp 142–144 °C; νmax/cm−1 (neat) 2940 (CH), 1612, 1481, 1466, 1319, 1250, 
1204, 1126, 1026, 1003, 918, 833, 795, 733; δH (500 MHz, CDCl3) 3.84 (3H, s, 
OCH3), 3.92 (3H, s, OCH3), 3.94 (3H, s, OCH3), 6.78 (1H, s, 3-H), 6.95 (2H, d, J 8.9 
Hz, 3′-H and 5′-H), 6.99 (1H, s, 7-H), 7.08 (1H, s, 4-H), 7.72 (2H, d, J 8.9 Hz, 2′-H 
and 6′-H); δC (126 MHz, CDCl3) 55.3 (CH3), 56.3 (CH3), 56.4 (CH3), 95.3 (CH), 99.8 
(CH), 102.1 (CH), 114.2 (2 × CH), 121.4 (C), 123.7 (C), 125.8 (2 × CH), 146.6 (C), 
147.6 (C), 149.4 (C), 155.3 (C), 159.5 (C); m/z (ESI) 307.0946 (MNa+. C17H16NaO4 
requires 307.0941). 
2-(4′-Methoxyphenyl)-5,6-(methylenedioxy)benzo[b]furan (190k) 
 
2-(4′-Methoxyphenyl)-5,6-(methylenedioxy)benzo[b]furan (190k) was synthesised 
according to method A except 1′-(3,4-methylenedioxyphenyl)-2′-(4′′-
methoxyphenyl)ethan-2′-one (184c) (0.0670 g, 0.250 mmol) was added to the 
reaction mixture as a solution of toluene (1.0 mL) and acetonitrile (0.1 mL). The 
iodination step was carried out at 40 °C for 3 h and the O-arylation step at 130 °C 
for 36 h. Purification by recrystallisation from chloroform:methanol, 1:1, gave 2-(4′-
methoxyphenyl)-5,6-(methylenedioxy)benzo[b]furan (190k) (0.0450 g, 68%) as a 
white crystalline solid. Mp 156–158 °C (from chloroform and methanol); νmax/cm−1 
(neat) 2901 (CH), 1460, 1323, 1250, 1175, 1144, 1038, 1022, 943, 829, 799; δH 
(400 MHz, CDCl3) 3.85 (3H, s, OCH3), 5.98 (2H, s, OCH2O), 6.77 (1H, s, 3-H), 6.92 
(1H, s, 7-H), 6.95 (2H, d, J 8.9 Hz, 3′-H and 5′-H), 7.00 (1H, s, 4-H), 7.70 (2H, d, J 
8.9 Hz, 2′-H and 6′-H); δC (101 MHz, CDCl3) 55.4 (CH3), 93.5 (CH), 99.1 (CH), 100.2 
(CH), 101.2 (CH2), 114.2 (2 × CH), 122.7 (C), 123.6 (C), 125.8 (2 × CH), 144.5 (C), 
145.7 (C), 149.9 (C), 155.7 (C), 159.6 (C); m/z (EI) 268.0733 (M+. C16H12O4 requires 
268.0736), 253 (59%), 226 (8), 139 (8),133 (10). 
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2-(4′-Methoxyphenyl)-5-methoxybenzo[b]furan (176)541 
 
2-(4′-Methoxyphenyl)-5-methoxybenzo[b]furan (176) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (157a) 
(0.0640 g, 0.250 mmol). The iodination step was carried out at 40 °C for 4 h and the 
O-arylation step at 130 °C for 36 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 2-(4′-methoxyphenyl)-5-
methoxybenzo[b]furan (176) (0.0470 g, 74%) as a yellow solid. Mp 159–162 °C 
(lit.541 163–165 °C); δH (400 MHz, CDCl3) 3.84 (6H, s, OCH3), 6.81 (1H, s, 3-H), 6.84 
(1H, dd, J 8.9, 2.5 Hz, 6-H), 6.96 (2H, d, J 8.5 Hz, 3′-H and 5′-H), 7.01 (1H, d, J 2.5 
Hz, 4-H), 7.37 (1H, d, J 8.9 Hz, 7-H), 7.76 (2H, d, J 8.5 Hz, 2′-H and 6′-H); δC (101 
MHz, CDCl3) 55.4 (CH3), 55.9 (CH3), 99.9 (CH), 103.2 (CH), 111.4 (CH), 112.3 (CH), 
114.2 (2 × CH), 123.4 (C), 126.3 (2 × CH), 130.1 (C), 149.7 (C), 156.0 (C), 156.9 
(C), 160.0 (C); m/z (EI) 254 (M+. 100%), 239 (55), 211 (16), 148 (11). 
2-(4′-Methoxyphenyl)-5-methoxybenzo[b]furan (176)541 
 
2-(4′-Methoxyphenyl)-5-methoxybenzo[b]furan (176) was synthesised according to 
method B using 1′-(3-methoxyphenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (157a) 
(0.0513 g, 0.200 mmol).The iodination step was carried out at 70 °C for 24 h and 
the O-arylation step at 130 °C for 36 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 2-(4′-methoxyphenyl)-5-
methoxybenzo[b]furan (176) (0.0208 g, 41%) as a yellow solid. Characterisation 
data as previously reported for 2-(4′-methoxyphenyl)-5-methoxybenzo[b]furan 
(176). 
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Gram-Scale Synthesis of 2-(4′-Methoxyphenyl)-5-methoxybenzo[b]furan 
(176)541 
 
Iron(III) chloride (0.0319 g, 0.197 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (0.172 mL, 0.591 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.886 g, 3.94 mmol) in toluene (5.0 mL). 1′-(3-Methoxyphenyl)-2′-
(4′′-methoxyphenyl)ethan-2′-one (157a) (1.01 g, 3.94 mmol) was added and the 
reaction mixture was stirred at 40 °C for 4 h. Upon completion of the iodination step, 
the reaction mixture was cooled to room temperature and copper(I) iodide (0.0750 
g, 0.394 mmol), N,N′-dimethylethylenediamine (0.0850 mL, 0.788 mmol), cesium 
carbonate (2.57 g, 7.88 mmol) and water (3.0 mL) were added. The reaction mixture 
was degassed under argon for 0.1 h and then heated to 130 °C for 36 h. After cooling 
to room temperature, the reaction mixture was diluted with ethyl acetate (20 mL) 
and washed with 1 M aqueous sodium thiosulfate solution (20 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 20 mL) and the combined organic 
extracts were washed with brine (60 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1 to petroleum ether/ethyl acetate, 4:1) gave 2-(4′-
methoxyphenyl)-5-methoxybenzo[b]furan (176) (0.844 g, 84%) as a yellow solid. 
Characterisation data as previously reported for 2-(4′-methoxyphenyl)-5-
methoxybenzo[b]furan (176). 
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Method C: Synthesis of 2-(4′-Methoxyphenyl)-5-N-
(benzyloxycarbonyl)aminobenzo[b]furan (192a) using Iron(III) Chloride (97%) 
and Copper(I) Iodide (10 mol%) 
 
Iron(III) chloride (1.71 mg, 0.211 mmol, 97% purity) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (9.20 µL, 0.0320 mmol) and 
stirred for 0.5 h at room temperature and then added to a suspension of N-
iodosuccinimide (0.0474 g, 0.211 mmol) in toluene (0.5 mL). 1′-(3-
Benzyloxycarbonylaminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (186a) 
(0.0791 g, 0.211 mmol) in toluene (0.5 mL) was then added and the mixture was 
stirred at 40 °C for 5 h. Upon completion of the iodination step, the reaction mixture 
was cooled to room temperature, diluted with toluene (1.0 mL) and cesium 
carbonate (0.138 g, 0.422 mmol), copper(I) iodide (4.02 mg, 0.0211 mmol), N,N′-
dimethylethylenediamine (4.50 µL, 0.0422 mmol) and water (0.6 mL) were added. 
The reaction mixture was degassed under argon for 0.1 h and then heated to 130 
°C for 22 h. The reaction mixture was then cooled to room temperature, diluted with 
ethyl acetate (10 mL) and washed with a 1 M aqueous sodium thiosulfate solution 
(10 mL). The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the 
combined organic extracts were washed with brine (30 mL). The organic phase was 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) gave 2-(4′-methoxyphenyl)-5-
N-(benzyloxycarbonyl)aminobenzo[b]furan (192a) (0.0379 g, 48%) as a yellow oil. 
νmax/cm−1 (neat) 3401 (NH), 3319, 2930 (CH), 1732 (C=O), 1705, 1612, 1539, 1506, 
1256, 1229, 1204, 1042, 835, 797, 739; δH (400 MHz, CDCl3) 3.86 (3H, s, OCH3), 
5.22 (2H, s, CH2O), 6.70 (1H, br s, 4-H), 6.82 (1H, d, J 0.7 Hz, 3-H), 6.97 (2H, d, J 
8.9 Hz, 3′-H and 5′-H), 7.11 (1H, dd, J 8.7, 2.2 Hz, 6-H), 7.31–7.46 (6H, m, 7-H and 
Ph), 7.69 (1H, br s, NH), 7.77 (2H, d, J 8.9 Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 
55.4 (CH3), 67.0 (CH2), 99.8 (CH), 111.0 (2 × CH), 114.3 (2 × CH), 116.0 (CH), 
123.2 (C), 126.5 (2 × CH), 128.3 (3 × CH), 128.6 (2 × CH), 128.9 (CH), 130.0 (C), 
133.0 (C), 136.2 (C), 151.5 (C), 153.8 (C), 157.1 (C), 160.1 (C); m/z (ESI) 396.1199 
(MNa+. C23H19NNaO4 requires 396.1206). 
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2-(4′-Methoxyphenyl)-5-N-(tert-butyloxycarbonyl)aminobenzo[b]furan (192b) 
 
2-(4′-Methoxyphenyl)-5-N-(tert-butyloxycarbonyl)aminobenzo[b]furan (192b) was 
synthesised according to method C using 1′-(3-N-(tert-
butyloxycarbonyl)aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (186b) (0.0518 
g, 0.150 mmol) in toluene (1.6 mL) and acetonitrile (0.4 mL). The iodination step 
was carried out at 40 °C for 5 h and the O-arylation step at 130 °C for 22 h. 
Purification by flash column chromatography (petroleum ether/dichloromethane, 
1:1) gave 2-(4′-methoxyphenyl)-5-N-(tert-butyloxycarbonyl)aminobenzo[b]furan 
(192b) (0.0335 g, 65%) as a white solid. Mp 104–106 °C; νmax/cm−1 (neat) 3416 
(NH), 2976 (CH), 1721 (C=O), 1526, 1504, 1342, 1252, 1161, 1040, 841, 818, 793; 
δH (500 MHz, CDCl3) 1.53 (9H, s, C(CH3)3), 3.84 (3H, s, OCH3), 6.53 (1H, br s, 4-
H), 6.79 (1H, s, 3-H), 6.95 (2H, d, J 8.8 Hz, 3′-H and 5′-H), 7.08 (1H, dd, J 8.7, 2.0 
Hz, 6-H), 7.37 (1H, d, J 8.7 Hz, 7-H), 7.67 (1H, br s, NH), 7.76 (2H, d, J 8.8 Hz, 2′-
H and 6′-H); δC (126 MHz, CDCl3) 28.4 (3 × CH3), 55.4 (CH3), 80.3 (C), 99.8 (CH), 
110.8 (CH), 110.9 (CH), 114.2 (2 × CH), 116.0 (CH), 123.3 (C), 126.4 (2 × CH), 
130.0 (C), 133.6 (C), 151.2 (C), 153.3 (C), 156.9 (C), 160.0 (C); m/z (ESI) 362.1357 
(MNa+. C20H21NNaO4 requires 362.1363). 
2-(4′-Methoxyphenyl)-5-acetamidobenzo[b]furan (192c) 
 
2-(4′-Methoxyphenyl)-5-acetamidobenzo[b]furan (192c) was synthesised according 
to method C using 1′-(3-acetamidophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one 
(186c) (0.0680 g, 0.240 mmol) in toluene (2.0 mL) and acetonitrile (0.2 mL). The 
iodination step was carried out at 40 °C at 5 h and the O-arylation step at 130 °C for 
36 h. Purification by flash column chromatography (dichloromethane/diethyl ether, 
9:1), followed by recrystallisation from hot ethanol gave 2-(4′-methoxyphenyl)-5-
acetamidobenzo[b]furan (192c) (0.0306 g, 45%) as a white crystalline solid. Mp 
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138–140 °C (from ethanol); νmax/cm−1 (neat) 1641 (C=O), 1612, 1477, 1254, 1042, 
829, 795; δH (500 MHz, DMSO-d6) 2.06 (3H, s, NHCOCH3), 3.82 (3H, s, OCH3), 
7.07 (2H, d, J 8.8 Hz, 3′-H and 5′-H), 7.25 (1H, s, 3-H), 7.34 (1H, dt, J 8.8, 2.1 Hz, 
6-H), 7.50 (1H, d, J 8.8 Hz, 7-H), 7.83 (2H, d, J 8.8 Hz, 2′-H and 6′-H), 7.97 (1H, t, 
J 2.1 Hz, 4-H), 9.94 (1H, br s, NH); δC (126 MHz, DMSO-d6) 24.4 (CH3), 55.8 (CH3), 
100.9 (CH), 111.2 (CH), 115.0 (2 × CH), 116.6 (CH), 116.8 (CH), 122.9 (C), 126.7 
(2 × CH), 129.6 (C), 135.5 (C), 150.7 (C), 156.4 (C), 160.3 (C), 168.5 (C); m/z (ESI) 
304.0936 (MNa+. C17H15NNaO3 requires 304.0944). 
2-(4′-Methoxyphenyl)-5-aminobenzo[b]furan (192d) 
 
2-(4′-Methoxyphenyl)-5-aminobenzo[b]furan (192d) was synthesised according to 
method C using 1′-(3-aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (185) 
(0.0750 g, 0.310 mmol) in toluene (2.0 mL) and acetonitrile (0.2 mL). The iodination 
step was carried out at 40 °C for 4 h and the O-arylation step at 130 °C for 24 h. 
Purification by flash column chromatography (dichloromethane) gave 2-(4′-
methoxyphenyl)-5-aminobenzo[b]furan (192d) (0.0210 g, 28%) as an orange oil. 
νmax/cm−1 (neat) 3350 (NH), 1611, 1506, 1477, 1454, 1252, 1177, 1040, 1022, 916, 
833, 797; δH (400 MHz, CDCl3) 3.58 (2H, br s, NH2), 3.85 (3H, s, OCH3), 6.63 (1H, 
dd, J 8.6, 2.4 Hz, 6-H), 6.73 (1H, br s, 3-H), 6.83 (1H, d, J 2.4 Hz, 4-H), 6.96 (2H, d, 
J 9.0 Hz, 3′-H and 5′-H), 7.27 (1H, d, J 8.6 Hz, 7-H), 7.75 (2H, d, J 9.0 Hz, 2′-H and 
6′-H); δC (101 MHz, CDCl3) 55.4 (CH3), 99.4 (CH), 105.6 (CH), 111.2 (CH), 113.0 
(CH), 114.2 (2 × CH), 123.6 (C), 126.3 (2 × CH), 130.3 (C), 142.1 (C), 149.4 (C), 
156.5 (C), 159.9 (C); m/z (ESI) 240.1012 (MH+. C15H14NO2 requires 240.1019). 
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2-Methyl-5-methoxybenzo[b]furan (192e)344 
 
2-Methyl-5-methoxybenzo[b]furan (192e) was synthesised according to method C 
using 1′-(3-methoxyphenyl)propan-2′-one (180c) (0.0792 g, 0.480 mmol). The 
iodination step was carried out at 40 °C for 4 h and the O-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (hexane/diethyl ether, 19:1) 
gave 2-methyl-5-methoxybenzo[b]furan (192e) (0.0423 g, 54%) as a colourless oil. 
Spectroscopic data were consistent with the literature.344 δH (400 MHz, CDCl3) 2.41 
(3H, d, J 1.0 Hz, 2-CH3), 3.81 (3H, s, OCH3), 6.29 (1H, quin., J 1.0 Hz, 3-H), 6.78 
(1H, dd, J 8.9, 2.6 Hz, 6-H), 6.93 (1H, br d, J 2.6 Hz, 4-H), 7.27 (1H, d, J 8.9 Hz, 7-
H); δC (101 MHz, CDCl3) 14.2 (CH3), 55.9 (CH3), 102.8 (CH), 103.1 (CH), 111.0 
(CH), 111.3 (CH), 129.8 (C), 149.7 (C), 155.8 (C), 156.3 (C); m/z (ESI) 185 (MNa+. 
100%). 
5,6-Dimethoxybenzo[b]furan (192f)542  
 
5,6-Dimethoxybenzo[b]furan (192f) was synthesised according to method C using 
3,4-dimethoxyphenylacetaldehyde (188) (0.0680 g, 0.377 mmol). The iodination 
step was carried out at 40 °C for 3 h and the O-arylation step at 130 °C for 22 h. 
Purification by flash column chromatography (hexane/diethyl ether, 9:1) gave 5,6-
dimethoxybenzo[b]furan (192f) (0.0270 g, 40%) as a colourless oil. Spectroscopic 
data were consistent with the literature.542 δH (500 MHz, CDCl3) 3.91 (3H, s, OCH3), 
3.92 (3H, s, OCH3), 6.67 (1H, dd, J 2.1, 0.8 Hz, 3-H), 7.03 (1H, s, 7-H), 7.06 (1H, br 
s, 4-H), 7.52 (1H, d, J 2.1 Hz, 2-H); δC (126 MHz, CDCl3) 56.2 (CH3), 56.4 (CH3), 
95.4 (CH), 102.4 (CH), 106.5 (CH), 119.1 (C), 144.0 (CH), 146.6 (C), 148.0 (C), 
149.7 (C); m/z (ESI) 201 (MNa+. 100%). 
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8-Methoxy-2,3,4,5-tetrahydrocyclohexabenzo[b]furan (192g)543 
 
8-Methoxy-2,3,4,5-tetrahydrocyclohexabenzo[b]furan (192g) was synthesised 
according to method C using 2′-(3-methoxyphenyl)cyclohexanone (189a) (0.0598 g, 
0.290 mmol). The iodination step was carried out at 40 °C for 4 h and the O-arylation 
step at 130 °C for 22 h. Purification by flash column chromatography (hexane/diethyl 
ether, 19:1) gave 8-methoxy-2,3,4,5-tetrahydrocyclohexabenzo[b]furan (192g) 
(0.0314 g, 53%) as a colourless oil. Spectroscopic data were consistent with the 
literature.543 δH (400 MHz, CDCl3) 1.80–1.96 (4H, m, 3-H2 and 4-H2), 2.55–2.62 (2H, 
m, 2-H2 or 5-H2), 2.68–2.74 (2H, m, 2-H2 or 5-H2), 3.84 (3H, s, OCH3), 6.78 (1H, dd, 
J 8.8, 2.6 Hz, 8-H), 6.87 (1H, d, J 2.6 Hz, 6-H), 7.27 (1H, d, J 8.8 Hz, 9-H); δC (101 
MHz, CDCl3) 20.5 (CH2), 22.7 (CH2), 23.0 (CH2), 23.6 (CH2), 56.0 (CH3), 101.6 (CH), 
111.0 (CH), 111.1 (CH), 113.0 (C), 129.4 (C), 149.2 (C), 155.0 (C), 155.7 (C); m/z 
(ESI) 225 (MNa+. 100%). 
9-Methoxy-6,7-dihydronaphthobenzo[b]furan (192h) 
 
9-Methoxy-6,7-dihydronaphthobenzo[b]furan (192h) was synthesised according to 
method C using 2′-(3-methoxyphenyl)-3′,4′-dihydronaphthalen-1′(2H)-one (189b) 
(0.0630 g, 0.250 mmol). The iodination step was carried out at 50 °C for 6 h and the 
O-arylation step at 130 °C for 24 h. Purification by flash column chromatography 
(hexane/diethyl ether, 19:1) gave 9-methoxy-6,7-dihydronaphthobenzo[b]furan 
(192h) (0.0382 g, 61%) as a white solid. Mp 185–188 °C; νmax/cm−1 (neat) 2934 
(CH), 1611, 1477, 1456, 1433, 1229, 1196, 1177, 1140, 1084, 1026, 797, 760; δH 
(500 MHz, CDCl3) 2.91 (2H, dd, J 8.0, 7.5 Hz, 7-H2), 3.08 (2H, dd, J 8.0, 7.5 Hz, 6-
H2), 3.85 (3H, s, OCH3), 6.85 (1H, dd, J 8.9, 2.7 Hz, 10-H), 6.93 (1H, d, J 2.7 Hz, 8-
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H), 7.18 (1H, td, J 7.5, 1.0 Hz, 4-H), 7.20–7.24 (1H, m, 5-H), 7.27 (1H, br t, J 7.5 Hz, 
3-H), 7.38 (1H, d, J 8.9 Hz, 11-H), 7.62 (1H, br d, J 7.5 Hz, 2-H); δC (126 MHz, 
CDCl3) 19.4 (CH2), 28.7 (CH2), 56.0 (CH3), 101.9 (CH), 111.8 (CH), 112.5 (CH), 
114.2 (C), 120.5 (CH), 126.9 (CH), 127.6 (CH), 127.9 (C), 128.0 (CH), 128.8 (C), 
136.0 (C), 150.3 (C), 152.7 (C), 156.1 (C); m/z (ESI) 273.0887 (MNa+. C17H14NaO2 
requires 273.0886). 
8-Methoxy-2,3,4,5-tetrahydrocycloheptabenzo[b]furan (192i) 
 
8-Methoxy-2,3,4,5-tetrahydrocycloheptabenzo[b]furan (192i) was synthesised 
according to method C using 2′-(3-methoxyphenyl)cycloheptanone (189c) (0.0639 
g, 0.290 mmol). The iodination step was carried out at 40 °C for 4 h and the O-
arylation step at 130 °C for 36 h. Purification by flash column chromatography 
(hexane/diethyl ether, 19:1) gave 8-methoxy-2,3,4,5-
tetrahydrocycloheptabenzo[b]furan (192i) (0.0362 g, 57%) as a colourless oil. 
νmax/cm−1 (neat) 2922 (CH), 1612, 1476, 1454, 1204, 1032, 800; δH (500 MHz, 
CDCl3) 1.73–1.88 (6H, m, 3-H2, 4-H2 and 5-H2), 2.65 (2H, dd, J 6.1, 5.5 Hz, 2-H2 or 
6-H2), 2.89 (2H, dd, J 6.1, 5.5 Hz, 2-H2 or 6-H2), 3.83 (3H, s, OCH3), 6.77 (1H, dd, J 
8.8, 2.6 Hz, 9-H), 6.86 (1H, d, J 2.6 Hz, 7-H), 7.23 (1H, d, J 8.8 Hz, 10-H); δC (126 
MHz, CDCl3) 23.3 (CH2), 26.3 (CH2), 28.2 (CH2), 29.2 (CH2), 30.6 (CH2), 56.0 (CH3), 
101.4 (CH), 110.8 (CH), 111.0 (CH), 116.0 (C), 131.0 (C), 148.2 (C), 155.6 (C), 
157.4 (C); m/z (ESI) 239.1033 (MNa+. C14H16NaO2 requires 239.1043). 
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2-(4′-Chlorophenyl)-5-methylbenzo[b]furan (195)544 
 
N-Iodosuccinimide (0.0439 g, 0.195 mmol) and iron(III) chloride (1.59 mg, 0.00980 
mmol) were dissolved in [BMIM]NTf2 (0.3 mL) and stirred at room temperature for 
0.5 h. 1′-(3-Methylphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (180b) (0.0478 g, 0.195 
mmol) in [BMIM]NTf2 (0.2 mL) was added to this suspension and the reaction 
mixture was heated to 70 °C for 16 h. After cooling to room temperature, the reaction 
mixture was extracted into hexane/ethyl acetate, 19:1 (3 × 20 mL). The combined 
organic extracts were washed with 1 M aqueous sodium thiosulfate (50 mL), brine 
(50 mL), dried (MgSO4), filtered and concentrated in vacuo. The crude residue was 
passed through a flash column, eluting with hexane/ethyl acetate, 19:1, which gave 
1′-(3-methyl-6-iodophenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (193) and 1′-(3-methyl-
4-iodophenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (194) in a 4:1 mixture (0.0398 g). 
This mixture was used without further purification in the next step. The 4:1 mixture 
of 1′-(3-methyl-6-iodophenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (193) and 1′-(3-
methyl-4-iodophenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (194) (0.0398 g, 0.0900 
mmol) was dissolved in toluene (1.0 mL) and copper iodide (1.30 mg, 0.00670 
mmol), cesium carbonate (0.0437 g, 0.134 mmol), N,N′-dimethylethylenediamine 
(1.40 µL, 0.0134 mmol) and water (0.4 mL) were added. The reaction mixture was 
degassed under argon for 0.1 h and then heated to 130 °C for 24 h. The reaction 
mixture was then cooled to room temperature, diluted with ethyl acetate (10 mL) 
and washed with a 1 M aqueous sodium thiosulfate solution (10 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 10 mL) and the combined organic 
extracts were washed with brine (30 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography 
(hexane/dichloromethane, 9:1), followed by recrystallisation from hot acetonitrile 
gave 2-(4′-chlorophenyl)-5-methylbenzo[b]furan (195) (0.0103 g, 26% over two 
steps) as a colourless crystalline solid. Mp 183–185 °C (from acetonitrile) (lit.544 Mp 
185–187 °C); δH (500 MHz, CDCl3) 2.44 (3H, s, 5-CH3), 6.93 (1H, s, 3-H), 7.10 (1H, 
dd, J 8.4, 1.5 Hz, 6-H), 7.36 (1H, br s, 4-H), 7.37–7.43 (3H, m, 7-H, 3′-H and 5′-H), 
7.77 (2H, d, J 8.6 Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 21.3 (CH3), 101.5 (CH), 
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110.7 (CH), 120.8 (CH), 125.9 (CH), 126.1 (2 × CH), 129.0 (2 × CH), 129.1 (C), 
129.2 (C), 132.5 (C), 134.2 (C), 153.4 (C), 154.8 (C); m/z (EI) 242 (M+. 100%), 179 
(45), 178 (65), 89 (28). 
1′-(3-Methoxyphenyl)-2′-(4′′-nitrophenyl)ethan-2′-one (198) 
 
An oven-dried 2-neck flask was flushed with argon and charged with 3-
methoxyphenylacetic acid (128) (0.500 g, 3.00 mmol), methyl 4-nitrobenzoate 
(0.544 g, 3.00 mmol) and dry tetrahydrofuran (15 mL). The solution was cooled to –
78 °C and lithium bis(trimethylsilyl)amide (12.0 mL, 12.0 mmol; 1.0 M in 
tetrahydrofuran) was added dropwise. The resulting reaction mixture was stirred at 
–78 °C for 3 h and then warmed to –20 °C with stirring for 2 h. A saturated aqueous 
solution of ammonium chloride (25 mL) was added at –20 °C and the solution was 
extracted with diethyl ether (3 × 50 mL). The combined organic extracts were 
washed with brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave 1′-(3-methoxyphenyl)-2′-(4′′-nitrophenyl)ethan-2′-one (198) (0.136 g, 17%) as 
a yellow oil. νmax/cm−1 (neat) 2940 (CH), 1690 (C=O), 1601, 1522 (NO), 1491, 1346 
(NO), 1317, 1261, 1049, 854, 746; δH (400 MHz, CDCl3) 3.78 (3H, s, OCH3), 4.29 
(2H, s, 1′-H2), 6.77–6.86 (3H, m, 2-H, 4-H and 6-H), 7.25 (1H, t, J 7.8 Hz, 5-H), 8.13 
(2H, d, J 9.0 Hz, 2′′-H and 6′′-H), 8.28 (2H, d, J 9.0 Hz, 3′′-H and 5′′-H); δC (101 MHz, 
CDCl3) 46.1 (CH2), 55.2 (CH3), 112.6 (CH), 115.2 (CH), 121.6 (CH), 123.9 (2 × CH), 
129.6 (2 × CH), 130.0 (CH), 134.8 (C), 140.9 (C), 150.3 (C), 160.0 (C), 195.9 (C); 
m/z (ESI) 294.0747 (MNa+. C15H13NNaO4 requires 294.0737). 
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2-(4′-Nitrophenyl)-5-methoxybenzo[b]furan (199)363 
 
2-(4′-Nitrophenyl)-5-methoxybenzo[b]furan (199) was synthesised according to 
method A using 1′-(3-methoxyphenyl)-2′-(4′′-nitrophenyl)ethan-2′-one (198) (0.0610 
g, 0.225 mmol). The iodination step was carried out at 40 °C for 3 h and the O-
arylation at 130 °C for 20 h. Purification by flash column chromatography (petroleum 
ether/dichloromethane, 1:1) gave 2-(4′-nitrophenyl)-5-methoxybenzo[b]furan (199) 
(0.0380 g, 63%) as a yellow solid. Spectroscopic data were consistent with the 
literature.363 Mp 178–180 °C; δH (500 MHz, CDCl3) 3.87 (3H, s, OCH3), 6.98 (1H, 
dd, J 9.0, 2.6 Hz, 6-H), 7.07 (1H, d, J 2.6 Hz, 4-H), 7.17 (1H, s, 3-H), 7.44 (1H, d, J 
9.0 Hz, 7-H), 7.97 (2H, d, J 8.9 Hz, 2′-H and 6′-H), 8.29 (2H, d, J 8.9 Hz, 3′-H and 
5′-H); δC (126 MHz, CDCl3) 55.9 (CH3), 103.5 (CH), 105.2 (CH), 112.0 (CH), 115.0 
(CH), 124.3 (2 × CH), 125.1 (2 × CH), 129.2 (C), 136.3 (C), 147.2 (C), 150.6 (C), 
154.0 (C), 156.4 (C); m/z (ESI) 292 (MNa+. 100%). 
2-(4′-Aminophenyl)-5-methoxybenzo[b]furan (196)363 
 
To a stirred solution of 2-(4′-nitrophenyl)-5-methoxybenzo[b]furan (199) (0.0320 g, 
0.108 mmol) in ethanol (5 mL) was added tin dichloride dihydrate (0.122 g, 0.540 
mmol) and the resulting mixture was stirred under reflux for 16 h. After cooling to 
room temperature, sodium bicarbonate (6 mL) was added and the suspension was 
stirred for 0.1 h. The suspension was diluted with ethyl acetate (20 mL), filtered 
through Celite® and concentrated in vacuo. The crude residue was dissolved in ethyl 
acetate (20 mL) and washed with water (25 mL) and brine (25 mL). The organic 
phase was dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/dichloromethane, 1:1) gave 2-(4′-
aminophenyl)-5-methoxybenzo[b]furan (196) (0.0256 g, 90%) as a yellow solid. 
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Spectroscopic data were consistent with the literature.363 Mp 148–150 °C; δH (500 
MHz, CDCl3) 3.83 (2H, br s, NH2), 3.85 (3H, s, OCH3), 6.73 (2H, d, J 8.5 Hz, 3′-H 
and 5′-H), 6.75 (1H, br s, 3-H), 6.81 (1H, dd, J 8.8, 2.6 Hz, 6-H), 7.00 (1H, d, J 2.6 
Hz, 4-H), 7.35 (1H, d, J 8.8 Hz, 7-H), 7.64 (2H, d, J 8.5 Hz, 2′-H and 6′-H); δC (126 
MHz, CDCl3) 55.9 (CH3), 98.8 (CH), 103.1 (CH), 111.2 (CH), 111.8 (CH), 115.0 (2 
× CH), 121.1 (C), 126.3 (2 × CH), 130.2 (C), 146.9 (C), 149.6 (C), 155.9 (C), 157.5 
(C); m/z (ESI) 240 (MH+. 100%). 
N-Methoxy-1′-(3,4-dimethoxyphenyl)-N-methylacetamide (201) 
 
N-Methoxy-1′-(3,4-dimethoxyphenyl)-N-methylacetamide (201) was synthesised as 
described for N-methoxy-1′-(3-methoxyphenyl)-N-methylacetamide (158) using 3,4-
dimethoxyphenylacetic acid (200) (1.00 g, 5.10 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1) gave N-methoxy-1′-(3,4-
dimethoxyphenyl)-N-methylacetamide (201) (0.730 g, 60%) as a colourless oil. 
νmax/cm−1 (neat) 2938 (CH), 1655 (C=O), 1514, 1260, 1236, 1153, 1140, 1026, 
1005, 787; δH (500 MHz, CDCl3) 3.20 (3H, s, N-CH3), 3.63 (3H, s, OCH3), 3.71 (2H, 
s, 1′-H2), 3.86 (3H, s, OCH3), 3.88 (3H, s, OCH3), 6.82 (2H, br s, 2-H and 5-H), 6.86 
(1H, br s, 6-H); δC (126 MHz, CDCl3) 32.3 (CH3), 38.9 (CH2), 55.9 (CH3), 55.9 (CH3), 
61.3 (CH3), 111.2 (CH), 112.5 (CH), 121.4 (CH), 127.4 (C), 147.9 (C), 148.9 (C), 
172.7 (C); m/z (ESI) 262.1049 (MNa+. C12H17NNaO4 requires 262.1050). 
1′-(3,4-Dimethoxyphenyl)butan-2′-one (202)545 
 
1′-(3,4-Dimethoxyphenyl)butan-2′-one (202) was synthesised as described for 1′-(3-
methoxyphenyl)-2′-(4′′-chlorophenyl)ethan-2′-one (157b) using N-methoxy-1′-(3,4-
dimethoxyphenyl)-N-methylacetamide (201) (0.700 g, 2.93 mmol) and 
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ethylmagnesium bromide (4.40 mL, 4.40 mmol; 1.0 M in tetrahydrofuran). 
Purification by flash column chromatography (hexane/ethyl acetate, 4:1) gave 1′-
(3,4-dimethoxyphenyl)butan-2′-one (202) (0.575 g, 94%) as a colourless oil. 
Spectroscopic data were consistent with the literature.545 δH (500 MHz, CDCl3) 1.03 
(3H, t, J 7.3 Hz, 4′-H3), 2.48 (2H, q, J 7.3 Hz, 3′-H2), 3.62 (2H, s, 1′-H2), 3.86 (3H, s, 
OCH3), 3.87 (3H, s, OCH3), 6.72 (1H, d, J 1.9 Hz, 2-H), 6.75 (1H, dd, J 8.2, 1.9 Hz, 
6-H), 6.83 (1H, d, J 8.2 Hz, 5-H); δC (126 MHz, CDCl3) 7.81 (CH3), 35.0 (CH2), 49.4 
(CH2), 55.9 (CH3), 55.9 (CH3), 111.4 (CH), 112.4 (CH), 121.5 (CH), 127.0 (C), 148.1 
(C), 149.1 (C), 209.4 (C); m/z (ESI) 231 (MNa+. 100%). 
2-Ethyl-5,6-dimethoxybenzo[b]furan (203) 
 
2-Ethyl-5,6-dimethoxybenzo[b]furan (203) was synthesised according to method C 
using 1′-(3,4-dimethoxyphenyl)butan-2′-one (202) (0.100 g, 0.480 mmol). The 
iodination step was carried out at 40 °C for 4 h and the O-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (hexane/diethyl ether, 9:1) 
gave 2-ethyl-5-methoxybenzo[b]furan (203) (0.0630 g, 64%) as a yellow oil. 
νmax/cm−1 (neat) 2940 (CH), 1622, 1487, 1319, 1209, 1192, 1115; δH (500 MHz, 
CDCl3) 1.31 (3H, t, J 7.6 Hz, 2-CH2CH3), 2.75 (2H, q, J 7.6 Hz, 2-CH2CH3), 3.90 
(6H, br s, 2 × OCH3), 6.26 (1H, br s, 3-H), 6.94 (1H, s, 7-H), 7.00 (1H, s, 4-H); δC 
(126 MHz, CDCl3) 12.1 (CH3), 21.8 (CH2), 56.3 (CH3), 56.5 (CH3), 95.3 (CH), 100.9 
(CH), 102.1 (CH), 120.7 (C), 146.2 (C), 147.0 (C), 149.1 (C), 160.0 (C); m/z (ESI) 
229.0832 (MNa+. C12H14NaO3 requires 229.0835). 
2-Acetyl-5,6-dimethoxybenzo[b]furan, caleprunin B (177)546 
 
To a stirred solution of 2-ethyl-5-methoxybenzo[b]furan (203) (0.0400 g, 0.190 
mmol) in anhydrous 1,4-dioxane (12 mL) was added selenium dioxide (0.0320 g, 
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0.290 mmol) and the resulting mixture was heated under reflux for 22 h. After cooling 
to room temperature, the reaction mixture was diluted with ethyl acetate (20 mL) 
and washed with water (30 mL). The aqueous layer was extracted with ethyl acetate 
(3 × 30 mL). The combined organic extracts were washed with brine (100 mL), dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (dichloromethane) gave 2-acetyl-5,6-dimethoxybenzo[b]furan 
(177) (0.0238 g, 56%) as a yellow oil. Spectroscopic data were consistent with the 
literature.546 δH (500 MHz, CDCl3) 2.56 (3H, s, 2-COCH3), 3.93 (3H, s, OCH3), 3.95 
(3H, s, OCH3), 7.04 (1H, s, 7-H), 7.06 (1H, s, 4-H), 7.42 (1H, s, 3-H); δC (126 MHz, 
CDCl3) 26.2 (CH3), 56.3 (CH3), 56.3 (CH3), 95.1 (CH), 102.8 (CH), 113.8 (CH), 119.1 
(C), 147.8 (C), 151.4 (C), 151.7 (C), 152.4 (C), 187.6 (C); m/z (ESI) 243 (MNa+. 
100%). 
Methyl 3,4-dihydroxybenzoate (207)547 
 
To a stirred solution of 3,5-dihydroxybenzoic acid (206) (2.00 g, 13.0 mmol) in 
methanol (40 mL) were added a few drops of concentrated sulfuric acid and the 
resulting mixture was stirred under reflux for 16 h. After cooling to room temperature, 
the methanol was removed in vacuo and the residue was dissolved in 
dichloromethane (50 mL). The solution was washed with water (4 × 50 mL) and 
brine (50 mL). The organic phase was dried (MgSO4), filtered and concentrated in 
vacuo and gave methyl 3,4-dihydroxybenzoate (207) (1.92 g, 88%) as a beige solid. 
Mp 161–163 °C (lit.547 164–165 °C); δH (500 MHz, DMSO-d6) 3.80 (3H, s, OCH3), 
6.46 (1H, t, J 2.3 Hz, 4-H), 6.84 (2H, d, J 2.3 Hz, 2-H and 6-H), 9.64 (2H, s, OH); δC 
(126 MHz, DMSO-d6) 52.4 (CH3), 107.6 (2 × CH), 107.6 (CH), 131.8 (C), 159.0 (2 × 
C), 166.7 (C); m/z (ESI) 191 (MNa+. 100%). 
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Methyl 3,5-bis(tert-butyldimethylsilyloxy)benzoate (208)548 
 
Methyl 3,4-dihydroxybenzoate (207) (1.00 g, 5.95 mmol) was dissolved in dry 
tetrahydrofuran (60 mL) and tert-butyldimethylsilyl chloride (2.25 g, 14.9 mmol), 
imidazole (1.22 g, 17.9 mmol) and 4-dimethylaminopyridine (0.0730 g, 0.595 mmol) 
were added. The resulting reaction mixture was stirred at room temperature for 16 
h. Water (50 mL) was added and the mixture was extracted with diethyl ether (3 × 
100 mL). The combined organic extracts were washed with saturated sodium 
hydrogen carbonate (150 mL), brine (150 mL), dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (hexane/diethyl 
ether, 19:1) gave methyl 3,5-bis(tert-butyldimethylsilyloxy)benzoate (208) (1.90 g, 
81%) as a colourless oil. Spectroscopic data were consistent with the literature.548 
δH (500 MHz, CDCl3) 0.21 (12H, s, 2 × Si(CH3)2), 0.98 (18H, s, 2 × Si(CH3)3), 3.88 
(3H, s, OCH3), 6.52 (1H, t, J 2.3 Hz, 4-H), 7.12 (2H, d, J 2.3 Hz, 2-H and 6-H); δC 
(126 MHz, CDCl3) −4.4 (4 × CH3), 18.2 (2 × C), 25.7 (6 × CH3), 52.1 (CH3), 114.6 (2 
× CH), 116.8 (CH), 131.9 (C), 156.5 (2 × C), 166.8 (C); m/z (ESI) 419 (MNa+. 100%). 
1′-(3,4-Dimethoxyphenyl)-2′-(3′′,5′′-bis[tert-
butyldimethylsilyloxy]phenyl)ethan-2′-one (209) 
 
1′-(3,4-Dimethoxyphenyl)-2′-(3′′,5′′-bis[tert-butyldimethylsilyloxy]phenyl)ethan-2′-
one (209) was synthesised as described for 1′-(3-methoxyphenyl)-2′-(3′′-
chlorophenyl)ethan-2′-one (181a) using 3,4-dimethoxyphenylacetic acid (200) 
(0.500 g, 2.55 mmol) and methyl 3,5-bis(tert-butyldimethylsilyloxy)benzoate (208) 
(1.01 g, 2.55 mmol). Purification by flash column chromatography (hexane/diethyl 
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ether, 4:1) gave 1′-(3,4-dimethoxyphenyl)-2′-(3′′,5′′-bis[tert-
butyldimethylsilyloxy]phenyl)ethan-2′-one (209) (0.821 g, 62%) as a yellow oil. 
νmax/cm−1 (neat) 2930 (CH), 1682 (C=O), 1585, 1437, 1335, 1260, 1236, 1163, 
1028, 829, 781; δH (500 MHz, CDCl3) 0.19 (12H, s, 2 × Si(CH3)2), 0.97 (18H, s, 2 × 
SiC(CH3)3), 3.85 (6H, br s, 2 × OCH3), 4.14 (2H, s, 1′-H2), 6.52 (1H, t, J 2.2 Hz, 4′′-
H), 6.75–6.85 (3H, m, 2-H, 5-H and 6-H), 7.07 (2H, d, J 2.2 Hz, 2′′-H and 6′′-H); δC 
(126 MHz, CDCl3) −4.4 (4 × CH3), 18.2 (2 × C), 25.6 (6 × CH3), 45.4 (CH2), 55.8 
(CH3), 55.9 (CH3), 111.4 (CH), 112.5 (CH), 113.6 (2 × CH), 117.0 (CH), 121.5 (CH), 
127.1 (C), 138.4 (C), 148.0 (C), 149.1 (C), 156.8 (2 × C), 197.4 (C); m/z (ESI) 
539.2617 (MNa+. C28H44NaO5Si2 requires 539.2619). 
2-(3′,5′-Bis[tert-butyldimethylsilyloxy]phenyl)-5,6-dimethoxybenzo[b]furan 
(212) 
 
2-(3′,5′-Bis[tert-butyldimethylsilyloxy]phenyl)-5,6-dimethoxybenzo[b]furan (212) 
was synthesised according to method A using 1′-(3,4-dimethoxyphenyl)-2′-(3′′,5′′-
bis[tert-butyldimethylsilyloxy])ethan-2′-one (209) (0.0690 g, 0.130 mmol). The 
iodination step was carried out at 40 °C for 4 h and the O-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (hexane/diethyl ether, 4:1) 
gave 2-(3′,5′-bis[tert-butyldimethylsilyloxy]phenyl)-5,6-dimethoxybenzo[b]furan 
(212) (0.0261 g, 36%) as a colourless oil. νmax/cm−1 (neat) 2930 (CH), 1589, 1435, 
1342, 1163, 1028, 907, 829, 781; δH (500 MHz, CDCl3) 0.24 (12H, s, 2 × Si(CH3)), 
1.01 (18H, s, 2 × SiC(CH3)3), 3.93 (3H, s, OCH3), 3.95 (3H, s, OCH3), 6.30 (1H, t, J 
2.2 Hz, 4′-H), 6.86 (1H, br s, 3-H), 6.91 (2H, d, J 2.2 Hz, 2′-H and 6′-H), 7.00 (1H, s, 
7-H), 7.10 (1H, s, 4-H); δC (126 MHz, CDCl3) −4.3 (4 × CH3), 18.3 (2 × C), 25.7 (6 × 
CH3), 56.3 (CH3), 56.4 (CH3), 95.3 (CH), 101.7 (CH), 102.1 (CH), 109.6 (2 × CH), 
111.9 (CH), 121.0 (C), 132.3 (C), 146.6 (C), 148.1 (C), 149.6 (C), 154.9 (C), 156.9 
(2 × C); m/z (ESI) 537.2441 (MNa+. C28H42NaO5Si2 requires 537.2463). 
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Methyl 3,5-bis(tert-butyldiphenylsilyloxy)benzoate (213) 
 
Methyl 3,5-bis(tert-butyldiphenylsilyloxy)benzoate (213) was synthesised as 
described for methyl 3,5-bis(tert-butyldimethylsilyloxy)benzoate (208) using methyl 
3,4-dihydroxybenzoate (207) (0.500 g, 2.97 mmol), tert-butyldiphenylsilyl chloride 
(1.93 mL, 7.43 mmol), imidazole (0.606 g, 8.91 mmol) and 4-dimethylaminopyridine 
(0.036 g, 0.297 mmol). Purification by flash column chromatography (hexane/ethyl 
acetate, 9:1) gave a colourless oil. Further purification by flash column 
chromatography (hexane/dichloromethane, 1:1) gave methyl 3,5-bis(tert-
butyldiphenylsilyloxy)benzoate (213) (1.14 g, 60%) as a colourless oil. νmax/cm−1 
(neat) 2932 (CH), 1724 (C=O), 1587, 1427, 1339, 1169, 1107, 1034, 1015, 822, 
756, 741, 698; δH (500 MHz, CDCl3) 0.98 (18H, s, 2 × SiC(CH3)3), 3.76 (3H, s, 
OCH3), 6.27 (1H, t, J 2.3 Hz, 4-H), 7.04 (2H, d, J 2.3 Hz, 2-H and 6-H), 7.25 (8H, t, 
J 7.5 Hz, ArH), 7.36 (4H, t, J 7.5 Hz, ArH), 7.49 (8H, d, J 7.5 Hz, ArH); δC (126 MHz, 
CDCl3) 19.4 (2 × C), 26.5 (6 × CH3), 52.0 (CH3), 114.3 (2 × CH), 116.0 (CH), 127.7 
(8 × CH), 129.8 (4 × CH), 131.5 (C), 132.3 (4 × C), 135.4 (8 × CH), 156.1 (2 × C), 
166.7 (C); m/z (ESI) 667.2648 (MNa+. C40H44NaO4Si2 requires 667.2670). 
1′-(3,4-Dimethoxyphenyl)-2′-(3′′,5′′-bis[tert-
butyldiphenylsilyloxy]phenyl)ethan-2′-one (214) 
 
1′-(3,4-Dimethoxyphenyl)-2′-(3′′,5′′-bis[tert-butyldiphenylsilyloxy]phenyl)ethan-2′-
one (214) was synthesised as described for 1′-(3-methoxyphenyl)-2′-(3′′-
chlorophenyl)ethan-2′-one (181a) using 3,4-dimethoxyphenylacetic acid (200) 
(0.184 g, 0.940 mmol) and methyl 3,5-bis(tert-butyldiphenylsilyloxy)benzoate (0.606 
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g, 0.940 mmol). Purification by flash column chromatography (hexane/ethyl acetate, 
7:3) gave a yellow oil. Further purification by flash column chromatography 
(hexane/diethyl ether, 4:1) gave 1′-(3,4-dimethoxyphenyl)-2′-(3′′,5′′-bis[tert-
butyldiphenylsilyloxy]phenyl)ethan-2′-one (214) (0.397 g, 55%) as a yellow foam. 
νmax/cm−1 (neat) 2932 (CH), 1682 (C=O), 1584, 1439, 1427, 1333, 1261, 1167, 
1113, 1028, 822, 737, 698; δH (500 MHz, CDCl3) 1.01 (18H, s, 2 × SiC(CH3)3), 3.71 
(2H, s, 1′-H2), 3.77 (3H, s, OCH3), 3.83 (3H, s, OCH3), 6.37 (1H, t, J 2.2 Hz, 4′′-H), 
6.43 (1H, dd, J 8.2, 1.9 Hz, 6-H), 6.57 (1H, d, J 1.9 Hz, 2-H), 6.65 (1H, d, J 8.2 Hz, 
5-H), 6.92 (2H, d, J 2.2 Hz, 2′′-H and 6′′-H), 7.26–7.31 (8H, m, ArH), 7.38 (4H, t, J 
7.4 Hz, ArH), 7.52–7.56 (8H, m, ArH); δC (126 MHz, CDCl3) 19.4 (2 × C), 26.5 (6 × 
CH3), 44.9 (CH2), 55.7 (CH3), 55.8 (CH3), 111.2 (CH), 112.2 (CH), 113.3 (2 × CH), 
116.4 (CH), 121.5 (CH), 126.9 (C), 127.7 (8 × CH), 129.9 (4 × CH), 132.4 (4 × C), 
135.4 (8 × CH), 137.9 (C), 147.8 (C), 148.9 (C), 156.4 (2 × C), 197.2 (C); m/z (ESI) 
787.3222 (MNa+. C48H52NaO5Si2 requires 787.3245). 
2-(3′,5′-Bis[tert-butyldiphenylsilyloxy]phenyl)-5,6-dimethoxybenzo[b]furan 
(215) 
 
2-(3′,5′-Bis[tert-butyldiphenylsilyloxy]phenyl)-5,6-dimethoxybenzo[b]furan (215) 
was synthesised according to method A using 1′-(3,4-dimethoxyphenyl)-2′-(3′′,5′′-
bis[tert-butyldiphenylsilyloxy])ethan-2′-one (214) (0.0820 g, 0.110 mmol). The 
iodination step was carried out at 40 °C for 5 h and the O-arylation step at 130 °C 
for 24 h. Purification by flash column chromatography (hexane/dichloromethane, 
1:1) gave 2-(3′,5′-bis[tert-butyldiphenylsilyloxy]phenyl)-5,6-dimethoxybenzo[b]furan 
(215) (0.0450 g, 55%) as a yellow oil. νmax/cm−1 (neat) 2932 (CH), 1589, 1427, 1169, 
1113, 907, 700; δH (500 MHz, CDCl3) 1.02 (18H, s, 2 × SiC(CH3)3), 3.91 (3H, s, 
OCH3), 3.93 (3H, s, OCH3), 6.09 (1H, t, J 2.2 Hz, 4′-H), 6.51 (1H, s, 3-H), 6.81 (2H, 
d, J 2.2 Hz, 2′-H and 6′-H), 6.92 (1H, s, 7-H), 7.01 (1H, s, 4-H), 7.28 (8H, t, J 7.6 Hz, 
ArH), 7.38 (4H, tt, J 7.6, 1.3 Hz, ArH), 7.54–7.60 (8H, m, ArH); δC (126 MHz, CDCl3) 
19.5 (2 × C), 26.6 (6 × CH3), 56.3 (CH3), 56.4 (CH3), 95.3 (CH), 101.5 (CH), 102.1 
(CH), 109.2 (2 × CH), 111.3 (CH), 121.0 (C), 127.7 (8 × CH), 129.8 (4 × CH), 131.9 
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(C), 132.7 (4 × C), 135.4 (8 × CH), 146.6 (C), 148.0 (C), 149.5 (C), 154.8 (C), 156.5 
(2 × C); m/z (ESI) 785.3087 (MNa+. C48H50NaO5Si2 requires 785.3089). 
2-(3′,5′-Dihydroxyphenyl)-5,6-dimethoxybenzo[b]furan, moracin F (178)377 
 
To a stirred solution of 2-(3′,5′-bis[tert-butyldiphenylsilyloxy]phenyl)-5,6-
dimethoxybenzo[b]furan (215) (0.0330 g, 0.0430 mmol) in dry tetrahydrofuran (4.0 
mL) was added tetrabutylammonium fluoride solution (0.110 mL, 0.108 mmol; 1.0 
M in tetrahydrofuran) at 0 °C. The resulting solution was warmed to room 
temperature and stirred for 2 h. The reaction mixture was quenched with water (5 
mL) and extracted with ethyl acetate (3 × 20 mL). The combined organic extracts 
were washed with brine (50 mL), dried (MgSO4), filtered and concentrated. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 1:1) 
gave 2-(3′,5′-dihydroxyphenyl)-5,6-dimethoxybenzo[b]furan (178) (0.00850 g, 69%) 
as a white solid. Mp 180–182 °C (lit.377 Mp 186–188 °C); δH (400 MHz, CD3OD) 3.86 
(3H, s, OCH3), 3.89 (3H, s, OCH3), 6.25 (1H, t, J 2.2 Hz, 4′-H), 6.76 (2H, d, J 2.2 Hz, 
2′-H and 6′-H), 6.93 (1H, br s, 3-H), 7.10 (1H, s, 7-H), 7.17 (1H, br s, 4-H); δC (101 
MHz, CD3OD) 55.5 (CH3), 55.7 (CH3), 95.3 (CH), 101.1 (CH), 102.2 (CH), 102.5 (2 
× CH), 102.9 (CH), 121.4 (C), 132.4 (C), 146.8 (C), 148.3 (C), 149.6 (C), 155.3 (C), 
158.6 (2 × C); m/z (ESI) 309 (MNa+. 100%). 
1′-(3-Nitrophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (218) 
 
To a stirred solution of 1′-(3-nitrophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-one (184d) 
(0.455 g, 1.68 mmol) in dry tetrahydrofuran (20 mL) was added lithium 
bis(trimethylsilyl)amide (1.85 mL, 1.85 mmol; 1.0 M in tetrahydrofuran) dropwise at 
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–78 °C. The reaction mixture was stirred at –78 °C for 0.5 h before methyl iodide 
(0.313 mL, 5.03 mmol) was added dropwise. The resulting solution was stirred for 
1 h at –78 °C, then slowly warmed to 0 °C and stirred for a further 1 h. A saturated 
solution of ammonium chloride (20 mL) was added at 0 °C and the solution was 
extracted with diethyl ether (4 × 50 mL). The combined organic extracts were 
washed with brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 4:1) 
gave 1′-(3-nitrophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (218) (0.454 g, 
95%) as a colourless oil. νmax/cm−1 (neat) 2934 (CH), 1672 (C=O), 1599, 1528 1510, 
1348, 1254, 1221, 1171; δH (500 MHz, CDCl3) 1.58 (3H, d, J 6.9 Hz, 1′-CH3), 3.84 
(3H, s, OCH3), 4.80 (1H, q, J 6.9 Hz, 1′-H), 6.91 (2H, d, J 9.1 Hz, 3′′-H and 5′′-H), 
7.47 (1H, t, J 8.1 Hz, 5-H), 7.64 (1H, br dt, J 8.1, 1.0 Hz, 6-H), 7.95 (2H, d, J 9.1 Hz, 
2′′-H and 6′′-H), 8.08 (1H, ddd, J 8.1, 2.2, 1.0 Hz, 4-H), 8.20 (1H, t, J 2.2 Hz, 2-H); 
δC (126 MHz, CDCl3) 19.5 (CH3), 46.7 (CH), 55.5 (CH3), 114.0 (2 × CH), 122.0 (CH), 
123.0 (CH), 128.8 (C), 129.8 (CH), 131.0 (2 × CH), 133.9 (CH), 143.7 (C), 148.6 
(C), 163.7 (C), 197.8 (C); m/z (ESI) 308.0882 (MNa+. C16H15NNaO4 requires 
308.0893). 
1′-(3-Aminophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (217) 
 
1′-(3-Aminophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (217) was 
synthesised as described for 1′-(3-aminophenyl)-2′-(4′′-methoxyphenyl)ethan-2′-
one (185) using 1′-(3-nitrophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one 
(218) (0.440 g, 1.54 mmol) and tin dichloride dihydrate (1.74 g, 7.72 mmol) in 
ethanol (25 mL). The reaction mixture was stirred under reflux for 24 h. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 7:3) gave 1′-(3-
aminophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (217) (0.311 g, 79%) as 
a brown oil. νmax/cm−1 (neat) 3453 (NH), 3368 (NH), 2932 (CH), 1668 (C=O), 1597, 
1574, 1246, 1219, 1173, 961, 845; δH (400 MHz, CDCl3) 1.47 (3H, d, J 6.9 Hz, 1′-
CH3), 3.55 (2H, br s, NH2), 3.81 (3H, s, OCH3), 4.52 (1H, q, J 6.9 Hz, 1′-H), 6.52 
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(1H, ddd, J 7.9, 2.4, 1.0 Hz, 4-H), 6.59 (1H, t, J 2.4 Hz, 2-H), 6.69 (1H, br dd, J 7.9, 
2.4 Hz, 6-H), 6.85 (2H, d, J 9.0 Hz, 3′′-H and 5′′-H), 7.07 (1H, t, J 7.9 Hz, 5-H), 7.94 
(2H, d, J 9.0 Hz, 2′′-H and 6′′-H); δC (101 MHz, CDCl3) 19.4 (CH3), 47.6 (CH), 55.4 
(CH3), 113.6 (2 × CH), 113.8 (CH), 114.2 (CH), 118.3 (CH), 129.6 (C), 129.8 (CH), 
131.1 (2 × CH), 143.2 (C), 146.6 (C), 163.2 (C), 198.9 (C); m/z (ESI) 278.1141 
(MNa+. C16H17NNaO2 requires 278.1151). 
1′-(3-Amino-6-iodophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (219) 
 
Iron(III) chloride (0.440 mg, 0.00270 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (2.30 µL, 0.00800 mmol) and 
stirred at room temperature for 0.5 h and then added to a stirred solution of 1′-(3-
aminophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (217) (0.0136 g, 0.0530 
mmol) in toluene (1.0 mL). This solution was cooled to –20 °C and N-
iodosuccinimide (0.0120 g, 0.0530 mmol) was slowly added. The resulting reaction 
mixture was stirred at –20 °C for 5 h. The reaction mixture was diluted with ethyl 
acetate (10 mL) and washed with a 1 M aqueous sodium thiosulfate solution (10 
mL). The aqueous layer was extracted with ethyl acetate (3 × 10 mL) and the 
combined organic extracts were washed with brine (30 mL). The organic phase was 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave 1′-(3-amino-6-
iodophenyl)-1′-methyl-2′-(4′′-methoxyphenyl)ethan-2′-one (219) (0.0133 g, 65%) as 
yellow oil. νmax/cm−1 (neat) 3474 (NH), 3366 (NH), 2930 (CH), 1670 (C=O), 1597, 
1470, 1261, 1242, 1169; δH (500 MHz, CDCl3) 1.39 (3H, d, J 6.8 Hz, 1′-CH3), 3.60 
(2H, br s, NH2), 3.82 (3H, s, OCH3), 4.77 (1H, q, J 6.8 Hz, 1′-H), 6.27 (1H, dd, J 8.5, 
2.8 Hz, 4-H), 6.43 (1H, d, J 2.8 Hz, 2-H), 6.87 (2H, d, J 9.0 Hz, 3′′-H and 5′′-H), 7.57 
(1H, d, J 8.5 Hz, 5-H), 7.90 (2H, d, J 9.0 Hz, 2′′-H and 6′′-H); δC (126 MHz, CDCl3) 
18.0 (CH3), 51.8 (CH), 55.4 (CH3), 85.7 (C), 113.7 (2 × CH), 114.3 (CH), 116.0 (CH), 
129.1 (C), 131.1 (2 × CH), 140.3 (CH), 145.3 (C), 147.3 (C), 163.3 (C), 198.8 (C); 
m/z (ESI) 404.0121 (MNa+. C16H16INNaO2 requires 404.0118). 
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4′-Chloro-N-(3,4-dimethoxyphenyl)benzamide (234c) 
 
4-Chlorobenzoic acid (0.399 g, 2.55 mmol) was dissolved in thionyl chloride (4.0 
mL) and the mixture was stirred under reflux for 1.5 h. After cooling to room 
temperature, the excess thionyl chloride was removed in vacuo. The resulting oil 
was dissolved in dry dichloromethane (10 mL) and the solution was cooled to 0 °C. 
3,4-Dimethoxyaniline (0.300 g, 1.96 mmol) and triethylamine (0.355 mL, 2.55 mmol) 
were added and the reaction mixture was stirred at 0 °C for 0.5 h, warmed to room 
temperature and stirred for 3 h. The reaction mixture was diluted with 
dichloromethane (20 mL) and washed with water (30 mL). The layers were 
separated and the aqueous layer was extracted with dichloromethane (2 × 30 mL). 
The combined organic extracts were washed with 1 M aqueous hydrochloric acid 
(60 mL), brine (60 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave 4′-chloro-N-(3,4-dimethoxyphenyl)benzamide (234c) (0.434 g, 78%) as a 
white solid. Mp 116–117 °C; νmax/cm−1 (neat) 3337 (NH), 2936 (CH), 1645 (C=O), 
1605 (C=C), 1510, 1487, 1464, 1450, 1406, 1260, 1231, 1026, 1015, 750; δH (500 
MHz, CDCl3) 3.86 (3H, s, OCH3), 3.86 (3H, s, OCH3), 6.82 (1H, d, J 8.6 Hz, 5-H), 
7.00 (1H, dd, J 8.6, 2.3 Hz, 6-H), 7.39–7.44 (3H, m, 2-H, 3′-H and 5′-H), 7.79 (2H, 
d, J 8.5 Hz, 2′-H and 6′-H), 7.95 (1H, br s, NH); δC (126 MHz, CDCl3) 55.9 (CH3), 
56.1 (CH3), 105.3 (CH), 111.3 (CH), 112.5 (CH), 128.4 (2 × CH), 129.0 (2 × CH), 
131.3 (C), 133.3 (C), 138.0 (C), 146.2 (C), 149.1 (C), 164.7 (C); m/z (ESI) 314.0561 
(MNa+. C15H1435ClNNaO3 requires 314.0554). 
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4′-Nitro-N-(3,4-dimethoxyphenyl)benzamide (234d)549 
 
To a stirred solution of 3,4-dimethoxyaniline (0.500 g, 3.26 mmol) in 
dichloromethane (20 mL) was added triethylamine (0.546 mL, 3.94 mmol). The 
resulting solution was cooled to 0 °C and 4-nitrobenzoyl chloride (0.727 g, 3.92 
mmol) was slowly added. The reaction mixture was stirred at 0 °C for 0.5 h, warmed 
to room temperature and stirred for 16 h. The resulting precipitate was collected, 
washed with dichloromethane (10 mL), 1 M aqueous hydrochloric acid (10 mL) and 
water (10 mL) then dried under high vacuum. This gave 4′-nitro-N-(3,4-
dimethoxyphenyl)benzamide (234d) (0.446 g, 45%) as a yellow crystalline solid. 
Spectroscopic data were consistent with the literature.549 Mp 171–174 °C (from 
chloroform); δH (500 MHz, DMSO-d6) 3.75 (3H, s, OCH3), 3.77 (3H, s, OCH3), 6.96 
(1H, d, J 8.7 Hz, 5-H), 7.35 (1H, dd, J 8.7, 1.5 Hz, 6-H), 7.46 (1H, d, J 1.5 Hz, 2-H), 
8.18 (2H, d, J 8.6 Hz, 2′-H and 6′-H), 8.37 (2H, d, J 8.6 Hz, 3′-H and 5′-H), 10.42 
(1H, br s, NH); δC (126 MHz, DMSO-d6) 55.9 (CH3), 56.2 (CH3), 106.0 (CH), 112.3 
(CH), 113.0 (CH), 124.0 (2 × CH), 129.5 (2 × CH), 132.6 (C), 141.2 (C), 146.0 (C), 
148.9 (C), 149.5 (C), 163.8 (C); m/z (ESI) 325 (MNa+. 100%). 
4′-Cyano-N-(3,4-dimethoxyphenyl)benzamide (234e) 
 
4′-Cyano-N-(3,4-dimethoxyphenyl)benzamide (234e) was synthesised as described 
for 4′-chloro-N-(3,4-dimethoxyphenyl)benzamide (234c) using 3,4-dimethoxyaniline 
(0.300 g, 1.96 mmol), 4-cyanobenzoic acid (0.375 g, 2.55 mmol), thionyl chloride 
(4.0 mL) and triethylamine (0.356 mL, 2.55 mmol). Purification by flash column 
chromatography (dichloromethane/ethyl acetate, 19:1) gave 4′-cyano-N-(3,4-
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dimethoxyphenyl)benzamide (234e) (0.402 g, 73%) as a yellow solid. Mp 183–185 
°C; νmax/cm−1 (neat) 3329 (NH), 2837 (CH), 2232 (CN), 1649 (C=O), 1510, 1464, 
1450, 1260, 1233, 1202, 1136, 1024, 752; δH (400 MHz, CDCl3) 3.86 (6H, s, 2 × 
OCH3), 6.83 (1H, d, J 8.5 Hz, 5-H), 7.02 (1H, d, J 8.5 Hz, 6-H), 7.41 (1H, s, 2-H), 
7.73 (2H, d, J 7.7 Hz, 2′-H and 6′-H), 7.95 (2H, d, J 7.7 Hz, 3′-H and 5′-H), 8.01 (1H, 
br s, NH); δC (101 MHz, CDCl3) 56.0 (CH3), 56.1 (CH3), 105.3 (CH), 111.3 (CH), 
112.6 (CH), 115.2 (C), 118.0 (C), 127.7 (2 × CH), 130.9 (C), 132.6 (2 × CH), 138.9 
(C), 146.5 (C), 149.1 (C), 163.9 (C); m/z (ESI) 305.0889 (MNa+. C16H14N2NaO3 
requires 305.0897). 
N-(3,4-Methylenedioxyphenyl)benzamide (234f)550 
 
N-(3,4-Methylenedioxyphenyl)thiobenzamide (234f) was synthesised as described 
for 4′-nitro-N-(3,4-dimethoxyphenyl)benzamide (234d) using 3,4-
methylenedioxyaniline (0.200 g, 1.46 mmol), benzoyl chloride (0.203 mL, 1.75 
mmol) and triethylamine (0.244 mL, 1.75 mmol). The reaction mixture was diluted 
with dichloromethane (30 mL) and washed with water (50 mL). The organic layer 
was separated and the aqueous layer was extracted with dichloromethane (2 × 50 
mL). The combined organic extracts were washed with 1 M aqueous hydrochloric 
acid (100 mL), brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/dichloromethane, 
9:1) gave N-(3,4-methylenedioxyphenyl)benzamide (234f) (0.213 g, 61%) as a 
white solid. Mp 133–135 °C (from chloroform) (lit.550 137–140 °C); δH (500 MHz, 
CDCl3) 5.97 (2H, s, OCH2O), 6.77 (1H, d, J 8.3 Hz, 5-H), 6.90 (1H, dd, J 8.3, 2.1 
Hz, 6-H), 7.35 (1H, br s, 2-H), 7.44–7.49 (2H, m, 3′-H and 5′-H), 7.51–7.56 (1H, m, 
4′-H), 7.80 (1H, br s, NH), 7.84 (2H, d, J 7.5 Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 
101.3 (CH2), 103.2 (CH), 108.1 (CH), 113.6 (CH), 127.0 (2 × CH), 128.8 (2 × CH), 
131.8 (CH), 132.1 (C), 134.9 (C), 144.5 (C), 147.9 (C), 165.7 (C); m/z (ESI) 264 
(MNa+. 100%). 
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4′-Chloro-N-(3,4-methylenedioxyphenyl)benzamide (234g) 
 
4′-Chloro-N-(3,4-methylenedioxyphenyl)benzamide (234g) was synthesised as 
described for 4′-chloro-N-(3,4-dimethoxyphenyl)benzamide (234c) using 3,4-
methylenedioxyaniline (0.500 g, 3.65 mmol), 4-chlorobenzoic acid (0.742 g, 4.74 
mmol), thionyl chloride (7.0 mL) and triethylamine (0.660 mL, 4.74 mmol). The 
reaction mixture was stirred at room temperature for 16 h. The crude residue was 
filtered through a short pad of silica, eluting with ethyl acetate, which gave 4′-chloro-
N-(3,4-methylenedioxyphenyl)benzamide (234g) (0.695 g, 69%) as a brown solid. 
Mp 185–187 °C; νmax/cm−1 (neat) 3300 (NH), 1645 (C=O), 1503, 1491, 1246, 1192, 
1038, 810; δH (500 MHz, DMSO-d6) 6.02 (2H, s, OCH2O), 6.90 (1H, d, J 8.4 Hz, 5-
H), 7.19 (1H, dd, J 8.4, 2.0 Hz, 6-H), 7.43 (1H, d, J 2.0 Hz, 2-H), 7.60 (2H, d, J 8.5 
Hz, 3′-H and 5′-H), 7.97 (2H, d, J 8.5 Hz, 2′-H and 6′-H), 10.22 (1H, br s, NH); δC 
(126 MHz, DMSO-d6) 101.5 (CH2), 103.0 (CH), 108.4 (CH), 113.9 (CH), 128.9 (2 × 
CH), 130.0 (2 × CH), 133.7 (C), 134.1 (C), 136.8 (C), 143.8 (C), 147.5 (C), 164.6 
(C); m/z (ESI) 298.0239 (MNa+. C14H1035ClNNaO3 requires 298.0241). 
N-(3-Methoxy-4-methylphenyl)benzamide (234h)551 
 
N-(3-Methoxy-4-methylphenyl)benzamide (234h) was synthesised as described for 
N-(3,4-methylenedioxyphenyl)benzamide (234f) using 3-methoxy-4-methylaniline 
(0.100 g, 0.730 mmol), benzoyl chloride (0.102 mL, 0.870 mmol) and triethylamine 
(0.121 mL, 0.870 mmol) in dichloromethane (10 mL). The reaction mixture was 
stirred at room temperature for 3 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 4:1) gave N-(3-methoxy-4-methylphenyl)benzamide 
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(234h) (0.156 g, 89%) as a white solid. Mp 126–128 °C (lit.551 130–131 °C); δH (400 
MHz, CDCl3) 2.19 (3H, s, 4-CH3), 3.84 (3H, s, OCH3), 6.89 (1H, dd, J 8.0, 2.0 Hz, 
6-H), 7.07 (1H, d, J 8.0 Hz, 5-H), 7.42–7.57 (4H, m, 2-H, 3′-H, 4’-H and 5′-H), 7.83–
7.88 (2H, m, 2′-H and 6′-H), 7.90 (1H, br s, NH); δC (101 MHz, CDCl3) 15.8 (CH3), 
55.4 (CH3), 103.1 (CH), 111.6 (CH), 122.9 (C), 127.0 (2 × CH), 128.8 (2 × CH), 
130.5 (CH), 131.8 (CH), 135.1 (C), 136.9 (C), 158.0 (C), 165.7 (C); m/z (ESI) 264 
(MNa+. 100%). 
4′-Chloro-N-(3-methoxy-4-methylphenyl)benzamide (234i) 
 
4′-Chloro-N-(3-methoxy-4-methylphenyl)benzamide (234i) was synthesised as 
described for 4′-chloro-N-(3,4-dimethoxyphenyl)benzamide (234c) using 3-
methoxy-4-methylaniline (0.100 g, 0.730 mmol), 4-chlorobenzoic acid (0.148 g, 
0.948 mmol), thionyl chloride (2.0 mL) and triethylamine (0.132 mL, 0.948 mmol). 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 9:1) 
gave 4′-chloro-N-(3-methoxy-4-methylphenyl)benzamide (234i) (0.176 g, 88%) as a 
white solid. Mp 160–162 °C; νmax/cm−1 (neat) 3296, 2918 (CH), 1641 (C=O), 1599 
(C=C), 1528, 1510, 1404, 1261, 1134, 843; δH (400 MHz, CDCl3) 2.20 (3H, s, 4-
CH3), 3.85 (3H, s, OCH3), 6.87 (1H, dd, J 8.0, 2.1 Hz, 6-H), 7.08 (1H, d, J 8.0 Hz, 5-
H), 7.42–7.48 (3H, m, 2-H, 3′-H and 5′-H), 7.75–7.82 (3H, m, NH, 2′-H and 6′-H); δC 
(101 MHz, CDCl3) 15.8 (CH3), 55.4 (CH3), 103.1 (CH), 111.6 (CH), 123.2 (C), 128.4 
(2 × CH), 129.1 (2 × CH), 130.5 (CH), 133.4 (C), 136.6 (C), 138.1 (C), 158.0 (C), 
164.6 (C); m/z (ESI) 298.0602 (MNa+. C15H1435ClNNaO2 requires 298.0605). 
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N-(3-Methoxyphenyl)benzamide (234j)552 
 
N-(3-Methoxyphenyl)benzamide (234j) was synthesised as described for N-(3,4-
methylenedioxyphenyl)benzamide (234f) using 3-methoxyaniline (0.500 g, 4.06 
mmol), benzoyl chloride (0.566 mL, 4.87 mmol) and triethylamine (0.677 mL, 4.87 
mmol) in dichloromethane (30 mL). The reaction mixture was stirred at room 
temperature for 3 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 4:1) gave purification by flash column chromatography 
(petroleum ether/ethyl acetate, 4:1) gave N-(3-methoxyphenyl)benzamide (234j) 
(0.891 g, 97%) as a white solid. Mp 109–111 °C (lit.552 112–114°C); δH (500 MHz, 
CDCl3) 3.80 (3H, s, OCH3), 6.70 (1H, ddd, J 8.2, 2.4, 1.0 Hz, 6-H), 7.11 (1H, br dd, 
J 8.2, 2.4 Hz, 4-H), 7.24 (1H, t, J 8.2 Hz, 5-H), 7.42–7.48 (3H, m, 2-H, 3′-H and 5′-
H), 7.50–7.55 (1H, m, 4′-H), 7.82–7.87 (2H, m, 2′-H and 6′-H), 7.97 (1H, br s, NH); 
δC (101 MHz, CDCl3) 55.3 (CH3), 105.8 (CH), 110.5 (CH), 112.3 (CH), 127.0 (2 × 
CH), 128.8 (2 × CH), 129.7 (CH), 131.8 (CH), 135.0 (C), 139.2 (C), 160.2 (C), 165.8 
(C); m/z (ESI) 250 (MNa+. 100%). 
4′-Fluoro-N-(3,4-dimethoxyphenyl)benzamide (234l) 
 
4′-Fluoro-N-(3,4-dimethoxyphenyl)benzamide (234l) was synthesised as described 
for 4′-chloro-N-(3,4-dimethoxyphenyl)benzamide (234c) using 3,4-dimethoxyaniline 
(0.300 g, 1.96 mmol), 4-fluorobenzoic acid (0.357 g, 2.55 mmol), thionyl chloride 
(4.0 mL) and triethylamine (0.356 mL, 2.55 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1) gave 4′-fluoro-N-(3,4-
dimethoxyphenyl)benzamide (234l) (0.304 g, 56%) as a white solid. Mp 153–155 
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°C; νmax/cm−1 (neat) 3292 (NH), 2839 (CH), 1638 (C=O), 1601 (C=C), 1508, 1449, 
1416, 1229, 1140, 1024, 843; δH (500 MHz, CDCl3) 3.86 (3H, s, OCH3), 3.86 (3H, 
s, OCH3), 6.82 (1H, d, J 8.6 Hz, 5-H), 7.00 (1H, dd, J 8.6, 2.4 Hz, 6-H), 7.12 (2H, t, 
J 8.6 Hz, 3′-H and 5′-H), 7.42 (1H, d, J 2.4 Hz, 2-H), 7.83–7.90 (2H, m, 2′-H and 5′-
H), 7.95 (1H, br s, NH); δC (101 MHz, CDCl3) 55.9 (CH3), 56.1 (CH3), 105.3 (CH), 
111.3 (CH), 112.5 (CH), 115.8 (2 × CH, d, 2JCF 21.8 Hz), 129.3 (2 × CH, d, 3JCF 9.0 
Hz), 131.1 (C, d, 4JCF 3.1 Hz), 131.4 (C), 146.2 (C), 149.1 (C), 164.7 (C), 164.8 (C, 
d, 1JCF 253.5 Hz); m/z (ESI) 298.0848 (MNa+. C15H14FNNaO3 requires 298.0850). 
N-(3,4-Dimethoxyphenyl)acetamide (234m)553 
 
To a stirred solution of 3,4-dimethoxyaniline (1.00 g, 6.53 mmol) in dichloromethane 
(40 mL) was added acetic anhydride (0.930 mL, 9.80 mmol). The resulting reaction 
mixture was stirred at room temperature for 3 h. A saturated aqueous solution of 
sodium bicarbonate (30 mL) was added, the layers separated and the aqueous layer 
was extracted with dichloromethane (2 × 40 mL). The combined organic extracts 
were washed with brine (100 mL), dried (MgSO4), filtered and concentrated in 
vacuo. Purification by flash column chromatography (ethyl acetate/petroleum ether, 
7:3) gave N-(3-methoxyphenyl)acetamide (234m) (1.02 g, 80%) as a pink solid. Mp 
127–129 °C (lit.553 130–131 °C); δH (500 MHz, CDCl3) 2.15 (3H, s, NHCOCH3), 3.85 
(6H, s, 2 × OCH3), 6.79 (1H, d, J 8.6 Hz, 5-H), 6.87 (1H, dd, J 8.6, 2.4 Hz, 6-H), 7.30 
(1H, dd, J 2.4 Hz, 2-H), 7.45 (1H, br s, NH); δC (126 MHz, CDCl3) 24.4 (CH3), 55.9 
(CH3), 56.1 (CH3), 105.1 (CH), 111.3 (CH), 112.0 (CH), 131.6 (C), 145.9 (C), 149.0 
(C), 168.4 (C); m/z (EI) 195 (M+. 100%), 153 (38), 138 (100), 110 (24). 
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N-(3,4-Dimethoxyphenyl)thiobenzamide (235a) 
 
To a stirred suspension of N-(3,4-dimethoxyphenyl)benzamide (234a) (0.100 g, 
0.340 mmol) in dry toluene (15 mL) was added Lawesson’s reagent (0.081 g, 0.200 
mmol) and the resulting reaction mixture was stirred under reflux for 4 h. After 
cooling to room temperature, the solvent was removed in vacuo and the crude 
residue was dissolved in ethyl acetate (20 mL). The organic layer was washed with 
water (3 × 20 mL), brine (20 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave N-(3,4-dimethoxyphenyl)thiobenzamide (235a) (0.0790 g, 74%) as a yellow 
solid. Mp 150–152 °C; νmax/cm−1 (neat) 3289 (NH), 2961 (CH), 1601, 1510, 1447, 
1263, 1231, 1132, 1024, 750, 692; δH (500 MHz, CDCl3) 3.90 (6H, s, 2 × OCH3), 
6.90 (1H, d, J 8.6 Hz, 5-H), 7.15 (1H, dd, J 8.6, 2.3 Hz, 6-H), 7.43 (2H, t, J 7.4 Hz, 
3′-H and 5′-H), 7.48–7.52 (1H, m, 4′-H), 7.59 (1H, br s, 2-H), 7.85 (2H, d, J 7.4 Hz, 
2′-H and 6′-H), 8.98 (1H, br s, NH); δC (101 MHz, CDCl3) 56.1 (CH3), 56.1 (CH3), 
107.9 (CH), 111.0 (CH), 116.0 (CH), 126.7 (2 × CH), 128.7 (2 × CH), 131.2 (CH), 
132.4 (C), 143.2 (C), 147.7 (C), 148.9 (C), 198.0 (C); m/z (ESI) 296.0715 (MNa+. 
C15H15NNaO2S requires 296.0716). 
4′-Methoxy-N-(3,4-dimethoxyphenyl)thiobenzamide (235b)554 
 
4′-Methoxy-N-(3,4-dimethoxyphenyl)thiobenzamide (235b) was synthesised as 
described for N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using 4′-methoxy-N-
(3,4-dimethoxyphenyl)benzamide (234b) (0.250 g, 0.870 mmol). Purification by 
flash column chromatography (dichloromethane) gave 4′-methoxy-N-(3,4-
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dimethoxyphenyl)thiobenzamide (235b) (0.244 g, 93%) as a yellow solid. 
Spectroscopic data were consistent with the literature.554 Mp 155–157 °C; δH (500 
MHz, CDCl3) 3.88 (3H, s, OCH3), 3.90 (3H, s, OCH3), 3.91 (3H, s, OCH3), 6.91 (1H, 
d, J 7.8 Hz, 5-H), 6.94 (2H, d, J 8.2 Hz, 3′-H and 5′-H), 7.13 (1H, d, J 7.8 Hz, 6-H), 
7.54 (1H, s, 2-H), 7.88 (2H, d, J 8.2 Hz, 2′-H and 6′-H), 8.96 (1H, br s, NH); δC (126 
MHz, CDCl3) 55.5 (CH3), 56.0 (2 × CH3), 108.3 (CH), 111.0 (2 × CH), 113.8 (CH), 
116.3 (CH), 128.6 (2 × CH), 132.6 (C), 135.3 (C), 147.6 (C), 148.9 (C), 162.3 (C), 
197.1 (C); m/z (ESI) 326 (MNa+. 100%). 
4′-Chloro-N-(3,4-dimethoxyphenyl)thiobenzamide (235c) 
 
4′-Chloro-N-(3,4-dimethoxyphenyl)thiobenzamide (235c) was synthesised as 
described for N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using 4′-chloro-N-(3,4-
dimethoxyphenyl)benzamide (234c) (0.200 g, 0.690 mmol). Purification by flash 
column chromatography (hexane/diethyl ether, 1:1) gave 4′-chloro-N-(3,4-
dimethoxyphenyl)thiobenzamide (235c) (0.141 g, 67%) as a yellow solid. Mp 159–
161 °C; νmax/cm−1 (neat) 3186 (NH), 2837 (CH), 1601, 1522, 1263, 1236, 1227, 
1163, 1134, 1090, 1028, 1003, 833; δH (500 MHz, CDCl3) 3.88 (3H, s, OCH3), 3.90 
(3H, s, OCH3), 6.89 (1H, d, J 8.6 Hz, 5-H), 7.13 (1H, dd, J 8.6, 2.2 Hz, 6-H), 7.39 
(2H, d, J 8.5 Hz, 3′-H and 5′-H), 7.53 (1H, d, J 2.2 Hz, 2-H), 7.78 (2H, d, J 8.5 Hz, 
2′-H and 6′-H), 8.98 (1H, br s, NH); δC (101 MHz, CDCl3) 56.0 (CH3), 56.1 (CH3), 
107.9 (CH), 111.0 (CH), 116.1 (CH), 128.0 (2 × CH), 128.8 (2 × CH), 132.2 (C), 
137.5 (C), 141.3 (C), 147.8 (C), 148.9 (C), 196.4 (C); m/z (ESI) 330.0322 (MNa+. 
C15H1435ClNNaO2S requires 330.0326). 
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4′-Fluoro-N-(3,4-dimethoxyphenyl)thiobenzamide (235d) 
 
4′-Fluoro-N-(3,4-dimethoxyphenyl)thiobenzamide (235d) was synthesised as 
described for N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using 4′-fluoro-N-(3,4-
dimethoxyphenyl)benzamide (234l) (0.269 g, 0.977 mmol) in toluene (30 mL) and 
tetrahydrofuran (10 mL). Purification by flash column chromatography 
(dichloromethane) gave 4′-fluoro-N-(3,4-dimethoxyphenyl)thiobenzamide (235d) 
(0.261 g, 94%) as a yellow solid. Mp 132–134 °C; νmax/cm−1 (neat) 3289 (NH), 2936 
(CH), 1599, 1464, 1261, 1227, 1157, 1132, 1022, 1001, 839, 723; δH (500 MHz, 
CDCl3) 3.85 (3H, s, OCH3), 3.87 (3H, s, OCH3), 6.87 (1H, d, J 8.6 Hz, 5-H), 7.08 
(2H, t, J 8.5 Hz, 3′-H and 5′-H), 7.12 (1H, dd, J 8.6, 2.2 Hz, 6-H), 7.49 (1H, d, J 2.2 
Hz, 2-H), 7.80–7.88 (2H, m, 2′-H and 6′-H), 9.05 (1H, br s, NH); δC (126 MHz, CDCl3) 
56.0 (CH3), 56.0 (CH3), 108.0 (CH), 110.9 (CH), 115.5 (2 × CH, d, 2JCF 21.8 Hz), 
116.2 (CH), 129.0 (2 × CH, d, 3JCF 8.9 Hz), 132.3 (C), 139.1 (C, d, 4JCF 2.7 Hz), 
147.7 (C), 148.9 (C), 164.5 (C, d, 1JCF 253.2 Hz), 196.5 (C); m/z (ESI) 314.0617 
(MNa+. C15H14FNNaO2S requires 314.0621). 
N-(3,4-Methylenedioxyphenyl)thiobenzamide (235e) 
 
N-(3,4-Methylenedioxyphenyl)thiobenzamide (235e) was synthesised as described 
for N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using N-(3,4-
methylenedioxyphenyl)benzamide (234f) (0.0975 g, 0.404 mmol) in toluene (20 mL) 
and tetrahydrofuran (2.0 mL). The crude residue was purified by flash column 
chromatography (petroleum ether/ethyl acetate, 4:1) to give a yellow oil. Further 
purification by flash column chromatography (hexane/dichloromethane, 1:1) gave 
3
4
5
6
1
2 H
N
S 2′
3′
4′
5′
6′
MeO
MeO
F
3
4
5
6
1
2 H
N
S 2′
3′
4′
5′
6′
O
O
 
317 
N-(3,4-methylenedioxyphenyl)thiobenzamide (235e) (0.0586 g, 56%) as a yellow 
crystalline solid. Mp 127–129 °C; νmax/cm−1 (neat) 3204 (NH), 2893 (CH), 1501, 
1485, 1447, 1346, 1248, 1227, 1190, 1036, 922, 731, 692; δH (500 MHz, CDCl3) 
6.01 (2H, s, OCH2O), 6.83 (1H, d, J 8.3 Hz, 5-H), 6.99 (1H, dd, J 8.3, 1.8 Hz, 6-H), 
7.37 (1H, d, J 1.8 Hz, 2-H), 7.42 (2H, t, J 7.4 Hz, 3′-H and 5′-H), 7.49 (1H, t, J 7.4 
Hz, 4′-H), 7.82 (2H, d, J 7.4 Hz, 2′-H and 6′-H), 8.93 (1H, br s, NH); δC (126 MHz, 
CDCl3) 101.7 (CH2), 106.1 (CH), 108.2 (CH), 117.7 (CH), 126.7 (2 × CH), 128.6 (2 
× CH), 131.3 (CH), 133.1 (C), 142.8 (C), 146.4 (C), 147.8 (C), 198.6 (C); m/z (ESI) 
280.0402 (MNa+. C14H11NNaO2S requires 280.0403). 
4′-Chloro-N-(3,4-methylenedioxyphenyl)thiobenzamide (235f) 
 
4′-Chloro-N-(3,4-methylenedioxyphenyl)thiobenzamide (235f) was synthesised as 
described for N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using 4′-chloro-N-(3,4-
methylenedioxyphenyl)benzamide (234g) (0.250 g, 0.907 mmol). Purification by 
flash column chromatography (dichloromethane/hexane, 3:2) gave 4′-chloro-N-(3,4-
methylenedioxyphenyl)thiobenzamide (235f) (0.208 g, 79%) as a yellow solid. Mp 
173–175 °C; νmax/cm−1 (neat) 3167 (NH), 1587, 1504, 1489, 1400, 1256, 1227, 
1088, 993, 837; δH (500 MHz, CDCl3) 6.02 (2H, s, OCH2O), 6.85 (1H, d, J 8.3 Hz, 
5-H), 6.99 (1H, dd, J 8.3 Hz, 6-H), 7.36 (1H, s, 2-H), 7.40 (2H, d, J 8.5 Hz, 3′-H and 
5′-H), 7.79 (2H, d, J 8.5 Hz, 2′-H and 6′-H), 8.86 (1H, br s, NH); δC (126 MHz, CDCl3) 
101.8 (CH2), 106.0 (CH), 108.2 (CH), 117.8 (CH), 128.1 (2 × CH), 128.8 (2 × CH), 
132.9 (C), 137.6 (C), 141.0 (C), 146.5 (C), 147.9 (C), 197.0 (C); m/z (ESI) 314.0015 
(MNa+. C14H1035ClNNaO2S requires 314.0013). 
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N-(3,4,5-Trimethoxyphenyl)thiobenzamide (235g) 
 
N-(3,4,5-Trimethoxyphenyl)thiobenzamide (235g) was synthesised as described for 
N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using N-(3,4,5-
trimethoxyphenyl)benzamide (0.300 g, 1.04 mmol). Purification by flash column 
chromatography (petroleum ether/diethyl ether, 1:1) gave N-(3,4,5-
trimethoxyphenyl)thiobenzamide (235g) (0.274 g, 87%) as a yellow solid. Mp 103–
105 °C; νmax/cm−1 (neat) 3202 (NH), 2936 (CH), 1597, 1499, 1447, 1329, 1233, 
1117, 1003, 943; δH (500 MHz, CDCl3) 3.84 (6H, s, 2 × OCH3), 3.85 (3H, s, OCH3), 
7.15 (2H, s, 2-H and 6-H), 7.42 (2H, t, J 7.4 Hz, 3′-H and 5′-H), 7.50 (1H, t, J 7.4 Hz, 
4′-H), 7.83 (2H, d, J 7.4 Hz, 2′-H and 6′-H), 9.13 (1H, br s, NH); δC (126 MHz, CDCl3) 
56.2 (CH3), 61.0 (2 × CH3), 101.1 (2 × CH), 126.7 (2 × CH), 128.6 (2 × CH), 131.2 
(CH), 135.0 (C), 136.4 (C), 143.3 (C), 153.2 (2 × C), 197.9 (C); m/z (ESI) 326.0816 
(MNa+. C16H17NNaO3S requires 326.0821). 
N-(3,4-Dimethoxyphenyl)thioacetamide (235h) 
 
N-(3,4-Dimethoxyphenyl)thioacetamide (235h) was synthesised as described for N-
(3,4-dimethoxyphenyl)thiobenzamide (235a) using N-(3-methoxyphenyl)acetamide 
(234m) (0.200 g, 1.02 mmol). Purification by flash column chromatography 
(dichloromethane to dichloromethane/ethyl acetate, 9:1) gave N-(3,4-
dimethoxyphenyl)thioacetamide (235h) (0.198 g, 92%) as a yellow solid. Mp 111–
112 °C; νmax/cm−1 (neat) 3285 (NH), 2934 (CH), 1603, 1512, 1462, 1375, 1261, 
1234, 1171, 1132 (C=S), 1022. NMR spectra showed a 10:1 mixture of rotamers. 
Only signals for the major rotamer are recorded. δH (400 MHz, DMSO-d6) 2.58 (3H, 
s, NHCSCH3), 3.73 (3H, s, OCH3), 3.76 (3H, s, OCH3), 6.96 (1H, d, J 8.7 Hz, 5-H), 
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7.31 (1H, dd, J 8.7, 2.4 Hz, 6-H), 7.57 (1H, d, J 2.4 Hz, 2-H), 11.47 (1H, br s, NH); 
δC (101 MHz, DMSO-d6) 35.5 (CH3), 56.0 (CH3), 56.1 (CH3), 108.2 (CH), 111.8 (CH), 
115.7 (CH), 133.5 (C), 147.1 (C), 148.5 (C), 198.4 (C); m/z (ESI) 234.0559 (MNa+. 
C10H13NNaO2S requires 234.0559). 
N-(4-Methylphenyl)thiobenzamide (235i)555 
 
N-(4-Methylphenyl)thiobenzamide (235i) was synthesised as described for N-(3,4-
dimethoxyphenyl)thiobenzamide (235a) using N-(4-methylphenyl)benzamide 
(234k) (0.500 g, 2.37 mmol). Purification by flash column chromatography 
(petroleum ether/dichloromethane, 1:1) gave N-(4-methylphenyl)thiobenzamide 
(235i) (0.293 g, 54%) as a yellow solid. Mp 116–118 °C (lit.555 116–117 °C); δH (400 
MHz, CDCl3) 2.38 (3H, s, 4-CH3), 7.23–7.27 (2H, m, 3-H and 5-H), 7.40–7.55 (3H, 
m, 3′-H, 4′-H and 5′-H), 7.63 (2H, d, J 8.1 Hz, 2-H and 6-H), 7.85 (2H, d, J 7.4 Hz, 
2′-H and 6′-H); δC (101 MHz, CDCl3) 21.2 (CH3), 123.8 (2 × CH), 126.7 (2 × CH), 
128.7 (2 × CH), 129.7 (2 × CH), 131.2 (CH), 136.5 (C), 137.1 (C), 143.2 (C), 198.4 
(C); m/z (ESI) 250 (MNa+. 100%). 
N-(3-Methoxy-4-methylphenyl)thiobenzamide (235j) 
 
N-(3-Methoxy-4-methylphenyl)thiobenzamide (235j) was synthesised as described 
for N-(3,4-dimethoxyphenyl)thiobenzamide (235a) using N-(3-methoxy-4-
methylphenyl)benzamide (234h) (0.297 g, 1.23 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave N-(3-methoxy-4-
methylphenyl)thiobenzamide (235j) (0.253 g, 80%) as a yellow solid. Mp 135–137 
°C νmax/cm−1 (neat) 3215 (NH), 2957 (CH), 1599, 1508, 1447, 1358, 1263, 1159, 
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1128, 1038, 1005, 692; δH (500 MHz, CDCl3) 2.23 (3H, s, 4-CH3), 3.85 (3H, s, 
OCH3), 7.03 (1H, d, J 7.8 Hz, 6-H), 7.16 (1H, d, J 7.8 Hz, 5-H), 7.43 (2H, t, J 7.5 Hz, 
3′-H and 5′-H), 7.47–7.52 (1H, m, 4′-H), 7.63 (1H, s, 2-H), 7.84 (2H, d, J 7.5 Hz, 2′-
H and 6′-H), 9.00 (1H, br s, NH); δC (126 MHz, CDCl3) 16.1 (CH3), 55.5 (CH3), 105.9 
(CH), 115.1 (CH), 125.7 (C), 126.6 (2 × CH), 128.7 (2 × CH), 130.5 (CH), 131.2 
(CH), 137.9 (C), 143.4 (C), 157.8 (C), 197.9 (C); m/z (ESI) 280.0763 (MNa+. 
C15H15NNaOS requires 280.0767). 
N-(3-Methoxyphenyl)thiobenzamide (235k)555 
 
N-(3-Methoxyphenyl)thiobenzamide (235k) was synthesised as described for N-
(3,4-dimethoxyphenyl)thiobenzamide (235a) using N-(3-methoxyphenyl)benzamide 
(234j) (0.864 g, 3.80 mmol). Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 4:1) gave a yellow oil. Further purification by flash 
column chromatography (petroleum ether/ethyl acetate, 9:1) gave N-(3-
methoxyphenyl)thiobenzamide (235k) (0.764 g, 83%) as a yellow solid. Mp 75–77 
°C (lit.555 79–80 °C); δH (400 MHz, CDCl3) 3.83 (3H, s, OCH3), 6.84 (1H, d, J 6.9 Hz, 
4-H), 7.16–7.54 (5H, m, Ph), 7.63 (1H, br s, 2-H), 7.75–7.88 (2H, m, 5-H and 6-H), 
9.00 (1H, br s, NH); δC (101 MHz, CDCl3) 55.5 (CH3), 109.0 (CH), 112.8 (CH), 115.6 
(2 × CH), 126.7 (CH), 128.7 (CH), 129.8 (2 × CH), 131.3 (CH), 140.2 (C), 143.4 (C), 
160.1 (C), 198.3 (C); m/z (ESI) 266 (MNa+. 100%). 
2-Phenyl-5,6-dimethoxy-1,3-benzoxazole (236a)556 
 
Iron(III) chloride (1.62 mg, 0.0100 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (8.70 µL, 0.0300 mmol) and 
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stirred for 0.5 h at room temperature and then added to a suspension of N-
bromosuccinimide (0.0360 g, 0.200 mmol) in toluene (0.5 mL). N-(3,4-
dimethoxyphenyl)benzamide (234a) (0.0510 g, 0.200 mmol) in toluene (0.5 mL) and 
acetonitrile (0.2 mL) was then added and the mixture was stirred at 40 °C for 4 h. 
Upon completion of the bromination step, the reaction mixture was cooled to room 
temperature, diluted with toluene (1.0 mL) and cesium carbonate (0.130 g, 0.400 
mmol), copper(I) iodide (3.80 mg, 0.0200 mmol), N,N′-dimethylethylenediamine 
(4.30 µL, 0.0400 mmol) and water (0.4 mL) were added. The reaction mixture was 
degassed under argon for 0.1 h and then heated to 130 °C for 18 h. The reaction 
mixture was then cooled to room temperature, diluted with ethyl acetate (10 mL) 
and washed with 1 M aqueous sodium thiosulfate solution (10 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 10 mL) and the combined organic 
extracts were washed with brine (30 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/ethyl acetate 7:3) gave 2-phenyl-5,6-dimethoxy-1,3-benzoxazole 
(236a) (0.0286 g, 57%) as a white solid. Mp 109–112 °C (lit.556 114–115 °C); δH 
(400 MHz, CDCl3) 3.95 (3H, s, OCH3), 3.96 (3H, s, OCH3), 7.13 (1H, s, 7-H), 7.25 
(1H, s, 4-H), 7.48–7.52 (3H, m, 3′-H, 4′-H and 5′-H), 8.16–8.20 (2H, m, 2′-H and 6′-
H); δC (101 MHz, CDCl3) 56.5 (CH3), 56.5 (CH3), 94.4 (CH), 101.8 (CH), 127.0 (2 × 
CH), 127.5 (C), 128.9 (2 × CH), 130.9 (CH), 135.0 (C), 145.2 (C), 147.8 (C), 148.4 
(C), 162.3 (C); m/z (ESI) 278 (MNa+. 100%). 
2-(4′-Methoxyphenyl)-5,6-dimethoxy-1,3-benzoxazole (236b) 
 
2-(4′-Methoxyphenyl)-5,6-dimethoxy-1,3-benzoxazole (236b) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using 4′-methoxy-N-
(3,4-dimethoxyphenyl)benzamide (234b) (0.0574 g, 0.200 mmol) in toluene (1.0 
mL) and acetonitrile (0.4 mL). The bromination step was carried out at 40 °C for 4 h 
and the O-arylation step at 130 °C for 48 h. Purification by flash column 
chromatography (hexane/ethyl acetate 4:1) gave 2-(4′-methoxyphenyl)-5,6-
dimethoxy-1,3-benzoxazole (236b) (0.0297 g, 52%) as a light yellow solid. Mp 118–
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120 °C; νmax/cm−1 (neat) 2928 (CH), 1605, 1481, 1250, 1219, 1128, 1057, 1018, 
837; δH (500 MHz, CDCl3) 3.88 (3H, s, OCH3), 3.94 (3H, s, OCH3), 3.95 (3H, s, 
OCH3), 7.01 (2H, d, J 8.9 Hz, 3′-H and 5′-H), 7.11 (1H, s, 7-H), 7.23 (1H, s, 4-H), 
8.11 (2H, d, J 8.9 Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 55.4 (CH3), 56.4 (CH3), 
56.5 (CH3), 94.3 (CH), 101.6 (CH), 114.3 (2 × CH), 120.1 (C), 128.7 (2 × CH), 135.0 
(C), 145.0 (C), 147.6 (C), 148.0 (C), 161.8 (C), 162.4 (C); m/z (ESI) 308.0883 (MNa+. 
C16H15NNaO4 requires 308.0893). 
2-(4′-Chlorophenyl)-5,6-dimethoxy-1,3-benzoxazole (236c) 
 
2-(4′-Chlorophenyl)-5,6-dimethoxy-1,3-benzoxazole (236c) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using 4′-chloro-N-
(3,4-dimethoxyphenyl)benzamide (234c) (0.0582 g, 0.200 mmol) in toluene (1.0 mL) 
and acetonitrile (0.2 mL). The bromination step was carried out at 40 °C for 4 h and 
the O-arylation step at 130 °C for 48 h. Purification by flash column chromatography 
(hexane/ethyl acetate 7:3) gave 2-(4′-chlorophenyl)-5,6-dimethoxy-1,3-benzoxazole 
(236c) (0.0382 g, 66%) as a light yellow solid. Mp 160–161 °C; νmax/cm−1 (neat) 
2928 (CH), 1481, 1159, 1134, 1007, 883, 824; δH (500 MHz, CDCl3) 3.95 (3H, s, 
OCH3), 3.96 (3H, s, OCH3), 7.11 (1H, s, 7-H), 7.23 (1H, s, 4-H), 7.46 (2H, d, J 8.7 
Hz, 3′-H and 5′-H), 8.09 (2H, d, J 8.7 Hz, 2′-H and 6′-H); δC (126 MHz, CDCl3) 56.4 
(CH3), 56.5 (CH3), 94.2 (CH), 101.7 (CH), 126.0 (C), 128.2 (2 × CH), 129.2 (2 × CH), 
134.8 (C), 137.0 (C), 145.2 (C), 147.9 (C), 148.6 (C), 161.2 (C); m/z (ESI) 312.0391 
(MNa+. C15H1235ClNNaO3 requires 312.0398). 
2-(4′-Nitrophenyl)-5,6-dimethoxy-1,3-benzoxazole (236d) 
 
2-(4′-Nitrophenyl)-5,6-dimethoxy-1,3-benzoxazole (236d) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using 4′-nitro-N-(3,4-
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dimethoxyphenyl)benzamide (234d) (0.0605 g, 0.200 mmol) in toluene (2.0 mL) and 
acetonitrile (0.5 mL). The bromination step was carried out at 40 °C for 3 h and the 
O-arylation step at 130 °C for 24 h. Purification by flash column chromatography 
(hexane/dichloromethane 4:1 to dichloromethane/ethyl acetate, 9:1) gave 2-(4′-
nitrophenyl)-5,6-dimethoxy-1,3-benzoxazole (236d) (0.0209 g, 35%) as a yellow 
solid. Mp 210–212 °C; νmax/cm−1 (neat) 2935 (CH), 1611, 1599, 1516, 1489, 1477, 
1346, 1323, 1294, 1275, 1192, 1134, 1003, 856, 700; δH (400 MHz, CDCl3) 3.90 
(3H, s, OCH3), 3.92 (3H, s, OCH3), 7.09 (1H, s, 7-H), 7.20 (1H, s, 4-H), 8.24–8.32 
(4H, m, 2′-H, 3′-H, 5′-H and 6′-H); δC (101 MHz, CDCl3) 56.5 (CH3), 56.6 (CH3), 94.2 
(CH), 101.8 (CH), 124.3 (2 × CH), 127.6 (2 × CH), 133.1 (C), 135.0 (C), 145.7 (C), 
148.4 (C), 148.9 (C), 149.6 (C), 159.8 (C); m/z (ESI) 323.0633 (MNa+. 
C15H12N2NaO5 requires 323.0638). 
2-(4′-Cyanophenyl)-5,6-dimethoxy-1,3-benzoxazole (236e) 
 
2-(4′-Cyanophenyl)-5,6-dimethoxy-1,3-benzoxazole (236e) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using 4′-cyano-N-
(3,4-dimethoxyphenyl)benzamide (234e) (0.0565 g, 0.200 mmol) in toluene (1.0 mL) 
and acetonitrile (1.0 mL). The bromination step was carried out at 40 °C for 4 h and 
the O-arylation step at 130 °C for 48 h. Purification by flash column chromatography 
(dichloromethane/ethyl acetate 19:1) gave 2-(4′-cyanophenyl)-5,6-dimethoxy-1,3-
benzoxazole (236e) (0.0286 g, 51%) as a white solid. Mp 247–248 °C; νmax/cm−1 
(neat) 2968 (CH), 2220 (CN), 1481, 1329, 1273, 1192, 1161, 1134, 1003, 887, 839; 
δH (400 MHz, CDCl3) 3.96 (3H, s, OCH3), 3.98 (3H, s, OCH3), 7.14 (1H, s, 7-H), 7.26 
(1H, s, 4-H), 7.78 (2H, d, J 8.4 Hz, 3′-H and 5′-H), 8.26 (2H, d, J 8.4 Hz, 2′-H and 6′-
H); δC (101 MHz, CDCl3) 56.5 (CH3), 56.5 (CH3), 94.2 (CH), 101.8 (CH), 113.9 (C), 
118.3 (C), 127.2 (2 × CH), 131.4 (C), 132.7 (2 × CH), 134.9 (C), 145.5 (C), 148.3 
(C), 149.4 (C), 160.1 (C); m/z (EI) 280.0860 (M+. C16H12N2O3 requires 280.0848), 
265 (62%), 237 (28), 130 (17), 109 (36), 81 (16). 
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2-Phenyl-5,6-methylenedioxy-1,3-benzoxazole (236f)557 
 
2-Phenyl-5,6-methylenedioxy-1,3-benzoxazole (236f) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using N-(3,4-
methylenedioxyphenyl)benzamide (234f) (0.0513 g, 0.213 mmol) in toluene (1.6 
mL) and tetrahydrofuran (0.4 mL). The bromination step was carried out at 40 °C for 
3 h and the O-arylation step at 130 °C for 20 h. Purification by flash column 
chromatography (hexane/diethyl ether, 19:1) gave 2-phenyl-5,6-methylenedioxy-
1,3-benzoxazole (236f) (0.0351 g, 69%) as a white solid. Mp 142–143 °C; (lit.557 
147–148 °C); δH (500 MHz, CDCl3) 6.03 (2H, s, OCH2O), 7.06 (1H, s, 7-H), 7.17 
(1H, s, 4-H), 7.46–7.52 (3H, m, 3′-H, 4′-H and 5′-H), 8.12–8.18 (2H, m, 2′-H and 6′-
H); δC (126 MHz, CDCl3) 92.6 (CH), 99.5 (CH), 101.7 (CH2), 126.9 (2 × CH), 127.4 
(C), 128.9 (2 × CH), 130.9 (CH), 136.1 (C), 145.7 (C), 145.8 (C), 146.4 (C), 162.6 
(C); m/z (ESI) 262 (MNa+. 100%).  
2-(4′-Chlorophenyl)-5,6-methylenedioxy-1,3-benzoxazole (236g)458 
 
2-(4′-Chlorophenyl)-5,6-methylenedioxy-1,3-benzoxazole (236g) was synthesised 
as described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using 4′-chloro-N-
(3,4-methylenedioxyphenyl)benzamide (234g) (0.0550 g, 0.200 mmol) in toluene 
(1.0 mL) and acetonitrile (1.0 mL). The bromination step was carried out at 40 °C 
for 3 h and the O-arylation step at 130 °C for 24 h. Purification by flash column 
chromatography (dichloromethane/hexane, 7:3) gave 2-(4′-chlorophenyl)-5,6-
methylenedioxy-1,3-benzoxazole (236g) (0.0412 g, 75%) as a white solid. 
Spectroscopic data were consistent with the literature.458 Mp 252–254 °C; δH (500 
MHz, DMSO-d6) 6.13 (2H, s, OCH2O), 7.36 (1H, s, 7-H), 7.49 (1H, s, 4-H), 7.65 (2H, 
d, J 8.6 Hz, 3′-H and 5′-H), 8.10 (2H, d, J 8.6 Hz, 2′-H and 6′-H); δC (126 MHz, 
DMSO-d6) 93.5 (CH2), 99.7 (CH), 102.4 (CH), 126.0 (C), 128.7 (2 × CH), 129.9 (2 × 
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CH), 135.8 (C), 136.4 (C), 145.9 (C), 146.1 (C), 146.9 (C), 161.2 (C); m/z (EI) 273 
(M+. 100%). 
2-Phenyl-5-methoxy-6-methyl-1,3-benzoxazole (236h)558 
 
2-Phenyl-5-methoxy-6-methyl-1,3-benzoxazole (236h) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using N-(3-methoxy-
4-methylphenyl)benzamide (234h) (0.0680 g, 0.280 mmol) in toluene (1.8 mL) and 
acetonitrile (0.2 mL). The bromination step was carried out at 40 °C for 3 h and the 
O-arylation step at 130 °C for 22 h. Purification by flash column chromatography 
(hexane/ethyl acetate 9:1) gave 2-phenyl-5-methoxy-6-methyl-1,3-benzoxazole 
(236h) (0.0416 g, 62%) as a white solid. Spectroscopic data were consistent with 
the literature.558 Mp 137–138 °C; δH (500 MHz, CDCl3) 2.34 (3H, s, 6-CH3), 3.89 
(3H, s, OCH3), 7.18 (1H, s, 4-H), 7.33 (1H, s, 7-H), 7.47–7.53 (3H, m, 3′-H, 4′-H and 
5′-H), 8.17–8.24 (2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 17.2 (CH3), 55.8 (CH3), 
100.4 (CH), 111.6 (CH), 125.3 (C), 127.3 (2 × CH), 127.5 (C), 128.9 (2 × CH), 131.1 
(CH), 140.7 (C), 145.0 (C), 155.7 (C), 162.7 (C); m/z (ESI) 262 (MNa+. 100%). 
2-(4′-Chlorophenyl)-5-methoxy-6-methyl-1,3-benzoxazole (236i) 
 
2-(4′-Chlorophenyl)-5-methoxy-6-methyl-1,3-benzoxazole (236i) was synthesised 
as described for 2-phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using 4′-chloro-N-
(3-methoxy-4-methylphenyl)benzamide (234i) (0.0700 g, 0.250 mmol) in toluene 
(2.5 mL) and tetrahydrofuran (1.0 mL). The bromination step was carried out at 40 
°C for 3 h and the O-arylation step at 130 °C for 18 h. Purification by flash column 
chromatography (hexane/diethyl ether, 19:1) gave 2-(4′-chlorophenyl)-5-methoxy-
6-methyl-1,3-benzoxazole (236i) (0.0502 g, 72%) as a white solid. Mp 141–143 °C; 
νmax/cm−1 (neat) 2926 (CH), 1597, 1468, 1402, 1271, 1196, 1155, 1057, 826; δH 
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(400 MHz, CDCl3) 2.33 (3H, s, 6-CH3), 3.88 (3H, s, OCH3), 7.15 (1H, s, 4-H), 7.30 
(1H, s, 7-H), 7.44 (2H, d, J 8.8 Hz, 3′-H and 5′-H), 8.10 (2H, d, J 8.8 Hz, 2′-H and 6′-
H); δC (101 MHz, CDCl3) 17.2 (CH3), 55.8 (CH3), 100.4 (CH), 111.5 (CH), 125.7 (C), 
126.0 (C), 128.5 (2 × CH), 129.2 (2 × CH), 137.2 (C), 140.6 (C), 145.0 (C), 155.8 
(C), 161.7 (C); m/z (ESI) 296.0443 (MNa+. C15H1235ClNNaO2 requires 296.0449). 
2-Phenyl-5-methoxy-1,3-benzoxazole (236j)557 
 
2-Phenyl-5-methoxy-1,3-benzoxazole (236j) was synthesised as described for 2-
phenyl-5,6-dimethoxy-1,3-benzoxazole (236a) using N-(3-
methoxyphenyl)benzamide (234j) (0.0460 g, 0.200 mmol). The bromination step 
was carried out at 40 °C for 3 h and the O-arylation step at 130 °C for 24 h. 
Purification by flash column chromatography (hexane/diethyl ether, 4:1) gave 2-
phenyl-5-methoxy-1,3-benzoxazole (236j) (0.0150 g, 33%) as a white solid. Mp 75–
77 °C (lit.557 79–80 °C); δH (500 MHz, CDCl3) 3.88 (3H, s, OCH3), 6.95 (1H, dd, J 
9.0, 2.6 Hz, 6-H), 7.27 (1H, d, J 2.6 Hz, 4-H), 7.46 (1H, d, J 9.0 Hz, 7-H), 7.49–7.55 
(3H, m, 3′-H, 4′-H and 5′-H), 8.20–8.26 (2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 
56.0 (CH3), 102.9 (CH), 110.7 (CH), 113.7 (CH), 127.3 (C), 127.5 (2 × CH), 128.9 
(2 × CH), 131.4 (CH), 143.0 (C), 145.4 (C), 157.4 (C), 163.8 (C); m/z (ESI) 248 
(MNa+. 100%). 
2-Phenyl-5,6-dimethoxy-1,3-benzothiazole (237a)559 
 
Iron(III) chloride (2.20 mg, 0.0138 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (12.0 µL, 0.0412 mmol) and 
stirred for 0.5 h at room temperature and then added to a solution of N-
bromosuccinimide (0.0538 g, 0.302 mmol) in acetonitrile (1.0 mL). N-(3,4-
Dimethoxyphenyl)thiobenzamide (235a) (0.0751 g, 0.275 mmol) in acetonitrile (2.0 
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mL) was then added and the mixture was stirred at 40 °C for 2 h. The reaction 
mixture was then cooled to room temperature, diluted with ethyl acetate (20 mL) 
and washed with 1 M aqueous sodium thiosulfate solution (20 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 20 mL) and the combined organic 
extracts were washed with brine (50 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography 
(hexane/ethyl acetate, 9:1 to 4:1) then recrystallisation from hot acetonitrile gave 2-
phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) (0.0402 g, 54%) as a yellow 
crystalline solid. Mp 123–125 °C (from acetonitrile) (lit.559 127–129 °C); δH (500 
MHz, CDCl3) 3.97 (3H, s, OCH3), 3.99 (3H, s, OCH3), 7.31 (1H, s, 7-H), 7.43–7.50 
(3H, m, 3′-H, 4′-H and 5′-H), 7.56 (1H, s, 4-H), 8.01–8.05 (2H, m, 2′-H and 6′-H); δC 
(126 MHz, CDCl3) 56.1 (CH3), 56.3 (CH3), 102.5 (CH), 104.8 (CH), 127.0 (2 × CH), 
127.1 (C), 129.0 (2 × CH), 130.4 (CH), 133.8 (C), 148.5 (C), 148.6 (C), 149.5 (C), 
166.3 (C); m/z (ESI) 272 (MH+. 100%). 
2-(4′-Methoxyphenyl)-5,6-dimethoxy-1,3-benzothiazole (237b)554 
 
2-(4′-Methoxyphenyl)-5,6-dimethoxy-1,3-benzothiazole (237b) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using 4′-methoxy-
N-(3,4-dimethoxyphenyl)thiobenzamide (235b) (0.0607 g, 0.200 mmol) in 
acetonitrile (2.6 mL) and dichloromethane (0.4 mL). The yellow precipitate was 
collected, washed with aqueous 1 M sodium thiosulfate solution (5 mL) and water 
(10 mL). Recrystallisation from hot acetonitrile gave 2-(4′-methoxyphenyl)-5,6-
dimethoxy-1,3-benzothiazole (237b) (0.0330 g, 55%) as a yellow crystalline solid. 
Mp 163–165 °C (from acetonitrile) (lit.554 159–160 °C); δH (500 MHz, CDCl3) 3.87 
(3H, s, OCH3), 3.96 (3H, s, OCH3), 3.98 (3H, s, OCH3), 6.98 (2H, d, J 8.9 Hz, 3′-H 
and 5′-H), 7.28 (1H, s, 7-H), 7.52 (1H, s, 4-H), 7.97 (2H, d, J 8.9 Hz, 2′-H and 6′-H); 
δC (126 MHz, CDCl3) 55.4 (CH3), 56.1 (CH3), 56.3 (CH3), 102.6 (CH), 104.6 (CH), 
114.3 (2 × CH), 126.7 (C), 126.7 (C), 128.5 (2 × CH), 148.3 (C), 148.6 (C), 149.4 
(C), 161.5 (C), 166.2 (C); m/z (EI) 301 (M+. 100%), 286 (30), 258 (16), 215 (12), 151 
(9), 125 (7), 82 (8). 
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2-(4′-Chlorophenyl)-5,6-dimethoxy-1,3-benzothiazole (237c) 
 
2-(4′-Chlorophenyl)-5,6-dimethoxy-1,3-benzothiazole (237c) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using 4′-chloro-N-
(3,4-dimethoxyphenyl)thiobenzamide (235c) (0.0363 g, 0.120 mmol) in acetonitrile 
(2.0 mL) and dichloromethane (0.2 mL). Purification by flash column 
chromatography (hexane/ethyl acetate, 7:3), followed by recrystallisation from hot 
acetonitrile gave 2-(4′-chlorophenyl)-5,6-dimethoxy-1,3-benzothiazole (237c) 
(0.0214 g, 59%) as a white crystalline solid. Mp 194–196 °C (from acetonitrile); 
νmax/cm−1 (neat) 2959 (CH), 1510, 1466, 1433, 1290, 1244, 1221, 1161, 1001, 835; 
δH (500 MHz, CDCl3) 3.97 (3H, s, OCH3), 3.98 (3H, s, OCH3), 7.29 (1H, s, 7-H), 7.44 
(2H, d, J 8.5 Hz, 3′-H and 5′-H), 7.53 (1H, s, 4-H), 7.95 (2H, d, J 8.5 Hz, 2′-H and 6′-
H); δC (126 MHz, CDCl3) 56.1 (CH3), 56.3 (CH3), 102.4 (CH), 104.7 (CH), 127.1 (C), 
128.2 (2 × CH), 129.2 (2 × CH), 132.4 (C), 136.4 (C), 148.5 (C), 148.8 (C), 149.6 
(C), 164.7 (C); m/z (ESI) 328.0158 (MNa+. C15H1235ClNNaO2S requires 328.0169). 
2-(4′-Fluorophenyl)-5,6-dimethoxy-1,3-benzothiazole (237d) 
 
2-(4′-Fluorophenyl)-5,6-dimethoxy-1,3-benzothiazole (237d) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using 4′-fluoro-N-
(3,4-dimethoxyphenyl)thiobenzamide (235d) (0.0583 g, 0.200 mmol). Purification by 
flash column chromatography (dichloromethane/hexane, 9:3 to dichloromethane), 
followed by recrystallisation from hot acetonitrile gave 2-(4′-fluorophenyl)-5,6-
dimethoxy-1,3-benzothiazole (237d) (0.0317 g, 55%) as a white crystalline solid. Mp 
146–148 °C (from acetonitrile); νmax/cm−1 (neat) 2936 (CH), 1520, 1468, 1435, 1285, 
1219, 1155, 999, 837; δH (500 MHz, CDCl3) 3.98 (3H, s, OCH3), 3.99 (3H, s, OCH3), 
7.16 (2H, t, J 8.6 Hz, 3′-H and 5′-H), 7.30 (1H, s, 7-H), 7.54 (1H, s, 4-H), 7.98–8.05 
(2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 56.1 (CH3), 56.4 (CH3), 102.5 (CH), 
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104.7 (CH), 116.1 (2 × CH, d, 2JCF 22.2 Hz), 127.1 (C), 128.9 (2 × CH, d, 3JCF 8.8 
Hz), 130.2 (C, d, 4JCF 3.4 Hz), 148.5 (C), 148.7 (C), 149.6 (C), 164.1 (C, d, 1JCF 
252.0 Hz), 165.0 (C); m/z (ESI) 312.0461 (MNa+. C15H12FNNaO2S requires 
312.0465). 
2-Phenyl-5,6-methylenedioxy-1,3-benzothiazole (237e) 
 
2-Phenyl-5,6-methylenedioxy-1,3-benzothiazole (237e) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using N-(3,4-
methylenedioxyphenyl)thiobenzamide (235e) (0.0315 g, 0.122 mmol). Purification 
by flash column chromatography (hexane/diethyl ether, 9:1) gave 2-phenyl-5,6-
methylenedioxy-1,3-benzothiazole (237e) (0.0148 g, 47%) as a white solid. Mp 160–
161 °C; νmax/cm−1 (neat) 2924 (CH), 1456, 1441, 1279, 1190, 1043, 945, 876, 833, 
756; δH (500 MHz, CDCl3) 5.98 (2H, s, OCH2O), 7.17 (1H, s, 7-H), 7.36–7.42 (4H, 
m, 4-H, 3′-H, 4′-H and 5′-H), 7.91–7.95 (2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 
100.2 (CH), 101.8 (CH2), 102.7 (CH), 127.0 (2 × CH), 128.3 (C), 129.0 (2 × CH), 
130.4 (CH), 133.8 (C), 146.9 (C), 148.0 (C), 149.3 (C), 166.4 (C); m/z (ESI) 
256.0428 (MH+. C14H10NO2S requires 256.0427). 
2-(4′-Chlorophenyl)-5,6-methylenedioxy-1,3-benzothiazole (237f) 
 
2-(4′-Chlorophenyl)-5,6-methylenedioxy-1,3-benzothiazole (237f) was synthesised 
as described for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using 4′-chloro-
N-(3,4-methylenedioxyphenyl)thiobenzamide (235f) (0.0425 g, 0.146 mmol) in 
acetonitrile (2.0 mL) and dichloromethane (0.5 mL). Purification by flash column 
chromatography (dichloromethane/hexane, 7:3) gave 2-(4′-chlorophenyl)-5,6-
methylenedioxy-1,3-benzothiazole (237f) (0.0274 g, 65%) as a white solid. Mp 220–
222 °C; νmax/cm−1 (neat) 2897 (CH), 1506, 1456, 1285, 1090, 941, 878, 833, 824; 
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δH (500 MHz, CDCl3) 6.07 (2H, s, OCH2O), 7.25 (1H, s, 7-H), 7.44 (2H, d, J 8.6 Hz, 
3′-H and 5′-H), 7.46 (1H, s, 4-H), 7.94 (2H, d, J 8.6 Hz, 2′-H and 6′-H); δC (126 MHz, 
CDCl3) 100.2 (CH), 101.9 (CH2), 102.7 (CH), 128.1 (2 × CH), 128.3 (C), 129.2 (2 × 
CH), 132.3 (C), 136.4 (C), 147.1 (C), 148.2 (C), 149.2 (C), 164.9 (C); m/z (ESI) 
311.9851 (MNa+. C14H835ClNNaO2S requires 311.9856). 
2-Phenyl-5,6,7-trimethoxy-1,3-benzothiazole (237g)559 
 
2-Phenyl-5,6,7-trimethoxy-1,3-benzothiazole (237g) was synthesised as described 
for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using N-(3,4,5-
trimethoxyphenyl)thiobenzamide (235g) (0.0440 g, 0.145 mmol). Purification by 
flash column chromatography (dichloromethane/hexane, 7:3 to 9:1) gave 2-phenyl-
5,6,7-trimethoxy-1,3-benzothiazole (237g) (0.0156 g, 36%) as a white solid. Mp 65–
67 °C (lit.559 61–63 °C); δH (500 MHz, CDCl3) 3.94 (3H, s, OCH3), 3.96 (3H, s, 
OCH3), 4.11 (3H, s, OCH3), 7.36 (1H, s, 4-H), 7.45–7.51 (3H, m, 3′-H, 4′-H and 5′-
H), 8.02–8.07 (2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 56.3 (CH3), 60.6 (CH3), 
61.5 (CH3), 100.8 (CH), 120.3 (C), 127.2 (2 × CH), 129.0 (2 × CH), 130.7 (CH), 
133.7 (C), 139.8 (C), 146.8 (C), 150.5 (C), 154.0 (C), 168.0 (C); m/z (ESI) 324 
(MNa+. 100%). 
2-Methyl-5,6-dimethoxy-1,3-benzothiazole (237h) 
 
2-Methyl-5,6-dimethoxy-1,3-benzothiazole (237h) was synthesised as described for 
2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using N-(3,4-
dimethoxyphenyl)thioacetamide (235h) (0.0423 g, 0.200 mmol). Purification by flash 
column chromatography (dichloromethane/ethyl acetate, 9:1) gave 2-methyl-5,6-
dimethoxy-1,3-benzothiazole (237h) (0.00710 g, 17%) as a light yellow oil. νmax/cm−1 
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(neat) 2938 (CH), 1479, 1464, 1285, 1223, 1200, 1159, 1061, 831; δH (500 MHz, 
CDCl3) 2.79 (3H, s, 2-CH3), 3.94 (3H, s, OCH3), 3.95 (3H, s, OCH3), 7.24 (1H, s, 7-
H), 7.44 (1H, s, 4-H); δC (126 MHz, CDCl3) 19.9 (CH3), 56.1 (CH3), 56.3 (CH3), 102.5 
(CH), 104.3 (CH), 127.2 (C), 147.6 (C), 148.1 (C), 149.1 (C), 165.0 (C); m/z (ESI) 
210.0587 (MH+. C10H12NO2S requires 210.0583). 
N-(4-methylphenyl)benzamide (234k) 
 
Iron(III) chloride (0.810 mg, 0.00500 mmol) was dissolved in 1-butyl-3-
methylimidazolium bis(trifluoromethanesulfonyl)imide (4.40 µL, 0.0150 mmol) and 
stirred for 0.5 h at room temperature and then added to a solution of N-
bromosuccinimide (0.0178 g, 0.100 mmol) in dichloromethane (1.0 mL). N-(4-
methylphenyl)thiobenzamide (235i) (0.0227 g, 0.100 mmol) in dichloromethane (2.0 
mL) was then added and the mixture was stirred at 40 °C for 2 h. The reaction 
mixture was then cooled to room temperature, diluted with ethyl acetate (20 mL) 
and washed with 1 M aqueous sodium thiosulfate solution (20 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 20 mL) and the combined organic 
extracts were washed with brine (50 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. The crude residue was filtered through a short 
pad of silica, eluting with petroleum ether/ethyl acetate, 7:3, to give N-(4-
methylphenyl)benzamide (235i) (0.0140 g, 67%) as a white solid. Mp 154–156 °C 
(lit. 155–156 °C); δH (400 MHz, CDCl3) 2.34 (3H, s, 4-CH3), 7.17 (2H, d, J 8.0 Hz, 
3-H and 5-H), 7.44–7.60 (5H, m, Ph), 7.80 (1H, br s, NH), 7.86 (2H, d, J 8.0 Hz, 2-
H and 6-H); δC (101 MHz, CDCl3) 20.9 (CH3), 120.5 (2 × CH), 127.1 (2 × CH), 128.6 
(2 × CH), 129.5 (2 × CH), 131.6 (CH), 134.1 (C), 135.0 (C), 135.4 (C), 165.9 (C); 
m/z (ESI) 234 (MNa+. 100%). 
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2-Phenyl-5-methoxy-6-methyl-1,3-benzothiazole (237i) 
 
2-Phenyl-5-methoxy-6-methyl-1,3-benzothiazole (237i) was synthesised as 
described for 2-phenyl-5,6-dimethoxy-1,3-benzothiazole (237a) using N-(3-
methoxy-4-methylphenyl)thiobenzamide (235j) (0.0646 g, 0.250 mmol). Purification 
by flash column chromatography (hexane/dichloromethane, 1:1) gave 2-phenyl-5-
methoxy-6-methyl-1,3-benzothiazole (237i) (0.0238 g, 37%) as a yellow solid. Mp 
156–157 °C; νmax/cm−1 (neat) 3001, 2970 (CH), 1456, 1445, 1279, 1244, 1186, 
1150, 1063, 1007, 997, 826, 760, 687; δH (500 MHz, CDCl3) 2.34 (3H, s, 6-CH3), 
3.93 (3H, s, OCH3), 7.44–7.50 (3H, m, 3′-H, 4′-H and 5′-H), 7.51 (1H, s, 4-H), 7.60 
(1H, s, 7-H), 8.03–8.08 (2H, m, 2′-H and 6′-H); δC (126 MHz, CDCl3) 16.9 (CH3), 
55.6 (CH3), 103.4 (CH), 121.9 (CH), 126.4 (C), 126.4 (C), 127.2 (2 × CH), 129.0 (2 
× CH), 130.6 (CH), 133.9 (C), 153.7 (C), 157.5 (C), 167.7 (C); m/z (ESI) 256.0788 
(MH+. C15H14NOS requires 256.0791).
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Appendix: Chiral and Racemic HPLC Traces for (1′R,2′R)-1′-(3-tert-
Butyldimethylsilyloxy-4-methoxyphenyl)-1′-methyl-2′-phenylethan-2′-ol (168) 
 
Racemate: 
 
Peak Retention Time Area (uAUmin × 100) Area % 
1 10.713 228262 52.877 
2 14.568 203425 47.123 
Enantioselective: 
 
Peak Retention Time Area (uAUmin × 100) Area % 
1 10.648 7580 2.330 
2 14.553 317714 97.670 
 
tBu(Me)2SiO
MeO
Me
OH
